SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Metlife Investors USA Separate Account A, et al. – ‘485BPOS’ on 4/30/04

On:  Friday, 4/30/04, at 11:43am ET   ·   Effective:  5/1/04   ·   Accession #:  1019687-4-941   ·   File #s:  33-37128, 811-03365

Previous ‘485BPOS’:  ‘485BPOS’ on 4/30/04   ·   Next:  ‘485BPOS’ on 7/15/04   ·   Latest:  ‘485BPOS’ on 4/12/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/30/04  Metlife Investors USA Sep Acct A  485BPOS     5/01/04    4:494K                                   Publicease Inc/FA
          Metlife Investors USA Separate Account A

Post-Effective Amendment
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 485BPOS     Post-Effective Amendment                             168    932K 
 3: EX-99.B10   Miscellaneous Exhibit                                  1      6K 
 4: EX-99.B13   Miscellaneous Exhibit                                 12     29K 
 2: EX-99.B9    Miscellaneous Exhibit                                  2±     8K 


485BPOS   —   Post-Effective Amendment
Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
"Metlife Investors Usa Separate Account A
3The Contracts
4Table of Contents
7Separate Account
9Free Look Period
10Fee Tables and Examples
12Fund Expenses
18The Separate Account
19The Funds
22Contract Charges
"Surrender Charge
25Description of the Contracts
"Transfers
26Market Timing
29Annuity Benefits
31Death Benefits
33Federal Tax Considerations
36Other Tax Withholding
37Surrender Charges
63Separate Accounts
99MetLife
162Item 24. Financial Statements and Exhibits
163Item 25. Directors and Officers of the Depositor
164Item 26. Persons Controlled by or Under Common Control With Depositor of Registrant
"Item 27. Number of Contract Owners
"Item 28. Indemnification
"Item 29. Principal Underwriters
166Item 30. Location of Accounts and Records
"Item 31. Management Services
"Item 32. Undertakings
485BPOS1st Page of 168TOCTopPreviousNextBottomJust 1st
 

'33 ACT FILE NO. 033-37128 '40 ACT FILE NO. 811-3365 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM N-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PRE-EFFECTIVE AMENDMENT NO. [ ] POST-EFFECTIVE AMENDMENT NO. 15 [X] AND/OR REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 AMENDMENT NO. 171 [X] (CHECK APPROPRIATE BOX OR BOXES.) METLIFE INVESTORS USA SEPARATE ACCOUNT A (EXACT NAME OF REGISTRANT) METLIFE INVESTORS USA INSURANCE COMPANY (NAME OF DEPOSITOR) 22 CORPORATE PLAZA DRIVE, NEWPORT BEACH, CA 92660 (ADDRESS OF DEPOSITOR'S PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE) DEPOSITOR'S TELEPHONE NUMBER, INCLUDING AREA CODE: 800-989-3752 RICHARD C. PEARSON EXECUTIVE VICE PRESIDENT & GENERAL COUNSEL METLIFE INVESTORS USA INSURANCE COMPANY 22 CORPORATE PLAZA DRIVE, NEWPORT BEACH, CA 92660 (NAME AND ADDRESS OF AGENT FOR SERVICE) IT IS PROPOSED THAT THIS FILING WILL BECOME EFFECTIVE (CHECK APPROPRIATE SPACE) [ ] IMMEDIATELY UPON FILING PURSUANT TO PARAGRAPH (b) OF RULE 485 [x] ON MAY 1, 2004, PURSUANT TO PARAGRAPH (b) OF RULE 485 [ ] 60 DAYS AFTER FILING PURSUANT TO PARAGRAPH (a) OF RULE 485 [ ] ON [DATE] PURSUANT TO PARAGRAPH (a) OF RULE 485 IF APPROPRIATE, CHECK THE FOLLOWING BOX: [ ] THIS POST-EFFECTIVE AMENDMENT DESIGNATES A NEW EFFECTIVE DATE FOR A PREVIOUSLY FILED POST-EFFECTIVE AMENDMENT. Title of Securities Registered: Group Variable Annuity Contracts
485BPOS2nd Page of 168TOC1stPreviousNextBottomJust 2nd
PART A GROUP FLEXIBLE PAYMENT VARIABLE ANNUITY CONTRACTS issued by METLIFE INVESTORS USA SEPARATE ACCOUNT A and METLIFE INVESTORS USA INSURANCE COMPANY ---------------------------------------------------------------------- This Prospectus gives you important information about the group flexible payment fixed and variable annuity contracts issued by MetLife Investors USA Separate Account A (the "Separate Account") by MetLife Investors USA Insurance Company ("MetLife Investors USA) (the "Contracts"). Please read it carefully before you invest and keep it for future reference. The Contracts provide annuity benefits through distributions made from certain retirement plans that qualify for special federal income tax treatment ("qualified plans"). You decide how to allocate your money among the available investment choices. You may choose to allocate your payments to the General Account, which is a fixed account (not described in this Prospectus) that offers an interest rate guaranteed by MetLife Investors USA Insurance Company, or to the Separate Account. The Separate Account, in turn, invests in the following underlying mutual funds: ALGER AMERICAN FUND (Class 0) Small Capitalization Portfolio* AMERICAN FUNDS INSURANCE SERIES (Class 2) Growth Fund Growth-Income Fund Global Small Capitalization Fund FIDELITY VARIABLE INSURANCE PRODUCTS (Initial Class) VIP Asset Manager(SM) Portfolio* VIP Contrafund(R) Portfolio VIP Growth Portfolio VIP Money Market Portfolio VIP Overseas Portfolio** MET INVESTORS SERIES TRUST (Class A) Met/AIM Small Cap Growth Portfolio J.P. Morgan Quality Bond Portfolio Lord Abbett Bond Debenture Portfolio Lord Abbett Growth and Income Portfolio MFS(R) Research International Portfolio PIMCO PEA Innovation Portfolio (formerly PIMCO Innovation Portfolio) PIMCO Total Return Portfolio Third Avenue Small Cap Value Portfolio METROPOLITAN SERIES FUND, INC. (Class A) Davis Venture Value Portfolio FI Mid Cap Opportunities Portfolio Harris Oakmark Focused Value Portfolio Harris Oakmark Large Cap Value Portfolio Lehman Brothers(R) Aggregate Bond Index Portfolio MetLife Mid Cap Stock Index Portfolio MetLife Stock Index Portfolio MFS(r) Total Return Portfolio Morgan Stanley EAFE(R) Index Portfolio Russell 2000(R) Index Portfolio State Street Research Aurora Portfolio State Street Research Bond Income Portfolio State Street Research Large Cap Growth Portfolio (formerly Alger Equity Growth Portfolio) State Street Research Large Cap Value Portfolio T. Rowe Price Small Cap Growth Portfolio
485BPOS3rd Page of 168TOC1stPreviousNextBottomJust 3rd
SCUDDER VARIABLE SERIES I (Class A) International Portfolio* T. ROWE PRICE GROWTH STOCK FUND** *Participant approval to substitute these portfolios was not obtained. **AT THIS TIME, FIDELITY VIP OVERSEAS PORTFOLIO (AVAILABLE IN RETIREMENT COMPANION) AND T. ROWE PRICE GROWTH STOCK FUND ARE NOT AVAILABLE FOR USE WITH CONTRACTS PURCHASED IN CONNECTION WITH 403(B) PLANS. You can choose any combination of these investment choices. Your Participant's Account will vary daily to reflect the investment experience of the funding options selected. These mutual funds are described in detail in the fund prospectuses that are attached to or delivered with this Prospectus. Please read these prospectuses carefully before you invest. The contracts: o are not bank deposits o are not FDIC insured o are not insured by any federal government agency o are not guaranteed by any bank or credit union o may be subject to loss of principal If you would like more information about the Contracts, you can obtain a copy of the Statement of Additional Information ("SAI") dated May 1, 2004. The SAI is legally considered a part of this Prospectus as though it were included in the Prospectus. The Table of Contents of the SAI appears on page ____ of the Prospectus. To request a free copy of the SAI or to ask questions, write or call: MetLife Investors USA Insurance Company 22 Corporate Plaza Drive Newport Beach, CA 92660-7901 Phone: (800) 343-8496 The Securities and Exchange Commission ("SEC") has a website (http://www.sec.gov) which you may visit to view this Prospectus, the SAI, or additional material that also is legally considered a part of this Prospectus, as well as other information. THE SEC HAS NOT APPROVED OR DISAPPROVED THESE SECURITIES NOR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
485BPOS4th Page of 168TOC1stPreviousNextBottomJust 4th
TABLE OF CONTENTS PAGE ---- Glossary Summary of the Contracts Fee Tables and Examples Financial and Performance Information Description of The Insurance Company, The General Account, The Separate Account, The Funds and Service Providers The Insurance Company The General Account The Separate Account The Funds Principal Underwriter Servicing Agent Custodian Contract Charges Premium Taxes Surrender Charge Administrative Fees Transaction Charges Mortality and Expense Risk Charges Distribution Expense Charge (Sales Load) Federal, State and Local Taxes Free Look Period Deferred Compensation Plans Description of the Contracts General Assignment Purchase Payments Transfers Market Timing Loans (403(b) Plans only) Modification of the Contracts Accumulation Period Crediting Accumulation Units in the Separate Account Surrender from the Separate Account Account Statements Annuity Benefits Variable Annuity Payments Election of Annuity Date and Form of Annuity Frequency of Payment Level Payments Varying Annually Annuity Unit Values Death Benefits Death Before the Annuity Date Death After the Annuity Date Federal Tax Considerations Voting Rights Legal Proceedings Additional Information Table of Contents of Statement of Additional Information APPENDIX A - CONDENSED FINANCIAL INFORMATION APPENDIX B - PARTICIPATING INVESTMENT PORTFOLIOS MetLife Investors USA does not intend to offer the Contracts anywhere or to anyone to whom they may not lawfully be offered or sold. MetLife Investors USA has not authorized any information or representations about the Contracts other than the information in this Prospectus, the attached prospectuses, or supplements to the prospectuses or any supplemental sales material MetLife Investors USA authorizes.
485BPOS5th Page of 168TOC1stPreviousNextBottomJust 5th
GLOSSARY These terms have the following meanings when used in this Prospectus: ACCUMULATION UNIT - A measuring unit used to determine the value of your interest in a Separate Account Series under a Contract at any time before Annuity payments commence. ANNUITANT - The person on whose life Annuity payments under a Contract are based. ANNUITY - A series of income payments made to an Annuitant for a defined period of time. ANNUITIZATION or ANNUITY DATE - The date on which Annuity payments begin. ANNUITY UNIT - A measuring unit used to determine the amount of Variable Annuity payments based on a Separate Account Series under a Contract after such payments have commenced. ASSUMED INVESTMENT RETURN - The investment rate selected by the Annuitant for use in determining the Variable Annuity payments. BENEFICIARY - The person who has the right to a Death Benefit upon your death. BUSINESS DAY - Each Monday through Friday except for days the New York Stock Exchange is not open for trading. CERTIFICATE - The form you are given which describes your rights under the Contract. No Certificates are issued for certain deferred compensation or qualified retirement plans. CERTIFICATE DATE - The date you are issued a Certificate. If you are not issued a Certificate, this is the date when your Account is established. CERTIFICATE YEAR - The 12 month period that begins on your Certificate Date and on each anniversary of this date. CONTRACT - The agreement between the Owner and MetLife Investors USA covering your rights. FIXED ANNUITY - An Annuity providing guaranteed level payments. These payments are not based upon the investment experience of the Separate Account. FREE LOOK PERIOD - The 20-day period when you first receive your Contract. During this time period, you may cancel your Contract for a full refund of all Purchase Payments (or the greater of Purchase Payments or the Contract Value in some states). FREE WITHDRAWAL AMOUNT - The amount that can be withdrawn in a Contract Year without incurring a surrender charge. FUND - A diversified, open-end management investment company, or series thereof, registered under the Investment Company Act of 1940 ("1940 Act") which serves as the underlying investment medium for a Series in the Separate Account. GENERAL ACCOUNT - All assets of MetLife Investors USA other than those in the Separate Account or any of its other segregated asset accounts. NORMAL ANNUITY DATE- The date on which Annuity payments begin if you do not select another date. It is the later of the Contract anniversary nearest the Annuitant's 75th birthday or the 10th anniversary of the Contract Date. OWNER - The person who has title to the Contract. PARTICIPANT - You, the person who makes Purchase Payments, or the person for whom Purchase Payments are made. PARTICIPANT'S ACCOUNT - The sum of your interest in the Separate Account Series and your interest in the General Account. Your interest in the Separate Account Series is the sum of the values of the Accumulation Units. Your interest in the General Account is the accumulated value of the amounts allocated to the General Account plus credited interest as guaranteed in the Contract, less any prior withdrawals and/or amounts applied to Annuity options. PLAN - The 403(b) plan, deferred compensation plan, qualified retirement plan, or individual retirement annuity to which the Contract is issued. PURCHASE PAYMENT - The amounts paid by or for you to MetLife Investors USA in order to provide benefits under the Contract.
485BPOS6th Page of 168TOC1stPreviousNextBottomJust 6th
SEPARATE ACCOUNT - The segregated asset account entitled "MetLife Investors USA Separate Account A" which has been established by MetLife Investors USA under Delaware law to receive and invest amounts allocated by you and by other contract owners and to provide Variable Annuity benefits under the Contracts. The Separate Account is registered as a unit investment trust under the 1940 Act. SERIES - The Accumulation Unit values and Annuity Unit values maintained separately for each Fund whose securities are owned by the Separate Account. SURRENDER CHARGE - A percentage charge which is deducted when you fully or partially surrender. The amount varies depending on how long Purchase Payments have been with MetLife Investors USA. VALUATION DATE - Any Business Day used by the Separate Account to determine the value of part or all of its assets for purposes of determining Accumulation and Annuity Unit values for the Contract. Accumulation Unit values will be determined each Business Day. There will be one Valuation Date in each calendar week for Annuity Unit values. MetLife Investors USA will establish the Valuation Date at its discretion, but until notice to the contrary is given, that date will be the last Business Day in a week. VALUATION PERIOD - The period of time from one Valuation Date through the next Valuation Date. VARIABLE ANNUITY - An Annuity providing payments that will vary annually in accordance with the net investment experience of the applicable Separate Account Series. SUMMARY OF THE CONTRACTS THE CONTRACTS The Contracts may be offered to: - Qualified Plans such as: - Section 403(b) tax-sheltered annuities; - Section 457 deferred compensation plans; and - Section 401 pension and profit sharing plans. Note: The dollars in a Qualified Plan are tax deferred. Contracts purchased for use with a Qualified Plan provide no additional tax deferral, and there should be reasons other than tax deferral for purchasing the Contract. THIS PROSPECTUS APPLIES ONLY TO THE VARIABLE PORTION OF THE CONTRACT [SIDE BAR: Please see the section "Federal Tax Considerations" on page ____ for more information.] PURCHASE PAYMENTS Purchase Payments under the Contracts are made to the General Account, the Separate Account, or allocated between them. The minimum Purchase Payment is as little as $20, but there is an annual minimum of $240 (for IRAs, the minimum is $2,000 for an initial Purchase Payment and $500 for each additional payment). There is no initial sales charge; however, the charges and deductions described under "Contract Charges" on page ___ will be deducted from the Participant's Account. Amounts allocated to the General Account may be transferred to the Separate Account subject to certain limitations as to time and amount. Unless you have exercised a special option, the minimum transfer is the lesser of $500 or the balance of your Account in the Series. You can transfer amounts allocated to the Separate Account: - between any of the mutual fund investment choices, at any time and as many times as you choose - to the General Account at any time before the amount has been applied to a variable annuity option See, however, restrictions on transfers in "Description of the Contracts - Market Timing." [SIDE BAR: Please see "Transfers" on page ____ for more information.]
485BPOS7th Page of 168TOC1stPreviousNextBottomJust 7th
SEPARATE ACCOUNT Purchase Payments allocated to the Separate Account are invested at net asset value in Accumulation Units in one or more of 34 Series, each of which invests in one of the following 34 Funds: Funds Investment Advisers ------------------------------------ ------------------------ ALGER AMERICAN FUND (Class 0) Fred Alger Management, Inc. Small Capitalization Portfolio (1) AMERICAN FUNDS INSURANCE SERIES (Class 2) Capital Research and Management Company ("CRM") American Funds Growth Fund American Funds Growth-Income Fund American Global Small Capitalization Fund FIDELITY VARIABLE INSURANCE Fidelity Management & PRODUCTS (Initial Class) Research Co. ("FMR") VIP Asset Manager(SM) Portfolio (1) VIP Contrafund(R) Portfolio VIP Growth Portfolio VIP Money Market Portfolio VIP Overseas Portfolio MET INVESTORS SERIES TRUST (Class A) Met Investors Advisory, LLC ("MIA")(2)(3) Met/AIM Small Cap Growth Portfolio J.P. Morgan Quality Bond Portfolio Lord Abbett Bond Debenture Portfolio Lord Abbett Growth and Income Portfolio MFS(R) Research International Portfolio PIMCO PEA Innovation Portfolio (formerly PIMCO Innovation Portfolio) PIMCO Total Return Portfolio Third Avenue Small Cap Value Portfolio METROPOLITAN SERIES FUND, INC. (Class A) (MetLife Advisers, LLC ("MA") (2)(3) Davis Venture Value Portfolio FI Mid Cap Opportunities Portfolio Harris Oakmark Focused Value Portfolio Harris Oakmark Large Cap Value Portfolio Lehman Brothers(R) Aggregate Bond Index Portfolio MetLife Mid Cap Stock Index Portfolio MetLife Stock Index Portfolio MFS(r) Total Return Portfolio Morgan Stanley EAFE(R) Index Portfolio Russell 2000(R) Index Portfolio State Street Research Aurora Portfolio State Street Research Bond Income Portfolio State Street Research Large Cap Growth Portfolio (formerly Alger Equity Growth Portfolio State Street Research Large Cap Value Portfolio T. Rowe Price Small Cap Growth Portfolio SCUDDER VARIABLE SERIES I Deutsche Investment International Portfolio (1) Management Americas Inc. T. ROWE PRICE GROWTH STOCK FUND Price Associates, Inc. ____________________ Note 1. Participants approval to substitute these portfolios was not obtained. Note 2. These investment advisers have engaged subadvisers to provide investment advice for individual Funds. Note 3. MIA and MA are affiliates of MetLife Investors USA. [SIDE BAR: Please see "The Separate Account" on page ____ and "The Funds" on page ____ for more information.]
485BPOS8th Page of 168TOC1stPreviousNextBottomJust 8th
CHARGES AND DEDUCTIONS The following fees and expenses apply to your Contract: Fee or expense Amount of fee -------------- ------------- DAILY DEDUCTIONS - Distribution expenses .000274% (.10% per year) - Mortality and Expense risks .003425% (1.25% per year) ANNUAL DEDUCTIONS There is an Administrative Fee of $21.50 plus $2.50 for each Series in which you invest. MetLife Investors USA will waive these administrative fees for any Certificate Year during which you contribute $2,000 or more to your account or your Participant's Account has a value at the end of the Certificate Year of $10,000 or more. This reduction is permanent for Certificates issued before the termination or reduction of the waiver. (No such termination or reduction of the waiver is contemplated at this time). TRANSACTION CHARGES A charge of $10 may be deducted for: - A transfer from any Series; - A full or partial surrender (the charge will be no more than 2% of the amount of the surrender); or - Annuitization of all or a part of your Participant's Account. We currently waive the transaction charge for transfers from any Series, but reserve the right to impose the charge in the future. See however restrictions on transfers in "Description of the Contracts - Market Timing." SURRENDER CHARGE (CONTINGENT DEFERRED SALES CHARGE) - Deducted if you request a full 7% of Purchase Payment and amounts or partial withdrawal of credited to it. This charge Purchase Payments from the applies for 60 months after the Separate Account within 60 Purchase Payment is received. months after the Purchase Payment is made. However, for 403(b) plans, we will not deduct any surrender charge once nine (9) full years have elapsed since your Certificate Date; and for the first surrender in each year, you may surrender up to 10% of the value of your interest in the Separate Account without a surrender charge. WITHDRAWALS FROM 403(b) PLANS MAY BE RESTRICTED BY THE INTERNAL REVENUE CODE. The following expenses may be waived for certain deferred compensation plans: - administrative fees - transaction charges - distribution fees - sales charges on certain surrenders PREMIUM TAXES - Payable to a state or government 0% - 3.5% agency with respect to your Contract. It may be deducted on or after the date the tax is incurred. Currently, MetLife Investors USA deducts these taxes upon annuitization. [SIDE BAR: Please see "Contract Charges" on page ___ for more information.]
485BPOS9th Page of 168TOC1stPreviousNextBottomJust 9th
FREE LOOK PERIOD You may cancel your interest in the Contract within 20 days after you receive your Certificate (or longer depending on state law) for a full refund of all Purchase Payments (or the greater of Purchase Payments or the Participant's Account in some states). Purchase Payments allocated to the Separate Account will be initially allocated to the Money Market Portfolio during the Free Look Period. [SIDE BAR: Please see "Free Look Period" on page ____ for more information.] VARIABLE ANNUITY PAYMENTS You select the Annuity Date, an Annuity payment option and an assumed investment return. You may change any of your selections before your Annuity Date. Your monthly Annuity payments will start on the Annuity Date and will vary from year to year based on a comparison of the assumed investment returns you selected with the actual investment experience of the Series in which the Participant's Account is invested. If your monthly payments from a particular Series are less than $50, MetLife Investors USA may change the frequency of your payments so that each payment will be at least $50 from that Series. SURRENDER You may surrender all or part of your Participant's Account before the Annuity Date. You may not make a partial withdrawal if: - it would cause your interest in any Series of the General Account to fall below $200 (unless you are surrendering your entire interest in a Series) However, if you are withdrawing the entire amount allocated to a Series; these restrictions do not apply. You may be assessed a surrender charge. In addition, any amounts surrendered will be taxed as ordinary income and may be subject to a penalty tax under the Internal Revenue Code. Certain restrictions apply for qualified contracts. [SIDE BAR: Please see "Surrender Charge" on page ___ and "Federal Tax Considerations" on page ___ for more information.] LOANS - 403(b) PLANS ONLY You may be able to obtain a loan from the portion of your Account allocated to the General Account. Loan proceeds may be considered taxable distributions under the Internal Revenue Code in the event of a default in repayments. MetLife Investors USA may: -- terminate loans -- change the terms under which loans are made Any action taken by MetLife Investors USA would not affect outstanding loans. DEATH BENEFIT You name your Beneficiary(ies). If you die before attaining age 65 and prior to the Annuity Date, the amount of any lump sum settlement will be the greater of: - the total of all Purchase Payments less any partial withdrawals; or - the value of the Participant's Account at settlement. If the death occurs on or after age 65, the death benefit will be equal to the Participant's Account.
485BPOS10th Page of 168TOC1stPreviousNextBottomJust 10th
STATE VARIATIONS Contracts issued in your state may provide different features and benefits from, and impose different costs than, those described in this prospectus. This prospectus provides a general description of the Contract. Your actual Certificate and any endorsements are the controlling documents. If you would like to review a copy of the Contract and endorsements, contact our administrative offices. [SIDE BAR: Please see "Death Benefits" on page ____ for more information.] MARKET TIMING MetLife Investors USA has adopted policies and procedures that attempt to detect transfer activity that may adversely affect Participants and the Funds. Upon detection of this activity, restrictions may be imposed on transfers. [SIDE BAR: Please see "Description of the Contracts - Market Timing" on page ___ for more information. FEE TABLES AND EXAMPLES THE FOLLOWING TABLES DESCRIBE THE FEES AND EXPENSES THAT YOU WILL PAY WHEN BUYING, OWNING, AND SURRENDERING THE CONTRACT. THE FIRST TABLE DESCRIBES THE FEES AND EXPENSES THAT YOU WILL PAY AT THE TIME THAT YOU BUY THE CONTRACT, SURRENDER THE CONTRACT, OR TRANSFER CASH VALUE BETWEEN INVESTMENT OPTIONS. STATE PREMIUM TAXES MAY ALSO BE DEDUCTED. _________________________________________________________________________ PARTICIPANT TRANSACTION EXPENSES TABLE SURRENDER CHARGE (Note 1) 7% [as a percentage of amounts accumulated with respect to a purchase payment, including earnings or losses credited to the purchase payment) TRANSACTION CHARGE (Note 2) (each surrender and annuitization) $10 TRANSFER FEE (Note 3) $10 per transfer __________________________________________________________________________ Note 1. Surrender charges decline based on date of purchase payment. (See Expenses - Surrender Charge) Number of Complete months from Receipt of Purchase Payment % Charge --------------------------- -------- 60 months or less 7 More than 60 months 0
485BPOS11th Page of 168TOC1stPreviousNextBottomJust 11th
Amounts surrendered are attributed to Purchase Payments made (and any accumulation) on a first-in, first-out basis. Note 2. In the event of a surrender, the charge is the lesser of $10 or 2% of the amount surrendered. Note 3. This fee applies to each transfer from a Series. We currently waive this charge THE NEXT TABLES DESCRIBE THE FEES AND EXPENSES THAT YOU WILL PAY PERIODICALLY DURING THE TIME THAT YOU OWN THE CONTRACT, NOT INCLUDING FUND FEES AND EXPENSES. ___________________________________________________________________________ PERIODIC FEES AND EXPENSES TABLE ADMINISTRATIVE CHARGE (Note 1) $21.50 plus (deducted annually) $2.50 for each Series SEPARATE ACCOUNT ANNUAL EXPENSES (referred to as Separate Account Product Charges) (as a percentage of average account value in the Separate Account) Mortality and Expense Charge 1.25% Distribution Expense Charge 0.10% ----- Total Separate Account Annual Expenses 1.35% ________________________________________________________________________________ Note 1. The Administrative Charge is currently waived if you make purchase payments of $2,000 or more in a Certificate Year or if your Series Participant's Account value is $10,000 or more at the end of the Certificate Year. THE NEXT TABLE SHOWS THE MINIMUM AND MAXIMUM TOTAL OPERATING EXPENSES CHARGED BY THE FUNDS THAT YOU MAY PAY PERIODICALLY DURING THE TIME THAT YOU OWN THE CONTRACT. MORE DETAIL CONCERNING EACH FUND'S FEES AND EXPENSES IS CONTAINED IN THE PROSPECTUSES FOR THE FUNDS AND IN THE FOLLOWING TABLES. Total Annual Fund Minimum Maximum Operating Expenses 0.29% 1.26% (expenses that are deducted from Fund assets, including management fees, 12b-1/service fees, and other expenses)
485BPOS12th Page of 168TOC1stPreviousNextBottomJust 12th
[Enlarge/Download Table] FUND EXPENSES (as a percentage of the average daily net assets of a Fund) The following table is a summary. For more complete information on Fund fees and expenses, please refer to the prospectus for each Fund. FIDELITY AMERICAN Global VARIABLE ALGER Small FUNDS Small INSURANCE AMERICAN Capital- INSURANCE Growth- Capital- PRODUCTS VIP Asset VIP VIP FUND ization SERIES Growth Income ization (INITIAL Manager(SM) Contrafund(R) Growth (CLASS O) Portfolio (CLASS 2) Fund Fund Fund CLASS) Portfolio Portfolio Portfolio --------- --------- --------- ---- ---- ---- ------ --------- --------- -------- Management Fees 0.85% 0.37% 0.33% 0.80% 0.53% 0.58% 0.58% 12b-1/Service Fees 0.00% 0.25% 0.25% 0.25% 0.00% 0.00% 0.00% Other Expenses(1) 0.12% 0.02% 0.01% 0.03% 0.10% 0.09% 0.09% Total Annual Portfolio Expenses 0.97% 0.64% 0.59% 1.08% 0.63% 0.67% 0.67% ------------------------------------------------------------------------------------------------------------------------------------ Contractual Expense Subsidy or Deferral 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% ------------------------------------------------------------------------------------------------------------------------------------ Net Total Annual Portfolio Expense(2) 0.97% 0.64% 0.59% 1.08% 0.63% 0.67% 0.67% ------------------------------------------------------------------------------------------------------------------------------------ (1) Other Expenses may include amounts repaid to investment advisers or managers pursuant to contractual arrangements for prior waivers or payment of portfolio expenses. The amounts repaid per portfolio are: 0.03% for the Lord Abbett Bond Debenture Portfolio; 0.02% for the PIMCO Total Return Portfolio; and 0.01% for the Third Avenue Small Cap Value Portfolio. (2) The Net Total Annual Portfolio Expenses have been restated to reflect contractual arrangements in effect as of May 1, 2004, under which investment advisers or managers of Funds have agreed to waive and/or pay expenses of the portfolios. Each of these arrangements terminates on April 30, 2005 (excluding optional extensions). Net Total Annual Portfolio Expenses have not been restated to reflect expense reductions that certain Funds achieved as a result of directed brokerage arrangements. The Funds provided the information on their expenses, and we have not independently verified the information. Unless otherwise indicated, the information provided is for the year ended December 31, 2003. continued below: ====================================================================================================================================
485BPOS13th Page of 168TOC1stPreviousNextBottomJust 13th
continued from above: MET J.P. Lord Lord MFS(R) VIP INVESTORS Met/AIM Morgan Abbett Abbett Research Money VIP SERIES Small Cap Quality Bond Growth and Inter- PIMCO PEA Market Overseas TRUST Growth Bond Debenture Income national Innovation Portfolio Portfolio (CLASS A) Portfolio Portfolio Portfolio Portfolio Portfolio Portfolio --------- --------- --------- --------- --------- --------- --------- --------- --------- Management Fees 0.20% 0.73% 0.90% 0.52% 0.60% 0.56% 0.80% 0.95% 12b-1/Service Fees 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% Other Expenses(1) 0.09% 0.17% 0.26% 0.15% 0.10% 0.06% 0.31% 0.31% Total Annual Portfolio Expenses 0.29% 0.90% 1.16% 0.67% 0.70% 0.62% 1.11% 1.26% ------------------------------------------------------------------------------------------------------------------------------------ Contractual Expense Subsidy or Deferral 0.00% 0.00% 0.12% 0.00% 0.00% 0.00% 0.02% 0.16% ------------------------------------------------------------------------------------------------------------------------------------ Net Total Annual Portfolio Expense(2) 0.29% 0.90% 1.04% 0.67% 0.70% 0.62% 1.09% 1.10% ------------------------------------------------------------------------------------------------------------------------------------ (1) Other Expenses may include amounts repaid to investment advisers or managers pursuant to contractual arrangements for prior waivers or payment of portfolio expenses. The amounts repaid per portfolio are: 0.03% for the Lord Abbett Bond Debenture Portfolio; 0.02% for the PIMCO Total Return Portfolio; and 0.01% for the Third Avenue Small Cap Value Portfolio. (2) The Net Total Annual Portfolio Expenses have been restated to reflect contractual arrangements in effect as of May 1, 2004, under which investment advisers or managers of Funds have agreed to waive and/or pay expenses of the portfolios. Each of these arrangements terminates on April 30, 2005 (excluding optional extensions). Net Total Annual Portfolio Expenses have not been restated to reflect expense reductions that certain investment portfolios achieved as a result of directed brokerage arrangements. The Funds provided the information on their expenses, and we have not independently verified the information. Unless otherwise indicated, the information provided is for the year ended December 31, 2003. continued below: ====================================================================================================================================
485BPOS14th Page of 168TOC1stPreviousNextBottomJust 14th
continued from above: Third FI Harris Harris Lehman MetLife PIMCO Avenue METROPOLITAN Davis Mid Cap Oakmark Oakmark Brothers(R) Mid Cap Total Small Cap SERIES Venture Oppor- Focused Large Cap Aggregate Stock Return Value FUND, INC. Value tunities Value Value Bond Index Index Portfolio Portfolio (CLASS A) Portfolio Portfolio Portfolio Portfolio Portfolio Portfolio --------- --------- --------- --------- --------- --------- --------- --------- --------- Management Fees 0.50% 0.75% 0.74% 0.69% 0.75% 0.74% 0.25% 0.25% 12b-1/Service Fees 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% Other Expenses(1) 0.09% 0.18% 0.05% 0.08% 0.05% 0.09% 0.09% 0.15% Total Annual Portfolio Expenses 0.59% 0.93% 0.79% 0.77% 0.80% 0.83% 0.34% 0.40% ------------------------------------------------------------------------------------------------------------------------------------ Contractual Expense Subsidy or Deferral 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% ------------------------------------------------------------------------------------------------------------------------------------ Net Total Annual Portfolio Expense(2) 0.59% 0.93% 0.79% 0.77% 0.80% 0.83% 0.34% 0.40% ------------------------------------------------------------------------------------------------------------------------------------ (1) Other Expenses may include amounts repaid to investment advisers or managers pursuant to contractual arrangements for prior waivers or payment of portfolio expenses. The amounts repaid per portfolio are: 0.03% for the Lord Abbett Bond Debenture Portfolio; 0.02% for the PIMCO Total Return Portfolio; and 0.01% for the Third Avenue Small Cap Value Portfolio. (2) The Net Total Annual Portfolio Expenses have been restated to reflect contractual arrangements in effect as of May 1, 2004, under which investment advisers or managers of Funds have agreed to waive and/or pay expenses of the portfolios. Each of these arrangements terminates on April 30, 2005 (excluding optional extensions). Net Total Annual Portfolio Expenses have not been restated to reflect expense reductions that certain investment portfolios achieved as a result of directed brokerage arrangements. The Funds provided the information on their expenses, and we have not independently verified the information. Unless otherwise indicated, the information provided is for the year ended December 31, 2003. continued below: ====================================================================================================================================
485BPOS15th Page of 168TOC1stPreviousNextBottomJust 15th
continued from above: State State State Morgan State Street Street Street T. Rowe MetLife MFS(R) Stanley Russell Street Research Research Research Price Stock Total EAFE(R) 2000(R) Research Bond Large Cap Large Cap Small Cap Index Return Index Index Aurora Income Growth Value Growth Portfolio Portfolio Portfolio Portfolio Portfolio Portfolio Portfolio Portfolio Portfolio --------- --------- --------- --------- --------- --------- --------- --------- --------- Management Fees 0.25% 0.50% 0.30% 0.25% 0.85% 0.40% 0.73% 0.70% 0.52% 12b-1/Service Fees 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% Other Expenses(1) 0.06% 0.19% 0.41% 0.22% 0.08% 0.07% 0.07% 0.35% 0.11% Total Annual Portfolio Expenses 0.31% 0.69% 0.71% 0.47% 0.93% 0.47% 0.80% 1.05% 0.63% ------------------------------------------------------------------------------------------------------------------------------------ Contractual Expense Subsidy or Deferral 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.10% 0.00% ------------------------------------------------------------------------------------------------------------------------------------ Net Total Annual Portfolio Expense(2) 0.31% 0.69% 0.71% 0.47% 0.93% 0.47% 0.80% 0.95% 0.63% ------------------------------------------------------------------------------------------------------------------------------------ (1) Other Expenses may include amounts repaid to investment advisers or managers pursuant to contractual arrangements for prior waivers or payment of portfolio expenses. The amounts repaid per portfolio are: 0.03% for the Lord Abbett Bond Debenture Portfolio; 0.02% for the PIMCO Total Return Portfolio; and 0.01% for the Third Avenue Small Cap Value Portfolio. (2) The Net Total Annual Portfolio Expenses have been restated to reflect contractual arrangements in effect as of May 1, 2004, under which investment advisers or managers of Funds have agreed to waive and/or pay expenses of the portfolios. Each of these arrangements terminates on April 30, 2005 (excluding optional extensions). Net Total Annual Portfolio Expenses have not been restated to reflect expense reductions that certain investment portfolios achieved as a result of directed brokerage arrangements. The Funds provided the information on their expenses, and we have not independently verified the information. Unless otherwise indicated, the information provided is for the year ended December 31, 2003. continued below: ====================================================================================================================================
485BPOS16th Page of 168TOC1stPreviousNextBottomJust 16th
continued from above: T. Rowe SCUDDER Price VARIABLE Growth SERIES I International T. ROWE Stock (CLASS A) Portfolio PRICE Fund --------- --------- ----- ---- Management Fees 0.88% 0.57% 12b-1/Service Fees 0.00% 0.00% Other Expenses(1) 0.17% 0.20% Total Annual Portfolio Expenses 1.05% 0.77% -------------------------------------------------------------------------------- Contractual Expense Subsidy or Deferral 0.00% 0.00% -------------------------------------------------------------------------------- Net Total Annual Portfolio Expense(2) 1.05% 0.77% -------------------------------------------------------------------------------- (1) Other Expenses may include amounts repaid to investment advisers or managers pursuant to contractual arrangements for prior waivers or payment of portfolio expenses. The amounts repaid per portfolio are: 0.03% for the Lord Abbett Bond Debenture Portfolio; 0.02% for the PIMCO Total Return Portfolio; and 0.01% for the Third Avenue Small Cap Value Portfolio. (2) The Net Total Annual Portfolio Expenses have been restated to reflect contractual arrangements in effect as of May 1, 2004, under which investment advisers or managers of Funds have agreed to waive and/or pay expenses of the portfolios. Each of these arrangements terminates on April 30, 2005 (excluding optional extensions). Net Total Annual Portfolio Expenses have not been restated to reflect expense reductions that certain investment portfolios achieved as a result of directed brokerage arrangements. The Funds provided the information on their expenses, and we have not independently verified the information. Unless otherwise indicated, the information provided is for the year ended December 31, 2003. ================================================================================
485BPOS17th Page of 168TOC1stPreviousNextBottomJust 17th
EXAMPLES THESE EXAMPLES ARE INTENDED TO HELP YOU COMPARE THE COST OF INVESTING IN THE CONTRACT WITH THE COST OF INVESTING IN OTHER VARIABLE ANNUITY CONTRACTS. THESE COSTS INCLUDE CONTRACT OWNER TRANSACTION EXPENSES, CONTRACT FEES, SEPARATE ACCOUNT ANNUAL EXPENSES, AND FUND FEES AND EXPENSES. THE EXAMPLES ASSUME THAT YOU INVEST $10,000 IN THE CONTRACT FOR THE TIME PERIODS INDICATED. THE EXAMPLES ALSO ASSUME THAT YOUR INVESTMENT HAS A 5% RETURN EACH YEAR AND ASSUME THE: A) MAXIMUM AND (B) MINIMUM FEES AND EXPENSES OF ANY OF THE FUNDS (BEFORE REIMBURSEMENT AND/OR WAIVER). ALTHOUGH YOUR ACTUAL COSTS MAY BE HIGHER OR LOWER, BASED ON THESE ASSUMPTIONS, YOUR COSTS WOULD BE: (1) IF YOU SURRENDER YOUR CONTRACT AT THE END OF THE APPLICABLE TIME PERIOD: TIME TIME TIME TIME 1 YEAR 3 YEAR 5 YEAR 10 YEAR (a) 990.25 (a) 1,495.24 (a) 2,098.58 (a) 2,941.93 (b) 899.93 (b) 1,221.60 (b) 1,641.93 (b) 1,949.07 (2) IF YOU DO NOT SURRENDER YOUR CONTRACT: TIME TIME TIME TIME 1 YEAR 3 YEAR 5 YEAR 10 YEAR (a) 264.20 (a) 810.90 (a) 1,382.97 (a) 2,931.93 (b) 166.90 (b) 517.35 (b) 891.25 (b) 1,939.07 (3) IF YOU ANNUITIZE AT THE END OF THE APPLICABLE TIME PERIOD: TIME TIME TIME TIME 1 YEAR 3 YEAR 5 YEAR 10 YEAR (a) 274.20 (a) 820.90 (a) 1,392.97 (a) 2,941.93 (b) 176.90 (b) 527.35 (b) 901.25 (b) 1,949.07 The Examples should not be considered a representation of past or future expenses or annual rates of return of any Fund. Actual expenses and annual rates of return may be more or less than those assumed for the purpose of the examples. FINANCIAL AND PERFORMANCE INFORMATION PERFORMANCE INFORMATION We periodically advertise subaccount performance relating to the various Funds. We will calculate performance by determining the percentage change in the value of an accumulation unit by dividing the increase (decrease) for that unit by the value of the accumulation unit at the beginning of the period. This performance number reflects the deduction of the Separate Account product charges and the Fund expenses. It does not reflect the deduction of any applicable transaction or transfer fee or surrender charge. The deduction of these charges would reduce the percentage increase or make greater any percentage decrease. Any advertisement will also include total return figures which reflect the deduction of the Separate Account product charges, account fees, surrender charges and the transaction or transfer expenses. For periods starting prior to the date the Contract was first offered, the performance will be based on the historical performance of the corresponding Funds for the periods commencing from the date on which the particular Fund was made available through the Separate Account. In addition, for certain Funds performance may be shown for the period commencing from the inception date of the Fund. These figures should not be interpreted to reflect actual historical performance of the Separate Account. We may, from time to time, include in our advertising and sales materials, performance information for funds or investment accounts related to the Funds and/or their investment advisers or subadvisers. Such related performance information also may reflect the deduction of certain contract charges. We may also include in our advertising and sales materials, tax deferred compounding charts and other hypothetical illustrations, which may include comparisons of currently taxable and tax deferred investment programs, based on selected tax brackets.
485BPOS18th Page of 168TOC1stPreviousNextBottomJust 18th
[SIDE BAR: All performance numbers are based upon historical earnings. These numbers are not intended to indicate future results. Yields and average annual total returns are determined in accordance with the computation methods required by the Securities and Exchange Commission (the "SEC") in the Form N-4 Registration Statement. These methods are described in detail in the Statement of Additional Information.] FINANCIAL INFORMATION Financial Statements of the Separate Account and MetLife Investors USA are contained in the Statement of Additional Information. Please see the first page of this Prospectus for information on how to obtain a copy of the Statement. DESCRIPTION OF METLIFE INVESTORS USA INSURANCE COMPANY, THE GENERAL ACCOUNT, THE SEPARATE ACCOUNT, THE FUNDS AND SERVICE PROVIDERS THE INSURANCE COMPANY MetLife Investors USA Insurance Company (MetLife Investors USA) is a stock life insurance company founded on September 13, 1960, and organized under the laws of the State of Delaware. Its principal executive offices are located at 22 Corporate Plaza Drive, Newport Beach, California 92660. MetLife Investors USA is authorized to transact the business of life insurance, including annuities, and is currently licensed to do business in all states except New York and in the District of Columbia. MetLife Investors USA is a wholly-owned subsidiary of MetLife Investors Group, Inc. ("MLIG"). We changed our name to MetLife Investors USA Insurance Company on February 12, 2001. On December 31, 2002, MetLife Investors USA became an indirect subsidiary of MetLife, Inc. (MetLife), the holding company of Metropolitan Life Insurance Company and a listed company on the New York Stock Exchange. MetLife is a leading provider of insurance and financial products and services to individual and group customers. We are a member of the Insurance Marketplace Standards Association ("IMSA"). Companies that belong to IMSA subscribe to a set of ethical standards covering the various aspects of sales and service for individually sold life insurance and annuities. THE GENERAL ACCOUNT All of the assets of MetLife Investors USA, except for those in the Separate Account and other segregated asset accounts, make up the assets of the General Account. You may allocate amounts to the General Account when you purchase your Contract or you may transfer amounts from the Separate Account at a later date. Amounts allocated to the General Account are credited with interest at an interest rate that is guaranteed by MetLife Investors USA. Instead of you bearing the risk of fluctuations in the value of the assets as is the case for amounts invested in the Separate Account, MetLife Investors USA bears the full investment risk for amounts in the General Account. MetLife Investors USA has sole discretion to invest the assets of the General Account, subject to applicable law. THE GENERAL ACCOUNT PROVISIONS OF THE CONTRACT ARE NOT INTENDED TO BE OFFERED BY THIS PROSPECTUS. Please see the terms of your Certificate for more information. THE SEPARATE ACCOUNT MetLife Investors USA established the Separate Account on May 29, 1980, in accordance with the Delaware Insurance Code. The purpose of the Separate Account is to hold the variable assets that underlie the Contracts and some other variable annuity contracts that MetLife Investors USA offers. The Separate Account is registered with the SEC as a unit investment trust under the 1940 Act. The assets of the Separate Account are held in MetLife Investors USA's name on behalf of the Separate Account and legally belong to MetLife Investors USA. Although the Separate Account, and each of the Series that make up the Separate Account, are considered as part of MetLife Investors USA's general business, the Separate Account's assets are solely for the benefit of those who invest in the Separate Account and no one else, including MetLife Investors USA's creditors. All the income, gains and losses (realized and unrealized) resulting from these assets are credited to or charged against the Contracts issued from this Separate Account without regard to MetLife Investors USA's other business. Under state law and the terms of the Contract, the assets of the Separate Account will not be responsible for liabilities arising out of MetLife Investors USA's other business. Furthermore, MetLife Investors USA is obligated to pay all money it owes under the Contracts even if that amount exceeds the assets in the Separate Account. However, the amount of these payments is guaranteed only to the extent of the level amount calculated at the beginning of each annuity year.
485BPOS19th Page of 168TOC1stPreviousNextBottomJust 19th
The Separate Account is divided into a number of investment Series of Accumulation and Annuity Units. Thirty- four of these Series are available under the Contracts as investment choices. Each Series invests in the shares of only one of the Funds. THE FUNDS The following Funds are available as investment options under the contract. You should read the prospectuses for these funds carefully. Copies of these prospectuses will accompany or precede the delivery of your contract. You can obtain copies of the fund prospectuses by calling or writing to us at: MetLife Investors USA Insurance Company, P.O. Box 46539, Denver, CO 80201-6539, (800) 238-4536. Certain Funds described in the portfolio prospectuses may not be available with your contract. Appendix B contains a summary of investment objectives and the names of the subadviser, if any, for each Fund. THE ALGER AMERICAN FUND The Alger American Fund is a mutual fund with multiple portfolios. Fred Alger Management, Inc. is the investment adviser to the fund. The following Class O portfolio is available under the Contract: Small Capitalization Portfolio (1) AMERICAN FUNDS INSURANCE SERIES(R) American Funds Insurance Series(r) is a mutual fund with multiple series, three of which are offered under the contract. Capital Research and Management Company is the investment adviser to each series. The following Class 2 portfolios are available under the Contract: Growth Fund Growth-Income Fund Global Small Capitalization Fund FIDELITY VARIABLE INSURANCE PRODUCTS Fidelity Variable Insurance Products is a mutual fund with multiple portfolios, five of which are offered under the contract. Fidelity Management & Research Company (FMR) is the investment adviser to each of the portfolios. The following Initial Class portfolios are available under the Contract: VIP Asset Manager(SM) Portfolio (1) VIP Contrafund(R) Portfolio VIP Growth Portfolio VIP Money Market Portfolio VIP Overseas Portfolio (2) MET INVESTORS SERIES TRUST Met Investors Series Trust is a mutual fund with multiple portfolios. Met Investors Advisory, LLC (Met Investors Advisory), an affiliate of MetLife Investors USA, is the investment manager of Met Investors Series Trust. Met Investors Advisory has engaged subadvisers to provide investment advice for the individual portfolios. The following Class A portfolios are available under the Contract: Met/AIM Small Cap Growth Portfolio J.P. Morgan Quality Bond Portfolio Lord Abbett Bond Debenture Portfolio Lord Abbett Growth and Income Portfolio MFS(R) Research International Portfolio PIMCO PEA Innovation Portfolio (formerly PIMCO Innovation Portfolio) PIMCO Total Return Portfolio Third Avenue Small Cap Value Portfolio
485BPOS20th Page of 168TOC1stPreviousNextBottomJust 20th
METROPOLITAN SERIES FUND, INC. Metropolitan Series Fund, Inc. is a mutual fund with multiple portfolios. MetLife Advisers, LLC (MetLife Advisers) is the investment adviser for all of the portfolios. MetLife Advisers is an affiliate of MetLife Investors USA, MetLife Advisers has engaged subadvisers to provide investment advice for the individual portfolios. The following Class A portfolios are available under the Contract: Davis Venture Value Portfolio FI Mid-Cap Opportunities Portfolio Harris Oakmark Focused Value Portfolio Harris Oakmark Large Cap Value Portfolio Lehman Brothers(R) Aggregate Bond Index Portfolio MetLife Mid-Cap Stock Index Portfolio MetLife Stock Index Portfolio MFS(r) Total Return Portfolio Morgan Stanley EAFE(R) Index Portfolio Russell 2000(R) Index Portfolio State Street Research Aurora Portfolio State Street Research Bond Income Portfolio State Street Research Large Cap Growth (formerly Alger Equity Growth Portfolio) State Street Research Large Cap Value Portfolio T. Rowe Price Small Cap Growth Portfolio SCUDDER VARIABLE SERIES I The Scudder Variable Series I is a mutual fund with multiple portfolios, one of which is offered under this contract. Deutsche Investment Management Americas Inc. ("DeIM") is the investment adviser for the portfolio. The following Class A portfolio is available under the Contract: International Portfolio (1) T. ROWE PRICE GROWTH STOCK FUND The T. Rowe Price Growth Stock Fund is a mutual fund. T. Rowe Price Associates is the investment manager for the fund. (2) (1) Participant approval to substitute these portfolios was not obtained. (2) Not available for 403(b) Plans Each Series buys and sells shares of the corresponding Fund. These Funds invest in stocks, bonds and other investments. All dividends declared by the Funds are earned by the Separate Account and reinvested. Therefore, no dividends are distributed to you under the Contract. Instead, dividends generally increase the Accumulation or Annuity Unit Value. You pay no transaction expenses (i.e., front-end or back-end load sales charges) as a result of the Separate Account's purchase or sale of these Fund shares. The Funds listed above are available only by purchasing annuities and life insurance policies offered by MetLife Investors USA or by other insurance companies and are never sold directly to the public. The shares of each Fund are purchased, without sales charge, for the corresponding Series at the next net asset value per share determined by a Fund after your payment is received by MetLife Investors USA. Fund shares will be redeemed by the Series to the extent necessary for MetLife Investors USA to make annuity or other payments under the Contracts. Each of the Funds is a portfolio or series of an open-end management investment company registered with the SEC under the 1940 Act. Registration does not involve supervision by the SEC of the investment or investment policies of the Funds. There can be no guarantee that a Fund will meet its investment objectives. An investment adviser or subadviser of a Fund or its affiliates may compensate MetLife Investors USA and/or certain affiliates for administrative or other services relating to the Funds. The amount of this compensation is based on a percentage of assets of the Funds attributable to the Contracts and certain other variable insurance products that we and our affiliates issue. These percentages differ and some advisers (or other affiliates) may pay us more than others. These percentages currently range up to 0.40% of assets.
485BPOS21st Page of 168TOC1stPreviousNextBottomJust 21st
The Funds are available to other registered separate accounts offering variable annuity and variable life products in addition to MetLife Investors USA's Separate Account. In the future, a conflict may develop between one or more separate accounts invested in the same Fund. The conflict could develop due to change in the law affecting variable annuity products or from differences in voting instructions of owners of the different separate accounts. MetLife Investors USA monitors the Series for this type of conflict and will remedy the situation if such a conflict develops. This may include the withdrawal of amounts invested in the Funds by you and other Participants and Contract Owners. [SIDE BAR: While the Series and their comparably named Funds may have names, investment objectives and management which are identical or similar to publicly available mutual funds, these are not those mutual funds. The Funds most likely will not have the same performance experience as any publicly available mutual fund.] SUBSTITUTION OF FUND SHARES MetLife Investors USA may substitute shares of another fund for fund shares directly purchased and apply future Purchase Payments under the Contracts to the purchase of these substituted shares if the shares of a Fund are no longer available or further investment in such shares is determined to be inappropriate by MetLife Investors USA's management in view of the purposes of the Contracts. The substituted fund may have different fees and expenses. However, no substitution is allowed unless a majority of the persons entitled to vote (those who have invested in the Series) and the SEC approve the substitution. Furthermore, we may close Funds to allocation of purchase payments or Contract value, or both, at any time in our sole discretion. [SIDE BAR: The Funds are more fully described in the Fund prospectuses and their Statements of Additional Information. PRINCIPAL UNDERWRITER MetLife Investors Distribution Company (" Distributor"), 22 Corporate Plaza Drive, Newport Beach, California 92660, a broker-dealer registered under the Securities Exchange Act of 1934 and a member of the National Association of Securities Dealers, Inc., is the principal underwriter for the Contracts. Distributor is a Delaware corporation and a subsidiary of MLIG. MetLife Investors USA has entered into a distribution agreement with MetLife Investors Distribution Company, for the distribution of the Certificates. Distributor and we have entered into a selling agreement with another broker-dealer ("selling firm") for the sale of Certificates. We pay compensation to Distributor for sales of the Contracts and Certificates by the selling firm. Certain Funds (see "Fee Tables and Examples - Fund Expenses" and the Fund prospectuses) make payments to Distributor under their distribution plans in consideration of services provided and expenses incurred by Distributor in distributing shares of Funds. These payments range up to 0.25% of Separate Account assets invested in the particular Fund. We pay amounts to Distributor that may be used for its operating and other expenses, including the following sales expenses: compensation and bonuses for the Distributor's management team, advertising expenses, and other expenses of distributing the contracts. Distributor's management team also may be eligible for non-cash compensation items that we may provide jointly with Distributor. Non-cash items include conferences, seminars and trips (including travel, lodging and meals in connection therewith), entertainment, merchandise and other similar items. The maximum commission payable for contract sales by the selling firm is 8.5% of purchase payments. Because registered representatives of the selling firm are also agents thereof, they are eligible for various cash benefits, such as bonuses, insurance benefits and financing arrangements, and non-cash compensation programs that the selling firm offers, such as conferences, trips, prizes, and awards. In addition, the selling firm's sales representatives who meet certain productivity, persistency, and length of service standards and/or their managers may be eligible for additional compensation. Other payments may be made for other services that do not directly involve the sale of the Contracts and Certificates. These services may include the recruitment and training of personnel, production of promotional literature, and similar services. Commissions and other incentives or payments described above are not charged directly to Participants or the Separate Account. We intend to recoup commissions and other sales expenses through fees and charges deducted under the Contracts and Certificates or from our general account.
485BPOS22nd Page of 168TOC1stPreviousNextBottomJust 22nd
SERVICING AGENT MetLife Group, Inc. and Metropolitan Life Insurance Company provide MetLife Investors USA with personnel and administrative services, including: officers, office space, supplies, utilities, office equipment, travel expenses and periodic reports. CUSTODIAN MetLife Investors USA is the custodian of the assets of the Separate Account. The assets of each Series will be physically segregated by MetLife Investors USA and held separate from the assets of the other Series and of any other firm, person or corporation. The assets of the Separate Account are further protected by fidelity bonds which cover all of MetLife Investors USA's officers and employees. CONTRACT CHARGES MetLife Investors USA deducts the charges described below, and we may also deduct a charge for taxes, if applicable. Unless otherwise specified, charges are deducted proportionately from all funding options in which you are invested. These charges may not be changed under the Contract, and MetLife Investors USA may profit from these charges in the aggregate. PREMIUM TAXES Some states assess premium taxes on the Purchase Payments you make. Generally, premium taxes range from 0% to 3.5%, depending on the state. The Contracts permit MetLife Investors USA to deduct any applicable premium taxes from the Participant's Account at or after the time they are incurred. MetLife Investors USA currently does not deduct for these taxes at the time you make a Purchase Payment. However, MetLife Investors USA reserves our right to deduct the total amount of premium taxes, if any, from the Participant's Account when you elect to begin receiving Annuity payments (Annuitization). SURRENDER CHARGE No sales charge is deducted from any Purchase Payment. However, a surrender charge (contingent deferred sales charge) may be imposed on a partial or full surrender of the Participant's Account. During the accumulation phase, you can withdraw part or all of the Participant's Account. For 403(b) Plans only, in the first surrender of each calendar year, you may surrender up to 10% of the value of your interest in the Separate Account without surrender charges, provided that the proceeds are paid solely to the Participant or the Beneficiary. If you withdraw money in excess of 10%, you might have to pay a surrender charge on the excess amount. Withdrawals from 403(b) Plans may be restricted by the Internal Revenue Code. The following schedule shows the surrender charges that apply during the sixty months following each Purchase Payment: Number of Months Since Surrender Purchase Payment Date Charge ---------------------- --------- 60 months or less 7% More than 60 months 0% The surrender charge is calculated by subtracting from the Series or General Account from which you are withdrawing a Purchase Payment an amount determined as follows: The Surrender Amount -------------------- 1 - the percentage surrender charge expressed as a decimal If you make a partial surrender, you will receive a check in the amount requested. The surrender charge, if any, will be deducted from the Series from which the partial surrender was taken. If the amount in a particular Series is completely surrendered, the charge will be taken from the remaining Series in which you have an interest. [SIDE BAR: The surrender charge covers marketing expenses for the sale of Contracts, such as commissions to sales personnel and other promotion and acquisition expenses.]
485BPOS23rd Page of 168TOC1stPreviousNextBottomJust 23rd
MetLife Investors USA will not deduct any surrender charge once 9 years have elapsed since your Certificate Date. EXCEPTIONS TO SURRENDER CHARGE In some cases, MetLife Investors USA will not charge you the surrender charge when you make a withdrawal. You do not pay the surrender charge: - on transfers made within the Contract; - on withdrawals of Purchase Payments you made over 60 months ago; - If you die during the pay-in phase. Your Beneficiary(ies) will receive the full death benefit without deduction; - If you are a 403(b) Plan Participant and you withdraw no more than 10% of your interest in any calendar year, (subject to Internal Revenue Code restrictions); - If you are confined to a hospital for at least 30 consecutive days or a skilled nursing home for at least 90 consecutive days. The withdrawal must be in a lump sum and must be requested within 60 days after termination of confinement; and - When you are an officer, director or full time employee of MetLife Investors USA or its affiliates. In this case, the purchase of the Contract is for personal investment purposes only. ADMINISTRATIVE FEES An administrative fee of $21.50 plus $2.50 for each Series in which you have Accumulation Units is deducted from your Account on a yearly basis. The fee is prorated between Series in your Account based on their values on the date of the deduction. Contract administration expenses include: - the cost of policy issuance; - rent; - stationery and postage; - telephone and travel expenses; - salaries; - legal, administrative, actuarial and accounting fees; - periodic reports; and - office equipment, and custodial expenses. The administrative fee will be waived for any Certificate Year during which you contribute Purchase Payments of $2,000 or more or your Participant's Account is $10,000 or more at the end of the Certificate Year. TRANSACTION CHARGES A $10 transaction charge will be deducted from your Account for each transfer from a Series (see "Transfers") and upon annuitizaton of all or a portion of your Account (see "Annuity Benefits"). When you make a full or partial surrender, a transaction charge will be deducted from your Account in an amount equal to the lesser of: - $10 or - 2% of the amount surrendered. These charges are at cost. MetLife Investors USA does not anticipate profiting from them. Transaction charges for transfers from one series of the Separate Account to another series of the Separate Account are currently waived. (See, however, "Description of the Contracts - Market Timing.") MORTALITY AND EXPENSE RISK CHARGE MetLife Investors USA charges a fee for bearing certain mortality and expense risks under the policy. Examples of these risks include a guarantee of annuity rates, the death benefits, and assuming the risk that the expense charges and fees are less than actual administrative and operating expenses. As compensation for assuming these risks, MetLife Investors USA will make a daily deduction from the value of the Separate Account's assets equal to 1.25% per year.
485BPOS24th Page of 168TOC1stPreviousNextBottomJust 24th
If MetLife Investors USA has gains from the receipt of the mortality and expense risk charges over its cost of assuming these risks, it may use the gains as it sees fit. This may include the reduction of expenses incurred in distributing the Contracts. MetLife Investors USA may voluntarily waive a portion of the mortality and administrative expense risk charges. Any waiver of these expenses may be terminated at any time. DISTRIBUTION EXPENSE CHARGE MetLife Investors USA also assumes the risk that surrender charges described above will be insufficient to cover the actual costs of distribution. These costs include: -- commissions, -- fees, -- registration costs, -- direct and indirect selling expenses (including advertising, sales materials, illustrations, marketing personnel, printing, and related overhead) As compensation for assuming this risk, MetLife Investors USA will make a deduction of .000274% on a daily basis (0.10% per year) from the value of the Separate Account assets funding the Contract (the staff of the Securities and Exchange Commission deems this charge a deferred sales charge). The distribution expense charge (sales load), together with any contingent deferred sales charge imposed as described on page ___ above, will never exceed 9% of purchase payments. FEDERAL, STATE AND LOCAL TAXES MetLife Investors USA may in the future deduct charges from the Participant's Account for any taxes it incurs because of the Contracts. However, no deductions are being made at the present time. [SIDE BAR: Please note that deductions are made and expenses paid out of the underlying Funds' assets, as well. A description of these fees and expenses are described in each Fund's prospectus. FREE LOOK PERIOD You may cancel your interest in the Contract within a certain time period. This is known as a "free look." Your Free Look Period is the 20-day period (or longer in certain states) starting when you receive your Certificate. If you decide to cancel your interest in the Contract, MetLife Investors USA must receive your request to cancel in writing at its administrative office within the 20-day period. If the Certificate is mailed to MetLife Investors USA, it will be considered to be received on the postmark date. If the Certificate is sent by certified or registered mail, the date of certification or registration will be considered the date of its return to MetLife Investors USA. The returned Certificate will be treated as if MetLife Investors USA never issued it, and MetLife Investors USA will refund your Purchase Payments or, if required by state law, the greater of the Purchase Payments or the Participant's Account. Purchase Payments that you make to the Separate Account will be allocated to the Money Market Portfolio for the number of days of the Free Look Period required by the state in which you live. At the end of the Free Look Period, the account value in the Money Market Portfolio will be reallocated to the Series of the Separate Account that you selected in your Contract application. DEFERRED COMPENSATION PLANS For qualified Section 457 deferred compensation Plans, MetLife Investors USA may agree to reduce or waive the administrative fees, transaction charges, and the distribution expense fee. Also, deductions for sales charges may be reduced or waived if a surrender is the result of your: -- death, -- disability, -- retirement, -- termination of employment, -- financial hardship, or -- transfer to another investment provider.
485BPOS25th Page of 168TOC1stPreviousNextBottomJust 25th
DESCRIPTION OF THE CONTRACTS GENERAL The Contracts (known as the Flexible Bonus Annuity, Form 226R1) are group contracts designed to provide annuity benefits to employees of the following: -- Public School Systems; -- Churches; -- Certain tax-exempt organizations under Section 501(c)(3) of the Code; -- Employees covered under various types of Section 457 deferred compensation Plans; and -- Retirement plans held by trusts which qualify under Section 401 of the Code. The Contracts are designed to fulfill long-term financial needs. They should not be considered as short-term or temporary investments. A group Contract is issued to an employer or organization which is the Owner. This Contract covers all present and future Participants. After completing an enrollment form and arranging for Purchase Payments to begin, you and all other Participants will receive a Certificate that gives you a summary of the Contract provisions. This Certificate also serves as evidence of your participation in the Plan. PLEASE NOTE THAT NO CERTIFICATES ARE ISSUED TO PARTICIPANTS UNDER DEFERRED COMPENSATION OR QUALIFIED CORPORATE RETIREMENT PLANS. The group Contracts may be restricted by the Plan as to your exercise of certain rights provided in the Contracts. You should refer to the Plan for information concerning these restrictions. ASSIGNMENT If permitted by the Plan, you may assign your interest in the Contract by providing MetLife Investors USA with written notice. Where a Contract is issued in connection with a deferred compensation plan, all rights and powers under the Contract are vested in the Owner, not you. PURCHASE PAYMENTS You may make Purchase Payments yearly, semi-yearly, quarterly, monthly, or in periods agreed to by MetLife Investors USA. You may change when you make Purchase Payments if permitted by the Plan. The minimum Purchase Payment is $20, with a yearly minimum of $240 (or such lesser amount as is required by federal tax law). Purchase Payments may be allocated to the Separate Account, the General Account, or between them according to your decision). You will periodically receive a confirmation of Purchase Payments which have been received. TRANSFERS ACCUMULATION UNITS Except as otherwise limited under market timing restrictions, you may transfer Accumulation Units among the Funds or to the General Account at any time. You may not make a transfer from the General Account to Accumulation Units of more than 20% of your interest in the General Account in any one year. Your transfer instructions must be in writing or, if permitted by MetLife Investors USA, by telephone, Internet or other means approved by MetLife Investors USA. If MetLife Investors USA permits Accumulation Units to be transferred by telephone, you will be required to complete an authorization on the contract application or on another form that MetLife Investors USA will require. MetLife Investors USA will employ reasonable procedures to confirm that telephone or Internet instructions are genuine. This will include a requirement that you provide one or more forms of personal identification when requesting a transfer. MetLife Investors USA will not be liable for following instructions it reasonably believes to be genuine. Because telephone or Internet transactions will be available to anyone who provides certain information about you or your Contract, you should protect that information. We may not be able to verify that you are the person providing telephone or Internet instructions, or that you have authorized any such person to act for you.
485BPOS26th Page of 168TOC1stPreviousNextBottomJust 26th
Telephone or computer systems may not always be available. Any telephone or computer system, whether it is your, your service provider's, your Financial Advisor's, or ours, can experience outages or slowdowns for a variety of reasons. These outages or slowdowns may delay or prevent our processing of your request. Although we have taken precautions to help our systems handle heavy use, we cannot promise complete reliability under all circumstances. If you are experiencing problems, you should make your request in writing to MetLife Investors USA Insurance Company, P.O. Box 46539, Denver, CO 80201-6539. Your Accumulation Units will be transferred on the first valuation after receipt of written, telephone or Internet instructions. Accumulation Unit values are determined at the close of trading on the New York Stock Exchange, which is currently 4:00 p.m. Eastern time. If your transfer instructions are received up to that time your transfer will be effected at the value calculated on that date. If your instructions are received after the close of trading on a valuation day, your transfer instructions will be carried out at the value next calculated. ANNUITY UNITS You may transfer Annuity Units among the Series at any time. You may not transfer Annuity Units to the General Account. However, any amounts that you have in the General Account that have not been applied to a fixed annuity income option may be transferred to Annuity Units in one or more Series for a variable payout. Transfers of Annuity Units may only be requested in writing and will be effective on the first valuation following receipt of the instructions. MINIMUM TRANSFER A minimum of $500 must be transferred from any Series or from the General Account. The value of the Accumulation and Annuity Units transferred will be calculated as of the close of business on the day that the transfer occurs. MARKET TIMING We have policies and procedures that attempt to detect transfer activity that may adversely affect other Participants or Funds in situations where there is potential for pricing inefficiencies or that involve relatively large single or grouped transactions by one or more Participants (i.e., market timing). We employ various means to try to detect such transfer activity. We may revise these policies and procedures in our sole discretion at any time without prior notice. The detection and deterrence of harmful transfer activity involves judgments that are inherently subjective. Our ability to detect such transfer activity may be limited by operational and technological systems, as well as our ability to predict strategies employed by Participants to avoid such detection. Our ability to restrict such transfer activity may be limited by provisions of the Contract. We apply our policies and procedures without exception, waiver, or special arrangement, although we may vary our policies and procedures among our variable contracts and Series and may be more restrictive with regard to certain contracts or Series than others. Accordingly, there is no assurance that we will prevent all transfer activity that may adversely affect Participants or Fund shareholders. In addition, we cannot guarantee that the Funds will not be harmed by transfer activity related to other insurance companies and/or retirement plans that may invest in the Funds. Our policies and procedures may result in restrictions being applied to Participant(s). These restrictions may include: - requiring you to send us by U.S. mail a signed, written request to make transfers; - charging a transfer or collecting a Fund redemption fee; - denying a transfer request from an authorized third party acting on behalf of multiple Participants; and - imposing other limitations and modifications where we determine that exercise of the transfer privilege may create a disadvantage to other Participants or the Funds. If restrictions are imposed on a Participant, we will reverse upon discovery any transaction inadvertently processed in contravention of such restrictions. In accordance with applicable law, we reserve the right to modify or terminate the transfer privilege at any time. We also reserve the right to defer or restrict the transfer privilege at any time that we are unable to purchase or redeem shares of any of the Funds, including any refusal or restriction on purchases or redemptions of their shares as a result of their own policies and procedures on market timing activities. You should read the Fund prospectuses for more details.
485BPOS27th Page of 168TOC1stPreviousNextBottomJust 27th
LOANS - 403(b) PLANS ONLY If you are in a 403(b) Plan, you may obtain a loan under the Contract from the part your Account allocated to the General Account. Accumulation Units in the Separate Account are taken into account in determining the maximum amount of the loan. You would then be permitted to transfer Accumulation Units from the Separate Account to the General Account before the loan is made. Your Account serves as the only security for the loan. MetLife Investors USA may terminate a loan at its discretion in the event of a request for surrender. The Internal Revenue Code imposes limits on the amounts, duration, and repayment schedule for all 403(b) plan loans. If the Plan is subject to the requirements of Title 1 of the Employee Retirement Income Security Act of 1974, eligibility for, and the terms and conditions of the loan may be further limited by the terms of the Plan and will be determined by the plan administrator or other designated Plan official. Loan proceeds may cause you to incur tax liability (see "Federal Tax Considerations"). MetLife Investors USA may modify or terminate the granting of loans at any time, provided that any modification or termination will not affect outstanding loans. Fees may be charged for loan set-up and administration. Currently, the loan set-up fee is $50. This amount is deducted from the proceeds. At this time, there is no fee for administration. MODIFICATION OF THE CONTRACTS MetLife Investors USA must make Annuity payments involving life contingencies at no less than the minimum guaranteed Annuity rates incorporated into the Contracts, even if actual mortality experience is different. MetLife Investors USA is legally bound under the Contract to maintain these Annuity purchase rates. MetLife Investors USA must also abide by the Contract's provisions concerning: - death benefits - deductions from Purchase Payments - deductions from Participant's Accounts for transaction charges - deductions from the Separate Account for actuarial risk and administrative expense risk fees - guaranteed rates with respect to fixed benefits MetLife Investors USA may change such provisions without your consent to the extent permitted by the Contract, but only: - with respect to any Purchase Payments received as a tax free transfer under the Code after the effective date of the change; - with respect to benefits and values provided by Purchase Payments made after the effective date of the change to the extent that such Purchase Payments in any Certificate Year exceed the first year's Purchase Payments; or - to the extent necessary to conform the Contract to any Federal or state law, regulation or ruling. If you have any questions about any of the provisions of your Contract, you may write or call: MetLife Investors USA Insurance Company P.O. Box 46539 Denver, CO 80201-6539 Phone: (800) 283-4536
485BPOS28th Page of 168TOC1stPreviousNextBottomJust 28th
ACCUMULATION PERIOD CREDITING ACCUMULATION UNITS IN THE SEPARATE ACCOUNT MetLife Investors USA will credit Accumulation Units to a Series upon receipt of your Purchase Payment or transfer. MetLife Investors USA determines the number of Accumulation Units to be credited to a Series by dividing the net amount allocated to a Series out of your Purchase Payment by the value of an Accumulation Unit in the Series next computed following receipt of the Purchase Payment or transfer. SEPARATE ACCOUNT ACCUMULATION UNIT CURRENT VALUES The current value of Accumulation Units of a particular Series depends upon the investment experience of the Fund in which the Series invests its assets. The value of Accumulation Units is determined each business day at the close of trading on the New York Stock Exchange (currently 4:00 p.m. Eastern time ). The value is calculated by multiplying the value of an Accumulation Unit in the Series on the immediately preceding valuation date by the net investment factor for the period since that day. You bear the risk that the aggregate current value invested in the Series may at any time be less than, equal to or more than the amount that you originally allocated to the Series. [Side Bar: The NET INVESTMENT FACTOR is an index of the percentage change (adjusted for distributions by the Fund and the deduction of the administration fee, mortality and expense risk fee) in the net asset value of the Fund in which a Series is invested, since the preceding Valuation Date. The net investment factor may be greater or less than 1 depending upon the Fund's investment performance. SURRENDER FROM THE SEPARATE ACCOUNT You may surrender all or a portion of the cash value of your Participant's Account at any time prior to the Annuity Date. A surrender may result in adverse federal income tax consequences to you including current taxation on the distribution and a penalty tax on the early withdrawal. These consequences are discussed in more detail under "Federal Tax Considerations." You should consult your tax adviser before making a withdrawal. The cash value of your interest in the Separate Account prior to the Annuity Date is determined by multiplying the number of Accumulation Units for each Series credited to your Contract by the current value of an Accumulation Unit in the Series and subtracting any applicable surrender charges. MetLife Investors USA will determine the value of the number of Accumulation Units withdrawn at the next computed Accumulation Unit value. If you request a partial surrender from more than one Series you must specify the allocation of the partial surrender among the Series. You may not make a partial surrender if a withdrawal would cause your interest in any Series or the General Account to have an after surrender value of less than $200. However, if you are withdrawing the entire amount allocated to a Series these restrictions do not apply. PAYMENT OF SURRENDER AMOUNT Payment of any amount surrendered from a Series will be made to you within seven days of the date that MetLife Investors USA receives your written request. MetLife Investors USA may suspend surrenders when: - The SEC restricts trading on the New York Stock Exchange or the Exchange is closed for other than weekends or holidays. - The SEC permits the suspension of withdrawals. - The SEC determines that an emergency exists that makes disposal of portfolio securities or valuation of assets of the Funds not reasonably practicable.
485BPOS29th Page of 168TOC1stPreviousNextBottomJust 29th
ACCOUNT STATEMENTS You will receive a written account statement each calendar quarter in which a transaction occurs before the Annuity Date. Even if you do not engage in any transactions you will receive at least one written account statement per year. The statement shows: - all transactions for the period being reported - the number of Accumulation Units that are credited to your Contract in each Series - the current Accumulation Unit value for each Series - your Participant's Account as of the end of the reporting period MetLife Investors USA is careful to ensure the accuracy of calculations and transfers to and within the Separate Account. However, errors may still occur. You should review your statements and confirmations of transactions carefully and promptly advise MetLife Investors USA of any discrepancy. Allocations and transfers reflected in a statement will be considered final at the end of 60 days from the date of the statement. ANNUITY BENEFITS VARIABLE ANNUITY PAYMENTS Your interest in the Series is applied to provide you with a Variable Annuity. The dollar amount of the Variable Annuity payments that you receive will reflect the investment experience of the Series, but will not be affected by adverse mortality experience which may exceed the mortality risk charge established under the Contract. ASSUMED INVESTMENT RETURN Unless you elect otherwise, the Assumed Investment Return is 4.25% per year. If the laws and regulations of your State allow, you may elect an Assumed Investment Return of 3.50%, 5% or 6%. The Assumed Investment Return does not bear any relationship to the actual net investment experience of the Series. Your choice of Assumed Investment Return affects the pattern of your Annuity payments. Your Annuity payments will vary from the Assumed Investment Return depending on whether the investment experience of the Series in which you have an interest is better or worse than the Assumed Investment Return. The higher your Assumed Investment Return, the higher your first Annuity payment will be. Your next payments will only increase in proportion to the amount the investment experience of your chosen Series exceeds the Assumed Investment Return and Separate Account charges. Likewise, your payments will decrease if the investment experience of your chosen Series is less than the Assumed Investment Return and Separate Account charges. A lower Assumed Investment Return will result in a lower initial Annuity payment, but subsequent Annuity payments will increase more rapidly or decline more slowly as changes occur in the investment experience of the Series. Conversely, a higher Assumed Investment Return would result in a higher initial payment than a lower Assumed Investment Return, but later payments will rise more slowly or fall more rapidly. ELECTION OF ANNUITY DATE AND FORM OF ANNUITY You choose the Annuity Date and the form of Annuity payment. ELECTION OF ANNUITY DATE If you do not choose an Annuity Date at least thirty-one days before Annuitization, your Normal Annuity Date automatically will be the later of: - the month in which you attain age 75, or - the date you are required to take a distribution under the terms of the Plan to which the Contract was issued. You may select an optional Annuity Date that is earlier than the Normal Annuity Date described above. This Annuity Date may be the first day of any month before the Normal Annuity Date. Please note that the Qualified Contracts may require a different Normal Annuity Date and may prohibit the selection of certain optional Annuity Dates.
485BPOS30th Page of 168TOC1stPreviousNextBottomJust 30th
FORM of ANNUITY [SIDE BAR: There are two people who are involved in payments under your Annuity: - you - the Beneficiary Currently, MetLife Investors USA provides you with five forms of Annuity payments. Each Annuity payment option, except Option 5, is available on both a Fixed and Variable Annuity basis. Option 5 is available on a Fixed basis only. OPTION 1 - LIFE ANNUITY You receive Annuity payments monthly during your lifetime. These payments stop with the last payment due before your death. Because MetLife Investors USA does not guarantee a minimum number of payments under this arrangement, this option offers the maximum level of monthly payments, involving a life contingency. OPTION 2 - LIFE ANNUITY WITH 120, 180, OR 240 MONTHLY PAYMENTS CERTAIN You receive a guaranteed minimum number of monthly Annuity payments during your lifetime. In addition, MetLife Investors USA guarantees that your Beneficiary will receive monthly payments for the remainder of the period certain, if the Annuitant dies during that period. OPTION 3 - INSTALLMENT REFUND LIFE ANNUITY An Annuity payable monthly during the lifetime of an individual. You receive a guaranteed minimum number of monthly payments which are equal to the amount of your Participant's Account allocated to this option divided by the first monthly payment. If you die before receiving the minimum number of payments, the remaining payments will be made to your Beneficiary. OPTION 4 - JOINT AND LAST SURVIVOR LIFE ANNUITY You receive Annuity payments monthly during the lifetime of you and another payee (the joint payee) and payments are made during the lifetime of the survivor of the two of you. MetLife Investors USA stops making payments with the last payment before the death of the last surviving payee. MetLife Investors USA does not guarantee a minimum number of payments under this arrangement. For example, you or the other payee might receive only one Annuity payment if both of you die before the second Annuity payment. The election of this option is ineffective if either of you dies before Annuitization. In that case, the survivor becomes the sole payee, and MetLife Investors USA does not pay death proceeds because of the death of the other payee. OPTION 5 - PAYMENTS FOR A DESIGNATED PERIOD (FIXED ANNUITY ONLY) MetLife Investors USA makes Annuity payments monthly to you or to the Beneficiary at your death, for a selected number of years ranging from five to thirty. The amount of each payment will be based on an interest rate determined by MetLife Investors USA that will not be less than an assumed rate of return of 3.50% per year. You may not commute Fixed Annuity payments to a lump sum under this option. If you do not choose a form of Annuity payment, Option 2, a life annuity with a guaranteed minimum of 120 monthly payments, will automatically be applied to your Contract. You may make changes in the optional form of Annuity payment at any time until 31 days before the Annuity date. The first year's Annuity payment described in Options 1 - 4 are calculated on the basis of: - the mortality table specified in the Contract - the age and where permitted the sex of the Annuitant - the type of Annuity payment option selected, and - the assumed investment return selected. The fixed Annuity payments described in Option 5 are calculated on the basis of: - the number of years in the payment period, and - the interest rate guaranteed with respect to the option. Fixed Annuities are funded through the General Account of MetLife Investors USA.
485BPOS31st Page of 168TOC1stPreviousNextBottomJust 31st
FREQUENCY OF PAYMENT Your payments under all options will be made on a monthly basis unless you and MetLife Investors USA have agreed to a different arrangement. Payments from each Series must be at least $50 each. If a payment from a Series will be less than $50, MetLife Investors USA has the right to decrease the frequency of payments so that each payment from a Series will be at least $50. LEVEL PAYMENTS VARYING ANNUALLY Your variable Annuity payments are determined yearly rather than monthly. As a result, you will receive a uniform monthly Annuity payment for each Annuity year. The level of payments for each year is based on the investment performance of the Series up to the Valuation Date as of which the payments are determined for the year. As a result, the amounts of the Annuity payments will vary with the investment performance of the Series from year to year rather than from month to month. Your monthly variable Annuity payments for the first year will be calculated on the last Valuation Date of the second calendar week before the Annuity date. The amount of your monthly variable Annuity payments will be calculated using a formula described in the Contract. On each anniversary of the Annuity date, MetLife Investors USA will determine the total monthly payments for the year then beginning. These payments will be determined by multiplying the number of Annuity units in each Series from which payments are to be made by the annuity unit value of that Series for the valuation period in which the first payment for that period is due. After calculating the amount due to you, MetLife Investors USA transfers the amount of the year's Variable Annuity payments to a General Account at the beginning of the year. Although the amount in the Separate Account is credited to you and transferred to the General Account, you do not have any property rights in this amount. You do have a contractual right to receive your Annuity payments. The monthly Annuity payments for the year are made from the General Account with interest using the standard assumed investment return of 4.25% or the Assumed Investment Return that you selected. As a result, MetLife Investors USA will experience profits or losses on the amounts placed in the General Account in providing level monthly payments to you during the year that meet the Assumed Investment Return that you selected. For example, if the net investment income and gains in the General Account are lower than the Assumed Investment Return selected, MetLife Investors USA will experience a loss. You will not benefit from any increases or be disadvantaged from any decreases in any Annuity Unit Values during the year because the Annuity payments for that year are set at the beginning of the year. These increases and decreases will be reflected in the calculation of Annuity payments for the following year. ANNUITY UNIT VALUES This is how MetLife Investors USA calculates the Annuity Unit Value for each Series: - First, MetLife Investors USA determines the change in investment experience (including any investment-related charge) for the underlying Fund from the previous trading day to the current trading day. - Next, it subtracts the daily equivalent of your insurance-related charge (general administrative expense and mortality and expense risk charges) for each day since the last day the Annuity Unit Value was calculated. - Then, it divides the result by the quantity of one plus the weekly equivalent of your Assumed Investment Return. - Finally, the previous Annuity Unit Value is multiplied by this result. DEATH BENEFITS DEATH BEFORE THE ANNUITY DATE If you die before the Annuity Date, your Beneficiary(ies) will receive a death benefit that is equal to the Participant's Account.
485BPOS32nd Page of 168TOC1stPreviousNextBottomJust 32nd
If you are younger than age 65 at the time of your death, your Beneficiary(ies) will be entitled to receive a lump sum settlement equal to the greater of: - your Purchase Payments less partial withdrawals or amounts already applied to Annuity payments; or - your Participant's Account. Your Beneficiary(ies) receive the death benefit as either: 1) A lump sum that must be made within five (5) years of your death; or 2) Annuity income under Annuity Income Options One, Two or Five described in Article 7 of the Contract. If your Beneficiary(ies) chooses one of the Annuity income options: - Payments must begin within one year of your death (However, your spouse may delay commencement of payments to the date that you would have reached 70 1/2.) - The guaranteed period under Option Two or the designated period under Option Five may not be longer than the Beneficiary's life expectancy under applicable tables specified by the Internal Revenue Service. - The Participant's Account on the date of the first Annuity payment will be used to determine the amount of the death benefit. If your spouse is your sole Beneficiary, he or she may choose to succeed to your rights as Participant rather than to take the death benefit. If you have more than one Beneficiary living at the time of your death, each will share the proceeds of the death benefit equally unless you elect otherwise. If you outlive all of your Beneficiaries, the death benefit will be paid to your estate in a lump sum. No Beneficiary shall have the right to assign or transfer any future payments under the Options, except as provided in the election or by law. You will also be considered to have outlived your Beneficiary(ies) in the following situations: - Your Beneficiary(ies) and you die at the same time. - Your Beneficiary(ies) dies within 15 days of your death and proof of your death is received by MetLife Investors USA before the date due. Proof of death includes a certified death certificate, or attending physician's statement, a decree of a court of competent jurisdiction as to the finding of death, or other documents that MetLife Investors USA agrees to accept as proof of death. DEATH AFTER THE ANNUITY DATE If the Annuitant dies on or after the Annuity Date, the amounts payable to the Beneficiary(ies) or other properly designated payees will consist of any continuing payments under the Annuity Payment option in effect. In this case, the Beneficiary will: - have all the remaining rights and powers under a Contract, and - be subject to all the terms and conditions of the Contract. If none of your Beneficiaries survive the Annuitant, the value of any remaining payments certain on the death of Annuitant, calculated on the basis of the assumed investment return that you previously chose, will be paid in a lump sum to the Annuitant's estate unless other provisions have been made and approved by MetLife Investors USA. This value is calculated on the next day of payment following receipt of due proof of death.
485BPOS33rd Page of 168TOC1stPreviousNextBottomJust 33rd
Unless otherwise restricted, a Beneficiary receiving variable payments under Option Two or Three may elect at any time to receive the present value of the remaining number of Annuity payments certain in a lump sum payment after the death of an Annuitant. The present value of the remaining Annuity payments will be calculated on the basis of the assumed investment return previously selected. This lump sum payment election is not available to a Beneficiary receiving Fixed Annuity payments. FEDERAL TAX CONSIDERATIONS Federal Tax Considerations The following general discussion of the federal income tax consequences under this Contract is not intended to cover all situations, and is not meant to provide tax advice. Because of the complexity of the law and the fact that the tax results will vary depending on many factors, you should consult your tax adviser regarding your personal situation. Additional tax information is included in the SAI. (Neither this Prospectus nor the SAI addresses state, local or foreign tax matters.) GENERAL TAXATION OF ANNUITIES Congress has recognized the value of saving for retirement by providing certain tax benefits, in the form of tax deferral, for money put into an annuity. The Internal Revenue Code (the "Code") governs how this money is ultimately taxed. There are different rules for Qualified and Non-qualified Contracts and depending on how the money is distributed, as briefly described below. You generally will not be taxed on increases in the value of your Contract until a distribution occurs - either as a withdrawal or as an Annuity payment. This concept is known as tax deferral. In addition, MetLife Investors USA will not be taxed on the investment income and capital gains of the Separate Account. In some circumstances, owners of variable annuity contracts who retain excessive control over the investment of the underlying separate account assets may be treated as the owners of those assets and may be subject to tax on income produced by those assets. Although published guidance in this area does not address certain aspects of the contracts, we believe that the owner of a contract should not be treated as the owner of the separate account assets. We reserve the right to modify the contract to bring it into conformity with applicable standards should such modification be necessary to prevent an owner of the contract from being treated as the owner of the underlying separate account assets. [SIDE BAR: A QUALIFIED CONTRACT is a Contract that is purchased for certain types of tax-advantaged retirement plans (previously defined as "qualified plans"). For purposes of this Prospectus, qualified plans include: - SECTION 401 PLANS and 403(a)(pension and profit-sharing plans, including plans for the self-employed) - SECTION 403(b) PLANS (tax-deferred annuities) - SECTION 457(b) PLANS (eligible deferred compensation plans of State and local governmental employees or other tax exempt employees)( "eligible Section 457 plan") - TRADITIONAL INDIVIDUAL RETIREMENT ACCOUNTS AND ANNUITIES ("IRAs") - ROTH IRAs A NON-QUALIFIED CONTRACT is a Contract that is purchased on an individual basis with after-tax dollars and not under one of the programs listed above in the description of a Qualified Contract.] [SIDE BAR: Please note that the terms of your particular plan, IRA or Roth IRA may limit your rights otherwise available under the Contract.]
485BPOS34th Page of 168TOC1stPreviousNextBottomJust 34th
QUALIFIED CONTRACTS [SIDE BAR: THE DOLLARS IN A QUALIFIED PLAN ARE TAX DEFERRED. CONTRACTS PURCHASED FOR USE WITH A QUALIFIED PLAN PROVIDE NO ADDITIONAL TAX DEFERRAL, AND THERE SHOULD BE REASONS OTHER THAN TAX DEFERRAL FOR PURCHASING THE CONTRACT.] The full amount of all distributions received from a Section 401, Section 403(a), 403(b), eligible Section 457 plan or IRA (except for a return of non-deductible employee or IRA contributions) are generally included in your gross income and are taxed at ordinary income rates unless the distribution is transferred in an eligible rollover. In certain cases, distributions received from a Roth IRA are also included in gross income. Generally, distributions are included in your income in the year in which they are paid. However, in the case of an eligible Section 457 plan of a tax exempt employer (other than a state or local government), a distribution is includible in the year it is paid or when it is made available, depending upon whether certain Code requirements are met. In very limited situations, a lump sum distribution from a Section 401 plan may qualify for special tax treatment, including special forward income averaging, special long term capital gain treatment or deferral with respect to net unrealized appreciation. If your tax deferred annuity contract permits loans, the amount of such loans, the repayment terms and the treatment of defaults are subject to limitations and rules under section 72(p) of the Code and the regulations thereunder. The terms of your loan will be governed by you loan agreement and the requirements of the tax law (and ERISA, where applicable). Failure to satisfy these requirements will result in adverse tax consequences. Consult your tax advisor prior to applying for a loan. MANDATORY MINIMUM DISTRIBUTIONS If you are a participant in a Section 401, Section 403(a), 403(b), eligible Section 457 plan or an IRA, you generally must begin receiving withdrawals from your Contract Value or Annuity payments for life or a period not exceeding the life expectancy of you or you and a beneficiary by April 1 of the calendar year following the year you turn 70-1/2 (or, except in the case of IRAs or where you are a 5% or more owner in your employer, the year you retire, if later). In addition, distributions under Section 401, 403(b) and eligible Section 457 plans and IRAs must satisfy the minimum incidental death benefit requirements of the Code, which impose additional minimum distribution requirements during life. However, if the distributions described in the preceding paragraph are made to you over your life expectancy or the joint life expectancy of you and your spouse, the minimum incidental death benefit requirements are treated as satisfied. If you are the owner of a Roth IRA, distributions are not required during your lifetime. EARLY SURRENDER PENALTY If you receive a taxable distribution from a Section 401 plan, Section 403(a), Section 403(b) plan or IRA under your Contract before you reach age 59-1/2, this amount may be subject to a 10% penalty tax in addition to ordinary income tax. Additionally, distributions from an eligible Section 457(b) plan of a state or local government are subject to the 10% penalty to the extent attributable to rollover contributions from Section 401, 403(a), 403(b), or an IRA plan. As indicated in the chart below, some distributions prior to age 59 1/2 are exempt from the penalty. Some of these exceptions include any amounts received. Type of Plan -------------------------------------------------------------------------- 401 403(b) IRA -------------------------------------------------------------------------- After you die x x x (paid to your Beneficiary(ies) -------------------------------------------------------------------------- After you become totally disabled (as x x x defined in the Code) -------------------------------------------------------------------------- If you separate from service after you x x reach age 55 --------------------------------------------------------------------------
485BPOS35th Page of 168TOC1stPreviousNextBottomJust 35th
In a series of substantially equal x(1) x(1) x payments made annually (or more frequently over your life or life expectancy or over the joint lives (or joint and last survivor life expectancy) of you and your designated beneficiary (SEPP exception). -------------------------------------------------------------------------- -------------------------------------------------------------------------- Pursuant to a domestic relations order x x -------------------------------------------------------------------------- (1) After separation from service. (Other exceptions to the penalty may be available, and if you are not yet age 59 1/2, you should consult your tax advisor to determine whether you have met all of the requirements for any particular exception.) The penalty also will be imposed (retroactively with interest) if you elect to receive payments under the SEPP exception prior to age 59 1/2 and then change the method of distribution (except on account of death or disability) before you reach the age of 59 1/2. You will be assessed the penalty even after age 59 1/2 if payments have not continued for at least five years. Distributions before age 59 1/2 generally are not permitted under eligible Section 457 plans. You may not receive distributions until you reach the age 70 1/2 unless you separate from service or are faced with an unforeseeable emergency. Distributions from eligible Section 457 plans of tax exempt employers are not subject to the penalty tax for early withdrawals. ROLLOVERS OF PLAN CONVERSIONS You may rollover distributions (other than certain distributions, such as required distributions) from one qualified plan or arrangement(except for eligible Section 457(b) plans of tax exempt employers or IRAs other than traditional IRAs) to another eligible retirement plan (as defined under the Code) without incurring any federal income tax under some circumstances. These circumstances are as follows: [Enlarge/Download Table] Distribution from: May be Rolled into: ------------------ ------------------- ---------------------------------------------------- -------------------------------------------------- Section 401 plan, Section 403(a) plan, Section Section 401 plan, Section 403(a) plan, 403(b) plan , eligible section 457(b) plan of a Section 403(b) plan , eligible section 457(b) governmental employer plan of a governmental employer or Traditional IRA ---------------------------------------------------- -------------------------------------------------- DEDUCTIONS FOR PLAN CONTRIBUTIONS You may deduct your contributions to Section 401 plans and Section 403(b) plans in the year when made up to the limits specified in the Code. These plans may also permit non-deductible employee contributions. Any non-deductible employee contribution that you make will be received tax free as a portion of each Annuity payment.
485BPOS36th Page of 168TOC1stPreviousNextBottomJust 36th
WITHHOLDING MANDATORY 20% WITHHOLDING FOR "ELIGIBLE ROLLOVER DISTRIBUTIONS" If you are participating in a Section 401 plan, Section 403(a) plan, or a Section 403(b) plan, or eligible Section 457(b) plan of a governmental employer, MetLife Investors USA is required to withhold 20% of the taxable portion of your withdrawal that constitutes an "eligible rollover distribution" for Federal income tax purposes. Generally, an "eligible rollover distribution" is any taxable amount that you receive from a Qualified Contract, except for distributions that are: o paid over your life or the joint life expectancy of you and your Beneficiary(ies); o paid over a period of 10 years or more; o necessary to satisfy the minimum distribution requirements; or o hardship distributions Non-taxable amounts may also be rolled over to a traditional IRA or to a defined contribution plan under Section 401(a) to the extent permitted under the code. The requirements discussed below under "Other Tax Withholding" will apply to any distribution that is not an eligible rollover distribution. You may not elect out of the 20% withholding requirement. However, MetLife Investors USA is not required to withhold the money if an eligible rollover distribution is directly transferred or directly rolled over into an IRA or other eligible retirement plan, or is directly transferred in a trustee-to-trustee transfer to either arrangement. OTHER TAX WITHHOLDING Different withholding rules apply to taxable withdrawals such as Annuity payments and partial withdrawals that are not eligible rollover distributions. The withholding rules are determined at the time of payment. You may elect out of these withholding requirements at any time. You also may revoke a non-withholding election made with respect to Annuity payments at any time and tax withholding will begin again at that time. MetLife Investors USA will notify you at least annually of your right to revoke or reinstate tax withholding. TAXPAYER IDENTIFICATION NUMBER ("TIN") You are required by law to provide MetLife Investors USA (as payor) with your correct TIN. If you are an individual, the TIN is your social security number. FOREIGN TAX CREDITS. To the extent permitted under the federal income tax law, we may claim the benefit of certain foreign tax credits attributable to taxes paid by certain of the Funds to foreign jurisdictions. VOTING RIGHTS As the owner of the Separate Account, MetLife Investors USA is the legal owner of the shares of the funding options. Based upon MetLife Investors USA's current view of applicable law, you have voting interests under the Contract concerning Fund shares and are entitled to vote on Fund proposals at all regular and special shareholders meetings. Therefore, you are entitled to give us instructions for the number of shares which are deemed attributable to your Participant's Accounts. MetLife Investors USA will vote all shares of the underlying Funds as directed by you and others who have voting interests in the Funds. MetLife Investors USA will send you, at a last known address, all periodic reports, proxy materials and written requests for instructions on how to vote those shares. When MetLife Investors USA receives these instructions, it will vote all of the shares in proportion to the instructions. If MetLife Investors USA does not receive your voting instructions, it will vote your interest in the same proportion as represented by the votes it receives from the other Owners and Participants. If MetLife Investors USA determines that it is permitted to vote the shares in its own right due to changes in the law or in the interpretation of the law it may do so.
485BPOS37th Page of 168TOC1stPreviousNextBottomJust 37th
MetLife Investors USA is under no duty to inquire into voting instructions or into the authority of the person issuing such instructions. All instructions will be valid unless MetLife Investors USA has actual knowledge that they are not. When Annuity payments begin, the Annuitant will have all voting rights in regard to Fund shares. There are certain circumstances under which MetLife Investors USA may disregard voting instructions. However, in this event, a summary of our action and the reasons for such action will appear in the next semiannual report. The number of votes that each person having the right to vote receives is determined on a record date that is set no more than 90 days before the meeting. Voting instructions will be requested at least 10 days before the meeting. Only Owners or Annuitants on the record date may vote. The number of shares to which you are entitled to vote is calculated by dividing the portion of your Participant's Account allocated to that Fund on the record date by the net asset value of a Fund share on the same date. LEGAL PROCEEDINGS There are no present or pending material legal proceedings affecting the Separate Account. MetLife Investors USA, in the ordinary course of its business, is engaged in litigation of various kinds which in its judgment is not of material importance in relation to its total assets. ADDITIONAL INFORMATION You may contact MetLife Investors USA at the address and phone number on the cover of this Prospectus for further information. A copy of the Statement of Additional Information, dated May 1, 2004, which provides more detailed information about the contracts, may also be obtained. The table of contents for the Statement of Additional Information is provided below. A Registration Statement has been filed with the SEC under the Securities Act of 1933 for the Contracts offered by this Prospectus. This Prospectus does not contain all of the information in the Registration Statement. Please refer to this Registration Statement for further information about the Separate Account, MetLife Investors USA and the Contracts. Any statements in this Prospectus about the contents of the Contracts and other legal instruments are only summaries. Please see the filed versions of these documents for a complete statement of any terms. TABLE OF CONTENTS The Insurance Company Surrender Charges Net Investment Factor Annuity Payments Underwriters, Distribution of the Contracts Calculation of Performance Voting Rights Safekeeping of Securities Servicing Agent Experts Legal Matters Regulation of MetLife Investors USA Financial Statements
485BPOS38th Page of 168TOC1stPreviousNextBottomJust 38th
APPENDIX A CONDENSED FINANCIAL INFORMATION The following table sets forth condensed financial information on Accumulation Units with respect to Contracts issued under this prospectus through the Separate Account. [Enlarge/Download Table] AUV at AUV at Accum Units Beginning End End of Period of Period of Period --------- --------- --------- MIST - JPM Quality Bond - Class A 7/31/1991 to 7/31/1992 5.00 5.34 4,339 7/31/1992 to 7/31/1993 5.34 7.66 16,762 7/31/1993 to 12/31/1993 7.66 7.78 25,753 1/1/1994 to 12/31/1994 7.78 7.42 42,544 1/1/1995 to 12/31/1995 7.42 8.55 64,174 1/1/1996 to 12/31/1996 8.55 8.68 139,116 1/1/1997 to 12/31/1997 8.68 9.35 215,747 1/1/1998 to 12/31/1998 9.35 9.92 516,448 1/1/1999 to 12/31/1999 9.92 9.54 657,761 1/1/2000 to 12/31/2000 9.54 10.28 671,742 1/1/2001 to 12/31/2001 10.28 10.88 994,785 1/1/2002 to 12/31/2002 10.88 11.70 1,542,200 1/1/2003 to 12/31/2003 11.70 12.00 1,502,954 MIST - LA Growth & Income - Class A 7/31/1991 to 7/31/1992 5.00 5.63 43,927 7/31/1992 to 7/31/1993 5.63 8.27 133,858 7/31/1993 to 12/31/1993 8.27 8.70 183,606 1/1/1994 to 12/31/1994 8.70 8.85 328,797 1/1/1995 to 12/31/1995 8.85 11.46 567,282 1/1/1996 to 12/31/1996 11.46 13.77 1,274,231 1/1/1997 to 12/31/1997 13.77 17.29 2,893,417 1/1/1998 to 12/31/1998 17.29 18.79 4,623,935 1/1/1999 to 12/31/1999 18.79 20.18 5,808,561 1/1/2000 to 12/31/2000 20.18 21.91 6,361,071 1/1/2001 to 12/31/2001 21.91 21.61 7,113,661 1/1/2002 to 12/31/2002 12.61 17.50 7,530,918 1/1/2003 to 12/31/2003 17.50 22.62 7,425,960 MIST - Met/AIM Small Cap Growth - Class A 5/1/2003 to 12/31/2003 8.74 11.67 30,334 MIST - Lord Abbett Bond Debenture - Class A 5/1/2003 to 12/31/2003 14.82 16.27 36,530 MIST - PIMCO Innovation - Class A 5/1/2003 to 12/31/2003 3.33 4.65 138,733 MIST - PIMCO Total Return - Class A 5/1/2003 to 12/31/2003 11.69 11.79 - MIST - Third Avenue Small Cap Value - Class A 5/1/2003 to 12/31/2003 8.48 11.52 49,249 Fidelity VIP II Asset Manager 5/13/1992 to 7/31/1993 5.00 5.15 38,782 7/31/1993 to 12/31/1993 5.15 5.62 258,061 1/1/1994 to 12/31/1994 5.62 5.21 2,516,326 1/1/1995 to 12/31/1995 5.21 6.02 4,182,918 1/1/1996 to 12/31/1996 6.02 6.81 5,464,114 1/1/1997 to 12/31/1997 6.81 8.12 6,838,501 1/1/1998 to 12/31/1998 8.12 9.21 8,505,603 1/1/1999 to 12/31/1999 9.21 10.10 9,842,875 1/1/2000 to 12/31/2000 10.10 9.58 10,471,037 1/1/2001 to 12/31/2001 9.58 9.06 11,212,634 1/1/2002 to 12/31/2002 9.06 8.16 11,340,299 1/1/2003 to 12/31/2003 8.16 9.50 10,931,444 Fidelity VIP Growth (MET) 5/24/1992 to 7/31/1993 5.00 5.06 5,573 7/31/1993 to 12/31/1993 5.06 5.40 110,644 1/1/1994 to 12/31/1994 5.40 5.33 1,202,458 1/1/1995 to 12/31/1995 5.33 7.13 2,758,913 1/1/1996 to 12/31/1996 7.13 8.08 5,003,453 1/1/1997 to 12/31/1997 8.08 9.85 6,614,665 1/1/1998 to 12/31/1998 9.85 13.55 8,140,376 1/1/1999 to 12/31/1999 13.55 18.39 10,212,262 1/1/2000 to 12/31/2000 18.39 16.15 12,289,987 1/1/2001 to 12/31/2001 16.15 13.12 13,869,929 1/1/2002 to 12/31/2002 13.12 9.04 14,654,896 1/1/2003 to 12/31/2003 9.04 11.85 14,704,494
485BPOS39th Page of 168TOC1stPreviousNextBottomJust 39th
Fidelity VIP II Index 500 6/30/1992 to 7/31/1993 5.00 4.97 593 7/31/1993 to 12/31/1993 4.97 5.20 13,988 1/1/1994 to 12/31/1994 5.20 5.19 82,152 1/1/1995 to 12/31/1995 5.19 7.04 416,557 1/1/1996 to 12/31/1996 7.04 8.54 1,543,796 1/1/1997 to 12/31/1997 8.54 11.19 3,577,094 1/1/1998 to 12/31/1998 11.19 14.17 6,150,094 1/1/1999 to 12/31/1999 14.17 16.85 8,754,667 1/1/2000 to 12/31/2000 16.85 15.07 10,754,745 1/1/2001 to 12/31/2001 15.07 13.07 12,576,542 1/1/2002 to 12/31/2002 13.07 10.03 13,723,297 1/1/2003 to 12/31/2003 10.03 12.70 12,705,145 Fidelity VIP Overseas 11/17/1994 to 12/31/1994 5.33 5.67 114 1/1/1995 to 12/31/1995 5.67 6.14 1,721 1/1/1996 to 12/31/1996 6.14 6.86 15,303 1/1/1997 to 12/31/1997 6.86 7.56 35,006 1/1/1998 to 12/31/1998 7.56 8.41 48,352 1/1/1999 to 12/31/1999 8.41 11.83 61,753 1/1/2000 to 12/31/2000 11.83 9.45 76,224 1/1/2001 to 12/31/2001 9.45 7.35 87,408 1/1/2002 to 12/31/2002 7.35 5.78 100,377 1/1/2003 to 12/31/2003 5.78 8.18 116,589 Fidelity VIP Money Market 11/12/1993 to 12/31/1993 5.00 5.01 2,080 1/1/1994 to 12/31/1994 5.01 5.16 67,692 1/1/1995 to 12/31/1995 5.16 5.40 239,983 1/1/1996 to 12/31/1996 5.40 5.62 411,615 1/1/1997 to 12/31/1997 5.62 5.85 652,200 1/1/1998 to 12/31/1998 5.85 6.08 1,150,279 1/1/1999 to 12/31/1999 6.08 6.31 2,221,857 1/1/2000 to 12/31/2000 6.31 6.62 2,125,892 1/1/2001 to 12/31/2001 6.62 6.81 2,605,363 1/1/2002 to 12/31/2002 6.81 6.83 2,564,150 1/1/2003 to 12/31/2003 6.83 6.80 2,631,705 Fidelity VIP II Contrafund 5/16/1995 to 12/31/1995 5.00 6.29 691,653 1/1/1996 to 12/31/1996 6.29 7.54 3,026,615 1/1/1997 to 12/31/1997 7.54 9.24 5,895,334 1/1/1998 to 12/31/1998 9.24 11.85 8,532,096 1/1/1999 to 12/31/1999 11.85 14.53 11,065,052 1/1/2000 to 12/31/2000 14.53 13.39 12,973,409 1/1/2001 to 12/31/2001 13.39 11.59 15,567,610 1/1/2002 to 12/31/2002 11.59 10.36 16,462,689 1/1/2003 to 12/31/2003 10.36 13.14 16,460,782 Scudder SVS I International Class A 5/22/1995 to 12/31/1995 5.00 5.84 757,010 1/1/1996 to 12/31/1996 5.84 6.62 284,277 1/1/1997 to 12/31/1997 6.62 7.13 653,022 1/1/1998 to 12/31/1998 7.13 8.33 914,883 1/1/1999 to 12/31/1999 8.33 12.71 1,276,154 1/1/2000 to 12/31/2000 12.71 9.81 1,857,179 1/1/2001 to 12/31/2001 9.81 6.68 2,466,404 1/1/2002 to 12/31/2002 6.68 5.39 2,896,996 1/1/2003 to 12/31/2003 5.39 6.79 3,068,497 Alger American Small Capitalization Fund Class O 5/22/1995 to 12/31/1995 5.00 6.54 458,300 1/1/1996 to 12/31/1996 6.54 6.73 1,973,165 1/1/1997 to 12/31/1997 6.73 7.40 3,353,442 1/1/1998 to 12/31/1998 7.40 8.44 4,365,889 1/1/1999 to 12/31/1999 8.44 11.95 4,972,727 1/1/2000 to 12/31/2000 11.95 8.58 6,111,440 1/1/2001 to 12/31/2001 8.58 5.96 7,337,073 1/1/2002 to 12/31/2002 5.96 4.34 8,087,639 1/1/2003 to 12/31/2003 4.34 6.10 8,038,173 American Funds Global Small Capitalization Class 2 5/1/2003 to 12/31/2003 11.21 16.42 76,632 American Funds Growth & Income Fund Class 2 5/1/2003 to 12/31/2003 72.37 90.71 52,546 American Funds Growth Fund Class 2 5/1/2003 to 12/31/2003 93.36 116.56 58,944 MSF - Alger Equity Growth - Class A 5/1/2003 to 12/31/2003 19.63 24.33 8,178 MSF - Davis Venture Value - Class A 5/1/2003 to 12/31/2003 22.65 28.56 26,885
485BPOS40th Page of 168TOC1stPreviousNextBottomJust 40th
MSF - FI Mid Cap Opportunities - Class A 5/1/2003 to 12/31/2003 8.55 11.41 68,455 MSF - Harris Oakmark Focused Value - Class A 5/1/2003 to 12/31/2003 24.57 31.46 114,793 MSF - Harris Oakmark Large Cap Value - Class A 5/1/2003 to 12/31/2003 10.08 12.12 143,540 MSF - Lehman Brothers Aggregate Bond Index Class A 5/1/2003 to 12/31/2003 12.69 12.76 54,840 MSF - MetLife Mid Cap Stock Index - Class A 5/1/2003 to 12/31/2003 8.83 11.57 121,376 MSF - MetLife Stock Index - Class A 5/1/2003 to 12/31/2003 29.40 35.70 936,369 MSF - MFS Total Return - Class A 5/1/2003 to 12/31/2003 34.33 38.75 19,447 MSF - Morgan Stanley EAFE Index - Class A 5/1/2003 to 12/31/2003 7.18 9.67 109,137 MSF - Russell 2000 Index - Class A 5/1/2003 to 12/31/2003 9.81 13.61 112,861 MSF - State Street Research Aurora - Class A 5/1/2003 to 12/31/2003 10.93 16.11 169,976 MSF - State Street Research Bond Income - Class A 5/1/2003 to 12/31/2003 45.60 46.37 14,126 MSF - State Street Research Large Cap Value - Class A 5/1/2003 to 12/31/2003 8.26 10.62 19,847
485BPOS41st Page of 168TOC1stPreviousNextBottomJust 41st
APPENDIX B PARTICIPATING INVESTMENT PORTFOLIOS Below are the investment objectives of each Fund available under the contract. The fund prospectuses contain more complete information, including a description of the investment objectives, policies, restrictions and risks. THERE CAN BE NO ASSURANCE THAT THE INVESTMENT OBJECTIVES WILL BE ACHIEVED. ALGER AMERICAN FUND (Class O) The Alger American Fund is a mutual fund with multiple portfolios. Fred Alger Management, Inc. is the investment adviser to the fund. The following Class O portfolio is available under the Contract: Small Capitalization Portfolio Investment Objective: Seeks long term growth of capital. AMERICAN FUNDS INSURANCE SERIES (Class 2) American Funds Insurance Series(r) is a mutual fund with multiple series, three of which are offered under the contract. Capital Research and Management Company is the investment adviser to each series. The following Class 2 portfolios are available under the Contract: Growth Fund Investment Objective: Seeks capital appreciation through stocks. Growth-Income Fund Investment Objective: Seeks both capital appreciation and income. Global Small Capitalization Fund Investment Objective: Seeks capital appreciation through stocks. FIDELITY VARIABLE INSURANCE PRODUCTS (Initial Class) Fidelity Variable Insurance Products is a mutual fund with multiple portfolios, five of which are offered under the contract. Fidelity Management & Research Company (FMR) is the investment adviser to each of the portfolios. The following Initial Class portfolios are available under the Contract: VIP Asset Manager(SM) Portfolio Investment Objective: Seeks to obtain high total return with reduced risk over the long term by allocating its assets among stocks, bonds, and short-term instruments. VIP Contrafund(R) Portfolio Investment Objective: Seeks long-term capital appreciation. VIP Growth Portfolio Investment Objective: Seeks capital appreciation. VIP Money Market Portfolio Investment Objective: Seeks a high level of current income as is consistent with preservation of capital and liquidity. VIP Overseas Portfolio Investment Objective: Seeks long-term growth of capital. MET INVESTORS SERIES TRUST (Class A) Met Investors Series Trust is a mutual fund with multiple portfolios. Met Investors Advisory, LLC (Met Investors Advisory), an affiliate of MetLife Investors USA, is the investment manager of Met Investors Series Trust. Met Investors Advisory has engaged subadvisers to provide investment advice for the individual portfolios. The following Class A portfolios are available under the Contract:
485BPOS42nd Page of 168TOC1stPreviousNextBottomJust 42nd
Met/AIM Small Cap Growth Portfolio Subadviser: A I M Capital Management, Inc. Investment Objective: Seeks long-term growth of capital. J.P. Morgan Quality Bond Portfolio Subadviser: J.P. Morgan Investment Management, LLC Investment Objective: Seeks to provide high total return consistent with moderate risk of capital and maintenance of liquidity. Lord Abbett Bond Debenture Portfolio Subadviser: Lord, Abbett & Co. LLC Investment Objective: Seeks high current income and the opportunity for capital appreciation to produce a high total return. Lord Abbett Growth and Income Portfolio Subadviser: Lord, Abbett & Co. LLC Investment Objective: Seeks long-term growth of capital and income without excessive fluctuations in market value. MFS(R) Research International Portfolio Subadviser: Massachusetts Financial Services Company Investment Objective: Seeks capital appreciation. PIMCO PEA Innovation Portfolio Subadviser: PEA Capital LLC Investment Objective: Seeks capital appreciation; no consideration is given to income. PIMCO Total Return Portfolio Subadviser: PIMCO Investment Objective: Seeks maximum total return, consistent with the preservation of capital and prudent investment management. Third Avenue Small Cap Value Portfolio Subadviser: Third Avenue Management LLC Investment Objective: Seeks long-term capital appreciation. METROPOLITAN SERIES FUND, INC. (Class A) Metropolitan Series Fund, Inc. is a mutual fund with multiple portfolios. MetLife Advisers, LLC (MetLife Advisers) is the investment adviser for all of the portfolios. MetLife Advisers is an affiliate of MetLife Investors USA, MetLife Advisers has engaged subadvisers to provide investment advice for the individual portfolios. The following Class A portfolios are available under the Contract: Davis Venture Value Portfolio Subadviser: Davis Advisers Investment Objective: Seeks growth of capital. FI Mid Cap Opportunities Portfolio Subadviser: Fidelity Management & Research Company Investment Objective: Seeks long-term growth of capital. Harris Oakmark Focused Value Portfolio
485BPOS43rd Page of 168TOC1stPreviousNextBottomJust 43rd
Subadviser: Harris Associates L.P. Investment Objective: Seeks long-term capital appreciation. Harris Oakmark Large Cap Value Portfolio Subadviser: Harris Associates L.P. Investment Objective: Seeks long-term capital appreciation. Lehman Brothers(R) Aggregate Bond Index Portfolio Subadviser: Metropolitan Life Insurance Company Investment Objective: Seeks to equal the performance of the Lehman Brothers Aggregate Bond Index. MetLife Mid Cap Stock Index Portfolio Subadviser: Metropolitan Life Insurance Company Investment Objective: Seeks to equal the performance of the Standard & Poor's Mid Cap 400 Composite Stock Price Index ("S&P MidCap 400 Index"). MetLife Stock Index Portfolio Subadviser: Metropolitan Life Insurance Company Investment Objective: Seeks to equal the performance of the Standard & Poor's 500 Composite Stock Price Index ("S&P 500 Index"). MFS(r) Total Return Portfolio Subadviser: Massachusetts Financial Services Company Investment Objective: Seeks long-term growth of capital with a secondary objective to seek reasonable current income. Morgan Stanley EAFE(R) Index Portfolio Subadviser: Metropolitan Life Insurance Company Investment Objective: Seeks to equal the performance of the MSCI EAFE Index. Russell 2000(R) Index Portfolio Subadviser: Metropolitan Life Insurance Company Investment Objective: Seeks to equal the return of the Russell 2000 Index. State Street Research Aurora Portfolio Subadviser: State Street Research & Management Company Investment Objective: Seeks high total return, consisting principally of capital appreciation. State Street Research Bond Income Portfolio Subadviser: State Street Research & Management Company Investment Objective: Seeks competitive total return primarily from investing in fixed-income securities. State Street Research Large Cap Growth Portfolio (formerly Alger Equity Growth Portfolio) Subadviser: State Street Research & Management Company Investment Objective: Seeks long term capital appreciation. State Street Research Large Cap Value Portfolio Subadviser: State Street Research & Management Company Investment Objective: Seeks long-term growth of capital.
485BPOS44th Page of 168TOC1stPreviousNextBottomJust 44th
T. Rowe Price Small Cap Growth Portfolio Subadviser: T. Rowe Price Associates, Inc. Investment Objective: Seeks long-term capital growth. SCUDDER VARIABLE SERIES I (Class A) The Scudder Variable Series I is a mutual fund with multiple portfolios, one of which is offered under this contract. Deutsche Investment Management Americas Inc. ("DeIM") is the investment adviser for the portfolio. The following Class A portfolio is available under the Contract: International Portfolio Investment Objective: Seeks long-term growth of capital. T. ROWE PRICE GROWTH STOCK FUND The T. Rowe Price Growth Stock Fund is a mutual fund. T. Rowe Price Associates is the investment manager for the fund. Investment Objective: Seeks to provide long-term capital growth and, secondarily, increasing dividend income through investments in the common stocks of well-established growth companies.
485BPOS45th Page of 168TOC1stPreviousNextBottomJust 45th
'33 Act File No. 033-37128 PART B STATEMENT OF ADDITIONAL INFORMATION METLIFE INVESTORS USA SEPARATE ACCOUNT A ---------------------------------------------------------- INDIVIDUAL FLEXIBLE PAYMENT VARIABLE ANNUITY CONTRACTS ---------------------------------------------------------- METLIFE INVESTORS USA INSURANCE COMPANY May 1, 2004 This Statement of Additional Information is not a prospectus and should be read in conjunction with the prospectus. A copy of the prospectus, dated May 1, 2004, may be obtained without charge by writing to MetLife Investors USA Insurance Company, P.O. Box 46539 Denver, CO 80201-6539 or by telephoning (800) 238-4536.
485BPOS46th Page of 168TOC1stPreviousNextBottomJust 46th
TABLE OF CONTENTS Page The Insurance Company Surrender Charges Net Investment Factor Annuity Payments Underwriters, Distribution of the contract Calculation of Performance Voting Rights Safekeeping of Securities Servicing Agent Experts Legal Matters Regulation of MetLife Investors USA Financial Statements
485BPOS47th Page of 168TOC1stPreviousNextBottomJust 47th
THE INSURANCE COMPANY MetLife Investors USA Insurance Company (MetLife Investors USA) is a stock life insurance company founded on September 13, 1960, and organized under the laws of the State of Delaware. Its principal executive offices are located at 22 Corporate Plaza Drive, Newport Beach, California 92660. MetLife Investors USA is authorized to transact the business of life insurance, including annuities, and is currently licensed to do business in all states except New York and in the District of Columbia. MetLife Investors USA is a wholly-owned subsidiary of MetLife Investors Group, Inc ("MLIG"). MLIG in turn is a wholly-owned subsidiary of Metropolitan Life Insurance Company , a New York life insurance company. We changed our name to MetLife Investors USA Insurance Company on February 12, 2001. On December 31, 2002, MetLife Investors became an indirect subsidiary of MetLife, Inc. (MetLife), the holding company of Metropolitan Life Insurance Company, and a listed company on the New York Stock Exchange. We are a member of the Insurance Marketplace Standards Association ("IMSA"). Companies that belong to IMSA subscribe to a set of ethical standards covering the various aspects of sales and service for individually sold life insurance and annuities. SURRENDER CHARGES Subject to the individual's retirement plan requirements, all or a portion of the Participant's account may be surrendered at any time prior to the annuity date. Unless a certificate has been in effect for more than nine full calendar years after the Certificate Date, a surrender charge (contingent deferred sales charge) will be deducted in the event the Participant requests a full or partial surrender from the Separate Account. The charge is based on a percentage of the amount surrendered. No surrender charge will be applied for that part of the first surrender from the Separate Account in a calendar year that does not exceed 10% of the value of the Participant's Account. The surrender charge amounts to 7% for surrenders attributable to purchase payments received within 60 months prior to the date of the surrender. In no event will the sum of these surrender charges and the distribution expense charge exceed 9% of the purchase payments. NET INVESTMENT FACTOR The Separate Account net investment factor is an index of the percentage change (adjusted for distributions by the Fund and the deduction of the actuarial risk fee) in the net asset value of each Fund in which the Series in invested, since the preceding Business Day. The Separate Account net investment factor for each Series of Accumulation Units is determined for any Business Day by dividing (i) the net asset value of a share of the Fund which is represented by such Series at the close of business on such day, plus the per share amount of any distributions made by such Fund on such day by (ii) the net asset value of a share of such Fund determined as of the close of business on the preceding Business Day and then subtracting from the result the daily factors for mortality and expense risks (.003836%) for each calendar day between the preceding Business Day and the end of the current Business Day. ANNUITY PAYMENTS Basis of Variable Benefits The Variable Annuity benefits rates used in determining Annuity Payments under the Contracts are based on actuarial assumptions, reflected in tables in the Contracts, as to the expected mortality and adjusted age and the form of Annuity selected. The mortality basis for these tables is Annuity 2000 Mortality Table, projected to the year 2020 on Projection Scale G, with interest at 4.25% for all functions involving life contingencies and the portion of any period certain beyond 10 years, and 3.25% for the first 10 years of any certain period. Adjusted age in those tables means actual age to the nearest birthday at the time the first payment is due, adjusted according to the following table: ---------------------------------------------------------------------- YEAR OF BIRTH AGE ADJUSTMENT BEFORE 1945 ACTUAL AGE 1946- 1965 AGE MINUS 1 YEAR 1966 - 1985 AGE MINUS 2 YEARS 1986 - 2005 AGE MINUS 3 YEARS ----------------------------------------------------------------------
485BPOS48th Page of 168TOC1stPreviousNextBottomJust 48th
Determination of Amount of Monthly Variable Annuity Payments for First Year The Separate Account value used to establish the monthly variable annuity payment for the first year consists of the value of accumulation units of each Series of the Separate Account credited to a Participant on the last valuation date of the second calendar week before the annuity date. The Contract contains tables showing monthly payment factors and annuity premium rates per $1,000 of Separate Account value to be applied under Options 1 through 4. At the beginning of the first payment year, an amount is transferred from the Separate Account to MetLife Investors USA's General Account and level monthly annuity payments for the year are made out of the General Account. The amount to be transferred is determined by multiplying the annuity premium rate per $1,000 set forth in the Contract tables by the number of thousands of dollars of Separate Account value credited to a Participant. The level monthly payment for the first payment year is then determined by multiplying the amount transferred (the "Annuity Premium") by the monthly payment factor in the same table. In the event the Contract involved has Separate Account accumulation units in more than one Series, the total monthly annuity payment for the first year is the sum of the monthly annuity payments, determined in the same manner as above, for each Series. At the time the first year's monthly payments are determined, a number of annuity units for each Separate Account Series is also established for the annuitant by dividing the first year monthly payment from that series by the Separate Account annuity unit values for the series on the last valuation date of the second calendar week before the first annuity payment is due. The number of annuity units remains fixed during the annuity period unless annuity units are converted to or from another series. Determination of Amount of Monthly Variable Annuity Payments for Second and Subsequent Years As of each anniversary of the annuity date, MetLife Investors USA will determine the amount of the monthly variable annuity payments for the year then beginning. Separate determinations will be made for each Separate Account Series in which the annuitant has annuity units, with the total annuity payment being the sum of the payments derived from the Series. The amount of monthly payments for any Separate Account Series for any year after the first will be determined by multiplying the number of annuity units for that Series by the annuity unit value for that Series for the valuation period in which the first payment for the year is due. It will be MetLife Investor USA's practice to mail variable annuity payments no later than seven days after the last day of the valuation period upon which they are based or the monthly anniversary thereof. The objective of a variable annuity contract is to provide level payments during periods when the economy is relatively stable and to reflect as increased payments only the excess of investment results flowing from inflation or an increase in productivity. The achievement of this objective will depend, in part, upon the validity of the assumption that the net investment return of the Separate Account equals the assumed investment return during periods of stable prices. Subsequent years' payments will be smaller than, equal to or greater than the first year's payments depending on whether the actual net investment return for the Separate Account is smaller than equal to or greater than the Assumed Investment Return. Annuity Unit Value The initial value of an Annuity Unit is $5 for each Series for the first Valuation Period as of which the first Variable Annuity Payment from such Series is made. The value of an Annuity Unit for each Series on any later date is determined by multiplying the value of an Annuity Unit at the end of the preceding Valuation Period by the "Annuity change factor" for the second preceding Valuation Period. The Annuity change factor is an adjusted measurement of the investment performance of the Fund since the end of the preceding Valuation Period. The Annuity change factor is determined by dividing the value of an Accumulation Unit at the end of the Valuation Period by the value of an Accumulation Unit at the end of the preceding Valuation Period and multiplying the result by a neutralization factor. Variable Annuity Payments for each year after the first reflect variations in the investment performance of the Separate Account above and below an Assumed Investment Return. This assumed investment rate is included for purposes of actuarial computations and does not relate to the actual investment performance of the underlying Fund. Therefore, the Assumed Investment Return must be "neutralized" in computing the Annuity change factor. For weekly Valuation Periods and a 4.25% Assumed Investment Return, the neutralization factor is 0.9991999.
485BPOS49th Page of 168TOC1stPreviousNextBottomJust 49th
UNDERWRITERS, DISTRIBUTION OF THE CONTRACTS The Contracts will be sold as a continuous offering by individuals who are appropriately licensed as insurance agents of MetLife Investors USA for the sale of life insurance and Variable Annuity Contracts in the state where the sale is made. In addition, these individuals will be registered representatives of the principal underwriter, MetLife Investors Distribution Company, or of other broker-dealers registered under the Securities Exchange Act of 1934 whose registered representatives are authorized by applicable law to sell Variable Annuity Contracts issued by MetLife Investors USA. Commissions on sales of contracts range from 0% to 8.5%. Agents are paid from the General Account of MetLife Investors USA. Such commissions bear no direct relationship to any of the charges under the Contracts. It is expected that the Contracts will be sold in 49 states and the District of Columbia. Information about the distribution of the contracts is contained in the prospectus. (See "Distributor.") Additional information is provided below. The contracts are not being offered to the public. MetLife Investors Distribution Company ("Distributor") serves as principal underwriter for the contracts. Distributor is a Delaware corporation and its home office is located at 22 Corporate Plaza Drive, Newport Beach, California 92660. Distributor is an indirect, wholly-owned subsidiary of MetLife, Inc. Distributor is registered as a broker-dealer with the Securities and Exchange Commission under the Securities Exchange Act of 1934 and is a member of NASD, Inc. Distributor is not a member of the Securities Investor Protection Corporation. Distributor has entered into selling agreements with other broker-dealers ("selling firms") and compensates them for their services. Distributor received sales compensation with respect to the contracts in the following amounts during the periods indicated: 2001 Received $35,670,155 Retained $0 2002 Received $90,280,308 Retained $0 2003 Received $169,179,314 Retained $0 CALCULATION OF PERFORMANCE Average annual total return was computed by finding the average annual compounded rates of return over the 1, 3, 5, and 10 year periods that would equate the initial amount invested to the ending redeemable value, according to the following formula: P(1+T)(n) = ERV Where: P = a hypothetical initial payment of $1,000 T = average annual total return n = number of years ERV = ending redeemable value of a hypothetical $1,000 payment made at the beginning of the 1, 5, or 10 year periods (or fractional portion thereof). The computation of average annual total returns does take into consideration recurring charges and any non-recurring charges applicable to a Contract which is surrendered in full at the end of the stated holding period. VOTING RIGHTS Unless otherwise restricted by the plan under which a Contract is issued each Owner will have the right to instruct MetLife Investors USA with respect to voting the Fund Shares which are the assets underlying the Owner's interest in the Separate Account, at all regular and special shareholders meetings. An Annuitant's voting power with respect to Fund shares held by the Separate Account declines during the time the Annuitant is receiving a Variable Annuity based on the investment performance of the Separate Account, because amounts attributable to the Annuitant's interest are being transferred annually to the General Account to provide the variable payments.
485BPOS50th Page of 168TOC1stPreviousNextBottomJust 50th
SAFEKEEPING OF SECURITIES Custody of all assets of the Separate Account are held by MetLife Investors USA. The assets of each Separate Account Series will be kept physically segregated by MetLife Investors USA and held separate from the assets of any other firm, person, or corporation. Additional protection for the assets of the Separate Account is afforded by fidelity bonds covering all of MetLife Investors USA's officers and employees. SERVICING AGENT Administrative services agreements have been entered into between MetLife Investors USA and each of MetLife Group, Inc and Metropolitan Life Insurance Company under which the latter have agreed to perform certain of the personnel and administrative services relating to the Contracts and for the Separate Account.. MetLife Investors USA has paid fees to MetLife Group and Metropolitan Life Insurance Company for these services. EXPERTS The financial statements of the Company included in this Statement of Additional Information have been audited by Deloitte & Touche LLP, independent auditors, as stated in their report appearing herein, and have been so included in reliance upon the report of such firm given upon their authority as experts in accounting and auditing. The financial statements of the sub-accounts of the Separate Account included in this Statement of Additional Information have been audited by Deloitte & Touche LLP, independent auditors, as stated in their report appearing herein, and have been so included in reliance upon the report of such firm given upon their authority as experts in accounting and auditing. The principal business address of Deloitte & Touche LLP is One City Centre, St. Louis, Missouri 63101. LEGAL MATTERS Richard C. Pearson, General Counsel of MetLife Investors USA Insurance Company, has provided advice on certain matters relating to the federal securities laws in connection with the Contracts. REGULATION OF METLIFE INVESTORS USA MetLife Investors USA is subject to the laws of the state of Delaware governing insurance companies and to regulation by the Delaware Commissioner of Insurance. An annual statement, in a prescribed form, is filed with the Commissioner on or before March 1 each year covering the operations of MetLife Investors USA for the preceding year and its financial condition on December 31 of such year. MetLife Investors USA's books and assets are subject to review or examination by the Commissioner or his agents at all times, and a full examination of its operations is usually conducted by the National Association of Insurance Commissioners at least once in every three years. MetLife Investors USA was last examined as of December 31, 2000. While Delaware insurance law prescribes permissible investments for MetLife Investors USA, it does not prescribe permissible investments for the Separate Account, nor does it involve supervision of the investment management or policy of MetLife Investors USA. In addition, MetLife Investors USA is subject to the insurance laws and regulations of other jurisdictions in which it is licensed to operate. State insurance laws generally provide regulations for the licensing of insurers and their agents, govern the financial affairs of insurers, require approval of policy forms, impose reserve requirements and require filing of an annual statement. Generally, the insurance departments of these other jurisdictions apply the laws of Delaware in determining permissible investments for MetLife Investors USA.
485BPOS51st Page of 168TOC1stPreviousNextBottomJust 51st
FINANCIAL STATEMENTS The financial statements of MetLife Investors USA contained herein should be considered only for the purposes of informing investors as to its ability to carry out the contractual obligations as depositor under the Annuity Contracts and as custodian as described elsewhere herein and in the Prospectus. The financial statements of the Separate Account are also included in this Statement of Additional Information.
485BPOS52nd Page of 168TOC1stPreviousNextBottomJust 52nd
Independent Auditors' Report To the Board of Directors and Stockholder of MetLife Investors USA Insurance Company: We have audited the accompanying balance sheets of MetLife Investors USA Insurance Company (the "Company") as of December 31, 2003 and 2002, and the related statements of income, stockholder's equity, and cash flows for each of the three years in the period ended December 31, 2003. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of MetLife Investors USA Insurance Company as of December 31, 2003 and 2002, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2003 in conformity with accounting principles generally accepted in the United States of America. /s/ DELOITTE & TOUCHE LLP Tampa, Florida April 12, 2004 1
485BPOS53rd Page of 168TOC1stPreviousNextBottomJust 53rd
METLIFE INVESTORS USA INSURANCE COMPANY (a wholly owned subsidiary of MetLife Investors Group, Inc.) BALANCE SHEETS DECEMBER 31, 2003 and 2002 (Dollars in thousands, except share and per share data) [Enlarge/Download Table] 2003 2002 ----------- ---------- ASSETS Investments: Fixed maturities available-for-sale, at fair value (amortized cost $3,413,677 and $2,511,089, respectively) $ 3,522,671 $2,599,321 Equity securities, at fair value (cost $1,660 and $1,735, respectively) 2,027 1,929 Mortgage loans on real estate 431,973 437,721 Policy loans 35,768 37,933 Other limited partnership interests 4,124 4,348 Short-term investments 137,295 63,340 Other invested assets 7,662 2 ----------- ---------- Total investments 4,141,520 3,144,594 Cash and cash equivalents 199,952 41,452 Accrued investment income 40,540 32,165 Premiums and other receivables 45,526 36,703 Deferred policy acquisition costs 502,249 272,242 Current income taxes receivable 37,585 26,650 Deferred income taxes receivable 22,786 - Other assets 97,746 41,694 Separate account assets 6,368,724 2,597,620 ----------- ---------- Total assets $11,456,628 $6,193,120 =========== ========== LIABILITIES AND STOCKHOLDER'S EQUITY Liabilities: Future policy benefits 124,998 118,928 Policyholder account balances 3,769,822 2,837,425 Other policyholder funds 3,755 2,839 Long-term debt 35,000 35,000 Deferred income taxes payable - 14,590 Payables under securities loaned transactions 667,853 224,569 Other liabilities 183,279 154,389 Separate account liabilities 6,368,724 2,597,620 ----------- ---------- Total liabilities $11,153,431 $5,985,360 =========== ========== Stockholder's Equity: Preferred stock, par value $1.00 per share; 1,000,000 shares authorized; 200,000 issued and outstanding 200 200 Common stock, par value $200.00 per share; 15,000 shares authorized; 11,000 shares issued and outstanding 2,300 2,300 Additional paid-in capital 98,047 48,047 Retained earnings 163,383 126,001 Accumulated other comprehensive income 39,267 31,212 ----------- ---------- Total stockholder's equity 303,197 207,760 ----------- ---------- Total liabilities and stockholder's equity $11,456,628 $6,193,120 =========== ========== See accompanying notes to financial statements. 2
485BPOS54th Page of 168TOC1stPreviousNextBottomJust 54th
METLIFE INVESTORS USA INSURANCE COMPANY (a wholly owned subsidiary of MetLife Investors Group, Inc.) STATEMENTS OF INCOME FOR THE YEARS ENDED DECEMBER 31, 2003, 2002, and 2001 (Dollars in thousands) [Enlarge/Download Table] 2003 2002 2001 -------- -------- -------- REVENUES Premiums $ 5,788 $ 23,961 $ 15,915 Investment-type product policy fees 88,441 33,761 20,515 Net investment income 199,039 173,387 173,745 Other revenues 278 792 2,243 Net investment losses (net of amounts allocable from deferred acquisition costs of ($1,878), $0 and $0, respectively) (8,131) (36,177) (13,129) -------- -------- -------- Total revenues 285,415 195,724 199,289 -------- -------- -------- EXPENSES Policyholder benefits and claims 7,256 30,968 18,009 Interest credited to policyholder account balances 146,146 122,802 123,354 Other expenses (excludes amounts directly related to net investment (losses) of ($1,878), $0 and $0, respectively) 76,336 59,947 104,128 -------- -------- -------- Total expenses 229,738 213,717 245,491 -------- -------- -------- Income (loss) before provision (benefit) for income taxes 55,677 (17,993) (46,202) Provision (benefit) for income taxes 18,295 (9,034) (18,856) -------- -------- -------- Net income (loss) $ 37,382 $ (8,959) $(27,346) ======== ======== ======== See accompanying notes to financial statements. 3
485BPOS55th Page of 168TOC1stPreviousNextBottomJust 55th
METLIFE INVESTORS USA INSURANCE COMPANY (a wholly owned subsidiary of MetLife Investors Group, Inc.) STATEMENTS OF STOCKHOLDER'S EQUITY FOR THE YEARS ENDED DECEMBER 31, 2003, 2002, and 2001 (Dollars in thousands) [Enlarge/Download Table] Accumulated Additional Other Preferred Common Paid-in Retained Comprehensive Stock Stock Capital Earnings Income (Loss) Total --------- ------ ---------- -------- ------------- -------- Balance at December 31, 2000 $200 $2,300 $48,047 $182,206 $ (741) $232,012 Dividends on common stock (18,688) (18,688) Dividends on preferred stock (1,212) (1,212) Comprehensive loss: Net loss (27,346) (27,346) Other comprehensive income: Unrealized investment gains, net of related offsets, reclassification adjustments and income taxes 6,842 6,842 -------- Comprehensive loss (20,504) ------------------------------------------------------------ Balance at December 31, 2001 200 2,300 48,047 134,960 6,101 191,608 Comprehensive income: Net loss (8,959) (8,959) Other comprehensive income: Unrealized investment gains, net of related offsets, reclassification adjustments and income taxes 25,111 25,111 -------- Comprehensive income 16,152 ------------------------------------------------------------ Balance at December 31, 2002 200 2,300 48,047 126,001 31,212 207,760 Capital contribution 50,000 50,000 Comprehensive income: Net income 37,382 37,382 Other comprehensive income: Unrealized investment gains, net of related offsets, reclassification adjustments and income taxes 8,055 8,055 -------- Comprehensive income 45,437 ------------------------------------------------------------ Balance at December 31, 2003 $200 $2,300 $98,047 $163,383 $39,267 $303,197 ============================================================ See accompanying notes to financial statements. 4
485BPOS56th Page of 168TOC1stPreviousNextBottomJust 56th
METLIFE INVESTORS USA INSURANCE COMPANY (a wholly owned subsidiary of MetLife Investors Group, Inc.) STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2003, 2002, and 2001 (Dollars in thousands) [Enlarge/Download Table] 2003 2002 2001 ----------- ----------- --------- Cash flows from operating activities Net income (loss) $ 37,382 $ (8,959) $ (27,346) Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities: Depreciation and amortization expenses - - (397) Amortization of premiums and accretion of discounts associated with investments, net 16,768 4,930 (328) Losses from sale of investments, net 10,009 36,177 13,129 Interest credited to other policyholder account balances 146,146 122,802 123,354 Investment-type product policy fees (88,441) (33,761) (20,515) Change in accrued investment income (8,375) (5,275) 491 Change in premiums and other receivables (4,970) 3,304 (36,323) Change in deferred policy acquisition costs, net (237,450) (126,822) (22,550) Change in insurance-related liabilities 6,058 10,859 108,432 Change in income taxes payable (52,649) (42,048) (16,668) Change in other liabilities 21,011 53,133 113,189 Other, net 57,753 16,600 59,400 ----------- ----------- --------- Net cash (used in) provided by operating activities (96,758) 30,940 293,868 ----------- ----------- --------- Cash flows from investing activities Sales, maturities and repayments of: Fixed maturities 1,490,770 819,352 322,789 Equity securities 353 - 415 Mortgage loans on real estate 54,189 20,428 18,033 Purchases of: Fixed maturities (2,418,070) (1,536,851) (431,412) Equity securities (19) (299) (413) Mortgage loans on real estate (49,869) (29,785) (23,898) Other limited partnership interests - (4,348) - Net change in short-term investments (73,953) (53,503) 48,090 Net change in policy loans 2,165 1,354 (1,379) Net change in payable under securities loaned transactions 443,284 224,569 - Other, net (5,630) 7,482 (1,818) ----------- ----------- --------- Net cash used in investing activities (556,780) (551,601) (69,593) ----------- ----------- --------- Cash flows from financing activities Policyholder account balances: Deposits 4,333,503 1,944,211 720,136 Withdrawals (3,571,465) (1,532,552) (774,891) Dividends on preferred stock - - (1,212) Dividends on common stock - - (18,688) Capital contribution 50,000 - - ----------- ----------- --------- Net cash provided by (used in) financing activities 812,038 411,659 (74,655) ----------- ----------- --------- Change in cash and cash equivalents 158,500 (109,002) 149,620 Cash and cash equivalents, beginning of year 41,452 150,454 834 ----------- ----------- --------- Cash and cash equivalents, end of year $ 199,952 $ 41,452 $ 150,454 =========== =========== ========= Supplemental disclosures of cash flow information: Cash paid (refunded) during the year: Interest $ 2,049 $ 1,640 $ 2,196 =========== =========== ========= Income taxes $ (12,260) $ 28,256 $ 399 =========== =========== ========= See accompanying notes to financial statements. 5
485BPOS57th Page of 168TOC1stPreviousNextBottomJust 57th
METLIFE INVESTORS USA INSURANCE COMPANY (a wholly owned subsidiary of MetLife Investors Group, Inc.) NOTES TO FINANCIAL STATEMENTS 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Business MetLife Investors USA Insurance Company (the "Company"), a Delaware domiciled life insurance company is a wholly owned subsidiary of MetLife Investors Group, Inc. ("MLIG"). MLIG is a wholly owned subsidiary of MetLife, Inc. ("MetLife"). At December 31, 2002, MLIG was sold from Metropolitan Life Insurance Company ("Metropolitan Life") to MetLife. The Company markets, administers and insures a broad range of term life insurance policies and variable and fixed annuity contracts. Basis of Presentation The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP"). The Delaware State Insurance Department (the "Department") recognizes only statutory accounting practices for determining and reporting the financial condition and results of operations of an insurance company for determining solvency under the Delaware Insurance Law. No consideration is given by the Department to financial statements prepared in accordance with GAAP in making such determination. The preparation of financial statements in conformity with GAAP requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the financial statements. The significant accounting policies, estimates and related judgments underlying the Company's financial statements are summarized below. In applying these policies, management makes subjective and complex judgments that frequently require estimates about matters that are inherently uncertain. Many of these policies, estimates and related judgements are common in the insurance and financial services industries; others are specific to the Company's businesses and operations. Certain amounts in the prior years' financial statements have been reclassified to conform with the 2003 presentation. Investments The Company's principal investments are in fixed maturities and mortgage loans, both of which are exposed to three primary sources of investment risk: credit, interest rate and market valuation. The financial statement risks are those associated with the recognition of impairments and income, as well as the determination of fair values. The assessment of whether impairments have occurred is based on management's case-by-case evaluation of the underlying reasons for the decline in fair value. Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management's evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used by the Company in the impairment evaluation process include, but are not limited to: (i) the length of 6
485BPOS58th Page of 168TOC1stPreviousNextBottomJust 58th
time and the extent to which the market value has been below cost; (ii) the potential for impairments of securities when the issuer is experiencing significant financial difficulties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments of securities where the issuer, series of issuers or industry has suffered a catastrophic type of loss or has exhausted natural resources; (vi) unfavorable changes in forecasted cash flows on asset-backed securities; and (vii) other subjective factors, including concentrations and information obtained from regulators and rating agencies. In addition, the earnings on certain investments are dependent upon market conditions, which could result in prepayments and changes in amounts to be earned due to changing interest rates or equity markets. The determination of fair values in the absence of quoted market values is based on: (i) valuation methodologies; (ii) securities the Company deems to be comparable; and (iii) assumptions deemed appropriate given the circumstances. The use of different methodologies and assumptions may have a material effect on the estimated fair value amounts. The Company's fixed maturity and equity securities are classified as available-for-sale and are reported at their estimated fair value. Unrealized investment gains and losses on securities are recorded as a separate component of other comprehensive income or loss, net of policyholder related amounts and deferred income taxes. The cost of fixed maturity and equity securities is adjusted for impairments in value deemed to be other-than-temporary. These adjustments are recorded as investment losses. Investment gains and losses on sales of securities are determined on a specific identification basis. All security transactions are recorded on a trade date basis. Mortgage loans on real estate are stated at amortized cost, net of valuation allowances. Valuation allowances are established for the excess carrying value of the mortgage loan over its estimated fair value when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the contractual terms of the loan agreement. Such valuation allowances are based upon the present value of expected future cash flows discounted at the loan's original effective interest rate or the collateral value if the loan is collateral dependent. The Company also establishes allowances for loan loss when a loss contingency exists for pools of loans with similar characteristics based on property types and loan to value risk factors. A loss contingency exists when the likelihood that a future event will occur is probable based on past events. Changes in valuation allowances are included in net investment gains and losses. Interest income earned on impaired loans is accrued on the principal amount of the loan based on the loan's contractual interest rate. However, interest ceases to be accrued for loans on which interest is generally more than 60 days past due and/or where the collection of interest is not considered probable. Cash receipts on impaired loans are recorded as a reduction of the recorded investment. Policy loans are stated at unpaid principal balances. Short-term investments are stated at amortized cost, which approximates fair value. Other invested assets, which are primarily made up of collateral received under interest rate swap transactions, are reported at their estimated fair value. Derivative Financial Instruments The Company enters into freestanding derivative transactions primarily to manage the risk associated with variability in cash flows or changes in fair values related to the Company's financial assets and 7
485BPOS59th Page of 168TOC1stPreviousNextBottomJust 59th
liabilities or to changing fair values. The associated financial statement risk is the volatility in net income which can result from (i) changes in fair value of derivatives not qualifying as accounting hedges; (ii) ineffectiveness of designated hedges; and (iii) counterparty default. In addition, there is a risk that embedded derivatives requiring bifurcation are not identified and reported at fair value in the financial statements. Accounting for derivatives is complex, as evidenced by significant authoritative interpretations of the primary accounting standards which continue to evolve, as well as the significant judgments and estimates involved in determining fair value in the absence of quoted market values. These estimates are based on valuation methodologies and assumptions deemed appropriate in the circumstances. Such assumptions include estimated volatility and interest rates used in the determination of fair value where quoted market values are not available. The use of different assumptions may have a material effect on the estimated fair value amounts. The Company uses derivative instruments to manage risk through one of five principal risk management strategies, the hedging of: (i) liabilities; (ii) invested assets; (iii) portfolios of assets or liabilities; (iv) net investments in certain foreign operations; and (v) firm commitments and forecasted transactions. Additionally, the Company enters into income generation and replication derivative transactions as permitted by its insurance subsidiaries' Derivatives Use Plans approved by the applicable state insurance departments. The Company's derivative hedging strategy employs a variety of instruments, including financial futures, financial forwards, interest rate, credit default and foreign currency swaps, foreign currency forwards, and options, including caps and floors. On the date the Company enters into a derivative contract, management designates the derivative as a hedge of the identified exposure (fair value, cash flow or foreign currency). If a derivative does not qualify for hedge accounting, according to Statement of Financial Accounting Standards ("SFAS") No. 133, Accounting for Derivative Instruments and Hedging Activities, as amended ("SFAS 133"), the changes in its fair value and all scheduled periodic settlement receipts and payments are reported in net investment gains or losses. The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk management objective and strategy for undertaking various hedge transactions. In this documentation, the Company specifically identifies the asset, liability, firm commitment, foreign operation, or forecasted transaction that has been designated as a hedged item, states how the hedging instrument is expected to hedge the risks related to the hedged item, and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument's effectiveness and the method that will be used to measure hedge ineffectiveness. The Company generally determines hedge effectiveness based on total changes in fair value of a derivative instrument. The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer effective in offsetting changes in the fair value or cash flows of a hedged item; (ii) the derivative expires or is sold, terminated, or exercised; (iii) the derivative is de-designated as a hedge instrument; (iv) it is probable that the forecasted transaction will not occur; (v) a hedged firm commitment no longer meets the definition of a firm commitment; or (vi) management determines that designation of the derivative as a hedge instrument is no longer appropriate. The Company designates and accounts for the following as cash flow hedges, when they have met the effectiveness requirements of SFAS 133: (i) various types of interest rate swaps to convert floating rate investments to fixed rate investments; (ii) various types of interest rate swaps to convert floating rate liabilities into fixed rate liabilities; (iii) receive U.S. dollar fixed on foreign currency swaps to 8
485BPOS60th Page of 168TOC1stPreviousNextBottomJust 60th
hedge the foreign currency cash flow exposure of foreign currency denominated investments; (iv) foreign currency forwards to hedge the exposure of future payments or receipts in foreign currencies; and (v) other instruments to hedge the cash flows of various other forecasted transactions. For all qualifying and highly effective cash flow hedges, the effective portion of changes in fair value of the derivative instrument is reported in other comprehensive income or loss. The ineffective portion of changes in fair value of the derivative instrument is reported in net investment gains or losses. Hedged forecasted transactions, other than the receipt or payment of variable interest payments, are not expected to occur more than 12 months after hedge inception. The Company designates and accounts for the following as fair value hedges when they have met the effectiveness requirements of SFAS 133: (i) various types of interest rate swaps to convert fixed rate investments to floating rate investments; (ii) receive U.S. dollar floating on foreign currency swaps to hedge the foreign currency fair value exposure of foreign currency denominated investments; (iii) pay U.S. dollar floating on foreign currency swaps to hedge the foreign currency fair value exposure of foreign currency denominated liabilities, and (iv) other instruments to hedge various other fair value exposures of investments. For all qualifying and highly effective fair value hedges, the changes in fair value of the derivative instrument are reported as net investment gains or losses. In addition, changes in fair value attributable to the hedged portion of the underlying instrument are reported in net investment gains and losses. In addition, changes in fair value attributable to the hedged portion of the underlying instrument are reported in net investment gains and losses. When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair value hedge, the derivative continues to be carried on the balance sheet at its fair value, but the hedged asset or liability will no longer be adjusted for changes in fair value. When hedge accounting is discontinued because the hedged item no longer meets the definition of a firm commitment, the derivative continues to be carried on the balance sheet at its fair value, and any asset or liability that was recorded pursuant to recognition of the firm commitment is removed from the balance sheet and recognized as a net investment gain or loss in the current period. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur, the derivative continues to be carried on the balance sheet at its fair value, and gains and losses that were accumulated in other comprehensive income or loss are recognized immediately in net investment gains or losses. When the hedged forecasted transaction is no longer probable, but is reasonably possible, the accumulated gain or loss remains in other comprehensive income or loss and is recognized when the transaction affects net income or loss; however, prospective hedge accounting for the transaction is terminated. In all other situations in which hedge accounting is discontinued, the derivative is carried at its fair value on the balance sheet, with changes in its fair value recognized in the current period as net investment gains or losses. The Company may enter into contracts that are not themselves derivative instruments but contain embedded derivatives. For each contract, the Company assesses whether the economic characteristics of the embedded derivative are clearly and closely related to those of the host contract and determines whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and that a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is separated 9
485BPOS61st Page of 168TOC1stPreviousNextBottomJust 61st
from the host contract and accounted for as a stand-alone derivative. Such embedded derivatives are recorded on the balance sheet at fair value and changes in their fair value are recognized in the current period in net investment gains or losses. If the Company is unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried on the balance sheet at fair value, with changes in fair value recognized in the current period as net investment gains or losses. Cash and Cash Equivalents The Company considers all investments purchased with an original maturity of three months or less to be cash equivalents. Deferred Policy Acquisition Costs The Company incurs significant costs in connection with acquiring new and renewal insurance business. These costs, which vary with and are primarily related to the production of that business, are deferred. The recovery of such costs is dependent upon the future profitability of the related business. The amount of future profit is dependent principally on investment returns in excess of the amounts credited to policyholders, mortality, morbidity, persistency, interest crediting rates, expenses to administer the business, creditworthiness of reinsurance counterparties and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns are most likely to impact the rate of amortization of such costs. The aforementioned factors enter into management's estimates of gross profits, which generally are used to amortize such costs. Revisions to estimates result in changes to the amounts expensed in the reporting period in which the revisions are made and could result in the impairment of the asset and a charge to income if estimated future gross profits are less than amounts deferred. In addition, the Company utilizes the reversion to the mean assumption, a standard industry practice, in its determination of the amortization of deferred policy acquisitions cost ("DAC"). Costs, which consist principally of commissions, and policy issue expenses, are amortized with interest over the expected life of the contract for investment-type products. Generally, DAC is amortized in proportion to the present value of estimated gross profits from investment, mortality, expense margins, and surrender charges. Interest rates are based on rates in effect at the inception or acquisition of the contracts. Actual gross profits can vary from management's estimates resulting in increases or decreases in the rate of amortization. This practice assumes that the expectation for long-term equity investment is not changed by minor short-term market fluctuations, but that it does change when large interim deviations have occurred. Management periodically updates these estimates and evaluates the recoverability of DAC. When appropriate, management revises its assumptions of the estimated gross profits of these contracts, and the cumulative amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. DAC for non-participating traditional life and annuity policies with life contingencies are amortized in proportion to anticipated premiums. Assumptions as to anticipated premiums are made at the date of policy issuance or acquisition and are consistently applied during the lives of the contracts. Deviations from estimated experience are included in operations when they occur. For these contracts, the amortization period is typically the estimated life of the policy. 10
485BPOS62nd Page of 168TOC1stPreviousNextBottomJust 62nd
Policy acquisition costs related to internally replaced contracts are expensed at the date of replacement. Future Policy Benefits The Company establishes liabilities for amounts payable under insurance policies, including traditional life insurance and annuities. Generally, amounts are payable over an extended period of time and liabilities are established based on methods and underlying assumptions in accordance with GAAP and applicable actuarial standards. Principal assumptions used in the establishment of liabilities for future policy benefits are mortality, morbidity, expenses, persistency, investment returns and inflation. Differences between the actual experience and assumptions used in pricing these policies and in the establishment of liabilities result in variances in profit and could result in losses. Recognition of Insurance Revenue and Related Benefits Premiums related to traditional life and annuity policies with life contingencies are recognized as revenues when due. Benefits and expenses are provided against such revenues to recognize profits over the estimated lives of the policies. When premiums are due over a significantly shorter period than the period over which benefits are provided, any excess profit is deferred and recognized into operations in a constant relationship to insurance in-force or, for annuities, the amount of expected future policy benefit payments. Deposits related to investment-type products are credited to policyholder account balances. Revenues from such contracts consist of amounts assessed against policyholder account balances for mortality, policy administration and surrender charges and are recognized in the period in which services are provided. Amounts that are charged to operations include interest credited and benefit claims incurred in excess of related policyholder account balances. Other Revenues Other revenues include asset management and advisory fees, commissions and fees, and administrative service fees. Such fees and commissions are recognized in the period in which services are performed. Income Taxes The Company applies the concepts of SFAS No. 109, Accounting for Income Taxes ("SFAS 109"), which establishes deferred tax assets and liabilities based upon the difference between the financial statement and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which the differences are expected to reverse. SFAS 109 allows recognition of deferred tax assets if future realization of the tax benefit is more likely than not, with a valuation allowance for the portion that is not likely to be realized. Reinsurance The Company enters into reinsurance transactions as a purchaser of reinsurance. Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future 11
485BPOS63rd Page of 168TOC1stPreviousNextBottomJust 63rd
performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the financial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed previously. Additionally, for each of its reinsurance contracts, the Company must determine if the contract provides indemnification against loss or liability relating to insurance risk, in accordance with applicable accounting standards. The Company must review all contractual features, particularly those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims. If the Company determines that a reinsurance contract does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the contract using the deposit method of accounting. In the normal course of business, the Company seeks to limit its exposure to losses on large risks by ceding risks to other insurance enterprises or reinsurers. Reinsurance activities are accounted for as consistent with the terms of the underlying contracts. Premiums ceded to other companies have been reported as a reduction of premiums. Amounts applicable to reinsurance ceded for future policy benefits and claim liabilities have been reported as assets for these items, and commissions and expense allowances received in connection with reinsurance ceded have been accounted for in income as earned. Reinsurance does not relieve the Company from its primary responsibility to meet claim obligations. The Company evaluates the financial conditions of its reinsurers periodically. Separate Accounts Separate accounts are established in conformity with insurance laws and are generally not chargeable with liabilities that arise from any other business of the Company. Separate account assets are subject to general account claims only to the extent the value of such assets exceeds the separate account liabilities. Investments (stated at estimated fair value) and liabilities of the separate accounts are reported separately as assets and liabilities. Deposits to separate accounts, investment income and recognized and unrealized gains and losses on the investments of the separate accounts accrue directly to contractholders and, accordingly, are not reflected in the revenues of the Company. Fees charged to contractholders, principally mortality, policy administration and surrender charges are included in investment-type products fees. Application of Recent Accounting Pronouncements Effective December 31, 2003, the Company adopted Emerging Issues Task Force ("EITF") Issue No. 03-1, The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments ("EITF 03-1"). EITF 03-1 provides guidance on the disclosure requirements for other-than-temporary impairments of debt and marketable equity investments that are accounted for under Statement of Financial Accounting Standards ("SFAS") No. 115, Accounting for Certain Investments in Debt and Equity Securities ("SFAS 115"). The adoption of EITF 03-1 requires the Company to include certain quantitative and qualitative disclosures for debt and marketable equity securities classified as available-for-sale or held-to-maturity under SFAS 115 that are impaired at the balance sheet date but for which an other-than-temporary impairment has not been recognized. See Note 2. The initial adoption of EITF 03-1, which only required additional disclosures, did not have a material impact on the Company's financial statements. 12
485BPOS64th Page of 168TOC1stPreviousNextBottomJust 64th
In July 2003, the Accounting Standards Executive Committee of the American Institute of Certified Public Accountants issued Statement of Position 03-1, Accounting and Reporting by Insurance Enterprises for Certain Nontraditional Long-Duration Contracts and for Separate Accounts ("SOP 03-1"). SOP 03-1 provides guidance on (i) the classification and valuation of long-duration contract liabilities, (ii) the accounting for sales inducements and (iii) separate account presentation and valuation. SOP 03-1 is effective for fiscal years beginning after December 15, 2003. As of January 1, 2004, the Company decreased future policyholder benefits for various guaranteed minimum death and income benefits net of DAC and unearned revenue liability offsets under certain variable annuity contracts of approximately $2,118 thousand, net of income tax, which will be reported as a cumulative effect of a change in accounting. Industry standards and practices continue to evolve relating to the valuation of liabilities relating to these types of benefits, which may result in further adjustments to the Company's measurement of liabilities associated with such benefits in subsequent accounting periods. Effective with the adoption of SOP 03-1, costs associated with enhanced or bonus crediting rates to contractholders must be deferred and amortized over the life of the related contract using assumptions consistent with the amortization of DAC, which has been the Company's accounting treatment The adoption of SOP 03-1 did not have a material impact on the Company's separate account presentation and valuation. In April 2003, the Financial Accounting Standards Board ("FASB") cleared Statement 133 Implementation Issue No. B36, Embedded Derivatives: Modified Coinsurance Arrangements and Debt Instruments That Incorporate Credit Risk Exposures That Are Unrelated or Only Partially Related to the Creditworthiness of the Obligor under Those Instruments ("Issue B36"). Issue B36 concluded that (i) a company's funds withheld payable and/or receivable under certain reinsurance arrangements, and (ii) a debt instrument that incorporates credit risk exposures that are unrelated or only partially related to the creditworthiness of the obligor include an embedded derivative feature that is not clearly and closely related to the host contract. Therefore, the embedded derivative feature must be measured at fair value on the balance sheet and changes in fair value reported in income. Issue B36 became effective on October 1, 2003 did not have a significant impact on the Company's financial statements. In April 2003, the FASB issued SFAS No. 149, Amendment of Statement 133 on Derivative Instruments and Hedging Activities ("SFAS 149"). SFAS 149 amends and clarifies the accounting and reporting for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. Except for certain implementation guidance that is incorporated in SFAS 149 and already effective, SFAS 149 is effective for contracts entered into or modified after June 30, 2003. The Company's adoption of SFAS 149 on July 1, 2003 did not have a significant impact on its financial statements. During 2003, the Company adopted FASB Interpretation No. 46 Consolidation of Variable Interest Entities--An Interpretation of ARB No. 51 ("FIN 46") and its December 2003 revision ("FIN 46(r)"). Certain of the Company's other limited partnership interests meet the definition of a variable interest entity ("VIE") and must be consolidated, in accordance with the transition rules and effective dates, if the Company is deemed to be the primary beneficiary. A VIE is defined as (i) any entity in which the equity investments at risk in such entity do not have the characteristics of a controlling financial interest or (ii) any entity that does not have sufficient equity at risk to finance its activities without additional subordinated support from other parties. Effective February 1, 2003, the Company adopted FIN 46 for VIEs created or acquired on or after February 1, 2003 and, effective December 31, 2003, the Company adopted FIN 46(r) with respect to interests in entities formerly considered special purpose entities ("SPEs") including interests in asset-backed securities and collateralized debt 13
485BPOS65th Page of 168TOC1stPreviousNextBottomJust 65th
obligations. In accordance with the provisions in FIN 46(r), the Company has elected to defer until March 31, 2004 the consolidation of interests in VIEs for non SPEs acquired prior to February 1, 2003 for which it is the primary beneficiary. The adoption of FIN 46 as of February 1, 2003 did not have a significant impact on the Company's financial statements. The adoption of the provisions of FIN 46(r) at December 31, 2003 did not have a material affect on the Company's financial statements. Effective January 1, 2003, the Company adopted FIN No. 45, Guarantor's Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others ("FIN 45"). FIN 45 requires entities to establish liabilities for certain types of guarantees and expands financial statement disclosures for others. The initial recognition and initial measurement provisions of FIN 45 are applicable on a prospective basis to guarantees issued or modified after December 31, 2002. The adoption of FIN 45 did not have a significant impact on the Company's financial statements. Effective January 1, 2003, the Company adopted SFAS No. 146, Accounting for Costs Associated with Exit or Disposal Activities ("SFAS 146"). SFAS 146 requires that a liability for a cost associated with an exit or disposal activity be recorded and measured initially at fair value only when the liability is incurred rather than at the date of an entity's commitment to an exit plan as required by EITF Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring). The Company's activities subject to this guidance in 2003 were not significant. Effective January 1, 2003, the Company adopted SFAS No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections ("SFAS 145"). In addition to amending or rescinding other existing authoritative pronouncements to make various technical corrections, clarify meanings, or describe their applicability under changed conditions, SFAS 145 generally precludes companies from recording gains and losses from the extinguishment of debt as an extraordinary item. SFAS 145 also requires sale-leaseback treatment for certain modifications of a capital lease that result in the lease being classified as an operating lease. The adoption of SFAS 145 did not have a significant impact on the Company's financial statements. Effective January 1, 2002, the Company adopted SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets ("SFAS 144"). SFAS 144 provides a single model for accounting for long-lived assets to be disposed of by superseding SFAS No. 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of ("SFAS 121"), and the accounting and reporting provisions of Accounting Principles Board Opinion No. 30, Reporting the Results of Operations--Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions ("APB 30"). Under SFAS 144, discontinued operations are measured at the lower of carrying value or fair value less costs to sell, rather than on a net realizable value basis. Future operating losses relating to discontinued operations also are no longer recognized before they occur. SFAS 144 (i) broadens the definition of a discontinued operation to include a component of an entity (rather than a segment of a business); (ii) requires long-lived assets to be disposed of other than by sale to be considered held and used until disposed; and (iii) retains the basic provisions of (a) APB 30 regarding the presentation of discontinued operations in the statements of income, (b) SFAS 121 relating to recognition and measurement of impaired long-lived assets (other than goodwill), and (c) SFAS 121 relating to the measurement of long-lived assets classified as held-for-sale. Adoption of SFAS 144 did not have a material impact on the Company's financial statements. 14
485BPOS66th Page of 168TOC1stPreviousNextBottomJust 66th
In July 2001, the U.S. Securities and Exchange Commission ("SEC") released Staff Accounting Bulletin ("SAB") No. 102, Selected Loan Loss Allowance and Documentation Issues ("SAB 102"). SAB 102 summarizes certain of the SEC's views on the development, documentation and application of a systematic methodology for determining allowances for loan and lease losses. The application of SAB 102 by the Company did not have a material impact on the Company's financial statements. Effective April 1, 2001, the Company adopted certain additional accounting and reporting requirements of SFAS No. 140, Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities--a Replacement FASB Statement No. 125, relating to the derecognition of transferred assets and extinguished liabilities and the reporting of servicing assets and liabilities. The adoption of these requirements did not have a material impact on the Company's financial statements. Effective April 1, 2001, the Company adopted EITF 99-20, Recognition of Interest Income and Impairment on Certain Investments ("EITF 99-20"). This pronouncement requires investors in certain asset-backed securities to record changes in their estimated yield on a prospective basis and to apply specific evaluation methods to these securities for an other-than-temporary decline in value. The adoption of EITF 99-20 did not have a material impact on the Company's financial statements. Effective January 1, 2001, the Company adopted SFAS 133 which established new accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. The cumulative effect of the adoption of SFAS 133, as of January 1, 2001, had no material impact on the Company's financial statements. The FASB continues to issue additional guidance relating to the accounting for derivatives under SFAS 133, which may result in further adjustments to the Company's treatment of derivatives in subsequent accounting periods. 15
485BPOS67th Page of 168TOC1stPreviousNextBottomJust 67th
2. INVESTMENTS Fixed Maturities and Equity Securities Fixed maturities and equity securities at December 31, 2003 were as follows: [Download Table] Cost or Gross Unrealized Estimated Amortized ---------------- Fair Cost Gain Loss Value ---------- -------- ------- ---------- (Dollars in thousands) Fixed Maturities: U.S. corporate securities $1,423,547 $ 76,237 $ 5,405 $1,494,379 Mortgage-backed securities 832,042 7,753 6,323 833,472 Foreign corporate securities 337,736 25,826 1,626 361,936 U.S. treasuries/agencies 57,399 2,886 75 60,210 Asset-backed securities 358,078 6,381 1,626 362,833 Commercial mortgage-backed securities 320,465 3,485 2,698 321,252 Foreign government securities 74,431 6,311 2,153 78,589 State and political subdivisions 9,979 21 - 10,000 ---------- -------- ------- ---------- Total fixed maturities $3,413,677 $128,900 $19,906 $3,522,671 ========== ======== ======= ========== Equity Securities: Common stocks $ 1,660 $ 367 $ - $ 2,027 ========== ======== ======= ========== Fixed maturities and equity securities at December 31, 2002 were as follows: [Download Table] Cost or Gross Unrealized Estimated Amortized ---------------- Fair Cost Gain Loss Value ---------- -------- ------- ---------- (Dollars in thousands) Fixed Maturities: U.S. corporate securities $ 959,507 $ 57,787 $22,130 $ 995,164 Mortgage-backed securities 596,478 14,602 1,190 609,890 Foreign corporate securities 298,136 23,062 2,911 318,287 U.S. treasuries/agencies 214,451 3,780 23 218,208 Asset-backed securities 283,223 9,658 1,071 291,810 Commercial mortgage-backed securities 114,523 3,782 465 117,840 Foreign government securities 44,771 3,444 93 48,122 ---------- -------- ------- ---------- Total fixed maturities $2,511,089 $116,115 $27,883 $2,599,321 ========== ======== ======= ========== Equity Securities: Common stocks $ 1,735 $ 194 $ - $ 1,929 ========== ======== ======= ========== The Company held foreign currency derivatives with notional amounts of $17,909 thousand to hedge the exchange rate risk associated with foreign bonds and loans at December 31, 2003. The Company did not hold any foreign currency derivatives with notional amounts to hedge the exchange rate risk associated with foreign bonds and loans at December 31, 2002. The Company held fixed maturities at estimated fair values that were below investment grade or not rated by an independent rating agency that totaled $247,679 thousand and $176,397 thousand at December 31, 2003 and 2002, respectively. These securities had a net unrealized gain of $12,569 16
485BPOS68th Page of 168TOC1stPreviousNextBottomJust 68th
thousand and a loss of $7,774 thousand at December 31, 2003 and 2002, respectively. At December 31, 2003 and 2002, non-income producing fixed maturities were $2,070 thousand and $2,588 thousand, respectively. The cost or amortized cost and estimated fair value of fixed maturities at December 31, 2003, by contractual maturity date (excluding scheduled sinking funds), are shown below: [Download Table] Cost or Estimated Amortized Fair Cost Value ---------- ---------- (Dollars in thousands) Due in one year or less $ 75,538 $ 77,261 Due after one year through five years 848,929 881,062 Due after five years through ten years 686,109 725,611 Due after ten years 292,516 321,180 ---------- ---------- Subtotal 1,903,092 2,005,114 Mortgage-backed and asset-backed securities 1,510,585 1,517,557 ---------- ---------- Total fixed maturities $3,413,677 $3,522,671 ========== ========== Fixed maturities not due at a single maturity date have been included in the above table in the year of final maturity. Actual maturities may differ from contractual maturities due to the exercise of prepayment options. Sales of fixed maturities and equity securities classified as available-for sale were as follows: [Download Table] Years Ended December 31, ---------------------------- 2003 2002 2001 -------- -------- -------- (Dollars in thousands) Proceeds $466,262 $344,356 $943,228 Gross investment gains 7,703 8,806 360 Gross investment losses (10,993) (22,705) (6,589) Gross investment losses above exclude writedowns recorded during 2003, 2002 and 2001 for other than temporarily impaired available-for-sale fixed maturities and equity securities of $1,852 thousand, $20,098 thousand, and $4,918 thousand, respectively. Excluding investments in U.S. Treasury securities and obligations of U.S. government corporations and agencies, the Company is not exposed to any significant concentration of credit risk in its fixed maturities portfolio. 17
485BPOS69th Page of 168TOC1stPreviousNextBottomJust 69th
The following table shows the estimated fair values and gross unrealized losses of the Company's fixed maturities, aggregated by sector and length of time that the securities have been in a continuous unrealized loss position at December 31, 2003: [Enlarge/Download Table] Equal to or greater Less than 12 months than 12 months Total -------------------- -------------------- --------------------- Estimated Gross Estimated Gross Estimated Gross Fair Unrealized Fair Unrealized Fair Unrealized Value Loss Value Loss Value Loss --------- ---------- --------- ---------- ---------- ---------- (Dollars in thousands) U.S. corporate securities $261,803 $ 4,696 $ 6,286 $ 709 $ 268,089 $ 5,405 Mortgage-backed securities 363,680 5,977 9,880 346 373,560 6,323 Foreign corporate securities 52,402 1,393 12,953 233 65,355 1,626 U.S. treasuries/agencies 13,620 75 - - 13,620 75 Asset-backed securities 90,572 1,337 8,015 289 98,587 1,626 Commercial mortgage-backed securities 161,184 2,682 12,484 16 173,668 2,698 Foreign government securities 14,039 2,153 - - 14,039 2,153 -------- ------- ------- ------ ---------- ------- Total fixed maturities $957,300 $18,313 $49,618 $1,593 $1,006,918 $19,906 ======== ======= ======= ====== ========== ======= There were no equity securities in a continuous unrealized loss position at December 31, 2003. Securities Lending Program The Company participates in securities lending programs whereby blocks of securities, which are included in investments, are loaned to third parties, primarily major brokerage firms. The Company requires a minimum of 102% of the fair value of the loaned securities to be separately maintained as collateral for the loans. Securities with a cost or amortized cost of $622,695 thousand and $201,585 thousand and an estimated fair value of $640,701 thousand and $219,662 thousand were on loan under the program at December 31, 2003 and 2002, respectively. The Company was liable for cash collateral under its control of $667,853 thousand and $224,569 thousand at December 31, 2003 and 2002 respectively. Security collateral on deposit from customers may not be sold or repledged and is not reflected in the financial statements. Assets on Deposit The Company had investment assets on deposit with regulatory agencies with a fair market value of $5,158 thousand and $5,515 thousand at December 31, 2003 and 2002, respectively. Mortgage Loans on Real Estate Mortgage loans on real estate were categorized as follows: [Download Table] December 31, -------------------------------- 2003 2002 --------------- --------------- Amount Percent Amount Percent -------- ------- -------- ------- (Dollars in thousands) Commercial mortgage loans $349,995 81% $373,007 85% Agricultural mortgage loans 83,213 19% 66,762 15% -------- --- -------- --- Total 433,208 100% 439,769 100% === === Less: Valuation allowances 1,235 2,048 -------- -------- Mortgage loans $431,973 $437,721 ======== ======== 18
485BPOS70th Page of 168TOC1stPreviousNextBottomJust 70th
Mortgage loans on real estate are collateralized by properties primarily located throughout the United States. At December 31, 2003, 28%, 12% and 7% of the properties were located in California, Rhode Island and Delaware, respectively. Generally, the Company (as the lender) requires that a minimum of one-fourth of the purchase price of the underlying real estate be paid by the borrower. Changes in mortgage loan valuation allowances were as follows: [Download Table] Years Ended December 31, --------------- 2003 2002 ------- ------ (Dollars in thousands) Balance at January 1 $ 2,048 $ - Additions 2,225 2,048 Deductions (3,038) - ------- ------ Balance at December 31 $ 1,235 $2,048 ======= ====== A portion of the Company's mortgage loans on real estate was impaired and consisted of the following: [Download Table] December 31, -------------- 2003 2002 ------ ------- (Dollars in thousands) Impaired mortgage loans with valuation allowances $ - $ 6,170 Impaired mortgage loans without valuation allowances 3,679 3,928 ------ ------- Total 3,679 10,098 Less: Valuation allowances on impaired mortgages - 2,048 ------ ------- Impaired mortgage loans $3,679 $ 8,050 ====== ======= The average investment in impaired mortgage loans on real estate was $3,875 thousand and $3,682 thousand for the years ended December 31, 2003 and 2002 respectively. Interest income on impaired mortgage loans was $289 thousand and $806 thousand for the years ended December 31, 2003 and 2002 respectively. The investment in restructured mortgage loans on real estate was $3,679 thousand and $3,928 thousand at December 31, 2003 and 2002, respectively. Interest income of $373 thousand and $282 thousand was recognized on restructured loans for the years ended December 31, 2003 and 2002, respectively. Gross interest income that would have been recorded in accordance with the original terms of such loans amounted to $358 thousand and $282 thousand for the years ended December 31, 2003 and 2002, respectively. 19
485BPOS71st Page of 168TOC1stPreviousNextBottomJust 71st
There were no mortgage loans on real estate with scheduled payments of 60 days (90 days for agriculture mortgages) or more past due or in foreclosure at December 31, 2003 and 2002. Net Investment Income The components of net investment income were as follows: [Download Table] Years Ended December 31, -------------------------- 2003 2002 2001 -------- -------- -------- (Dollars in thousands) Fixed maturities $165,910 $138,069 $130,888 Equity securities - - (52) Mortgage loans on real estate 32,474 30,950 33,852 Policy loans 1,756 1,813 1,800 Cash, cash equivalents and short-term investments 5,770 3,424 6,054 Other - - 1,983 -------- -------- -------- Total 205,910 174,256 174,525 Less: Investment expenses 6,871 869 780 -------- -------- -------- Net investment income $199,039 $173,387 $173,745 ======== ======== ======== Net Investment Gains (Losses) Net investment gains (losses), including changes in valuation allowances, were as follows: [Download Table] Years Ended December 31, ---------------------------- 2003 2002 2001 -------- -------- -------- (Dollars in thousands) Fixed maturities $ (5,401) $(33,476) $(11,152) Equity securities 259 (521) 5 Mortgage loans on real estate (2,708) (2,048) - Derivatives (2,161) (151) (1,982) Other 2 19 - -------- -------- -------- Total (10,009) (36,177) (13,129) Amounts allocable to: Deferred policy acquisition costs 1,878 - - -------- -------- -------- Net investment losses $ (8,131) $(36,177) $(13,129) ======== ======== ======== 20
485BPOS72nd Page of 168TOC1stPreviousNextBottomJust 72nd
Net Unrealized Investment Gains (Losses) The components of net unrealized investment gains (losses), included in accumulated other comprehensive income, were as follows: [Download Table] Years Ended December 31, --------------------------- 2003 2002 2001 -------- -------- ------- (Dollars in thousands) Fixed maturities $110,105 $ 88,232 $14,972 Equity securities 367 194 (428) Derivatives (2,211) - - -------- -------- ------- Total 108,261 88,426 14,544 -------- -------- ------- Amounts allocable to: Deferred policy acquisition costs (47,850) (40,408) (4,572) Deferred income taxes (21,144) (16,806) (3,871) -------- -------- ------- Total (68,994) (57,214) (8,443) -------- -------- ------- Net unrealized investment gains (losses) $ 39,267 $ 31,212 $ 6,101 ======== ======== ======= The changes in net unrealized investment gains (losses) were as follows: [Download Table] Years Ended December 31, -------------------------- 2003 2002 2001 ------- -------- ------- (Dollars in thousands) Balance at January 1 $31,212 $ 6,101 $ (741) Unrealized investment gains during the year 19,835 73,882 17,312 Unrealized investment losses relating to: Deferred policy acquisition costs (7,442) (35,836) (6,199) Deferred income taxes (4,338) (12,935) (4,271) ------- -------- ------- Balance at December 31 $39,267 $ 31,212 $ 6,101 ======= ======== ======= Net change in unrealized investment gains $ 8,055 $ 25,111 $ 6,842 ======= ======== ======= Variable Interest Entities As discussed in Note 1, the Company has adopted the provisions of FIN 46 and FIN 46(r). At December 31, 2003, FIN 46(r) did not require the Company to consolidate any additional VIEs that were not previously consolidated. 21
485BPOS73rd Page of 168TOC1stPreviousNextBottomJust 73rd
The following table presents the total assets of and the maximum exposure to loss relating to VIEs for which the Company holds significant valuable interests but it is not the primary beneficiary: [Download Table] As of December 31, 2003 ---------------------- Maximum Total Exposure Assets (1) to Loss (2) ---------- ----------- (Dollars in Thousands) Other Limited Partnerships (3) $4,726 $- ------ -- $4,726 $- ====== == (1) The assets of the other limited partnerships are reflected at the carrying amounts at which such assets would have been reflected on the Company's balance sheet had the Company consolidated the VIE from the date of its initial investment in the entity. (2) The maximum exposure to loss relating to other limited partnerships is equal to the carrying amounts plus any unfunded commitments which reduced by amounts guaranteed by other partners. (3) Other limited partnerships include partnerships established for the purpose of investing in public and private debt and equity securities, as well as limited partnerships established for the purpose of investing in low-income housing that qualifies for Federal tax credits 3. DERIVATIVE FINANCIAL INSTRUMENTS The table below provides a summary of the notional amount and fair value of derivative financial instruments held at December 31, 2003 and 2002: [Download Table] 2003 2002 --------------------------- --------------------------- Current Market or Current Market or Fair Value Fair Value Notional ------------------ Notional ------------------ Amount Assets Liabilities Amount Assets Liabilities -------- ------ ----------- -------- ------ ----------- (Dollars in thousands) Financial futures $106,500 $ - $2,051 $ - $- $- Caps 150,000 10 - 270,000 2 - Foreign currency swaps 17,909 - 2,813 - - - -------- --- ------ -------- -- -- Total contractual commitments $274,409 $10 $4,864 $270,000 $2 $- ======== === ====== ======== == == 22
485BPOS74th Page of 168TOC1stPreviousNextBottomJust 74th
The following is a reconciliation of the notional amounts by derivative type at December 31, 2003 and 2002: [Download Table] December 31, December 31, 2002 2003 Notional Terminations/ Notional Amount Additions Maturities Amount ------------ --------- ------------- ------------ (Dollars in thousands) BY DERIVATIVE TYPE Financial futures $ - $213,000 $106,500 $106,500 Caps 270,000 - 120,000 150,000 Foreign currency swaps - 17,909 - 17,909 -------- -------- -------- -------- Total contractual commitments $270,000 $230,909 $226,500 $274,409 ======== ======== ======== ======== BY DERIVATIVE STRATEGY Liability hedging $270,000 $ - $120,000 $150,000 Invested asset hedging - 230,909 106,500 124,409 -------- -------- -------- -------- Total contractual commitments $270,000 $230,909 $226,500 $274,409 ======== ======== ======== ======== The following table presents the notional amounts of derivative financial instruments by maturity at December 31, 2003: [Download Table] Remaining Life ------------------------------------------------------- After One Year After Five Years After One Year Through Five Through Ten Ten or Less Years Years Years Total -------- -------------- ---------------- ----- -------- (Dollars in thousands) Financial futures $106,500 $ - $ - $- $106,500 Caps 150,000 - - - 150,000 Foreign currency swaps - 5,866 12,043 - 17,909 -------- ------ ------- -- -------- Total contractual commitments $256,500 $5,866 $12,043 $- $274,409 ======== ====== ======= == ======== The following table presents the notional amounts and fair values of derivatives by type of hedge designation at December 31, 2003 and 2002: [Download Table] 2003 2002 --------------------------- --------------------------- Fair Value Fair Value Notional ------------------ Notional ------------------ Amount Assets Liabilities Amount Assets Liabilities -------- ------ ----------- -------- ------ ----------- (Dollars in thousands) BY TYPE OF HEDGE Fair value $112,366 $ - $2,509 $ - $- $- Cash flow 12,043 - 2,355 - - - Non qualifying 150,000 10 - 270,000 2 - -------- --- ------ -------- -- -- Total $274,409 $10 $4,864 $270,000 $2 $- ======== === ====== ======== == == The Company recognized net investment expense of $420 thousand from the periodic settlement of foreign currency swaps that qualify as accounting hedges under SFAS 133, as amended, for the year 23
485BPOS75th Page of 168TOC1stPreviousNextBottomJust 75th
ended December 31, 2003. During the years ended December 31, 2002 and 2001, there were no derivative instruments designated as qualifying accounting hedges under SFAS No. 133. During the year ended December 31, 2003, the Company recognized $2,509 thousand in net investment losses related to qualifying fair value hedges. Accordingly, $427 thousand of net unrealized gains on fair value hedged investments were recognized in net investment losses during the year ended December 31, 2003. There were no discontinued fair value hedges during the year ended December 31, 2003. There were no derivatives designated as fair value hedges during the years ended December 31, 2001 or 2002. For the year ended December 31, 2003, the net amounts accumulated in other comprehensive income relating to cash flow hedges were losses of $2,211 thousand. There were no amounts accumulated in other comprehensive income at December 31, 2002. For the year ended December 31, 2003 the market value of cash flow hedges decreased by $2,355 thousand. During the year ended December 31, 2003, the Company recognized $2,211 thousand of other comprehensive net losses relating to the effective portion of cash flow hedges. During the year ended December 31, 2003 there were no amounts of other comprehensive expense was reclassified to net investment income. During the year ended December 31, 2003 no cash flow hedges were discontinued. During the years ended December 31, 2002 and 2001 there were no cash flow hedges. The Company has no SFAS 133 transition adjustment. There are no amounts of investment expense or net loss reported in accumulated other comprehensive income at December 31, 2003 that are expected to be reclassified during the year ending December 31, 2004 into net investment income and net investment gains and losses, respectively, as the derivatives and underlying investments mature or expire according to their original terms. For the years ended December 31, 2003, 2002 and 2001, the Company recognized $66 thousand, $48 thousand, and $39 thousand in net investment expense from the periodic settlement payments on derivative instruments, respectively, and $0 thousand, $104 thousand, and $1,982 thousand, respectively, in net investment losses from changes in fair value related to derivatives not qualifying as accounting hedges. 24
485BPOS76th Page of 168TOC1stPreviousNextBottomJust 76th
4. INSURANCE Deferred Policy Acquisition Costs Information regarding DAC for the years ended December 31, 2003, 2002 and 2001 is as follows (dollars in thousands): [Download Table] Balance at January 1, 2001 $164,905 Capitalizations 7,579 -------- Total 172,484 -------- Amortization allocated to: Unrealized investment gains (losses) 6,199 Other expenses (14,971) -------- Total amortization (8,772) -------- Balance at December 31, 2001 181,256 Capitalizations 128,517 -------- Total 309,773 -------- Amortization allocated to: Unrealized investment gains (losses) 35,836 Other expenses 1,695 -------- Total amortization 37,531 -------- Balance at December 31, 2002 272,242 Capitalizations 248,954 -------- Total 521,196 -------- Amortization allocated to: Net investment gains (losses) (1,878) Unrealized investment gains (losses) 7,442 Other expenses 13,383 -------- Total amortization 18,947 -------- Balance at December 31, 2003 $502,249 ======== Amortization of DAC is allocated to (i) investment gains and losses to provide statement of income information regarding the impact of such gains and losses on the amount of the amortization, (ii) unrealized investment gains and losses to provide information regarding the amount that would have been amortized if such gains and losses had been recognized, and (iii) other expenses to provide amounts related to the gross profits originating from transactions other than investment gains and losses. Investment gains and losses related to certain products have a direct impact on the amortization of DAC. Presenting investment gains and losses net of related amortization of DAC provides information useful in evaluating the operating performance of the Company. This presentation may not be comparable to presentations made by other insurers. 25
485BPOS77th Page of 168TOC1stPreviousNextBottomJust 77th
Future Policy Benefits Future policy benefit liabilities for traditional annuities are equal to accumulated contractholder fund balances during the accumulation period and the present value of expected future payments after annuitization. Interest rates used in establishing such liabilities range from 4% to 9%. Policyholder account balances for investment-type contracts are equal to the policy account values, which consist of an accumulation of gross premium payments plus credited interest, ranging from 2% to 9%, less expenses, mortality charges, and withdrawals. Separate Accounts Separate accounts include one category of account type: non-guaranteed separate accounts totaling $6,368,724 thousand and $2,597,620 thousand at December 31, 2003 and 2002, respectively, for which the policyholder assumes the investment risk. Fees charged to the separate accounts by the Company (including mortality charges, policy administration fees and surrender charges) are reflected in the Company's revenues as investment-type product policy fees and totaled $88,441 thousand, $33,761 thousand and $20,515 thousand for the years ended December 31, 2003, 2002 and 2001, respectively. 5. REINSURANCE Effective April 1, 2001, the Company entered into a Yearly Renewable Term reinsurance agreement with Exeter Reassurance Company, Ltd., (a MetLife affiliate) to automatically cede varying percentages of the Guaranteed Minimum Death Benefit Rider, Guaranteed Minimum Income Benefit Rider and Earnings Preservation Benefit Rider associated with certain variable annuity contracts. The Company ceded liabilities of $1,322 thousand and $267 thousand at December 31, 2003 and 2002, respectively. The Company recognized operating losses of approximately $2,626 thousand, $560 thousand and $61 thousand from this transaction in 2003, 2002 and 2001, respectively. The Company currently reinsures 90% of its new production of variable and fixed annuities to an affiliate. Also, the Company currently reinsures 55% of the riders containing benefit guarantees related to variable annuities. The Company is contingently liable with respect to ceded reinsurance should any reinsurer be unable to meet its obligations under these agreements. The amounts in the statements of income are presented net of reinsurance ceded. The effects of reinsurance were as follows: [Download Table] Year Ended December 31, ------------------------- 2003 2002 2001 ------- ------- ------- (Dollars in thousands) Direct premiums $10,886 $28,835 $21,031 Reinsurance ceded (5,098) (4,874) (5,116) ------- ------- ------- Net premiums $ 5,788 $23,961 $15,915 ======= ======= ======= Reinsurance recoveries netted against policyholder benefits $ 3,567 $ 4,910 $ 2,942 ======= ======= ======= 26
485BPOS78th Page of 168TOC1stPreviousNextBottomJust 78th
Reinsurance recoverables, included in premiums and other receivables, were $31,793 thousand and $30,309 thousand at December 31, 2003 and 2002, respectively. 6. DEBT Debt consisted of the following: [Download Table] December 31, --------------- 2003 2002 ------- ------- (Dollars in thousands) Surplus notes, interest rate 5% $25,000 $25,000 Surplus notes, interest rate LIBOR plus .75% 10,000 10,000 ------- ------- Total long-term debt $35,000 $35,000 ======= ======= Payments of interest and principal on the surplus notes, subordinated to all other indebtedness, may be made only with the prior approval of the insurance department of the state of domicile. Subject to the prior approval of the Superintendent, the surplus notes may be redeemed, in whole or in part, at the election of MLIG at any time. The aggregate maturities of long-term debt for the Company are payable upon regulatory approval. There are no principal payments due on the notes payable during the next five years. Interest expense related to the Company's indebtedness, included in other expenses, was $2,049 thousand, $1,640 thousand and $2,136 thousand for the years ended December 31, 2003, 2002 and 2001, respectively. 7. INCOME TAXES The provision for income taxes for operations was as follows: [Download Table] Years Ended December 31, ---------------------------- 2003 2002 2001 -------- -------- -------- (Dollars in thousands) Current income tax expense (benefit) Federal $ 55,612 $ 15,353 $ (9,669) State 2,507 - - Deferred income tax benefit Federal (38,540) (24,387) (9,187) State (1,284) - - -------- -------- -------- Provision for income tax expense (benefit) $ 18,295 $ (9,034) $(18,856) ======== ======== ======== 27
485BPOS79th Page of 168TOC1stPreviousNextBottomJust 79th
Reconciliations of the income tax provision at the U.S. statutory rate to the provision for income taxes as reported for operations were as follows: [Download Table] Years Ended December 31, -------------------------- 2003 2002 2001 ------- ------- -------- (Dollars in thousands) Tax provision (benefit) at U.S. statutory rate $19,487 $(6,298) $(16,171) Tax effect of: Tax exempt investment income (2,212) (2,735) (2,685) State tax net of federal benefit 795 (1) - Other, net 225 - - ------- ------- -------- Provision for income tax expense (benefit) $18,295 $(9,034) $(18,856) ======= ======= ======== Deferred income taxes represent the tax effect of the differences between the book and tax bases of assets and liabilities. Net deferred income tax assets and liabilities consisted of the following: [Download Table] December 31, -------------------- 2003 2002 -------- -------- (Dollars in thousands Deferred income tax assets: Liability for future policy benefits $218,403 $ 97,708 Loss and credit carryforwards - 6,118 Other, net 1,878 875 -------- -------- Total deferred tax assets 220,281 104,701 -------- -------- Deferred income tax liabilities: Deferred policy acquisition costs 158,701 82,535 Investments 16,366 19,950 Unrealized gain on investments 21,144 16,806 Other, net 1,284 - -------- -------- Total deferred tax liabilities 197,495 119,291 -------- -------- Net deferred income tax asset (liability) $ 22,786 $(14,590) ======== ======== The Company had no valuation allowance related to tax benefits for the years ended December 31, 2003 and 2002. All years through and including 1999 are closed and no longer subject to IRS audit. The years 2000 and forward are open and subject to audit. The Company believes that any adjustments that might be required for the open years will not have a material effect on the Company's financial statements. The Company joins MetLife's includable affiliates in filing a federal income tax return in 2003. The consolidating companies have executed a Tax Allocation Agreement. Under this agreement, current federal income tax expense (benefit) is computed on a separate return basis and provides that members shall make payments or receive reimbursements to the extent that their income (losses) contributes to or reduces consolidated federal tax expense. Pursuant to the tax allocation agreement, the amounts due from affiliates are $32,021 thousand at December 31, 2003. 28
485BPOS80th Page of 168TOC1stPreviousNextBottomJust 80th
8. COMMITMENTS AND CONTINGENCIES Litigation Regulatory bodies have contacted the Company or its affiliates and have requested information relating to market timing and late trading of mutual funds and variable insurance products. The Company believes that these inquiries are similar to those made to many financial services companies as part of an industry-wide investigation by various regulatory agencies into the practices, policies and procedures relating to trading in mutual fund shares. The Company or its affiliates are in the process of responding and are fully cooperating with regard to these information requests and inquiries. The Company at the present time is not aware of any systemic problems with respect to such matters that may have a material adverse effect on the Company's financial position. Various litigation, claims and assessments against the Company, in addition to those discussed above and those otherwise provided for in the Company's financial statements, have arisen in the course of the Company's business, including, but not limited to, in connection with its activities as an insurer, employer, investor, investment advisor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company's compliance with applicable insurance and other laws and regulations. Summary It is not feasible to predict or determine the ultimate outcome of all pending investigations and legal proceedings or provide reasonable ranges of potential losses, in connection with specific matters. In some of the matters referred to above, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Although in light of these considerations it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company's financial position, based on information currently known by the Company's management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material adverse effect on the Company's net income or cash flows in particular quarterly or annual periods. Commitments to Fund Partnership Investments Starting in 2003, the Company makes commitments to fund partnership investments in the normal course of business. The amounts of these unfunded commitments were $652 thousand at December 31, 2003. The Company anticipates that these amounts will be invested in the partnerships over the next three to five years. 9. EQUITY Dividend restrictions Under the Delaware Insurance Law, the maximum amount of distributions which can be made to the Company's parent in any given year, without prior approval by the Delaware Commissioner of Insurance, is equal to the greater of (i) 10% of the Company's surplus as of December 31 of the preceding calendar year, or (ii) the net gain from operations for the preceding calendar year (excluding realized investment gains). Any dividends paid, whether or not in excess of the 29
485BPOS81st Page of 168TOC1stPreviousNextBottomJust 81st
aforementioned threshold, from a source other than statutory earned surplus also requires the prior approval of the Delaware Commissioner of Insurance. At December 31, 2003, the maximum amount of dividends the Company could pay MLIG in 2004 without prior approval from the state insurance regulatory authorities is $ 95,915 thousand. Statutory Equity and Income Applicable insurance department regulations require that insurance subsidiaries prepare statutory financial statements in accordance with statutory accounting practices prescribed or permitted by the insurance department of the state of domicile. Statutory accounting practices primarily differ from GAAP by charging policy acquisition costs to expense as incurred, establishing future policy benefit liabilities using different actuarial assumptions, reporting surplus notes as surplus instead of debt and valuing securities on a different basis. Statutory net income of the Company, as filed with the Department, was $101,210 thousand, $13,402 thousand and $1,334 thousand for the years ended December 31, 2003, 2002, and 2001, respectively; statutory capital and surplus, as filed, was $295,857 thousand and $148,055 thousand at December 31, 2003 and 2002, respectively. The National Association of Insurance Commissioners adopted the Codification of Statutory Accounting Principles (the "Codification"), which is intended to standardize regulatory accounting and reporting to state insurance departments, and became effective January 1, 2001. However, statutory accounting principles continue to be established by individual state laws and permitted practices. The Department required adoption of the Codification, with certain modifications, for the preparation of statutory financial statements effective January 1, 2001. Other Comprehensive Income The following table sets forth the reclassification adjustments required for the years ended December 31, 2003, 2002 and 2001 in other comprehensive income that are included as part of net income for the current year that have been reported as a part of other comprehensive income in the current or prior year: [Enlarge/Download Table] Years Ended December 31, -------------------------- 2003 2002 2001 ------- -------- ------- (Dollars in thousands) Holding gains (losses) on investments arising during the year $(2,590) $ 34,600 $(6,644) Income tax effect of holding (gains) or losses 906 (11,749) 1,945 Reclassification adjustments: Recognized holding losses included in current year income 4,377 33,997 24,008 Amortization of premiums and accretion of discounts associated with investments 18,048 5,285 (52) Recognized holding (losses) gains allocated to other policyholder amounts (1,878) - - Income tax effect (7,191) (13,513) (8,385) Allocation of holding losses on investments relating to other policyholder amounts (5,564) (35,836) (6,199) Income tax effect of allocation of holding gains or losses to other policyholder amounts 1,947 12,327 2,169 ------- -------- ------- Other comprehensive income $ 8,055 $ 25,111 $ 6,842 ======= ======== ======= 30
485BPOS82nd Page of 168TOC1stPreviousNextBottomJust 82nd
10. OTHER EXPENSES Other expenses were comprised of the following: [Download Table] Years Ended December 31, ------------------------------ 2003 2002 2001 --------- --------- -------- (Dollars in thousands) Commissions $ 202,395 $ 100,871 $ 29,518 Interest and debt issue costs 2,049 1,640 2,136 Amortization of policy acquisition costs 13,383 1,695 (14,971) Capitalization of policy acquisition costs (248,954) (128,517) (7,579) Rent, net of sublease income - (122) 714 Other 107,463 84,380 94,310 --------- --------- -------- Total other expenses $ 76,336 $ 59,947 $104,128 ========= ========= ======== 11. FAIR VALUE INFORMATION The estimated fair values of financial instruments have been determined by using available market information and the valuation methodologies described below. Considerable judgment is often required in interpreting market data to develop estimates of fair value. Accordingly, the estimates presented herein may not necessarily be indicative of amounts that could be realized in a current market exchange. The use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts. Amounts related to the Company's financial instruments were as follows: [Download Table] Estimated Notional Carrying Fair Amount Value Value December 31, 2003 -------- ---------- ---------- (Dollars in thousands) Assets: Fixed maturities $3,522,671 $3,522,671 Equity securities $ 2,027 $ 2,027 Mortgage loans on real estate $ 431,973 $ 467,190 Policy loans $ 35,768 $ 35,768 Short-term investments $ 137,295 $ 137,295 Cash and cash equivalents $ 199,952 $ 199,952 Commitments to fund partnership investments $652 $ - $ - Liabilities: Policyholder account balances $3,769,822 $3,317,970 Long-term debt $ 35,000 $ 35,000 Payable under securities loaned transactions $ 667,853 $ 667,853 31
485BPOS83rd Page of 168TOC1stPreviousNextBottomJust 83rd
[Download Table] Carrying Estimated Value Fair Value December 31, 2002 ---------- ---------- (Dollars in thousands) Assets: Fixed maturities $2,599,321 $2,599,321 Equity securities $ 1,929 $ 1,929 Mortgage loans on real estate $ 437,721 $ 483,604 Policy loans $ 37,933 $ 37,933 Short-term investments $ 63,340 $ 63,340 Cash and cash equivalents $ 41,452 $ 41,452 Liabilities: Policyholder account balances $2,837,425 $2,713,674 Long-term debt $ 35,000 $ 35,000 Payable under securities loaned transactions $ 224,569 $ 224,569 The methods and assumptions used to estimate the fair values of financial instruments are summarized as follows: Fixed Maturities and Equity Securities The fair value of fixed maturities and equity securities are based upon quotations published by applicable stock exchanges or received from other reliable sources. For securities for which the market values were not readily available, fair values were estimated using quoted market prices of comparable investments. Mortgage Loans on Real Estate and Commitments to Fund Partnership Investments Fair values for mortgage loans on real estate are estimated by discounting expected future cash flows, using current interest rates for similar loans with similar credit risk. Commitments to fund partnership investments have no stated interest rate and are assumed to have a fair value of zero. Policy Loans The carrying values for policy loans approximate fair value. Cash and Cash Equivalents and Short-term Investments The carrying values for cash and cash equivalents and short-term investments approximated fair values due to the short-term maturities of these instruments. Policyholder Account Balances The fair value of policyholder account balances is estimated by discounting expected future cash flows based upon interest rates currently being offered for similar contracts with maturities consistent with those remaining for the agreements being valued. 32
485BPOS84th Page of 168TOC1stPreviousNextBottomJust 84th
Long-term Debt and Payables Under Securities Loaned Transactions The fair values of long-term debt and payables under securities loaned transactions are determined by discounting expected future cash flows, using risk rates currently available for debt with similar terms and remaining maturities. Derivative Financial Instruments The fair value of derivative instruments, including financial futures, foreign currency swaps and interest rate caps are based upon quotations obtained from dealers or other reliable sources. See Note 3 for derivative fair value disclosures. 12. RELATED PARTY TRANSACTIONS The Company entered into a Service Agreement, an Investment Management Agreement and a Principal Underwriters and Selling Agreement with its affiliated companies for the years 2003, 2002 and 2001. The affiliated companies are Metropolitan Life, which provides management services, employees, policy administration functions and investment advice necessary to conduct the activities of the Company and MLIG and MetLife Investors Distribution Company, which provide distribution services to the Company. Expenses charged to the Company for these distribution services are limited to amounts that effectively equal pricing expense levels. This results in residual expenses reflected in the results of MLIG. Expenses and fees paid to affiliated companies in 2003, 2002 and 2001 for the Company, recorded in other expenses, were $94,935 thousand, $58,728 thousand and $33,169 thousand, respectively. The Company received a cash capital contribution of $50,000 thousand from MLIG for the year ended 2003. There were no capital contributions for the years ended 2002 and 2001. In December 2001, the Company paid dividends on preferred and common stock in the amount of $19,900 thousand to MLIG. 33
485BPOS85th Page of 168TOC1stPreviousNextBottomJust 85th
INDEPENDENT AUDITORS' REPORT Board of Directors and Shareholders of MetLife Investors USA Insurance Company and Contract Owners of MetLife Investors USA Separate Account A We have audited the accompanying statement of assets and liabilities of each of the sub-accounts (as disclosed in Note 1 to the financial statements) comprising MetLife Investors USA Separate Account A (the Separate Account) of MetLife Investors USA Insurance Company as of December 31, 2003, the related statement of operations for each of the periods in the year then ended, the statements of changes in net assets for each of the periods in the two year period then ended, and the financial highlights for each of the periods in the three year period then ended. These financial statements and financial highlights are the responsibility of the Separate Account's management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. Our procedures included confirmation of securities owned as of December 31, 2003, by correspondence with the custodians and brokers. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the financial statements and financial highlights referred to above present fairly, in all material respects, the financial position of each of the sub-accounts of MetLife Investors USA Separate Account A of MetLife Investors USA Insurance Company as of December 31, 2003, the results of their operations for each of the periods in the year then ended, the changes in their net assets for each of the periods in the two year period then ended, and their financial highlights for each of the periods in the three year period then ended, in conformity with accounting principles generally accepted in the United States of America. /s/ DELOITTE & TOUCHE LLP St. Louis, Missouri April 15, 2004
485BPOS86th Page of 168TOC1stPreviousNextBottomJust 86th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Assets and Liabilities December 31, 2003 [Enlarge/Download Table] Sub-account assets: Investments: Met Investors Series Trust (Met Investors): Lord Abbett Growth & Income Portfolio 12,225,790 shares $ 298,431,528 Lord Abbett Growth & Income Portfolio B 25,776,118 shares 626,101,909 Lord Abbett Bond Debenture Portfolio 82,941 shares 998,612 Lord Abbett Bond Debenture Portfolio B 40,524,126 shares 485,073,792 JP Morgan Quality Bond Portfolio 2,803,352 shares 33,219,726 Met/Putnam Research Portfolio 2,848,316 shares 22,815,011 Met/Putnam Research Portfolio B 8,592,649 shares 68,483,413 Oppenheimer Capital Appreciation Portfolio B 49,152,473 shares 407,474,001 PIMCO Inflation Protected Bond Portfolio B 26,024,744 shares 267,794,617 PIMCO Money Market Portfolio B 117,274,847 shares 117,274,847 Janus Aggressive Growth Portfolio B 25,310,246 shares 176,918,622 PIMCO Total Return Bond Portfolio 1,956,136 shares 22,710,739 PIMCO Total Return Bond Portfolio B 41,590,191 shares 479,950,800 PIMCO Innovation Portfolio 133,964 shares 647,044 PIMCO Innovation Portfolio B 8,771,997 shares 42,017,863 T Rowe Price Mid Cap Growth Portfolio B 32,172,312 shares 203,972,459 MFS Research International Portfolio B 12,410,696 shares 121,500,710 AIM Small Cap Growth Portfolio 30,680 shares 369,081 AIM Small Cap Growth Portfolio B 12,025,747 shares 143,948,196 AIM Mid Cap Core Equity Portfolio B 11,957,797 shares 146,961,328 Harris Oakmark International Portfolio B 16,674,384 shares 197,424,709 Third Avenue Small Cap Value Portfolio 49,725 shares 577,800 Third Avenue Small Cap Value Portfolio B 19,257,809 shares 223,583,167 AIM Variable Insurance Funds, Inc. (AIM): Premier Equity Fund 75,797 shares 1,533,375 Capital Appreciation Fund 37,655 shares 801,309 International Growth Fund 41,364 shares 663,479 Balanced Fund 117,541 shares 1,174,236 MFS Variable Insurance Trust (MFS): Research Series 28,194 shares 376,389 Investors Trust Series 12,223 shares 199,719 New Discovery Series 25,034 shares 349,469 Oppenheimer Variable Account Funds (Oppenheimer): Main Street Growth & Income Fund 88,435 shares 1,697,953 Bond Fund 38,853 shares 443,706 Money Fund 541,687 shares 541,687 Main Street Small Cap Growth Fund 13,578 shares 182,493 Strategic Bond Fund 49,961 shares 252,302 Variable Insurance Products Fund, Fund II and Fund III (Fidelity): Asset Manager Portfolio 11,994,812 shares 173,444,974 Growth Portfolio 8,695,448 shares 269,906,711 Contrafund Portfolio 10,801,141 shares 249,830,386 Overseas Portfolio 791,883 shares 12,345,462 Equity-Income Portfolio 1,091,819 shares 25,308,360 Index 500 Portfolio 1,308,897 shares 165,091,158 Money Market Portfolio 26,629,538 shares 26,629,538 See accompanying notes to financial statements. (Continued) 2
485BPOS87th Page of 168TOC1stPreviousNextBottomJust 87th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Assets and Liabilities December 31, 2003 [Enlarge/Download Table] Sub-account assets, continued: Investments, continued: Scudder Variable Series I (Scudder I): International Portfolio 2,561,151 shares $ 21,155,108 Metropolitan Life Series (MetLife): Davis Venture Value Fund 30,997 shares 783,302 Davis Venture Value Fund E 16,758,415 shares 421,976,900 Harris Oakmark Focused Value Fund 16,261 shares 3,646,678 Harris Oakmark Focused Value Fund B 1,853,516 shares 409,942,096 Jennison Growth Portfolio B 18,457,647 shares 184,022,742 MFS Total Return Series 5,552 shares 766,951 Putnam International Stock Portfolio 37,085 shares 365,662 Janus Mid Cap Portfolio 64,936 shares 909,749 Russell 2000 Index Portfolio 186,646 shares 2,230,425 Met/Putnam Voyager Portfolio A 92,797 shares 419,443 SSR Aurora Portfolio 165,756 shares 2,754,861 SSR Bond Income Portfolio 5,698 shares 658,735 SSR Large Cap Value Portfolio 19,905 shares 212,385 Stock Index Portfolio 2,365,941 shares 69,676,956 Stock Index Portfolio B 4,718,077 shares 135,880,626 Alger Equity Growth 10,941 shares 204,813 Lehman Brothers Aggregate Bond Index 64,298 shares 702,781 FI Mid Cap Opportunities 71,202 shares 819,540 Harris Oakmark Large Cap Value 145,209 shares 1,751,217 Morgan Stanley EAFE Index 109,178 shares 1,069,948 Mid Cap Stock Index 124,865 shares 1,485,897 VanKampen LIT Funds (VanKampen): Emerging Growth Fund 21,804 shares 530,047 Enterprise Fund 12,958 shares 170,007 Growth & Income Fund 18,494 shares 315,500 Federated Investors Insurance Company (Federated): American Leaders Fund II 33,936 shares 648,169 High Income Bond Fund II 32,929 shares 263,099 Growth Strategic Fund II 11,113 shares 202,365 Equity Income Fund II 27,739 shares 336,474 Neuberger Berman (Neuberger): Genesis Trust 449 shares 16,629 The Alger American Fund (Alger): Small Capitalization Fund 3,424,905 shares 59,524,857 T Rowe Price Funds (T Rowe): Growth Fund 436,588 shares 10,622,175 International Stock Fund 91,808 shares 1,054,871 Prime Reserve Fund 1,437,342 shares 1,437,342 Janus Capital Funds Corp. (Janus): Aspen Worldwide Growth 262 shares 6,753 American Funds Corp. (American): Global Small Capitalization Fund 90,992 shares 1,281,166 Growth Fund 153,385 shares 6,979,020 Growth & Income Fund 145,649 shares 4,876,338 -------------- Total assets $6,368,724,307 ============== See accompanying notes to financial statements. (Continued) 3
485BPOS88th Page of 168TOC1stPreviousNextBottomJust 88th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Assets and Liabilities December 31, 2003 [Download Table] Sub-account liabilities: Due to/(from) general account, net Met Investors Lord Abbett Growth & Income Portfolio $ 257,572 Met Investors Lord Abbett Growth & Income Portfolio B 4 Met Investors Lord Abbett Bond Debenture Portfolio 1,368 Met Investors Lord Abbett Bond Debenture Portfolio B 2 Met Investors JP Morgan Quality Bond Portfolio 35,568 Met Investors Met/Putnam Research Portfolio 24,405 Met Investors Met/Putnam Research Portfolio B 42 Met Investors Oppenheimer Capital Appreciation Portfolio B 2 Met Investors PIMCO Inflation Protected Bond Portfolio B 10 Met Investors PIMCO Money Market Portfolio B (12,611) Met Investors Janus Aggressive Growth Portfolio B 62 Met Investors PIMCO Total Return Bond Portfolio 24,051 Met Investors PIMCO Total Return Bond Portfolio B 3 Met Investors PIMCO Innovation Portfolio 757 Met Investors PIMCO Innovation Portfolio B 142 Met Investors T Rowe Price Mid Cap Growth Portfolio B 15 Met Investors MFS Research International Portfolio B 17 Met Investors AIM Small Cap Growth Portfolio 532 Met Investors AIM Small Cap Growth Portfolio B 10 Met Investors AIM Mid Cap Core Equity Portfolio B 68 Met Investors Harris Oakmark International Portfolio B 35 Met Investors Third Avenue Small Cap Value Portfolio 721 Met Investors Third Avenue Small Cap Value Portfolio B 72 AIM Premier Equity Fund 1,924 AIM Capital Appreciation Fund 1,003 AIM International Growth Fund 849 AIM Balanced Fund 1,497 MFS Research Series 481 MFS Investors Trust Series 252 MFS New Discovery Series 429 Oppenheimer Main Street Growth & Income Fund 2,117 Oppenheimer Bond Fund 571 Oppenheimer Money Fund 597 Oppenheimer Main Street Small Cap Growth Fund 230 Oppenheimer Strategic Bond Fund 323 Fidelity Asset Manager Portfolio (115,404) Fidelity Growth Portfolio 647,200 Fidelity Contrafund Portfolio 324,421 Fidelity Overseas Portfolio 11,106 Fidelity Equity-Income Portfolio 32,514 Fidelity Index 500 Portfolio 178,781 Fidelity Money Market Portfolio (43,494) Scudder I International Portfolio (124,460) MetLife Davis Venture Value Fund 971 MetLife Davis Venture Value Fund E 2 MetLife Harris Oakmark Focused Value Fund 4,322 MetLife Harris Oakmark Focused Value Fund B 46 MetLife Jennison Growth Portfolio B 53 See accompanying notes to financial statements. (Continued) 4
485BPOS89th Page of 168TOC1stPreviousNextBottomJust 89th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Assets and Liabilities December 31, 2003 [Download Table] Sub-account liabilities, continued: Due to/(from) general account, net, continued: MetLife MFS Total Return Series $ 997 MetLife Putnam International Stock Portfolio 484 MetLife Janus Mid Cap Portfolio 1,026 MetLife Russell 2000 Index Portfolio 2,668 MetLife Met/Putnam Voyager Portfolio A 456 MetLife SSR Aurora Portfolio 3,167 MetLife SSR Bond Income Portfolio 1,184 MetLife SSR Large Cap Value Portfolio 238 MetLife Stock Index Portfolio 82,109 MetLife Stock Index Portfolio B 57 MetLife Alger Equity Growth 262 MetLife Lehman Brothers Aggregate Bond Index 839 MetLife FI Mid Cap Opportunities 1,006 MetLife Harris Oakmark Large Cap Value 1,976 MetLife Morgan Stanley EAFE Index 1,305 MetLife Mid Cap Stock Index 1,798 Van Kampen Emerging Growth Fund 628 Van Kampen Enterprise Fund 144 Van Kampen Growth & Income Fund 355 Federated American Leaders Fund II 829 Federated High Income Bond Fund II 337 Federated Growth Strategic Fund II 254 Federated Equity Income Fund II 431 Neuberger Genesis Trust (1,289) Alger Small Capitalization Fund 54,950 T Rowe Growth Fund (15,504) T Rowe International Stock Fund (2,865) T Rowe Prime Reserve Fund 477 Janus Aspen Worldwide Growth (2,852) American Global Small Capitalization Fund 1,450 American Growth Fund 8,394 American Growth & Income Fund 5,786 -------------- Total liabilities $ 1,410,275 ============== Sub-account net assets: Accumulation units: Met Investors Lord Abbett Growth & Income Portfolio $ 298,173,956 Met Investors Lord Abbett Growth & Income Portfolio B 626,036,268 Met Investors Lord Abbett Bond Debenture Portfolio 997,244 Met Investors Lord Abbett Bond Debenture Portfolio B 485,042,869 Met Investors JP Morgan Quality Bond Portfolio 33,184,158 Met Investors Met/Putnam Research Portfolio 22,790,606 Met Investors Met/Putnam Research Portfolio B 68,342,062 Met Investors Oppenheimer Capital Appreciation Portfolio B 407,457,734 Met Investors PIMCO Inflation Protected Bond Portfolio B 267,766,810 Met Investors PIMCO Money Market Portfolio B 117,134,203 Met Investors Janus Aggressive Growth Portfolio B 176,918,560 Met Investors PIMCO Total Return Bond Portfolio 22,686,688 See accompanying notes to financial statements. (Continued) 5
485BPOS90th Page of 168TOC1stPreviousNextBottomJust 90th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Assets and Liabilities December 31, 2003 [Download Table] Sub-account net assets, continued: Accumulation units, continued: Met Investors PIMCO Total Return Bond Portfolio B $ 479,813,419 Met Investors PIMCO Innovation Portfolio 646,287 Met Investors PIMCO Innovation Portfolio B 42,017,721 Met Investors T Rowe Price Mid Cap Growth Portfolio B 203,962,594 Met Investors MFS Research International Portfolio B 121,466,834 Met Investors AIM Small Cap Growth Portfolio 368,549 Met Investors AIM Small Cap Growth Portfolio B 143,948,186 Met Investors AIM Mid Cap Core Equity Portfolio B 146,954,193 Met Investors Harris Oakmark International Portfolio B 197,424,674 Met Investors Third Avenue Small Cap Value Portfolio 577,079 Met Investors Third Avenue Small Cap Value Portfolio B 223,572,668 AIM Premier Equity Fund 1,531,451 AIM Capital Appreciation Fund 800,306 AIM International Growth Fund 662,630 AIM Balanced Fund 1,172,739 MFS Research Series 375,908 MFS Investors Trust Series 199,467 MFS New Discovery Series 349,040 Oppenheimer Main Street Growth & Income Fund 1,695,836 Oppenheimer Bond Fund 443,135 Oppenheimer Money Fund 541,090 Oppenheimer Main Street Small Cap Growth Fund 182,263 Oppenheimer Strategic Bond Fund 251,979 Fidelity Asset Manager Portfolio 173,560,378 Fidelity Growth Portfolio 269,259,511 Fidelity Contrafund Portfolio 249,505,965 Fidelity Overseas Portfolio 12,334,356 Fidelity Equity-Income Portfolio 25,275,846 Fidelity Index 500 Portfolio 164,912,377 Fidelity Money Market Portfolio 26,673,032 Scudder I International Portfolio 21,279,568 MetLife Davis Venture Value Fund 782,331 MetLife Davis Venture Value Fund E 421,802,752 MetLife Harris Oakmark Focused Value Fund 3,642,356 MetLife Harris Oakmark Focused Value Fund B 409,859,958 MetLife Jennison Growth Portfolio B 184,013,470 MetLife MFS Total Return Series 765,954 MetLife Putnam International Stock Portfolio 365,178 MetLife Janus Mid Cap Portfolio 908,723 MetLife Russell 2000 Index Portfolio 2,227,757 MetLife Met/Putnam Voyager Portfolio A 418,987 MetLife SSR Aurora Portfolio 2,751,694 MetLife SSR Bond Income Portfolio 657,551 MetLife SSR Large Cap Value Portfolio 212,147 MetLife Stock Index Portfolio 69,594,847 MetLife Stock Index Portfolio B 135,880,569 MetLife Alger Equity Growth 204,551 MetLife Lehman Brothers Aggregate Bond Index 701,942 See accompanying notes to financial statements. (Continued) 6
485BPOS91st Page of 168TOC1stPreviousNextBottomJust 91st
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Assets and Liabilities December 31, 2003 [Download Table] Sub-account net assets, continued: Accumulation units, continued: MetLife FI Mid Cap Opportunities $ 818,534 MetLife Harris Oakmark Large Cap Value 1,749,241 MetLife Morgan Stanley EAFE Index 1,068,643 MetLife Mid Cap Stock Index 1,484,099 Van Kampen Emerging Growth Fund 529,419 Van Kampen Enterprise Fund 169,863 Van Kampen Growth & Income Fund 315,145 Federated American Leaders Fund II 647,340 Federated High Income Bond Fund II 262,762 Federated Growth Strategic Fund II 202,111 Federated Equity Income Fund II 336,043 Neuberger Genesis Trust 17,918 Alger Small Capitalization Fund 59,469,907 T Rowe Growth Fund 10,637,679 T Rowe International Stock Fund 1,057,736 T Rowe Prime Reserve Fund 1,436,865 Janus Aspen Worldwide Growth 9,605 American Global Small Capitalization Fund 1,279,716 American Growth Fund 6,970,626 American Growth & Income Fund 4,870,552 -------------- $6,366,414,810 ============== Annuitization units: Met Investors Lord Abbett Growth & Income Portfolio B $ 65,637 Met Investors Lord Abbett Bond Debenture Portfolio B 30,921 Met Investors Met/Putnam Research Portfolio B 141,309 Met Investors Oppenheimer Capital Appreciation Portfolio B 16,265 Met Investors PIMCO Inflation Protected Bond Portfolio B 27,797 Met Investors PIMCO Money Market Portfolio B 153,255 Met Investors PIMCO Total Return Bond Portfolio B 137,378 Met Investors T Rowe Price Mid Cap Growth Portfolio B 9,850 Met Investors MFS Research International Portfolio B 33,859 Met Investors AIM Mid Cap Core Equity Portfolio B 7,067 Met Investors Third Avenue Small Cap Value Portfolio B 10,427 MetLife Davis Venture Value Fund E 174,146 MetLife Harris Oakmark Focused Value Fund B 82,092 MetLife Jennison Growth Portfolio B 9,219 -------------- $ 899,222 -------------- Total Net Assets $6,367,314,032 ============== See accompanying notes to financial statements. 7
485BPOS92nd Page of 168TOC1stPreviousNextBottomJust 92nd
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Operations Year ended December 31, 2003 [Enlarge/Download Table] Met Investors ------------------------------------------------------------------------------ Lord Abbett Lord Abbett Lord Abbett Lord Abbett JP Morgan Growth & Growth & Bond Bond Quality Income Income Debenture Debenture Bond Portfolio Portfolio B Portfolio Portfolio B Portfolio -------------- ------------- ------------- ------------- ------------- Income: Dividends $ 2,993,767 2,396,162 15,506 7,582,717 1,330,119 -------------- ------------- ------------- ------------- ------------- Expenses: Mortality and expense risk 2,883,632 4,740,456 4,460 3,829,632 392,448 Administrative fee 585,000 856,723 500 686,584 80,300 -------------- ------------- ------------- ------------- ------------- Total expenses 3,468,632 5,597,179 4,960 4,516,216 472,748 -------------- ------------- ------------- ------------- ------------- Net investment income (loss) (474,865) (3,201,017) 10,546 3,066,501 857,371 -------------- ------------- ------------- ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares (10,538,981) (8,478) 19,636 1,053,682 419,961 Realized gain distributions - - - - - -------------- ------------- ------------- ------------- ------------- Net realized gain (loss) (10,538,981) (8,478) 19,636 1,053,682 419,961 -------------- ------------- ------------- ------------- ------------- Change in unrealized appreciation (depreciation) 79,535,337 103,296,681 38,036 38,206,055 (402,827) -------------- ------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations $ 68,521,491 100,087,186 68,218 42,326,238 874,505 ============== ============= ============= ============= ============= [Download Table] ------------------------ Met/ Met/ Putnam Putnam Research Research Portfolio Portfolio B ------------- ------------- Income: Dividends 6,738 - ------------- ------------- Expenses: Mortality and expense risk 217,401 643,042 Administrative fee 55,630 115,906 ------------- ------------- Total expenses 273,031 758,948 ------------- ------------- Net investment income (loss) (266,293) (758,948) ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares (453,002) (107,147) Realized gain distributions - - ------------- ------------- Net realized gain (loss) (453,002) (107,147) ------------- ------------- Change in unrealized appreciation (depreciation) 5,364,572 11,223,620 ------------- ------------- Net increase (decrease) in net assets from operations 4,645,277 10,357,525 ============= ============= See accompanying notes to financial statements. (Continued) 8
485BPOS93rd Page of 168TOC1stPreviousNextBottomJust 93rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Operations Year ended December 31, 2003 [Enlarge/Download Table] Met Investors ------------------------------------------------------------------------------ Oppenheimer PIMCO PIMCO Janus PIMCO Capital Inflation Money Aggressive Total Return Appreciation Protected Bond Market Growth Bond Portfolio B Portfolio B (a) Portfolio B Portfolio B Portfolio -------------- --------------- ------------- ------------- ------------- Income: Dividends $ - 796,252 505,127 - 255,450 -------------- ------------- ------------- ------------- ------------- Expenses: Mortality and expense risk 3,061,780 1,577,758 1,822,891 1,282,511 249,321 Administrative fee 551,626 277,710 328,325 231,042 60,270 -------------- ------------- ------------- ------------- ------------- Total expenses 3,613,406 1,855,468 2,151,216 1,513,553 309,591 -------------- ------------- ------------- ------------- ------------- Net investment income (loss) (3,613,406) (1,059,216) (1,646,089) (1,513,553) (54,141) -------------- ------------- ------------- ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares (573) - - 29,372 696,906 Realized gain distributions - 5,184,054 - - 209,796 -------------- ------------- ------------- ------------- ------------- Net realized gain (loss) (573) 5,184,054 - 29,372 906,702 -------------- ------------- ------------- ------------- ------------- Change in unrealized appreciation (depreciation) 60,680,428 2,075,094 - 26,337,281 (88,845) -------------- ------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations $ 57,066,449 6,199,932 (1,646,089) 24,853,100 763,716 ============== ============= ============= ============= ============= [Download Table] --------------------------- PIMCO Total Return PIMCO Bond Innovation Portfolio B Portfolio (a) ------------- ------------- Income: Dividends 5,066,621 - ------------- ------------- Expenses: Mortality and expense risk 5,141,448 2,818 Administrative fee 931,989 - ------------- ------------- Total expenses 6,073,437 2,818 ------------- ------------- Net investment income (loss) (1,006,816) (2,818) ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares 3,769,151 4,056 Realized gain distributions 4,368,096 - ------------- ------------- Net realized gain (loss) 8,137,247 4,056 ------------- ------------- Change in unrealized appreciation (depreciation) 2,138,500 55,774 ------------- ------------- Net increase (decrease) in net assets from operations 9,268,931 57,012 ============= ============= (a) For the period from May 1, 2003 to December 31, 2003. See accompanying notes to financial statements. (Continued) 9
485BPOS94th Page of 168TOC1stPreviousNextBottomJust 94th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Operations Year ended December 31, 2003 [Enlarge/Download Table] Met Investors ----------------------------------------------------------------------------- T Rowe Price MFS AIM AIM PIMCO Mid Cap Research Small Cap Small Cap Innovation Growth International Growth Growth Portfolio B Portfolio B Portfolio B Portfolio (a) Portfolio B -------------- ------------- ------------- ------------- ------------- Income: Dividends $ - - 680,298 - - -------------- ------------- ------------- ------------- ------------- Expenses: Mortality and expense risk 317,238 1,476,428 1,041,524 1,804 1,063,224 Administrative fee 56,483 266,659 189,932 - 192,351 -------------- ------------- ------------- ------------- ------------- Total expenses 373,721 1,743,087 1,231,456 1,804 1,255,575 -------------- ------------- ------------- ------------- ------------- Net investment income (loss) (373,721) (1,743,087) (551,158) (1,804) (1,255,575) -------------- ------------- ------------- ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares (189,629) (17,543) 201,866 13,265 219,596 Realized gain distributions - - - - - -------------- ------------- ------------- ------------- ------------- Net realized gain (loss) (189,629) (17,543) 201,866 13,265 219,596 -------------- ------------- ------------- ------------- ------------- Change in unrealized appreciation (depreciation) 9,550,569 34,788,215 24,339,743 22,604 25,849,273 -------------- ------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations $ 8,987,219 33,027,585 23,990,451 34,065 24,813,294 ============== ============= ============= ============= ============= [Download Table] --------------------------- AIM Harris Mid Cap Oakmark Core Equity International Portfolio B Portfolio B ------------- ------------- Income: Dividends 1,138,558 1,522,348 ------------- ------------- Expenses: Mortality and expense risk 1,024,434 1,110,688 Administrative fee 183,673 197,674 ------------- ------------- Total expenses 1,208,107 1,308,362 ------------- ------------- Net investment income (loss) (69,549) 213,986 ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares (10,930) (50,029) Realized gain distributions - 489,525 ------------- ------------- Net realized gain (loss) (10,930) 439,496 ------------- ------------- Change in unrealized appreciation (depreciation) 18,668,662 32,012,248 ------------- ------------- Net increase (decrease) in net assets from operations 18,588,183 32,665,730 ============= ============= (a) For the period from May 1, 2003 to December 31, 2003. See accompanying notes to financial statements. (Continued) 10
485BPOS95th Page of 168TOC1stPreviousNextBottomJust 95th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Operations Year ended December 31, 2003 [Enlarge/Download Table] Met Investors ----------------------------- -------------- Third Avenue Third Avenue Small Cap Small Cap Premier Value Value Equity Portfolio (a) Portfolio B Fund -------------- ------------- ------------- Income: Dividends $ 1,964 502,815 4,258 -------------- ------------- ------------- Expenses: Mortality and expense risk 2,293 1,424,675 17,786 Administrative fee - 254,379 1,887 -------------- ------------- ------------- Total expenses 2,293 1,679,054 19,673 -------------- ------------- ------------- Net investment income (loss) (329) (1,176,239) (15,415) -------------- ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares 2,439 26,824 (95,670) Realized gain distributions 3,389 1,296,167 - -------------- ------------- ------------- Net realized gain (loss) 5,828 1,322,991 (95,670) -------------- ------------- ------------- Change in unrealized appreciation (depreciation) 61,093 38,801,843 405,709 -------------- ------------- ------------- Net increase (decrease) in net assets from operations $ 66,592 38,948,595 294,624 ============== ============= ============= [Enlarge/Download Table] AIM MFS -------------------------------------------- ------------- Capital International Appreciation Growth Balanced Research Fund Fund Fund Series ------------- ------------- ------------- ------------- Income: Dividends - 3,169 21,776 2,376 ------------- ------------- ------------- ------------- Expenses: Mortality and expense risk 9,205 7,323 12,841 4,472 Administrative fee 982 770 2,800 482 ------------- ------------- ------------- ------------- Total expenses 10,187 8,093 15,641 4,954 ------------- ------------- ------------- ------------- Net investment income (loss) (10,187) (4,924) 6,135 (2,578) ------------- ------------- ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares (72,431) (44,012) (55,483) (32,903) Realized gain distributions - - - - ------------- ------------- ------------- ------------- Net realized gain (loss) (72,431) (44,012) (55,483) (32,903) ------------- ------------- ------------- ------------- Change in unrealized appreciation (depreciation) 258,319 191,317 199,770 108,011 ------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations 175,701 142,381 150,422 72,530 ============= ============= ============= ============= (a) For the period from May 1, 2003 to December 31, 2003. See accompanying notes to financial statements. (Continued) 11
485BPOS96th Page of 168TOC1stPreviousNextBottomJust 96th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Operations Year ended December 31, 2003 [Enlarge/Download Table] MFS Oppenheimer ----------------------------- --------------------------------------------- Main Street Investors New Growth & Trust Discovery Income Bond Money Series Series Fund Fund Fund -------------- ------------- ------------- ------------- ------------- Income: Dividends $ 1,224 - 14,619 23,813 6,929 -------------- ------------- ------------- ------------- ------------- Expenses: Mortality and expense risk 2,310 4,113 19,209 5,520 8,423 Administrative fee 245 453 2,044 589 1,800 -------------- ------------- ------------- ------------- ------------- Total expenses 2,555 4,566 21,253 6,109 10,223 -------------- ------------- ------------- ------------- ------------- Net investment income (loss) (1,331) (4,566) (6,634) 17,704 (3,294) -------------- ------------- ------------- ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares (7,103) (38,979) (63,615) 517 - Realized gain distributions - - - - - -------------- ------------- ------------- ------------- ------------- Net realized gain (loss) (7,103) (38,979) (63,615) 517 - -------------- ------------- ------------- ------------- ------------- Change in unrealized appreciation (depreciation) 42,890 130,599 406,032 3,878 - -------------- ------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations $ 34,456 87,054 335,783 22,099 (3,294) ============== ============= ============= ============= ============= [Download Table] --------------------------- Main Street Small Strategic Cap Bond Growth Fund Fund ------------- ------------- Income: Dividends - 16,090 ------------- ------------- Expenses: Mortality and expense risk 1,639 3,130 Administrative fee 350 361 ------------- ------------- Total expenses 1,989 3,491 ------------- ------------- Net investment income (loss) (1,989) 12,599 ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares (2,047) 141 Realized gain distributions - - ------------- ------------- Net realized gain (loss) (2,047) 141 ------------- ------------- Change in unrealized appreciation (depreciation) 54,353 24,587 ------------- ------------- Net increase (decrease) in net assets from operations 50,317 37,327 ============= ============= See accompanying notes to financial statements. (Continued) 12
485BPOS97th Page of 168TOC1stPreviousNextBottomJust 97th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Operations Year ended December 31, 2003 [Enlarge/Download Table] Fidelity ------------------------------------------------------------------ Asset Manager Growth Contrafund Overseas Portfolio Portfolio Portfolio Portfolio -------------- ------------- ------------- ------------- Income: Dividends $ 5,827,007 623,982 983,616 91,552 -------------- ------------- ------------- ------------- Expenses: Mortality and expense risk 1,829,757 2,714,311 2,511,346 110,027 Administrative fee 408,500 540,000 468,000 26,360 -------------- ------------- ------------- ------------- Total expenses 2,238,257 3,254,311 2,979,346 136,387 -------------- ------------- ------------- ------------- Net investment income (loss) 3,588,750 (2,630,329) (1,995,730) (44,835) -------------- ------------- ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares (4,651,518) (16,397,960) (1,627,928) (1,261,416) Realized gain distributions - - - - -------------- ------------- ------------- ------------- Net realized gain (loss) (4,651,518) (16,397,960) (1,627,928) (1,261,416) -------------- ------------- ------------- ------------- Change in unrealized appreciation (depreciation) 25,905,819 83,691,437 56,105,559 5,096,073 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations $ 24,843,051 64,663,148 52,481,901 3,789,822 ============== ============= ============= ============= [Enlarge/Download Table] -------------------------------------- Equity- Index Money Income 500 Market Portfolio Portfolio Portfolio ------------- ------------- ------------- Income: Dividends 430,293 3,072,856 306,459 ------------- ------------- ------------- Expenses: Mortality and expense risk 293,211 2,087,526 303,708 Administrative fee 29,081 458,868 70,772 ------------- ------------- ------------- Total expenses 322,292 2,546,394 374,480 ------------- ------------- ------------- Net investment income (loss) 108,001 526,462 (68,021) ------------- ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares (807,406) (14,361,585) - Realized gain distributions - - - ------------- ------------- ------------- Net realized gain (loss) (807,406) (14,361,585) - ------------- ------------- ------------- Change in unrealized appreciation (depreciation) 6,483,503 57,042,919 - ------------- ------------- ------------- Net increase (decrease) in net assets from operations 5,784,098 43,207,796 (68,021) ============= ============= ============= See accompanying notes to financial statements. (Continued) 13
485BPOS98th Page of 168TOC1stPreviousNextBottomJust 98th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Operations Year ended December 31, 2003 [Enlarge/Download Table] Scudder I MetLife -------------- ----------------------------------------------------------------- Davis Davis Harris Harris Venture Venture Oakmark Oakmark International Value Value Focused Focused Portfolio Fund (a) Fund E Value Fund (a) Value Fund B -------------- ------------- ------------- -------------- ------------- Income: Dividends $ 133,048 - 670,195 - 111,223 -------------- ------------- ------------- ------------- ------------- Expenses: Mortality and expense risk 208,946 3,388 3,371,430 11,975 3,194,599 Administrative fee 35,000 - 611,775 - 576,839 -------------- ------------- ------------- ------------- ------------- Total expenses 243,946 3,388 3,983,205 11,975 3,771,438 -------------- ------------- ------------- ------------- ------------- Net investment income (loss) (110,898) (3,388) (3,313,010) (11,975) (3,660,215) -------------- ------------- ------------- ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares (1,728,672) 264 (102,267) 556 (5,872) Realized gain distributions - - - - - -------------- ------------- ------------- ------------- ------------- Net realized gain (loss) (1,728,672) 264 (102,267) 556 (5,872) -------------- ------------- ------------- ------------- ------------- Change in unrealized appreciation (depreciation) 6,214,219 88,012 74,510,314 355,482 74,648,276 -------------- ------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations $ 4,374,649 84,888 71,095,037 344,063 70,982,189 ============== ============= ============= ============= ============= [Download Table] ----------------------- MFS Jennison Total Growth Return Portfolio B Series (a) ------------- ------------- Income: Dividends 136,299 - ------------- ------------- Expenses: Mortality and expense risk 1,337,527 2,927 Administrative fee 241,239 - ------------- ------------- Total expenses 1,578,766 2,927 ------------- ------------- Net investment income (loss) (1,442,467) (2,927) ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares 1,849,073 774 Realized gain distributions - - ------------- ------------- Net realized gain (loss) 1,849,073 774 ------------- ------------- Change in unrealized appreciation (depreciation) 25,140,667 46,065 ------------- ------------- Net increase (decrease) in net assets from operations 25,547,273 43,912 ============= ============= (a) For the period from May 1, 2003 to December 31, 2003. See accompanying notes to financial statements. (Continued) 14
485BPOS99th Page of 168TOC1stPreviousNextBottomJust 99th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Operations Year ended December 31, 2003 [Enlarge/Download Table] MetLife ------------------------------------------------------------------------------- Putnam Russell Met/ International Janus 2000 Putnam SSR Stock Mid Cap Index Voyager Aurora Portfolio Portfolio Portfolio Portfolio A Portfolio (a) -------------- ------------- ------------- ------------- ------------- Income: Dividends $ 1,973 - 2,669 - - -------------- ------------- ------------- ------------- ------------- Expenses: Mortality and expense risk 4,088 8,932 9,763 4,426 9,354 Administrative fee 413 1,900 2,000 461 - -------------- ------------- ------------- ------------- ------------- Total expenses 4,501 10,832 11,763 4,887 9,354 -------------- ------------- ------------- ------------- ------------- Net investment income (loss) (2,528) (10,832) (9,094) (4,887) (9,354) -------------- ------------- ------------- ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares (23,229) (119,488) 10,428 (40,469) 3,784 Realized gain distributions - - - - - -------------- ------------- ------------- ------------- ------------- Net realized gain (loss) (23,229) (119,488) 10,428 (40,469) 3,784 -------------- ------------- ------------- ------------- ------------- Change in unrealized appreciation (depreciation) 106,170 347,581 341,057 119,930 348,713 -------------- ------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations $ 80,413 217,261 342,391 74,574 343,143 ============== ============= ============= ============= ============= [Download Table] ------------------------- SSR SSR Large Cap Bond Income Value Portfolio (a) Portfolio (a) ------------- ------------- Income: Dividends - 1,361 ------------- ------------- Expenses: Mortality and expense risk 2,565 731 Administrative fee - - ------------- ------------- Total expenses 2,565 731 ------------- ------------- Net investment income (loss) (2,565) 630 ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares 108 (106) Realized gain distributions - - ------------- ------------- Net realized gain (loss) 108 (106) ------------- ------------- Change in unrealized appreciation (depreciation) 12,545 20,377 ------------- ------------- Net increase (decrease) in net assets from operations 10,088 20,901 ============= ============= (a) For the period from May 1, 2003 to December 31, 2003. See accompanying notes to financial statements. (Continued) 15
485BPOS100th Page of 168TOC1stPreviousNextBottomJust 100th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Operations Year ended December 31, 2003 [Enlarge/Download Table] MetLife ---------------------------------------------------------------- Lehman Stock Stock Alger Brothers Index Index Equity Aggregate Portfolio (a) Portfolio B Growth (a) Bond Index (a) -------------- ------------- ------------- -------------- Income: Dividends $ - 1,044,199 - - -------------- ------------- ------------- ------------- Expenses: Mortality and expense risk 291,546 1,149,358 975 3,040 Administrative fee 58,930 205,282 - - -------------- ------------- ------------- ------------- Total expenses 350,476 1,354,640 975 3,040 -------------- ------------- ------------- ------------- Net investment income (loss) (350,476) (310,441) (975) (3,040) -------------- ------------- ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares 106,930 193,706 340 (1,569) Realized gain distributions - - - - -------------- ------------- ------------- ------------- Net realized gain (loss) 106,930 193,706 340 (1,569) -------------- ------------- ------------- ------------- Change in unrealized appreciation (depreciation) 7,763,978 21,269,435 20,041 8,123 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations $ 7,520,432 21,152,700 19,406 3,514 ============== ============= ============= ============= [Enlarge/Download Table] ------------------------------------------- Harris Oakmark Morgan Stanley FI Mid Cap Large Cap EAFE Opportunities (a) Value (a) Index (a) ----------------- -------------- -------------- Income: Dividends - - - ------------- ------------- ------------- Expenses: Mortality and expense risk 3,090 5,942 5,931 Administrative fee - - - ------------- ------------- ------------- Total expenses 3,090 5,942 5,931 ------------- ------------- ------------- Net investment income (loss) (3,090) (5,942) (5,931) ------------- ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares 3,384 316 74,614 Realized gain distributions 10,704 - - ------------- ------------- ------------- Net realized gain (loss) 14,088 316 74,614 ------------- ------------- ------------- Change in unrealized appreciation (depreciation) 88,530 129,746 96,659 ------------- ------------- ------------- Net increase (decrease) in net assets from operations 99,528 124,120 165,342 ============= ============= ============= (a) For the period from May 1, 2003 to December 31, 2003. See accompanying notes to financial statements. (Continued) 16
485BPOS101st Page of 168TOC1stPreviousNextBottomJust 101st
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Operations Year ended December 31, 2003 [Enlarge/Download Table] MetLife Van Kampen -------------- ------------------------------------------- -------------- Mid Emerging Growth & American Cap Stock Growth Enterprise Income Leaders Index (a) Fund Fund Fund Fund II -------------- ------------- ------------- ------------- ------------- Income: Dividends $ - - 826 2,255 9,901 -------------- ------------- ------------- ------------- ------------- Expenses: Mortality and expense risk 5,905 5,745 1,875 3,087 6,807 Administrative fee - 1,100 350 600 1,409 -------------- ------------- ------------- ------------- ------------- Total expenses 5,905 6,845 2,225 3,687 8,216 -------------- ------------- ------------- ------------- ------------- Net investment income (loss) (5,905) (6,845) (1,399) (1,432) 1,685 -------------- ------------- ------------- ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares 5,458 (62,002) (7,910) (566) (24,215) Realized gain distributions - - - - - -------------- ------------- ------------- ------------- ------------- Net realized gain (loss) 5,458 (62,002) (7,910) (566) (24,215) -------------- ------------- ------------- ------------- ------------- Change in unrealized appreciation (depreciation) 144,303 179,009 43,499 67,709 158,025 -------------- ------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations $ 143,856 110,162 34,190 65,711 135,495 ============== ============= ============= ============= ============= [Download Table] Federated ----------------------------- High Growth Income Bond Strategic Fund II Fund II ------------- ------------- Income: Dividends 19,418 - ------------- ------------- Expenses: Mortality and expense risk 2,982 2,148 Administrative fee 601 400 ------------- ------------- Total expenses 3,583 2,548 ------------- ------------- Net investment income (loss) 15,835 (2,548) ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares (3,235) (16,005) Realized gain distributions - - ------------- ------------- Net realized gain (loss) (3,235) (16,005) ------------- ------------- Change in unrealized appreciation (depreciation) 34,423 77,183 ------------- ------------- Net increase (decrease) in net assets from operations 47,023 58,630 ============= ============= (a) For the period from May 1, 2003 to December 31, 2003. See accompanying notes to financial statements. (Continued) 17
485BPOS102nd Page of 168TOC1stPreviousNextBottomJust 102nd
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Operations Year ended December 31, 2003 [Enlarge/Download Table] Federated Neuberger Alger -------------- ------------- -------------- ---------------- Equity Small Income Genesis Capitalization Growth Fund II Trust Fund Fund -------------- ------------- -------------- ------------- Income: Dividends $ 5,835 - - 21,511 -------------- ------------- ------------- ------------- Expenses: Mortality and expense risk 3,512 1,054 578,156 67,928 Administrative fee 705 380 123,008 25,150 -------------- ------------- ------------- ------------- Total expenses 4,217 1,434 701,164 93,078 -------------- ------------- ------------- ------------- Net investment income (loss) 1,618 (1,434) (701,164) (71,567) -------------- ------------- ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares (17,041) 156,865 (5,252,739) (9,975,488) Realized gain distributions - 8 - - -------------- ------------- ------------- ------------- Net realized gain (loss) (17,041) 156,873 (5,252,739) (9,975,488) -------------- ------------- ------------- ------------- Change in unrealized appreciation (depreciation) 83,956 (160,697) 23,298,902 13,059,440 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations $ 68,533 (5,258) 17,344,999 3,012,385 ============== ============= ============= ============= [Enlarge/Download Table] T Rowe Janus --------------------------- ------------- Prime Aspen International Reserve Worldwide Stock Fund Fund Growth ------------- ------------- ------------- Income: Dividends 11,732 11,823 65 ------------- ------------- ------------- Expenses: Mortality and expense risk 7,018 11,309 1,713 Administrative fee 2,500 4,205 580 ------------- ------------- ------------- Total expenses 9,518 15,514 2,293 ------------- ------------- ------------- Net investment income (loss) 2,214 (3,691) (2,228) ------------- ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares (2,170,223) - (3,519,195) Realized gain distributions 2,707 - - ------------- ------------- ------------- Net realized gain (loss) (2,167,516) - (3,519,195) ------------- ------------- ------------- Change in unrealized appreciation (depreciation) 2,421,369 - 3,562,040 ------------- ------------- ------------- Net increase (decrease) in net assets from operations 256,067 (3,691) 40,617 ============= ============= ============= See accompanying notes to financial statements. (Continued) 18
485BPOS103rd Page of 168TOC1stPreviousNextBottomJust 103rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Operations Year ended December 31, 2003 [Enlarge/Download Table] American -------------------------------------------- Global Small Growth & Capitalization Growth Income Fund (a) Fund (a) Fund (a) Total -------------- ------------- ------------- ------------- Income: Dividends $ 481 6,302 35,149 38,450,726 -------------- ------------- ------------- ------------- Expenses: Mortality and expense risk 4,422 27,701 17,718 53,637,376 Administrative fee - - - 10,011,927 -------------- ------------- ------------- ------------- Total expenses 4,422 27,701 17,718 63,649,303 -------------- ------------- ------------- ------------- Net investment income (loss) (3,941) (21,399) 17,431 (25,198,577) -------------- ------------- ------------- ------------- Net realized gain (loss) on investments: Realized gain (loss) on sale of fund shares 6,885 662 3,541 (65,091,559) Realized gain distributions - - - 11,564,446 -------------- ------------- ------------- ------------- Net realized gain (loss) 6,885 662 3,541 (53,527,113) -------------- ------------- ------------- ------------- Change in unrealized appreciation (depreciation) 134,325 611,512 404,263 1,004,499,912 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations $ 137,269 590,775 425,235 925,774,222 ============== ============= ============= ============= (a) For the period from May 1, 2003 to December 31, 2003. See accompanying notes to financial statements. 19
485BPOS104th Page of 168TOC1stPreviousNextBottomJust 104th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2003 [Enlarge/Download Table] Met Investors ---------------------------------------------------------------- Lord Abbett Lord Abbett Lord Abbett Lord Abbett Growth & Growth & Bond Bond Income Income Debenture Debenture Portfolio Portfolio B Portfolio Portfolio B -------------- ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (474,865) (3,201,017) 10,546 3,066,501 Net realized gain (loss) (10,538,981) (8,478) 19,636 1,053,682 Change in unrealized appreciation (depreciation) 79,535,337 103,296,681 38,036 38,206,055 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations 68,521,491 100,087,186 68,218 42,326,238 -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - MetLife Investors USA Insurance Company redemptions - (322) - (532) Payments received from contract owners 19,613,525 260,422,193 17,695 222,862,988 Transfers between sub-accounts (including fixed account), net (7,550,610) 122,241,842 802,554 117,771,785 Transfers for contract benefits and terminations (39,311,746) (15,117,838) - (13,141,993) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (27,248,831) 367,545,875 820,249 327,492,248 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets 41,272,660 467,633,061 888,467 369,818,486 Net assets at beginning of period 256,901,296 158,468,844 108,777 115,255,304 -------------- ------------- ------------- ------------- Net assets at end of period $ 298,173,956 626,101,905 997,244 485,073,790 ============== ============= ============= ============= [Enlarge/Download Table] --------------------------------------- JP Morgan Met/ Met/ Quality Putnam Putnam Bond Research Research Portfolio Portfolio Portfolio B ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) 857,371 (266,293) (758,948) Net realized gain (loss) 419,961 (453,002) (107,147) Change in unrealized appreciation (depreciation) (402,827) 5,364,572 11,223,620 ------------- ------------- ------------- Net increase (decrease) in net assets from operations 874,505 4,645,277 10,357,525 ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - MetLife Investors USA Insurance Company redemptions - - (281) Payments received from contract owners 4,009,305 85,903 25,640,188 Transfers between sub-accounts (including fixed account), net (3,343,771) 73,360 7,933,788 Transfers for contract benefits and terminations (6,610,028) (5,048,268) (2,509,954) ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (5,944,494) (4,889,005) 31,063,741 ------------- ------------- ------------- Net increase (decrease) in net assets (5,069,989) (243,728) 41,421,266 Net assets at beginning of period 38,254,147 23,034,334 27,062,105 ------------- ------------- ------------- Net assets at end of period 33,184,158 22,790,606 68,483,371 ============= ============= ============= See accompanying notes to financial statements. (Continued) 20
485BPOS105th Page of 168TOC1stPreviousNextBottomJust 105th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2003 [Enlarge/Download Table] Met Investors ----------------------------------------------------------------- Oppenheimer PIMCO PIMCO Janus Capital Inflation Money Aggressive Appreciation Protected Bond Market Growth Portfolio B Portfolio B (a) Portfolio B Portfolio B -------------- --------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (3,613,406) (1,059,216) (1,646,089) (1,513,553) Net realized gain (loss) (573) 5,184,054 - 29,372 Change in unrealized appreciation (depreciation) 60,680,428 2,075,094 - 26,337,281 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations 57,066,449 6,199,932 (1,646,089) 24,853,100 -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - 7 - - MetLife Investors USA Insurance Company redemptions (198) - (194) (419) Payments received from contract owners 188,753,265 121,735,770 133,547,824 86,760,521 Transfers between sub-accounts (including fixed account), net 71,858,634 144,006,005 (85,041,381) 31,646,467 Transfers for contract benefits and terminations (8,041,312) (4,147,107) (20,037,004) (3,243,271) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 252,570,389 261,594,675 28,469,245 115,163,298 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets 309,636,838 267,794,607 26,823,156 140,016,398 Net assets at beginning of period 97,837,161 - 90,464,302 36,902,162 -------------- ------------- ------------- ------------- Net assets at end of period $ 407,473,999 267,794,607 117,287,458 176,918,560 ============== ============= ============= ============= [Enlarge/Download Table] ---------------------------------------- PIMCO PIMCO Total Return Total Return PIMCO Bond Bond Innovation Portfolio Portfolio B Portfolio (a) ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) (54,141) (1,006,816) (2,818) Net realized gain (loss) 906,702 8,137,247 4,056 Change in unrealized appreciation (depreciation) (88,845) 2,138,500 55,774 ------------- ------------- ------------- Net increase (decrease) in net assets from operations 763,716 9,268,931 57,012 ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - MetLife Investors USA Insurance Company redemptions - (320) - Payments received from contract owners 555,459 239,018,306 49,510 Transfers between sub-accounts (including fixed account), net 1,553,618 11,715,817 550,134 Transfers for contract benefits and terminations (5,672,669) (18,322,754) (10,369) ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (3,563,592) 232,411,049 589,275 ------------- ------------- ------------- Net increase (decrease) in net assets (2,799,876) 241,679,980 646,287 Net assets at beginning of period 25,486,564 238,270,817 - ------------- ------------- ------------- Net assets at end of period 22,686,688 479,950,797 646,287 ============= ============= ============= (a) For the period from May 1, 2003 to December 31, 2003. See accompanying notes to financial statements. (Continued) 21
485BPOS106th Page of 168TOC1stPreviousNextBottomJust 106th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2003 [Enlarge/Download Table] Met Investors ------------------------------------------------------------------------------- T Rowe Price MFS AIM AIM PIMCO Mid Cap Research Small Cap Small Cap Innovation Growth International Growth Growth Portfolio B Portfolio B Portfolio B Portfolio (a) Portfolio B -------------- ------------- ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (373,721) (1,743,087) (551,158) (1,804) (1,255,575) Net realized gain (loss) (189,629) (17,543) 201,866 13,265 219,596 Change in unrealized appreciation (depreciation) 9,550,569 34,788,215 24,339,743 22,604 25,849,273 -------------- ------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations 8,987,219 33,027,585 23,990,451 34,065 24,813,294 -------------- ------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - - MetLife Investors USA Insurance Company redemptions (478) (262) (296) - (1,257) Payments received from contract owners 14,451,983 97,011,990 55,324,638 30,350 72,425,989 Transfers between sub-accounts (including fixed account), net 9,838,258 34,773,115 (1,039,158) 310,138 15,214,670 Transfers for contract benefits and terminations (1,454,941) (3,774,959) (3,173,276) (6,004) (2,833,669) -------------- ------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 22,834,822 128,009,884 51,111,908 334,484 84,805,733 -------------- ------------- ------------- ------------- ------------- Net increase (decrease) in net assets 31,822,041 161,037,469 75,102,359 368,549 109,619,027 Net assets at beginning of period 10,195,680 42,934,975 46,398,334 - 34,329,159 -------------- ------------- ------------- ------------- ------------- Net assets at end of period $ 42,017,721 203,972,444 121,500,693 368,549 143,948,186 ============== ============= ============= ============= ============= [Download Table] ------------------------- AIM Harris Mid Cap Oakmark Core Equity International Portfolio B Portfolio B ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) (69,549) 213,986 Net realized gain (loss) (10,930) 439,496 Change in unrealized appreciation (depreciation) 18,668,662 32,012,248 ------------- ------------- Net increase (decrease) in net assets from operations 18,588,183 32,665,730 ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - MetLife Investors USA Insurance Company redemptions (1,284) (1,543) Payments received from contract owners 61,585,611 94,371,544 Transfers between sub-accounts (including fixed account), net 46,007,619 60,043,174 Transfers for contract benefits and terminations (2,495,851) (2,343,006) ------------- ------------- Net increase (decrease) in net assets from contract transactions 105,096,095 152,070,169 ------------- ------------- Net increase (decrease) in net assets 123,684,278 184,735,899 Net assets at beginning of period 23,276,982 12,688,775 ------------- ------------- Net assets at end of period 146,961,260 197,424,674 ============= ============= (a) For the period from May 1, 2003 to December 31, 2003. See accompanying notes to financial statements. (Continued) 22
485BPOS107th Page of 168TOC1stPreviousNextBottomJust 107th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2003 [Enlarge/Download Table] Met Investors ----------------------------- ---------------- Third Avenue Third Avenue Small Cap Small Cap Premier Value Value Equity Portfolio (a) Portfolio B Fund -------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (329) (1,176,239) (15,415) Net realized gain (loss) 5,828 1,322,991 (95,670) Change in unrealized appreciation (depreciation) 61,093 38,801,843 405,709 -------------- ------------- ------------- Net increase (decrease) in net assets from operations 66,592 38,948,595 294,624 -------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - MetLife Investors USA Insurance Company redemptions - (1,570) - Payments received from contract owners 51,071 107,259,101 (2,966) Transfers between sub-accounts (including fixed account), net 461,106 54,904,636 (36,874) Transfers for contract benefits and terminations (1,690) (3,056,301) (82,055) -------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 510,487 159,105,866 (121,895) -------------- ------------- ------------- Net increase (decrease) in net assets 577,079 198,054,461 172,729 Net assets at beginning of period - 25,528,634 1,358,722 -------------- ------------- ------------- Net assets at end of period $ 577,079 223,583,095 1,531,451 ============== ============= ============= [Enlarge/Download Table] AIM MFS ------------------------------------------ ------------- Capital International Appreciation Growth Balanced Research Fund Fund Fund Series ------------- ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) (10,187) (4,924) 6,135 (2,578) Net realized gain (loss) (72,431) (44,012) (55,483) (32,903) Change in unrealized appreciation (depreciation) 258,319 191,317 199,770 108,011 ------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations 175,701 142,381 150,422 72,530 ------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - MetLife Investors USA Insurance Company redemptions - - - - Payments received from contract owners 3,595 4,025 3,150 (9,701) Transfers between sub-accounts (including fixed account), net (21,836) (2,530) 366 (6,399) Transfers for contract benefits and terminations (70,493) (37,820) (133,539) (40,242) ------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (88,734) (36,325) (130,023) (56,342) ------------- ------------- ------------- ------------- Net increase (decrease) in net assets 86,967 106,056 20,399 16,188 Net assets at beginning of period 713,339 556,574 1,152,340 359,720 ------------- ------------- ------------- ------------- Net assets at end of period 800,306 662,630 1,172,739 375,908 ============= ============= ============= ============= (a) For the period from May 1, 2003 to December 31, 2003. See accompanying notes to financial statements. (Continued) 23
485BPOS108th Page of 168TOC1stPreviousNextBottomJust 108th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2003 [Enlarge/Download Table] MFS Op ----------------------------- --------------------------------- Main Street Investors New Growth & Trust Discovery Income Bond Series Series Fund Fund -------------- ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (1,331) (4,566) (6,634) 17,704 Net realized gain (loss) (7,103) (38,979) (63,615) 517 Change in unrealized appreciation (depreciation) 42,890 130,599 406,032 3,878 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations 34,456 87,054 335,783 22,099 -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - MetLife Investors USA Insurance Company redemptions - - - - Payments received from contract owners - (9,656) 1,824 6,300 Transfers between sub-accounts (including fixed account), net 4,912 (18,786) (15,669) 18,825 Transfers for contract benefits and terminations (16,768) (49,805) (111,339) (23,961) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (11,856) (78,247) (125,184) 1,164 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets 22,600 8,807 210,599 23,263 Net assets at beginning of period 176,867 340,233 1,485,237 419,872 -------------- ------------- ------------- ------------- Net assets at end of period $ 199,467 349,040 1,695,836 443,135 ============== ============= ============= ============= [Enlarge/Download Table] penheimer ---------------------------------------- Main Street Small Strategic Money Cap Bond Fund Growth Fund Fund ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) (3,294) (1,989) 12,599 Net realized gain (loss) - (2,047) 141 Change in unrealized appreciation (depreciation) - 54,353 24,587 ------------- ------------- ------------- Net increase (decrease) in net assets from operations (3,294) 50,317 37,327 ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - MetLife Investors USA Insurance Company redemptions - - - Payments received from contract owners - 240 166 Transfers between sub-accounts (including fixed account), net (348,854) 16,829 490 Transfers for contract benefits and terminations (16,881) (8,502) (34,103) ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (365,735) 8,567 (33,447) ------------- ------------- ------------- Net increase (decrease) in net assets (369,029) 58,884 3,880 Net assets at beginning of period 910,119 123,379 248,099 ------------- ------------- ------------- Net assets at end of period 541,090 182,263 251,979 ============= ============= ============= See accompanying notes to financial statements. (Continued) 24
485BPOS109th Page of 168TOC1stPreviousNextBottomJust 109th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2003 [Enlarge/Download Table] Fidelity ---------------------------------------------------------------- Asset Manager Growth Contrafund Overseas Portfolio Portfolio Portfolio Portfolio -------------- ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ 3,588,750 (2,630,329) (1,995,730) (44,835) Net realized gain (loss) (4,651,518) (16,397,960) (1,627,928) (1,261,416) Change in unrealized appreciation (depreciation) 25,905,819 83,691,437 56,105,559 5,096,073 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations 24,843,051 64,663,148 52,481,901 3,789,822 -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - MetLife Investors USA Insurance Company redemptions - - - - Payments received from contract owners 11,059,497 22,745,698 20,674,012 217,854 Transfers between sub-accounts (including fixed account), net (4,610,577) (8,545,847) (5,253,201) 86,744 Transfers for contract benefits and terminations (20,510,654) (32,090,528) (19,249,685) (2,034,089) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (14,061,734) (17,890,677) (3,828,874) (1,729,491) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets 10,781,317 46,772,471 48,653,027 2,060,331 Net assets at beginning of period 162,779,061 222,487,040 200,852,938 10,274,025 -------------- ------------- ------------- ------------- Net assets at end of period $ 173,560,378 269,259,511 249,505,965 12,334,356 ============== ============= ============= ============= [Enlarge/Download Table] ---------------------------------------- Equity- Index Money Income 500 Market Portfolio Portfolio Portfolio ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) 108,001 526,462 (68,021) Net realized gain (loss) (807,406) (14,361,585) - Change in unrealized appreciation (depreciation) 6,483,503 57,042,919 - ------------- ------------- ------------- Net increase (decrease) in net assets from operations 5,784,098 43,207,796 (68,021) ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - MetLife Investors USA Insurance Company redemptions - - - Payments received from contract owners 80,351 15,170,894 6,932,123 Transfers between sub-accounts (including fixed account), net (403,381) (72,470,331) (5,357,390) Transfers for contract benefits and terminations (2,820,510) (23,222,948) (5,746,401) ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (3,143,540) (80,522,385) (4,171,668) ------------- ------------- ------------- Net increase (decrease) in net assets 2,640,558 (37,314,589) (4,239,689) Net assets at beginning of period 22,635,288 202,226,966 30,912,721 ------------- ------------- ------------- Net assets at end of period 25,275,846 164,912,377 26,673,032 ============= ============= ============= See accompanying notes to financial statements. (Continued) 25
485BPOS110th Page of 168TOC1stPreviousNextBottomJust 110th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2003 [Enlarge/Download Table] Scudder I MetLife -------------- ----------------------------------------------------------- Davis Davis Harris Harris Venture Venture Oakmark Oakmark International Value Value Focused Focused Portfolio Fund (a) Fund E Value Fund (a) Value Fund B -------------- ------------- ------------- -------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (110,898) (3,388) (3,313,010) (11,975) (3,660,215) Net realized gain (loss) (1,728,672) 264 (102,267) 556 (5,872) Change in unrealized appreciation (depreciation) 6,214,219 88,012 74,510,314 355,482 74,648,276 -------------- ------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations 4,374,649 84,888 71,095,037 344,063 70,982,189 -------------- ------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - - MetLife Investors USA Insurance Company redemptions - - (42) - (52) Payments received from contract owners 2,912,417 82,244 187,975,968 565,168 167,425,874 Transfers between sub-accounts (including fixed account), net (1,001,568) 626,320 45,469,829 2,768,656 67,493,776 Transfers for contract benefits and terminations (1,032,892) (11,121) (11,408,815) (35,531) (9,899,063) -------------- ------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 877,957 697,443 222,036,940 3,298,293 225,020,535 -------------- ------------- ------------- ------------- ------------- Net increase (decrease) in net assets 5,252,606 782,331 293,131,977 3,642,356 296,002,724 Net assets at beginning of period 16,026,962 - 128,844,921 - 113,939,326 -------------- ------------- ------------- ------------- ------------- Net assets at end of period $ 21,279,568 782,331 421,976,898 3,642,356 409,942,050 ============== ============= ============= ============= ============= [Download Table] ----------------------------- MFS Jennison Total Growth Return Portfolio B Series (a) ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) (1,442,467) (2,927) Net realized gain (loss) 1,849,073 774 Change in unrealized appreciation (depreciation) 25,140,667 46,065 ------------- ------------- Net increase (decrease) in net assets from operations 25,547,273 43,912 ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - MetLife Investors USA Insurance Company redemptions (47) - Payments received from contract owners 115,370,120 120,657 Transfers between sub-accounts (including fixed account), net 4,486,868 614,370 Transfers for contract benefits and terminations (3,407,507) (12,985) ------------- ------------- Net increase (decrease) in net assets from contract transactions 116,449,434 722,042 ------------- ------------- Net increase (decrease) in net assets 141,996,707 765,954 Net assets at beginning of period 42,025,982 - ------------- ------------- Net assets at end of period 184,022,689 765,954 ============= ============= (a) For the period from May 1, 2003 to December 31, 2003. See accompanying notes to financial statements. (Continued) 26
485BPOS111th Page of 168TOC1stPreviousNextBottomJust 111th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2003 [Enlarge/Download Table] MetLife ------------------------------------------------------------------ Putnam Russell Met/ International Janus 2000 Putnam Stock Mid Cap Index Voyager Portfolio Portfolio Portfolio Portfolio A -------------- ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (2,528) (10,832) (9,094) (4,887) Net realized gain (loss) (23,229) (119,488) 10,428 (40,469) Change in unrealized appreciation (depreciation) 106,170 347,581 341,057 119,930 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations 80,413 217,261 342,391 74,574 -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - MetLife Investors USA Insurance Company redemptions - - - - Payments received from contract owners - 5,687 174,766 885 Transfers between sub-accounts (including fixed account), net 29,057 65,277 1,563,207 44,506 Transfers for contract benefits and terminations (21,045) (83,195) (231,104) (27,282) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 8,012 (12,231) 1,506,869 18,109 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets 88,425 205,030 1,849,260 92,683 Net assets at beginning of period 276,753 703,693 378,497 326,304 -------------- ------------- ------------- ------------- Net assets at end of period $ 365,178 908,723 2,227,757 418,987 ============== ============= ============= ============= [Enlarge/Download Table] -------------------------------------- SSR SSR SSR Large Cap Aurora Bond Income Value Portfolio (a) Portfolio (a) Portfolio (a) ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) (9,354) (2,565) 630 Net realized gain (loss) 3,784 108 (106) Change in unrealized appreciation (depreciation) 348,713 12,545 20,377 ------------- ------------- ------------- Net increase (decrease) in net assets from operations 343,143 10,088 20,901 ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - MetLife Investors USA Insurance Company redemptions - - - Payments received from contract owners 269,110 88,642 23,374 Transfers between sub-accounts (including fixed account), net 2,174,389 572,884 169,762 Transfers for contract benefits and terminations (34,948) (14,063) (1,890) ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 2,408,551 647,463 191,246 ------------- ------------- ------------- Net increase (decrease) in net assets 2,751,694 657,551 212,147 Net assets at beginning of period - - - ------------- ------------- ------------- Net assets at end of period 2,751,694 657,551 212,147 ============= ============= ============= (a) For the period from May 1, 2003 to December 31, 2003. See accompanying notes to financial statements. (Continued) 27
485BPOS112th Page of 168TOC1stPreviousNextBottomJust 112th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2003 [Enlarge/Download Table] MetLife ------------------------------------------------------------------ Lehman Stock Stock Alger Brothers Index Index Equity Aggregate Portfolio (a) Portfolio B Growth (a) Bond Index (a) -------------- ------------- ------------- -------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (350,476) (310,441) (975) (3,040) Net realized gain (loss) 106,930 193,706 340 (1,569) Change in unrealized appreciation (depreciation) 7,763,978 21,269,435 20,041 8,123 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations 7,520,432 21,152,700 19,406 3,514 -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - MetLife Investors USA Insurance Company redemptions - (879) - - Payments received from contract owners 2,270,143 52,379,728 18,900 146,341 Transfers between sub-accounts (including fixed account), net 62,008,296 24,073,826 166,404 572,888 Transfers for contract benefits and terminations (2,204,024) (3,214,862) (159) (20,801) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 62,074,415 73,237,813 185,145 698,428 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets 69,594,847 94,390,513 204,551 701,942 Net assets at beginning of period - 41,490,056 - - -------------- ------------- ------------- ------------- Net assets at end of period $ 69,594,847 135,880,569 204,551 701,942 ============== ============= ============= ============= [Enlarge/Download Table] ----------------------------------------- Harris Oakmark Morgan Stanley FI Mid Cap Large Cap EAFE Opportunities (a) Value (a) Index (a) ----------------- -------------- -------------- Increase (decrease) in net assets from operations: Net investment income (loss) (3,090) (5,942) (5,931) Net realized gain (loss) 14,088 316 74,614 Change in unrealized appreciation (depreciation) 88,530 129,746 96,659 ------------- ------------- ------------- Net increase (decrease) in net assets from operations 99,528 124,120 165,342 ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - MetLife Investors USA Insurance Company redemptions - - - Payments received from contract owners 98,391 248,630 130,969 Transfers between sub-accounts (including fixed account), net 632,576 1,378,139 795,880 Transfers for contract benefits and terminations (11,961) (1,648) (23,548) ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 719,006 1,625,121 903,301 ------------- ------------- ------------- Net increase (decrease) in net assets 818,534 1,749,241 1,068,643 Net assets at beginning of period - - - ------------- ------------- ------------- Net assets at end of period 818,534 1,749,241 1,068,643 ============= ============= ============= (a) For the period from May 1, 2003 to December 31, 2003. See accompanying notes to financial statements. (Continued) 28
485BPOS113th Page of 168TOC1stPreviousNextBottomJust 113th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2003 [Enlarge/Download Table] MetLife Van Kampen -------------- ------------------------------------------- Mid Emerging Growth & Cap Stock Growth Enterprise Income Index (a) Fund Fund Fund -------------- ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (5,905) (6,845) (1,399) (1,432) Net realized gain (loss) 5,458 (62,002) (7,910) (566) Change in unrealized appreciation (depreciation) 144,303 179,009 43,499 67,709 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations 143,856 110,162 34,190 65,711 -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - MetLife Investors USA Insurance Company redemptions - - - - Payments received from contract owners 185,742 405 (9,701) - Transfers between sub-accounts (including fixed account), net 1,176,097 17,750 (8,142) 35,761 Transfers for contract benefits and terminations (21,596) (57,744) (1,784) (6,985) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 1,340,243 (39,589) (19,627) 28,776 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets 1,484,099 70,573 14,563 94,487 Net assets at beginning of period - 458,846 155,300 220,658 -------------- ------------- ------------- ------------- Net assets at end of period $ 1,484,099 529,419 169,863 315,145 ============== ============= ============= ============= [Enlarge/Download Table] Federated ------------------------------------------- American High Growth Leaders Income Bond Strategic Fund II Fund II Fund II ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) 1,685 15,835 (2,548) Net realized gain (loss) (24,215) (3,235) (16,005) Change in unrealized appreciation (depreciation) 158,025 34,423 77,183 ------------- ------------- ------------- Net increase (decrease) in net assets from operations 135,495 47,023 58,630 ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - MetLife Investors USA Insurance Company redemptions - - - Payments received from contract owners 6,180 - 690 Transfers between sub-accounts (including fixed account), net (37,951) 1,712 (7,677) Transfers for contract benefits and terminations (49,996) (30,074) (7,662) ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (81,767) (28,362) (14,649) ------------- ------------- ------------- Net increase (decrease) in net assets 53,728 18,661 43,981 Net assets at beginning of period 593,612 244,101 158,130 ------------- ------------- ------------- Net assets at end of period 647,340 262,762 202,111 ============= ============= ============= (a) For the period from May 1, 2003 to December 31, 2003. See accompanying notes to financial statements. (Continued) 29
485BPOS114th Page of 168TOC1stPreviousNextBottomJust 114th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2003 [Enlarge/Download Table] Federated Neuberger Alger -------------- ------------- -------------- ---------------- Equity Small Income Genesis Capitalization Growth Fund II Trust Fund Fund -------------- ------------- -------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ 1,618 (1,434) (701,164) (71,567) Net realized gain (loss) (17,041) 156,873 (5,252,739) (9,975,488) Change in unrealized appreciation (depreciation) 83,956 (160,697) 23,298,902 13,059,440 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations 68,533 (5,258) 17,344,999 3,012,385 -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - MetLife Investors USA Insurance Company redemptions - - - - Payments received from contract owners 629 3,656 5,741,989 441,349 Transfers between sub-accounts (including fixed account), net (5,346) 3,457 (2,327,509) (218,637) Transfers for contract benefits and terminations (28,557) (3,176,724) (3,893,264) (20,566,154) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (33,274) (3,169,611) (478,784) (20,343,442) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets 35,259 (3,174,869) 16,866,215 (17,331,057) Net assets at beginning of period 300,784 3,192,787 42,603,692 27,968,736 -------------- ------------- ------------- ------------- Net assets at end of period $ 336,043 17,918 59,469,907 10,637,679 ============== ============= ============= ============= [Enlarge/Download Table] T Rowe Janus --------------------------- ------------- Prime Aspen International Reserve Worldwide Stock Fund Fund Growth ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) 2,214 (3,691) (2,228) Net realized gain (loss) (2,167,516) - (3,519,195) Change in unrealized appreciation (depreciation) 2,421,369 - 3,562,040 ------------- ------------- ------------- Net increase (decrease) in net assets from operations 256,067 (3,691) 40,617 ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - MetLife Investors USA Insurance Company redemptions - - - Payments received from contract owners 76,061 (13,752) 7,003 Transfers between sub-accounts (including fixed account), net (39,262) (83,983) (22,741) Transfers for contract benefits and terminations (3,610,120) (300,571) (5,187,724) ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (3,573,321) (398,306) (5,203,462) ------------- ------------- ------------- Net increase (decrease) in net assets (3,317,254) (401,997) (5,162,845) Net assets at beginning of period 4,374,990 1,838,862 5,172,450 ------------- ------------- ------------- Net assets at end of period 1,057,736 1,436,865 9,605 ============= ============= ============= See accompanying notes to financial statements. (Continued) 30
485BPOS115th Page of 168TOC1stPreviousNextBottomJust 115th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2003 [Enlarge/Download Table] American -------------------------------------------- Global Small Growth & Capitalization Growth Income Fund (a) Fund (a) Fund (a) Total -------------- ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (3,941) (21,399) 17,431 (25,198,577) Net realized gain (loss) 6,885 662 3,541 (53,527,113) Change in unrealized appreciation (depreciation) 134,325 611,512 404,263 1,004,499,912 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations 137,269 590,775 425,235 925,774,222 -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - 7 MetLife Investors USA Insurance Company redemptions - - - (9,976) Payments received from contract owners 130,939 720,748 538,731 2,420,600,818 Transfers between sub-accounts (including fixed account), net 1,012,398 5,681,430 3,962,633 761,613,623 Transfers for contract benefits and terminations (890) (22,327) (56,047) (335,370,996) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 1,142,447 6,379,851 4,445,317 2,846,833,476 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets 1,279,716 6,970,626 4,870,552 3,772,607,698 Net assets at beginning of period - - - 2,594,706,334 -------------- ------------- ------------- ------------- Net assets at end of period $ 1,279,716 6,970,626 4,870,552 6,367,314,032 ============== ============= ============= ============= (a) For the period from May 1, 2003 to December 31, 2003. See accompanying notes to financial statements. 31
485BPOS116th Page of 168TOC1stPreviousNextBottomJust 116th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2002 [Enlarge/Download Table] Met Investors ---------------------------------------------------------------- Lord Abbett Lord Abbett Lord Abbett Lord Abbett Growth & Growth & Bond Bond Income Income Debenture Debenture Portfolio Portfolio B Portfolio (b) Portfolio B -------------- ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (1,138,649) 111,314 (977) 1,578,316 Net realized gain (loss) 15,626,004 11,124,550 (896) (773,645) Change in unrealized appreciation (depreciation) (77,572,328) (28,389,839) 102 1,257,236 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations (63,084,973) (17,153,975) (1,771) 2,061,907 -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - MetLife Investors USA Insurance Company redemptions - (374) - (293) Payments received from contract owners 25,971,706 91,817,429 1,230 59,833,185 Transfers between sub-accounts (including fixed account), net (8,150,338) 52,906,691 115,317 41,955,527 Transfers for contract benefits and terminations (23,488,798) (3,378,135) (5,999) (1,840,756) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (5,667,430) 141,345,611 110,548 99,947,663 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets (68,752,403) 124,191,636 108,777 102,009,570 Net assets at beginning of period 325,653,699 34,277,208 - 13,245,734 -------------- ------------- ------------- ------------- Net assets at end of period $ 256,901,296 158,468,844 108,777 115,255,304 ============== ============= ============= ============= [Enlarge/Download Table] ---------------------------------------- JP Morgan Met/ Met/ Quality Putnam Putnam Bond Research Research Portfolio Portfolio Portfolio B ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) 1,270,331 (234,889) (165,090) Net realized gain (loss) 73,635 (670,404) (234,087) Change in unrealized appreciation (depreciation) 1,086,975 (6,476,873) (3,299,270) ------------- ------------- ------------- Net increase (decrease) in net assets from operations 2,430,941 (7,382,166) (3,698,447) ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - MetLife Investors USA Insurance Company redemptions - - (81) Payments received from contract owners 4,016,933 105,010 12,665,806 Transfers between sub-accounts (including fixed account), net 6,899,181 (577,919) 9,445,184 Transfers for contract benefits and terminations (3,071,140) (4,612,308) (590,039) ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 7,844,974 (5,085,217) 21,520,870 ------------- ------------- ------------- Net increase (decrease) in net assets 10,275,915 (12,467,383) 17,822,423 Net assets at beginning of period 27,978,232 35,501,717 9,239,682 ------------- ------------- ------------- Net assets at end of period 38,254,147 23,034,334 27,062,105 ============= ============= ============= (b) For the period from April 26, 2002 to December 31, 2002. See accompanying notes to financial statements. (Continued) 32
485BPOS117th Page of 168TOC1stPreviousNextBottomJust 117th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2002 [Enlarge/Download Table] Met Investors ------------------------------------------------------------------ Oppenheimer PIMCO Janus PIMCO Capital Money Aggressive Total Return Appreciation Market Growth Bond Portfolio B Portfolio B Portfolio B Portfolio -------------- ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (850,938) (341,003) (333,800) (345,747) Net realized gain (loss) (149,511) - (119,094) 179,184 Change in unrealized appreciation (depreciation) (11,600,543) - (6,107,360) 2,227,788 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations (12,600,992) (341,003) (6,560,254) 2,061,225 -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - 100 - - MetLife Investors USA Insurance Company redemptions (84) (200) - - Payments received from contract owners 58,590,707 89,900,591 23,942,950 145,191 Transfers between sub-accounts (including fixed account), net 31,825,076 (12,384,178) 9,850,187 151,886 Transfers for contract benefits and terminations (1,723,549) (7,391,851) (599,007) (5,060,861) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 88,692,150 70,124,462 33,194,130 (4,763,784) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets 76,091,158 69,783,459 26,633,876 (2,702,559) Net assets at beginning of period 21,746,003 20,680,843 10,268,286 28,189,123 -------------- ------------- ------------- ------------- Net assets at end of period $ 97,837,161 90,464,302 36,902,162 25,486,564 ============== ============= ============= ============= [Enlarge/Download Table] -------------------------------------- PIMCO T Rowe Price Total Return PIMCO Mid Cap Bond Innovation Growth Portfolio B Portfolio B Portfolio B ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) (1,720,899) (123,809) (407,716) Net realized gain (loss) 46,268 (201,351) 27,331 Change in unrealized appreciation (depreciation) 10,076,696 (4,813,192) (11,731,559) ------------- ------------- ------------- Net increase (decrease) in net assets from operations 8,402,065 (5,138,352) (12,111,944) ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - MetLife Investors USA Insurance Company redemptions (103) - (144) Payments received from contract owners 122,406,152 5,973,353 27,351,253 Transfers between sub-accounts (including fixed account), net 85,492,935 5,114,891 14,641,601 Transfers for contract benefits and terminations (3,532,621) (128,982) (659,896) ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 204,366,363 10,959,262 41,332,814 ------------- ------------- ------------- Net increase (decrease) in net assets 212,768,428 5,820,910 29,220,870 Net assets at beginning of period 25,502,389 4,374,770 13,714,105 ------------- ------------- ------------- Net assets at end of period 238,270,817 10,195,680 42,934,975 ============= ============= ============= See accompanying notes to financial statements. (Continued) 33
485BPOS118th Page of 168TOC1stPreviousNextBottomJust 118th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2002 [Enlarge/Download Table] Met Investors ---------------------------------------------------------------- MFS AIM AIM Harris Research Small Cap Mid Cap Oakmark International Growth Core Equity International Portfolio B Portfolio B Portfolio B Portfolio B -------------- ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (298,125) (236,084) (188,931) (64,652) Net realized gain (loss) (510,120) (81,381) (130,466) (35,949) Change in unrealized appreciation (depreciation) (1,617,055) (3,280,761) (1,443,650) (601,328) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations (2,425,300) (3,598,226) (1,763,047) (701,929) -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - MetLife Investors USA Insurance Company redemptions (166) (428) (433) - Payments received from contract owners 29,812,221 25,237,357 15,589,943 9,759,385 Transfers between sub-accounts (including fixed account), net 12,032,231 11,546,362 8,839,084 3,511,599 Transfers for contract benefits and terminations (687,778) (268,708) (398,760) (99,011) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 41,156,508 36,514,583 24,029,834 13,171,973 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets 38,731,208 32,916,357 22,266,787 12,470,044 Net assets at beginning of period 7,667,126 1,412,802 1,010,195 218,731 -------------- ------------- ------------- ------------- Net assets at end of period $ 46,398,334 34,329,159 23,276,982 12,688,775 ============== ============= ============= ============= [Enlarge/Download Table] AIM ----------- ---------------------------- Third Avenue Small Cap Premier Capital Value Equity Appreciation Portfolio B (c) Fund Fund --------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) (56,207) (19,514) (12,521) Net realized gain (loss) 30,890 (425,721) (278,584) Change in unrealized appreciation (depreciation) 66,218 (229,205) 35,711 ------------- ------------- ------------- Net increase (decrease) in net assets from operations 40,901 (674,440) (255,394) ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments 1,500 - - MetLife Investors USA Insurance Company redemptions - - - Payments received from contract owners 15,248,088 8,310 260 Transfers between sub-accounts (including fixed account), net 10,381,518 (67,187) 13,898 Transfers for contract benefits and terminations (143,373) (207,697) (108,752) ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 25,487,733 (266,574) (94,594) ------------- ------------- ------------- Net increase (decrease) in net assets 25,528,634 (941,014) (349,988) Net assets at beginning of period - 2,299,736 1,063,327 ------------- ------------- ------------- Net assets at end of period 25,528,634 1,358,722 713,339 ============= ============= ============= (c) For the period from May 1, 2002 to December 31, 2002. See accompanying notes to financial statements. (Continued) 34
485BPOS119th Page of 168TOC1stPreviousNextBottomJust 119th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2002 [Enlarge/Download Table] AIM MFS ----------------------------- ------------------------------- International Investors Growth Balanced Research Trust Fund Fund Series Series -------------- ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (5,895) 12,198 (5,109) (1,858) Net realized gain (loss) (139,519) (145,764) (130,736) (30,552) Change in unrealized appreciation (depreciation) 29,252 (146,217) 760 (22,271) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations (116,162) (279,783) (135,085) (54,681) -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - MetLife Investors USA Insurance Company redemptions - - - - Payments received from contract owners 740 200 9,861 - Transfers between sub-accounts (including fixed account), net (12,152) (6,839) (9,513) 1,359 Transfers for contract benefits and terminations (66,339) (140,825) (40,290) (24,241) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (77,751) (147,464) (39,942) (22,882) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets (193,913) (427,247) (175,027) (77,563) Net assets at beginning of period 750,487 1,579,587 534,747 254,430 -------------- ------------- ------------- ------------- Net assets at end of period $ 556,574 1,152,340 359,720 176,867 ============== ============= ============= ============= [Enlarge/Download Table] Oppenheimer ------------ ---------------------------- Main Street New Growth & Discovery Income Bond Series Fund Fund ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) (6,509) (11,925) 23,378 Net realized gain (loss) (94,147) (228,579) (5,566) Change in unrealized appreciation (depreciation) (86,158) (176,542) 10,343 ------------- ------------- ------------- Net increase (decrease) in net assets from operations (186,814) (417,046) 28,155 ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - MetLife Investors USA Insurance Company redemptions - - - Payments received from contract owners 12,659 2,601 1,103 Transfers between sub-accounts (including fixed account), net (73,381) (218,399) 111,827 Transfers for contract benefits and terminations (17,837) (230,459) (92,902) ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (78,559) (446,257) 20,028 ------------- ------------- ------------- Net increase (decrease) in net assets (265,373) (863,303) 48,183 Net assets at beginning of period 605,606 2,348,540 371,689 ------------- ------------- ------------- Net assets at end of period 340,233 1,485,237 419,872 ============= ============= ============= See accompanying notes to financial statements. (Continued) 35
485BPOS120th Page of 168TOC1stPreviousNextBottomJust 120th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2002 [Enlarge/Download Table] Oppenheimer -------------------------------------------- -------------- Main Street Small Strategic Asset Money Cap Bond Manager Fund Growth Fund Fund Portfolio -------------- ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ 193 (2,100) 21,920 4,605,137 Net realized gain (loss) - (1,967) (5,014) (3,833,433) Change in unrealized appreciation (depreciation) - (22,202) 285 (19,943,022) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations 193 (26,269) 17,191 (19,171,318) -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - MetLife Investors USA Insurance Company redemptions - - - - Payments received from contract owners (22,830) 240 - 14,348,141 Transfers between sub-accounts (including fixed account), net 123,973 (3,838) (73,887) (6,809,387) Transfers for contract benefits and terminations (83,312) (6,813) (19,145) (15,375,384) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 17,831 (10,411) (93,032) (7,836,630) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets 18,024 (36,680) (75,841) (27,007,948) Net assets at beginning of period 892,095 160,059 323,940 189,787,009 -------------- ------------- ------------- ------------- Net assets at end of period $ 910,119 123,379 248,099 162,779,061 ============== ============= ============= ============= [Enlarge/Download Table] Fidelity -------------------------------------------- Growth Contrafund Overseas Portfolio Portfolio Portfolio ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) (2,872,160) (1,151,462) (58,165) Net realized gain (loss) (8,434,983) (1,424,664) (1,395,556) Change in unrealized appreciation (depreciation) (91,373,406) (21,506,132) (1,608,623) ------------- ------------- ------------- Net increase (decrease) in net assets from operations (102,680,549) (24,082,258) (3,062,344) ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - MetLife Investors USA Insurance Company redemptions - - - Payments received from contract owners 32,539,185 26,210,040 255,900 Transfers between sub-accounts (including fixed account), net (11,860,922) (6,113,610) (454,718) Transfers for contract benefits and terminations (22,778,587) (14,796,387) (1,663,976) ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (2,100,324) 5,300,043 (1,862,794) ------------- ------------- ------------- Net increase (decrease) in net assets (104,780,873) (18,782,215) (4,925,138) Net assets at beginning of period 327,267,913 219,635,153 15,199,163 ------------- ------------- ------------- Net assets at end of period 222,487,040 200,852,938 10,274,025 ============= ============= ============= See accompanying notes to financial statements. (Continued) 36
485BPOS121st Page of 168TOC1stPreviousNextBottomJust 121st
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2002 [Enlarge/Download Table] Fidelity Scudder I -------------------------------------------- ------------- -------------- Davis Equity- Money Venture Income Index 500 Market International Value Portfolio Portfolio Portfolio Portfolio Fund E -------------- ------------- ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ 123,246 (60,161) 114,274 (89,593) (682,137) Net realized gain (loss) (467,205) (2,601,002) - (2,171,519) (79,480) Change in unrealized appreciation (depreciation) (5,448,571) (59,492,684) - (1,387,554) (10,644,714) -------------- ------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations (5,792,530) (62,153,847) 114,274 (3,648,666) (11,406,331) -------------- ------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - - MetLife Investors USA Insurance Company redemptions - - - - (252) Payments received from contract owners 139,571 32,701,709 3,458,477 3,614,551 73,472,705 Transfers between sub-accounts (including fixed account), net (1,628,784) (10,730,284) (1,597,458) (29,908) 42,451,975 Transfers for contract benefits and terminations (2,943,318) (15,391,836) (5,582,028) (1,047,538) (2,520,827) -------------- ------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (4,432,531) 6,579,589 (3,721,009) 2,537,105 113,403,601 -------------- ------------- ------------- ------------- ------------- Net increase (decrease) in net assets (10,225,061) (55,574,258) (3,606,735) (1,111,561) 101,997,270 Net assets at beginning of period 32,860,349 257,801,224 34,519,456 17,138,523 26,847,651 -------------- ------------- ------------- ------------- ------------- Net assets at end of period $ 22,635,288 202,226,966 30,912,721 16,026,962 128,844,921 ============== ============= ============= ============= ============= [Download Table] MetLife ------------------------------ Harris Oakmark Jennison Focused Growth Value Fund B Portfolio B (c) ------------- --------------- Increase (decrease) in net assets from operations: Net investment income (loss) (953,356) (156,833) Net realized gain (loss) (207,588) (8,105) Change in unrealized appreciation (depreciation) (5,211,041) (2,035,146) ------------- ------------- Net increase (decrease) in net assets from operations (6,371,985) (2,200,084) ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - 1,500 MetLife Investors USA Insurance Company redemptions (276) (1,190) Payments received from contract owners 58,011,135 31,241,035 Transfers between sub-accounts (including fixed account), net 42,103,479 13,161,775 Transfers for contract benefits and terminations (2,025,627) (177,054) ------------- ------------- Net increase (decrease) in net assets from contract transactions 98,088,711 44,226,066 ------------- ------------- Net increase (decrease) in net assets 91,716,726 42,025,982 Net assets at beginning of period 22,222,600 - ------------- ------------- Net assets at end of period 113,939,326 42,025,982 ============= ============= (c) For the period from May 1, 2002 to December 31, 2002. See accompanying notes to financial statements. (Continued) 37
485BPOS122nd Page of 168TOC1stPreviousNextBottomJust 122nd
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2002 [Enlarge/Download Table] MetLife ------------------------------------------------------------------ Putnam Russell Met/ International Janus 2000 Putnam Stock Mid Cap Index Voyager Portfolio Portfolio Portfolio Portfolio A -------------- ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (1,740) (12,502) (4,074) (5,997) Net realized gain (loss) (16,231) (254,537) (32,735) (61,371) Change in unrealized appreciation (depreciation) (45,681) (71,946) (91,061) (87,937) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations (63,652) (338,985) (127,870) (155,305) -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - MetLife Investors USA Insurance Company redemptions - - - - Payments received from contract owners - 35,471 6,652 7,997 Transfers between sub-accounts (including fixed account), net 27,139 43,394 130,182 36,091 Transfers for contract benefits and terminations (15,391) (72,147) (38,685) (23,014) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 11,748 6,718 98,149 21,074 -------------- ------------- ------------- ------------- Net increase (decrease) in net assets (51,904) (332,267) (29,721) (134,231) Net assets at beginning of period 328,657 1,035,960 408,218 460,535 -------------- ------------- ------------- ------------- Net assets at end of period $ 276,753 703,693 378,497 326,304 ============== ============= ============= ============= [Enlarge/Download Table] Van Kampen ----------------------- ------------- Loomis Sayles Stock Emerging High Yield Index Growth Bond (d) Portfolio B Fund ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) 9,332 (249,848) (6,607) Net realized gain (loss) (508) (1,214,414) (366,637) Change in unrealized appreciation (depreciation) 8,635 (4,231,246) 119,225 ------------- ------------- ------------- Net increase (decrease) in net assets from operations 17,459 (5,695,508) (254,019) ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - MetLife Investors USA Insurance Company redemptions - (511) - Payments received from contract owners 378 24,510,041 5,649 Transfers between sub-accounts (including fixed account), net (84,444) 21,034,980 (17,241) Transfers for contract benefits and terminations (17,077) (163,796) (117,619) ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (101,143) 45,380,714 (129,211) ------------- ------------- ------------- Net increase (decrease) in net assets (83,684) 39,685,206 (383,230) Net assets at beginning of period 83,684 1,804,850 842,076 ------------- ------------- ------------- Net assets at end of period - 41,490,056 458,846 ============= ============= ============= (d) For the period from January 1, 2002 to April 29, 2002. See accompanying notes to financial statements. (Continued) 38
485BPOS123rd Page of 168TOC1stPreviousNextBottomJust 123rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2002 [Enlarge/Download Table] Van Kampen -------------------------------------------- -------------- Growth & American Enterprise Income Strategic Leaders Fund Fund (c) Stock (e) Fund II -------------- ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (1,913) (2,262) 5,363 (1,235) Net realized gain (loss) (82,135) 6,859 17,308 (137,726) Change in unrealized appreciation (depreciation) 9,598 (33,073) (12,418) (95,148) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations (74,450) (28,476) 10,253 (234,109) -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - MetLife Investors USA Insurance Company redemptions - - - - Payments received from contract owners 9,701 7,412 - 555 Transfers between sub-accounts (including fixed account), net (17,369) 282,495 (278,619) (113,675) Transfers for contract benefits and terminations (29,156) (40,773) (16,884) (220,922) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (36,824) 249,134 (295,503) (334,042) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets (111,274) 220,658 (285,250) (568,151) Net assets at beginning of period 266,574 - 285,250 1,161,763 -------------- ------------- ------------- ------------- Net assets at end of period $ 155,300 220,658 - 593,612 ============== ============= ============= ============= [Enlarge/Download Table] Federated -------------------------------------------- High Growth Equity Income Bond Strategic Income Fund II Fund II Fund II ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) 23,480 (2,826) 2,837 Net realized gain (loss) (24,865) (19,591) (82,379) Change in unrealized appreciation (depreciation) 1,375 (40,427) (24,522) ------------- ------------- ------------- Net increase (decrease) in net assets from operations (10) (62,844) (104,064) ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - MetLife Investors USA Insurance Company redemptions - - - Payments received from contract owners 4,912 690 380 Transfers between sub-accounts (including fixed account), net (300) 648 (11,774) Transfers for contract benefits and terminations (31,993) (15,437) (73,820) ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (27,381) (14,099) (85,214) ------------- ------------- ------------- Net increase (decrease) in net assets (27,391) (76,943) (189,278) Net assets at beginning of period 271,492 235,073 490,062 ------------- ------------- ------------- Net assets at end of period 244,101 158,130 300,784 ============= ============= ============= (c) For the period from May 1, 2002 to December 31, 2002. (e) For the period from January 1, 2002 to May 1, 2002. See accompanying notes to financial statements. (Continued) 39
485BPOS124th Page of 168TOC1stPreviousNextBottomJust 124th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2002 [Enlarge/Download Table] Neuberger Alger ----------------------------- -------------- ---------------- Small Genesis Capitalization Growth Trust Partners (e) Fund Fund -------------- ------------- -------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (32,557) (4,320) (667,746) (245,790) Net realized gain (loss) 55,917 (187,558) (3,434,135) (2,686,483) Change in unrealized appreciation (depreciation) (224,296) 183,291 (11,676,385) (6,737,895) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from operations (200,936) (8,587) (15,778,266) (9,670,168) -------------- ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - - MetLife Investors USA Insurance Company redemptions - - - - Payments received from contract owners 1,078,133 82,942 7,610,984 2,213,367 Transfers between sub-accounts (including fixed account), net 36,201 (1,247,168) (1,879,659) (570,412) Transfers for contract benefits and terminations (1,038,344) (409,838) (3,237,431) (5,084,435) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions 75,990 (1,574,064) 2,493,894 (3,441,480) -------------- ------------- ------------- ------------- Net increase (decrease) in net assets (124,946) (1,582,651) (13,284,372) (13,111,648) Net assets at beginning of period 3,317,733 1,582,651 55,888,064 41,080,384 -------------- ------------- ------------- ------------- Net assets at end of period $ 3,192,787 - 42,603,692 27,968,736 ============== ============= ============= ============= [Enlarge/Download Table] T Rowe Janus --------------------------- ------------- Prime Aspen International Reserve Worldwide Stock Fund Fund Growth ------------- ------------- ------------- Increase (decrease) in net assets from operations: Net investment income (loss) 8,379 7,152 (3,450) Net realized gain (loss) (314,464) - (1,253,444) Change in unrealized appreciation (depreciation) (736,567) - (837,115) ------------- ------------- ------------- Net increase (decrease) in net assets from operations (1,042,652) 7,152 (2,094,009) ------------- ------------- ------------- Contract transactions: MetLife Investors USA Insurance Company payments - - - MetLife Investors USA Insurance Company redemptions - - - Payments received from contract owners 440,676 1,053 1,851,311 Transfers between sub-accounts (including fixed account), net (34,460) 450,046 (103,543) Transfers for contract benefits and terminations (646,288) (127,835) (2,806,857) ------------- ------------- ------------- Net increase (decrease) in net assets from contract transactions (240,072) 323,264 (1,059,089) ------------- ------------- ------------- Net increase (decrease) in net assets (1,282,724) 330,416 (3,153,098) Net assets at beginning of period 5,657,714 1,508,446 8,325,548 ------------- ------------- ------------- Net assets at end of period 4,374,990 1,838,862 5,172,450 ============= ============= ============= (e) For the period from January 1, 2002 to May 1, 2002. See accompanying notes to financial statements. (Continued) 40
485BPOS125th Page of 168TOC1stPreviousNextBottomJust 125th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Statement of Changes in Net Assets Year ended December 31, 2002 [Download Table] Total -------------- Increase (decrease) in net assets from operations: Net investment income (loss) $ (5,922,831) Net realized gain (loss) (7,997,855) Change in unrealized appreciation (depreciation) (386,099,473) -------------- Net increase (decrease) in net assets from operations (400,020,159) -------------- Contract transactions: MetLife Investors USA Insurance Company payments 3,100 MetLife Investors USA Insurance Company redemptions (4,535) Payments received from contract owners 932,242,387 Transfers between sub-accounts (including fixed account), net 359,557,366 Transfers for contract benefits and terminations (157,250,488) -------------- Net increase (decrease) in net assets from contract transactions 1,134,547,830 -------------- Net increase (decrease) in net assets 734,527,671 Net assets at beginning of period 1,860,178,663 -------------- Net assets at end of period $2,594,706,334 ============== See accompanying notes to financial statements. 41
485BPOS126th Page of 168TOC1stPreviousNextBottomJust 126th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (1) Organization MetLife Investors USA Separate Account A (the Separate Account), a unit investment trust registered under the Investment Company Act of 1940 as amended, was established by MetLife Investors USA Insurance Company (MLIUSA) and exists in accordance with the regulations of the Delaware Department of Insurance. The Separate Account is a funding vehicle for variable annuity contracts issued by MLIUSA. The Separate Account is divided into sub-accounts with the assets of each sub-account invested in corresponding portfolios of the following investment companies which are diversified, open-end, management investment companies registered under the Investment Company Act of 1940 as amended. The sub-accounts available for investment vary between variable annuity contracts offered for sale by MLIUSA. Under applicable insurance law, the assets and liabilities of the Separate Account are clearly identified and distinguished from MLIUSA's other assets and liabilities. The portion of the Separate Account's assets applicable to the variable contracts is not chargeable with liabilities arising out of any other business MLIUSA may conduct. The following sub-accounts were available for investment as of December 31, 2003: [Download Table] Met Investors Series Trust (Met Investors): Lord Abbett Growth & Income Portfolio Lord Abbett Growth & Income Portfolio B Lord Abbett Bond Debenture Portfolio Lord Abbett Bond Debenture Portfolio B JP Morgan Quality Bond Portfolio Met/Putnam Research Portfolio Met/Putnam Research Portfolio B Oppenheimer Capital Appreciation Portfolio B PIMCO Inflation Protected Bond Portfolio B PIMCO Money Market Portfolio B Janus Aggressive Growth Portfolio B PIMCO Total Return Bond Portfolio PIMCO Total Return Bond Portfolio B PIMCO Innovation Portfolio PIMCO Innovation Portfolio B T Rowe Price Mid Cap Growth Portfolio B MFS Research International Portfolio B AIM Small Cap Growth Portfolio AIM Small Cap Growth Portfolio B AIM Mid Cap Core Equity Portfolio B Harris Oakmark International Portfolio B Third Avenue Small Cap Value Portfolio Third Avenue Small Cap Value Portfolio B AIM Variable Insurance Funds, Inc. (AIM): Premier Equity Fund Capital Appreciation Fund International Growth Fund Balanced Fund MFS Variable Insurance Trust (MFS): Research Series Investors Trust Series New Discovery Series [Download Table] Oppenheimer Variable Account Funds (Oppenheimer): Main Street Growth & Income Fund Bond Fund Money Fund Main Street Small Cap Growth Fund Strategic Bond Fund Variable Insurance Products Fund, Fund II and Fund III (Fidelity): Asset Manager Portfolio Growth Portfolio Contrafund Portfolio Overseas Portfolio Equity-Income Portfolio Index 500 Portfolio Money Market Portfolio Scudder Variable Series I (Scudder I): International Portfolio Metropolitan Life Series Funds (MetLife): Davis Venture Value Fund Davis Venture Value Fund E Harris Oakmark Focused Value Fund Harris Oakmark Focused Value Fund B Jennison Growth Portfolio B MFS Total Return Series Putnam International Stock Portfolio Janus Mid Cap Portfolio Russell 2000 Index Portfolio Met/Putnam Voyager Portfolio A SSR Aurora Portfolio SSR Bond Income Portfolio SSR Large Cap Value Portfolio Stock Index Portfolio Stock Index Portfolio B Alger Equity Growth (Continued) 42
485BPOS127th Page of 168TOC1stPreviousNextBottomJust 127th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (1) Organization, continued: Metropolitan Life Series Funds (MetLife), (continued): Lehman Brothers Aggregate Bond Index FI Mid Cap Opportunities Harris Oakmark Large Cap Value Morgan Stanley EAFE Index Mid Cap Stock Index VanKampen LIT Funds (VanKampen): Emerging Growth Fund Enterprise Fund Growth & Income Fund Federated Investors Insurance Company (Federated): American Leaders Fund II High Income Bond Fund II Growth Strategic Fund II Equity Income Fund II Neuberger Berman (Neuberger Berman): Genesis Trust The Alger American Fund (Alger): Small Capitalization Fund T Rowe Price Funds (T Rowe): Growth Fund International Stock Fund Prime Reserve Fund Janus Capital Funds Corp. (Janus): Aspen Worldwide Growth American Funds (American): Global Small Capitalization Fund Growth Fund Growth & Income Fund During 2003, the following sub-accounts changed names: Met Investors Series Trust - MFS Mid Cap Growth Portfolio B to T Rowe Price Mid Cap Growth Portfolio B Met Investors Series Trust - SSR Concentrated International Portfolio B to Harris Oakmark International Portfolio B MetLife Series - Putnam Large Cap Growth Portfolio to Met/Putnam Voyager Portfolio A The following sub-accounts ceased operations during the years ended December 31, 2003 and 2002: Year ended December 31, 2003: Date Ceased Operations ----------------------------- ---------------------- None. Year ended December 31, 2002: ----------------------------- MetLife Loomis Sayles High Yield Bond April 26, 2002 Van Kampen Strategic Stock May 1, 2002 Neuberger Partners Trust May 1, 2002 The following sub-accounts began operations during the years ended December 31, 2003 and 2002: Year ended December 31, 2003: Date Began Operations ----------------------------- --------------------- Met Investors PIMCO Inflation Protected Bond Portfolio B May 1, 2003 Met Investors PIMCO Innovation Portfolio May 1, 2003 Met Investors AIM Small Cap Growth Portfolio May 1, 2003 Met Investors Third Avenue Small Cap Value Portfolio May 1, 2003 MetLife Davis Venture Value Fund May 1, 2003 MetLife Harris Oakmark Focused Value Fund May 1, 2003 MetLife MFS Total Return Series May 1, 2003 MetLife SSR Aurora Portfolio May 1, 2003 MetLife SSR Bond Income Portfolio May 1, 2003 MetLife SSR Large Cap Value Portfolio May 1, 2003 MetLife Stock Index Portfolio May 1, 2003 MetLife Alger Equity Growth May 1, 2003 (Continued) 43
485BPOS128th Page of 168TOC1stPreviousNextBottomJust 128th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (1) Organization, continued: [Download Table] Year ended December 31, 2003 continued: Date Began Operations --------------------------------------- --------------------- MetLife Lehman Brothers Aggregate Bond Index May 1, 2003 MetLife FI Mid Cap Opportunities May 1, 2003 MetLife Harris Oakmark Large Cap Value May 1, 2003 MetLife Morgan Stanley EAFE Index May 1, 2003 MetLife Mid Cap Stock Index May 1, 2003 American Global Small Capitalization Fund May 1, 2003 American Growth Fund May 1, 2003 American Growth & Income Fund May 1, 2003 Year ended December 31, 2002: ----------------------------- Met Investors Lord Abbett Bond Debenture Portfolio April 26, 2002 Met Investors Third Avenue Small Cap Value Portfolio B May 1, 2002 MetLife Jennison Growth Portfolio B May 1, 2002 Van Kampen Growth & Income Fund May 1, 2002 (2) Significant Accounting Policies (a) Investment Valuation Investments made in the portfolios of the investment companies are valued at the reported net asset value of such portfolios. These investment companies value their investment securities at fair value. Realized gains and losses on the sale of portfolio shares owned by the sub-accounts are computed on the basis of the identified cost of the portfolio shares sold. Income from dividends and gains from realized capital gain distributions are recorded on the ex-distribution date. (b) Reinvestment of Distributions Dividends and gains from realized gain distributions are reinvested in additional shares of the portfolio. (c) Federal Income Taxes The operations of the Separate Account are included in the federal income tax return of MLI which is taxed as a Life Insurance Company under the provisions of the Internal Revenue Code (IRC). Under current IRC provisions, MLI believes it will be treated as the owner of the Separate Account assets for federal income tax purposes and does not expect to incur federal income taxes on the earnings of the Separate Account to the extent the earnings are credited to the variable annuity contracts. Based on this, no charge has been made to the Separate Account for federal income taxes. A charge may be made in future years for federal income taxes that would be attributable to the variable annuity contracts. (d) Estimates The preparation of the financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect amounts reported therein. Actual results could differ from these estimates. (3) Separate Account Expenses For variable annuity contracts, MLIUSA deducts a daily charge from the net assets of the Separate Account sub-accounts for mortality and administrative expenses that ranges from an annual rate of 0.89% to an annual rate of 2.25%. This varies according to the product specifications. The mortality risks assumed by MLIUSA arise from its contractual obligation to make annuity payments after the annuity date for the life of the annuitant and to waive the withdrawal fee in the event of the death of the contract owner. The administrative fees cover the cost of establishing and maintaining the variable annuity contracts and the Separate Account. (Continued) 44
485BPOS129th Page of 168TOC1stPreviousNextBottomJust 129th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (4) Contract Fees There are no deductions made from purchase payments for sales fees at the time a variable annuity contract is purchased. However, if all or a portion of the contract value is withdrawn, a withdrawal fee may be assessed and deducted from the contract value or payment to the contract owner. The withdrawal fee is imposed on withdrawals of contract values attributable to purchase payments within seven years after receipt and is equal to 7% of the purchase payment withdrawn in the first and second years, 5% of the purchase payments withdrawn in the third, fourth and fifth years, 3% of the purchase payments withdrawn in the sixth and seventh years, and 0% of the purchase payments withdrawn thereafter. After the first contract anniversary, provided the contract value exceeds $5,000, the contract owner may make one withdrawal each contract year of up to 10% of the aggregate purchase payments (on deposit for more than one year) without incurring a surrender fee. For variable annuity contracts with a sales charge, MLIUSA deducts a sales charge from the gross purchase payment before the payment is allocated to the Separate Account and / or a fixed account. The amount of the sales charge depends on the contract owner's investment at the time of the payment as follows: [Download Table] Owner's Sales Charge as a % of Investment Gross Purchase Payment ---------- ---------------------- less than $50,000 6.00% $50,000 - $99,999.99 5.00% $100,000 - $249,999.99 4.00% $250,000 - $499,999.99 3.00% $500,000 - $999,999.99 2.00% $1,000,000 or more 1.00% Depending on the product, an annual contract maintenance fee of $0-49 is imposed on variable annuity contracts with contract values less than $50,000 on their anniversary. This fee covers the cost of contract administration for the previous year and is prorated between the Separate Account sub-accounts and the fixed rate account to which the contract value is allocated. Subject to certain restrictions, the contract owner may transfer all or a part of the accumulated value of the contract among the available sub-accounts and the fixed rate account. After 12 transfers are made in a contract year, MLIUSA may deduct a transfer fee of the lesser of $25 per additional transfer or 2% of the amount transferred. Transfers made in a dollar cost averaging program are not subject to the transfer fee. During the year ended December 31, 2003, contract maintenance, surrender, and transfer fees of $7,983,013 were deducted. Currently, MLIUSA advances any premium taxes due at the time purchase payments are made and then deducts premium taxes at the time annuity payments begin. MLIUSA reserves the right to deduct premium taxes when incurred. (Continued) 45
485BPOS130th Page of 168TOC1stPreviousNextBottomJust 130th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (5) Cost Basis of Investments The cost basis of each sub-account's investment as of December 31, 2003 follows: [Download Table] Met Investors Lord Abbett Growth & Income Portfolio $ 307,992,279 Met Investors Lord Abbett Growth & Income Portfolio B 550,017,771 Met Investors Lord Abbett Bond Debenture Portfolio 960,474 Met Investors Lord Abbett Bond Debenture Portfolio B 445,544,110 Met Investors JP Morgan Quality Bond Portfolio 32,476,052 Met Investors Met/Putnam Research Portfolio 21,538,397 Met Investors Met/Putnam Research Portfolio B 60,485,920 Met Investors Oppenheimer Capital Appreciation Portfolio B 358,418,515 Met Investors PIMCO Inflation Protected Bond Portfolio B 265,719,523 Met Investors PIMCO Money Market Portfolio B 117,274,847 Met Investors Janus Aggressive Growth Portfolio B 156,625,035 Met Investors PIMCO Total Return Portfolio 20,919,820 Met Investors PIMCO Total Return Portfolio B 468,025,020 Met Investors PIMCO Innovation Portfolio 591,270 Met Investors PIMCO Innovation Portfolio B 37,305,275 Met Investors T Rowe Price Mid Cap Growth Portfolio B 180,383,538 Met Investors MFS Research International Portfolio B 98,826,228 Met Investors AIM Small Cap Growth Portfolio 346,477 Met Investors AIM Small Cap Growth Portfolio B 121,335,341 Met Investors AIM Mid Cap Core Equity Portfolio B 129,713,592 Met Investors Harris Oakmark International Portfolio B 166,009,964 Met Investors Third Avenue Small Cap Value Portfolio 516,707 Met Investors Third Avenue Small Cap Value Portfolio B 184,715,106 AIM Premier Equity Fund 2,008,181 AIM Capital Appreciation Fund 989,400 AIM International Growth Fund 842,767 AIM Balanced Fund 1,335,201 MFS Research Series 468,144 MFS Investors Trust Series 213,838 MFS New Discovery Series 374,872 Oppenheimer Main Street Growth & Income Fund 1,844,014 Oppenheimer Bond Fund 424,023 Oppenheimer Money Fund 541,687 Oppenheimer Main Street Small Cap Growth Fund 161,004 Oppenheimer Strategic Bond Fund 228,450 Fidelity Asset Manager Portfolio 191,014,051 Fidelity Growth Portfolio 332,251,552 Fidelity Contrafund Portfolio 228,558,006 Fidelity Overseas Portfolio 14,839,077 Fidelity Equity-Income Portfolio 25,180,263 Fidelity Index 500 Portfolio 166,111,195 [Download Table] Fidelity Money Market Portfolio $ 26,629,538 Scudder International Portfolio 27,951,835 MetLife Davis Venture Value Fund 695,290 MetLife Davis Venture Value Fund E 357,459,894 MetLife Harris Oakmark Focused Value Fund 3,291,196 MetLife Harris Oakmark Focused Value Fund B 339,059,006 MetLife Jennison Growth Portfolio B 160,917,221 MetLife MFS Total Return Series 720,886 MetLife Putnam International Stock Portfolio 370,723 MetLife Janus Mid Cap Portfolio 1,356,181 MetLife Russell 2000 Index Portfolio 1,999,267 MetLife Met/Putnam Voyager Portfolio A 577,867 MetLife SSR Aurora Portfolio 2,406,148 MetLife SSR Bond Income Portfolio 646,190 MetLife SSR Large Cap Value Portfolio 192,008 MetLife Stock Index Portfolio 61,912,978 MetLife Stock Index Portfolio B 118,828,583 MetLife Alger Equity Growth 184,772 MetLife Lehman Brothers Aggregate Bond Index 694,658 MetLife FI Mid Cap Opportunities 731,010 MetLife Harris Oakmark Large Cap Value 1,621,471 MetLife Morgan Stanley EAFE Index 973,289 MetLife Mid Cap Stock Index 1,341,594 Van Kampen Emerging Growth Fund 705,544 Van Kampen Enterprise Fund 199,732 Van Kampen Growth & Income Fund 280,864 Federated American Leaders Fund II 631,710 Federated High Income Bond Fund II 259,101 Federated Growth Strategic Fund II 314,890 Federated Equity Income Fund II 356,099 Neuberger Berman Genesis Trust 12,178 Alger American Small Capitalization Fund 103,638,816 T Rowe Price Growth Fund 12,100,295 T Rowe Price International Fund 1,266,887 T Rowe Price Prime Reserve Fund 1,437,342 Janus Aspen Worldwide Growth 5,800 American Growth Fund 1,146,841 American Growth & Income Fund 6,367,508 American Global Small Capitalization Fund 4,472,075 -------------- $5,936,884,273 ============== (Continued) 46
485BPOS131st Page of 168TOC1stPreviousNextBottomJust 131st
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (6) Changes in Units Outstanding The changes in units outstanding for the years ended December 31, 2002 and 2003 were as follows: [Enlarge/Download Table] Met Investors ----------------------------------------------------------------------------------------- Lord Abbett Lord Abbett Lord Abbett Lord Abbett JP Morgan Met/ Met/ Growth & Growth & Bond Bond Quality Putnam Putnam Income Income Debenture Debenture Bond Research Research Portfolio Portfolio B Portfolio Portfolio B Portfolio Portfolio Portfolio B ----------- ----------- ----------- ----------- ----------- ----------- ----------- Accumulation Units: Unit Balance at January 1, 2002 13,056,744 829,894 - 949,659 2,400,419 4,271,829 1,148,099 Units Issued 1,549,693 4,305,256 27,783 9,394,264 1,134,762 155,184 3,804,684 Units Redeemed (1,759,662) (372,072) (4,391) (1,894,405) (475,242) (906,198) (635,480) ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 12,846,775 4,763,078 23,392 8,449,518 3,059,939 3,520,815 4,317,303 Units Issued 1,219,207 10,714,433 243,062 25,392,846 624,403 60,653 6,293,780 Units Redeemed (1,917,032) (847,953) (158,323) (3,513,084) (1,007,135) (753,055) (1,698,082) ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 12,148,950 14,629,558 108,131 30,329,280 2,677,207 2,828,413 8,913,001 =========== =========== =========== =========== =========== =========== =========== Annuitization Units: Unit Balance at January 1, 2002 - - - - - - - Units Issued - - - - - - - Units Redeemed - - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 - - - - - - - Units Issued - 1,658 - 2,676 - - 20,018 Units Redeemed - (4) - (592) - - (92) ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 - 1,654 - 2,084 - - 19,926 =========== =========== =========== =========== =========== =========== =========== (Continued) 47
485BPOS132nd Page of 168TOC1stPreviousNextBottomJust 132nd
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (6) Changes in Units Outstanding, continued: [Enlarge/Download Table] Met Investors ------------------------------------------------------------------------------------- Oppenheimer PIMCO PIMCO Janus PIMCO PIMCO Capital Inflation Money Aggressive Total Return Total Return Appreciation Protected Bond Market Growth Bond Bond Portfolio B Portfolio B Portfolio B Portfolio B Portfolio Portfolio B ------------ -------------- ----------- ----------- ------------ ------------ Accumulation Units: Unit Balance at January 1, 2002 2,574,330 - 2,040,930 1,408,153 3,960,781 2,425,689 Units Issued 14,586,041 - 17,646,874 6,396,924 496,215 20,415,679 Units Redeemed (1,517,417) - (10,706,168) (676,086) (1,145,748) (1,756,563) ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 15,642,954 - 8,981,636 7,128,991 3,311,248 21,084,805 Units Issued 37,979,598 26,664,957 29,097,422 21,329,554 574,005 33,897,043 Units Redeemed (2,110,773) (959,762) (26,308,739) (1,923,320) (1,032,426) (13,623,028) ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 51,511,779 25,705,195 11,770,319 26,535,225 2,852,827 41,358,820 =========== =========== =========== =========== =========== =========== Annuitization Units: Unit Balance at January 1, 2002 - - - - - - Units Issued - - - - - - Units Redeemed - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 - - - - - - Units Issued 2,268 2,767 17,124 - - 12,838 Units Redeemed (44) (50) (458) - - (30) ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 2,224 2,717 16,666 - - 12,808 =========== =========== =========== =========== =========== =========== [Download Table] ------ PIMCO Innovation Portfolio ----------- Accumulation Units: Unit Balance at January 1, 2002 - Units Issued - Units Redeemed - ----------- Unit Balance at December 31, 2002 - Units Issued 216,314 Units Redeemed (77,191) ----------- Unit Balance at December 31, 2003 139,123 =========== Annuitization Units: Unit Balance at January 1, 2002 - Units Issued - Units Redeemed - ----------- Unit Balance at December 31, 2002 - Units Issued - Units Redeemed - ----------- Unit Balance at December 31, 2003 - =========== (Continued) 48
485BPOS133rd Page of 168TOC1stPreviousNextBottomJust 133rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (6) Changes in Units Outstanding, continued: [Enlarge/Download Table] Met Investors ------------------------------------------------------------------------------------------- T Rowe Price MFS AIM AIM AIM Harris PIMCO Mid Cap Research Small Cap Small Cap Mid Cap Oakmark Innovation Growth International Growth Growth Core Equity International Portfolio B Portfolio B Portfolio B Portfolio Portfolio B Portfolio B Portfolio B ----------- ------------ ------------- ----------- ----------- ----------- ------------- Accumulation Units: Unit Balance at January 1, 2002 719,543 1,668,902 916,898 - 119,269 91,975 20,012 Units Issued 3,285,269 8,867,108 7,647,919 - 4,384,817 2,782,051 2,076,456 Units Redeemed (545,597) (1,045,601) (2,170,029) - (439,321) (457,630) (654,717) ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 3,459,215 9,490,409 6,394,788 - 4,064,765 2,416,396 1,441,751 Units Issued 9,239,970 26,258,579 11,350,573 58,223 10,289,124 10,491,174 16,407,912 Units Redeemed (3,498,556) (2,223,849) (4,862,091) (26,655) (1,878,113) (619,349) (960,226) ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 9,200,629 33,525,139 12,883,270 31,568 12,475,776 12,288,221 16,889,437 =========== =========== =========== =========== =========== =========== =========== Annuitization Units: Unit Balance at January 1, 2002 - - - - - - - Units Issued 3,515 - - - - - - Units Redeemed (1,752) - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 1,763 - - - - - - Units Issued - 1,788 3,894 - - 641 - Units Redeemed (1,763) (36) (9) - - (13) - ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 - 1,752 3,885 - - 628 - =========== =========== =========== =========== =========== =========== =========== (Continued) 49
485BPOS134th Page of 168TOC1stPreviousNextBottomJust 134th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (6) Changes in Units Outstanding, continued: [Enlarge/Download Table] Met Investors AIM ------------------------ --------------------------------------------------- Third Avenue Third Avenue Small Cap Small Cap Premier Capital International Value Value Equity Appreciation Growth Balanced Portfolio Portfolio B Fund Fund Fund Fund ------------ ------------ ----------- ------------ ------------- ----------- Accumulation Units: Unit Balance at January 1, 2002 - - 544,055 236,958 189,032 334,293 Units Issued - 3,351,666 214,480 119,900 62,473 125,998 Units Redeemed - (244,877) (291,126) (143,742) (82,911) (161,963) ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 - 3,106,789 467,409 213,116 168,594 298,328 Units Issued 54,100 17,714,300 9,559 9,235 8,983 11,432 Units Redeemed (3,990) (1,264,357) (49,841) (35,148) (19,864) (45,166) ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 50,110 19,556,732 427,127 187,203 157,713 264,594 =========== =========== =========== =========== =========== =========== Annuitization Units: Unit Balance at January 1, 2002 - - - - - - Units Issued - - - - - - Units Redeemed - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 - - - - - - Units Issued - 974 - - - - Units Redeemed - (20) - - - - ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 - 954 - - - - =========== =========== =========== =========== =========== =========== [Download Table] MFS ----------- Research Series ----------- Accumulation Units: Unit Balance at January 1, 2002 126,396 Units Issued 70,559 Units Redeemed (82,693) ----------- Unit Balance at December 31, 2002 114,262 Units Issued 2,134 Units Redeemed (19,299) ----------- Unit Balance at December 31, 2003 97,097 =========== Annuitization Units: Unit Balance at January 1, 2002 - Units Issued - Units Redeemed - ----------- Unit Balance at December 31, 2002 - Units Issued - Units Redeemed - ----------- Unit Balance at December 31, 2003 - =========== (Continued) 50
485BPOS135th Page of 168TOC1stPreviousNextBottomJust 135th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (6) Changes in Units Outstanding, continued: [Enlarge/Download Table] MFS Oppenheimer ------------------------ --------------------------------------------------------------- Main Street Main Street Investors New Growth & Small Strategic Trust Discovery Income Bond Money Cap Bond Series Series Fund Fund Fund Growth Fund Fund ----------- ----------- ----------- ----------- ----------- ----------- ----------- Accumulation Units: Unit Balance at January 1, 2002 60,869 90,551 552,681 66,734 164,326 26,017 60,360 Units Issued 30,846 54,473 189,616 51,420 742,197 798 9,925 Units Redeemed (37,423) (69,565) (305,791) (48,069) (738,979) (2,676) (26,652) ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 54,292 75,459 436,506 70,085 167,544 24,139 43,633 Units Issued 3,663 3,512 7,657 4,433 288 2,677 1,131 Units Redeemed (7,122) (20,263) (45,312) (4,270) (67,609) (1,766) (6,703) ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 50,833 58,708 398,851 70,248 100,223 25,050 38,061 =========== =========== =========== =========== =========== =========== =========== Annuitization Units: Unit Balance at January 1, 2002 - - - - - - - Units Issued - - - - - - - Units Redeemed - - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 - - - - - - - Units Issued - - - - - - - Units Redeemed - - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 - - - - - - - =========== =========== =========== =========== =========== =========== =========== (Continued) 51
485BPOS136th Page of 168TOC1stPreviousNextBottomJust 136th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (6) Changes in Units Outstanding, continued: [Enlarge/Download Table] Fidelity --------------------------------------------------------------------------------------- Asset Equity- Index Manager Growth Contrafund Overseas Income 500 Portfolio Portfolio Portfolio Portfolio Portfolio Portfolio ----------- ----------- ----------- ----------- ----------- ----------- Accumulation Units: Unit Balance at January 1, 2002 21,022,339 25,015,822 19,181,427 2,228,327 3,242,873 19,727,766 Units Issued 2,059,632 3,426,291 2,781,999 130,146 88,856 3,288,938 Units Redeemed (3,062,973) (3,791,926) (2,371,021) (444,342) (604,163) (2,847,878) ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 20,018,998 24,650,187 19,592,405 1,914,131 2,727,566 20,168,826 Units Issued 1,555,082 2,796,790 2,208,124 90,040 49,896 1,712,892 Units Redeemed (3,238,573) (4,702,540) (2,799,528) (384,586) (407,592) (8,899,802) ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 18,335,507 22,744,437 19,001,001 1,619,585 2,369,870 12,981,916 =========== =========== =========== =========== =========== =========== Annuitization Units: Unit Balance at January 1, 2002 - - - - - - Units Issued - - - - - - Units Redeemed - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 - - - - - - Units Issued - - - - - - Units Redeemed - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 - - - - - - =========== =========== =========== =========== =========== =========== [Download Table] -- Money Market Portfolio ----------- Accumulation Units: Unit Balance at January 1, 2002 5,072,413 Units Issued 2,258,178 Units Redeemed (2,804,936) ----------- Unit Balance at December 31, 2002 4,525,655 Units Issued 2,756,152 Units Redeemed (3,362,416) ----------- Unit Balance at December 31, 2003 3,919,391 =========== Annuitization Units: Unit Balance at January 1, 2002 - Units Issued - Units Redeemed - ----------- Unit Balance at December 31, 2002 - Units Issued - Units Redeemed - ----------- Unit Balance at December 31, 2003 - =========== (Continued) 52
485BPOS137th Page of 168TOC1stPreviousNextBottomJust 137th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (6) Changes in Units Outstanding, continued: [Enlarge/Download Table] Scudder I MetLife ------------- -------------------------------------------------------------------- Davis Davis Harris Harris Venture Venture Oakmark Oakmark Jennison International Value Value Focused Focused Growth Portfolio Fund Fund E Value Fund Value Fund B Portfolio B ------------- ----------- ----------- ----------- ------------ ----------- Accumulation Units: Unit Balance at January 1, 2002 2,560,863 - 2,649,034 - 1,863,945 - Units Issued 1,189,230 - 14,004,607 - 9,960,577 5,747,313 Units Redeemed (776,660) - (1,167,076) - (1,139,281) (228,132) ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 2,973,433 - 15,486,565 - 10,685,241 5,519,181 Units Issued 958,872 29,130 29,515,663 120,508 21,294,615 18,720,667 Units Redeemed (800,024) (1,759) (5,589,696) (4,762) (2,461,629) (5,296,950) ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 3,132,281 27,371 39,412,532 115,746 29,518,227 18,942,898 =========== =========== =========== =========== =========== =========== Annuitization Units: Unit Balance at January 1, 2002 - - - - - - Units Issued - - - - - - Units Redeemed - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 - - - - - - Units Issued - - 17,613 - 6,413 1,013 Units Redeemed - - (65) - (38) (20) ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 - - 17,548 - 6,375 993 =========== =========== =========== =========== =========== =========== [Download Table] -------- MFS Total Return Series ----------- Accumulation Units: Unit Balance at January 1, 2002 - Units Issued - Units Redeemed - ----------- Unit Balance at December 31, 2002 - Units Issued 20,499 Units Redeemed (743) ----------- Unit Balance at December 31, 2003 19,756 =========== Annuitization Units: Unit Balance at January 1, 2002 - Units Issued - Units Redeemed - ----------- Unit Balance at December 31, 2002 - Units Issued - Units Redeemed - ----------- Unit Balance at December 31, 2003 - =========== (Continued) 53
485BPOS138th Page of 168TOC1stPreviousNextBottomJust 138th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (6) Changes in Units Outstanding, continued: [Enlarge/Download Table] MetLife ------------------------------------------------------------------------------------------ Putnam Russell Met/ Loomis International Janus 2000 Putnam Sayles SSR SSR Stock Mid Cap Index Voyager High Yield Aurora Bond Income Portfolio Portfolio Portfolio Portfolio A Bond Portfolio Portfolio ------------- ----------- ----------- ----------- ----------- ----------- ----------- Accumulation Units: Unit Balance at January 1, 2002 94,368 501,084 89,476 190,680 17,973 - - Units Issued 19,999 142,919 53,356 45,393 1,780 - - Units Redeemed (16,692) (157,900) (37,051) (43,341) (19,753) - - ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 97,675 486,103 105,781 192,732 - - - Units Issued 48,800 64,607 208,690 35,180 - 180,972 15,799 Units Redeemed (44,400) (77,711) (84,724) (28,587) - (10,158) (1,620) ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 102,075 472,999 229,747 199,325 - 170,814 14,179 =========== =========== =========== =========== =========== =========== =========== Annuitization Units: Unit Balance at January 1, 2002 - - - - - - - Units Issued - - - - - - - Units Redeemed - - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 - - - - - - - Units Issued - - - - - - - Units Redeemed - - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 - - - - - - - =========== =========== =========== =========== =========== =========== =========== (Continued) 54
485BPOS139th Page of 168TOC1stPreviousNextBottomJust 139th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (6) Changes in Units Outstanding, continued: [Enlarge/Download Table] MetLife ------------------------------------------------------------------------------------ SSR Lehman Large Cap Stock Stock Alger Brothers Value Index Index Equity Aggregate FI Mid Cap Portfolio Portfolio Portfolio B Growth Bond Index Opportunities ----------- ----------- ----------- ----------- ----------- ------------- Accumulation Units: Unit Balance at January 1, 2002 - - 166,446 - - - Units Issued - - 6,874,465 - - - Units Redeemed - - (2,019,099) - - - ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 - - 5,021,812 - - - Units Issued 21,321 2,064,241 11,278,710 10,994 68,128 77,968 Units Redeemed (1,340) (107,827) (3,234,790) (2,588) (13,098) (6,260) ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 19,981 1,956,414 13,065,732 8,406 55,030 71,708 =========== =========== =========== =========== =========== =========== Annuitization Units: Unit Balance at January 1, 2002 - - - - - - Units Issued - - - - - - Units Redeemed - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 - - - - - - Units Issued - - - - - - Units Redeemed - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 - - - - - - =========== =========== =========== =========== =========== =========== [Download Table] -------- Harris Oakmark Large Cap Value -------------- Accumulation Units: Unit Balance at January 1, 2002 - Units Issued - Units Redeemed - ----------- Unit Balance at December 31, 2002 - Units Issued 145,332 Units Redeemed (974) ----------- Unit Balance at December 31, 2003 144,358 =========== Annuitization Units: Unit Balance at January 1, 2002 - Units Issued - Units Redeemed - ----------- Unit Balance at December 31, 2002 - Units Issued - Units Redeemed - ----------- Unit Balance at December 31, 2003 - =========== (Continued) 55
485BPOS140th Page of 168TOC1stPreviousNextBottomJust 140th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (6) Changes in Units Outstanding, continued: [Enlarge/Download Table] MetLife Van Kampen -------------------------- -------------------------------------------------- Morgan Stanley Mid Emerging Growth & EAFE Cap Stock Growth Enterprise Income Strategic Index Index Fund Fund Fund Stock -------------- ----------- ----------- ----------- ----------- ----------- Accumulation Units: Unit Balance at January 1, 2002 - - 174,665 68,149 - 60,282 Units Issued - - 136,454 54,763 123,984 - Units Redeemed - - (168,159) (65,939) (69,510) (60,282) ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 - - 142,960 56,973 54,474 - Units Issued 748,243 138,931 14,980 220 8,985 - Units Redeemed (637,808) (10,655) (26,588) (6,993) (1,837) - ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 110,435 128,276 131,352 50,200 61,622 - =========== =========== =========== =========== =========== =========== Annuitization Units: Unit Balance at January 1, 2002 - - - - - - Units Issued - - - - - - Units Redeemed - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 - - - - - - Units Issued - - - - - - Units Redeemed - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 - - - - - - =========== =========== =========== =========== =========== =========== [Download Table] Federated ----------- American Leaders Fund II ----------- Accumulation Units: Unit Balance at January 1, 2002 249,732 Units Issued 145,362 Units Redeemed (232,904) ----------- Unit Balance at December 31, 2002 162,190 Units Issued 7,454 Units Redeemed (29,183) ----------- Unit Balance at December 31, 2003 140,461 =========== Annuitization Units: Unit Balance at January 1, 2002 - Units Issued - Units Redeemed - ----------- Unit Balance at December 31, 2002 - Units Issued - Units Redeemed - ----------- Unit Balance at December 31, 2003 - =========== (Continued) 56
485BPOS141st Page of 168TOC1stPreviousNextBottomJust 141st
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (6) Changes in Units Outstanding, continued: [Enlarge/Download Table] Federated Neuberger Alger T Rowe ------------------------------------- ------------------------ -------------- ----------- High Income Growth Equity Small Bond Strategic Income Genesis Capitalization Growth Fund II Fund II Fund II Trust Partners Fund Fund ----------- ----------- ----------- ----------- ----------- -------------- ----------- Accumulation Units: Unit Balance at January 1, 2002 60,212 55,308 116,932 478,656 295,027 9,374,497 656,181 Units Issued 34,908 1,344 79,954 180,589 12,514 1,845,548 58,302 Units Redeemed (40,971) (5,425) (105,059) (180,154) (307,541) (1,401,918) (129,121) ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 54,149 51,227 91,827 479,091 - 9,818,127 585,362 Units Issued 385 759 4,811 1,076 - 1,578,628 15,281 Units Redeemed (6,170) (4,587) (14,895) (478,107) - (1,638,205) (429,468) ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 48,364 47,399 81,743 2,060 - 9,758,550 171,175 =========== =========== =========== =========== =========== =========== =========== Annuitization Units: Unit Balance at January 1, 2002 - - - - - - - Units Issued - - - - - - - Units Redeemed - - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 - - - - - - - Units Issued - - - - - - - Units Redeemed - - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 - - - - - - - =========== =========== =========== =========== =========== =========== =========== (Continued) 57
485BPOS142nd Page of 168TOC1stPreviousNextBottomJust 142nd
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (6) Changes in Units Outstanding, continued: [Enlarge/Download Table] T Rowe Janus American ------------------------- ----------- --------------------------------------- Global Prime Aspen Small Growth & International Reserve Worldwide Capitalization Growth Income Fund Fund Growth Fund Fund Fund ------------- ----------- ----------- -------------- ----------- ----------- Accumulation Units: Unit Balance at January 1, 2002 664,996 91,744 1,246,925 - - - Units Issued 78,426 91,477 324,304 - - - Units Redeemed (109,299) (71,943) (522,053) - - - ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 634,123 111,278 1,049,176 - - - Units Issued 10,392 59,766 1,815 87,998 61,620 57,449 Units Redeemed (526,688) (83,835) (1,049,406) (10,076) (1,866) (3,817) ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 117,827 87,209 1,585 77,922 59,754 53,632 =========== =========== =========== =========== =========== =========== Annuitization Units: Unit Balance at January 1, 2002 - - - - - - Units Issued - - - - - - Units Redeemed - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2002 - - - - - - Units Issued - - - - - - Units Redeemed - - - - - - ----------- ----------- ----------- ----------- ----------- ----------- Unit Balance at December 31, 2003 - - - - - - =========== =========== =========== =========== =========== =========== 58
485BPOS143rd Page of 168TOC1stPreviousNextBottomJust 143rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (7) Realized Gain (Loss) and Change in Unrealized Appreciation (Depreciation) The realized gain (loss) on the sale of fund shares and the change in unrealized appreciation (depreciation) for each sub-account during the years ended December 31, 2003 and December 31, 2002 follows: [Enlarge/Download Table] Realized Gain (Loss) ------------------------------------------------------- Aggregate Aggregate Cost Year or Proceeds from Sales of Fund Shares Realized Period of Fund Shares Redeemed Gain (Loss) ------- ------------------- -------------- ------------ Met Investors Lord Abbett Growth & Income Portfolio 2003 $ 42,903,909 $ 53,442,890 $(10,538,981) 2002 291,523,289 294,835,936 (3,312,647) Met Investors Lord Abbett Growth & Income Portfolio B 2003 58,245 66,723 (8,478) 2002 595,910 714,200 (118,290) Met Investors Lord Abbett Bond Debenture Portfolio 2003 2,328,817 2,309,181 19,636 2002 18,015 18,911 (896) Met Investors Lord Abbett Bond Debenture Portfolio B 2003 21,704,064 20,650,382 1,053,682 2002 16,689,856 17,463,501 (773,645) Met Investors JP Morgan Quality Bond Portfolio 2003 10,947,509 10,527,548 419,961 2002 25,597,796 25,524,161 73,635 Met Investors Met/Putnam Research Portfolio 2003 5,381,062 5,834,064 (453,002) 2002 6,099,157 6,769,561 (670,404) Met Investors Met/Putnam Research Portfolio B 2003 3,438,660 3,545,807 (107,147) 2002 1,255,930 1,490,017 (234,087) Met Investors Oppenheimer Capital Appreciation Portfolio B 2003 20,539 21,112 (573) 2002 1,052,602 1,202,113 (149,511) Met Investors PIMCO Inflation Protected Bond Portfolio B 2003 - - - 2002 - - - Met Investors PIMCO Money Market Portfolio B 2003 130,730,917 130,730,917 - 2002 49,095,311 49,095,311 - Met Investors Janus Aggressive Growth Portfolio B 2003 1,342,395 1,313,023 29,372 2002 654,286 773,380 (119,094) Met Investors PIMCO Total Return Bond Portfolio 2003 7,681,124 6,984,218 696,906 2002 7,495,714 7,316,530 179,184 Met Investors PIMCO Total Return Bond Portfolio B 2003 80,310,479 76,541,328 3,769,151 2002 1,574,251 1,527,983 46,268 Met Investors PIMCO Innovation Portfolio 2003 269,449 265,393 4,056 2002 - - - Met Investors PIMCO Innovation Portfolio B 2003 7,344,791 7,534,420 (189,629) 2002 430,803 632,154 (201,351) (Continued) 59
485BPOS144th Page of 168TOC1stPreviousNextBottomJust 144th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (7) Realized Gain (Loss) and Change in Unrealized Appreciation (Depreciation), continued: [Enlarge/Download Table] Realized Gain (Loss) ----------------------------------------------------- Aggregate Aggregate Cost Year or Proceeds from Sales of Fund Shares Realized Period of Fund Shares Redeemed Gain (Loss) ------- ------------------- -------------- ----------- Met Investors T Rowe Price Mid Cap Growth Portfolio B 2003 $ 155,464 $ 173,007 $ (17,543) 2002 642,350 858,443 (216,093) Met Investors MFS Research International B 2003 24,739,315 24,537,449 201,866 2002 10,070,141 10,580,261 (510,120) Met Investors AIM Small Cap Growth Portfolio 2003 285,642 272,377 13,265 2002 - - - Met Investors AIM Small Cap Growth Portfolio B 2003 8,256,125 8,036,529 219,596 2002 704,109 785,490 (81,381) Met Investors AIM Mid Cap Core Equity Portfolio B 2003 140,962 151,892 (10,930) 2002 1,232,763 1,379,477 (146,714) Met Investors Harris Oakmark International Portfolio B 2003 912,138 962,167 (50,029) 2002 4,769,015 4,804,964 (35,949) Met Investors Third Avenue Small Cap Value Portfolio 2003 33,736 31,297 2,439 2002 - - - Met Investors Third Avenue Small Cap Value Portfolio B 2003 647,373 620,549 26,824 2002 403,229 407,288 (4,059) AIM Premier Equity Fund 2003 172,220 267,890 (95,670) 2002 835,523 1,261,244 (425,721) AIM Capital Appreciation Fund 2003 132,613 205,044 (72,431) 2002 510,548 789,132 (278,584) AIM International Growth Fund 2003 76,503 120,515 (44,012) 2002 272,932 412,451 (139,519) AIM Balanced Fund 2003 189,273 244,756 (55,483) 2002 631,610 777,374 (145,764) MFS Research Series 2003 68,660 101,563 (32,903) 2002 266,053 396,789 (130,736) MFS Investors Trust Series 2003 26,493 33,596 (7,103) 2002 127,785 158,337 (30,552) MFS New Discovery Series 2003 99,065 138,044 (38,979) 2002 327,864 422,011 (94,147) Oppenheimer Main Street Growth & Income Fund 2003 176,304 239,919 (63,615) 2002 980,235 1,208,814 (228,579) (Continued) 60
485BPOS145th Page of 168TOC1stPreviousNextBottomJust 145th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (7) Realized Gain (Loss) and Change in Unrealized Appreciation (Depreciation), continued: [Enlarge/Download Table] Realized Gain (Loss) ------------------------------------------------------- Aggregate Aggregate Cost Year or Proceeds from Sales of Fund Shares Realized Period of Fund Shares Redeemed Gain (Loss) ------- ------------------- -------------- ------------ Oppenheimer Bond Fund 2003 $ 33,094 $ 32,577 $ 517 2002 244,130 249,696 (5,566) Oppenheimer Money Fund 2003 379,228 379,228 - 2002 699,283 699,283 - Oppenheimer Main Street Small Cap Growth Fund 2003 11,883 13,930 (2,047) 2002 12,911 14,878 (1,967) Oppenheimer Strategic Bond Fund 2003 44,399 44,258 141 2002 150,423 155,437 (5,014) Fidelity Asset Manager Portfolio 2003 22,393,960 27,045,478 (4,651,518) 2002 393,445,900 397,279,333 (3,833,433) Fidelity Growth Portfolio 2003 33,722,099 50,120,059 (16,397,960) 2002 314,967,074 323,402,057 (8,434,983) Fidelity Contrafund Portfolio 2003 16,245,844 17,873,772 (1,627,928) 2002 212,046,853 213,471,517 (1,424,664) Fidelity Overseas Portfolio 2003 2,263,767 3,525,183 (1,261,416) 2002 3,421,687 4,817,243 (1,395,556) Fidelity Equity-Income Portfolio 2003 3,917,020 4,724,426 (807,406) 2002 5,170,737 6,343,165 (1,172,428) Fidelity Index 500 Portfolio 2003 90,774,161 105,135,746 (14,361,585) 2002 226,822,745 229,423,747 (2,601,002) Fidelity Money Market Portfolio 2003 16,762,058 16,762,058 - 2002 65,970,622 65,970,622 - Scudder I International Portfolio 2003 2,629,841 4,358,513 (1,728,672) 2002 30,506,860 32,678,379 (2,171,519) MetLife Davis Venture Value Fund 2003 38,328 38,064 264 2002 - - - MetLife Davis Venture Value Fund E 2003 24,941,792 25,044,059 (102,267) 2002 967,804 1,047,284 (79,480) MetLife Harris Oakmark Focused Value Fund 2003 24,562 24,006 556 2002 - - - MetLife Harris Oakmark Focused Value Fund B 2003 314,319 320,191 (5,872) 2002 1,530,063 1,737,651 (207,588) (Continued) 61
485BPOS146th Page of 168TOC1stPreviousNextBottomJust 146th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (7) Realized Gain (Loss) and Change in Unrealized Appreciation (Depreciation), continued: [Enlarge/Download Table] Realized Gain (Loss) ------------------------------------------------------ Aggregate Aggregate Cost Year or Proceeds from Sales of Fund Shares Realized Period of Fund Shares Redeemed Gain (Loss) ------- ------------------- -------------- ----------- MetLife Jennison Growth Portfolio B 2003 $36,733,966 $34,884,893 $ 1,849,073 2002 131,074 139,179 (8,105) MetLife MFS Total Return Series 2003 31,105 30,331 774 2002 - - - MetLife Putnam International Stock Portfolio 2003 147,723 170,952 (23,229) 2002 55,498 71,729 (16,231) MetLife Janus Mid Cap Portfolio 2003 135,378 254,866 (119,488) 2002 258,078 512,615 (254,537) MetLife Russell 2000 Index Portfolio 2003 630,231 619,803 10,428 2002 144,723 177,708 (32,985) MetLife Met/Putnam Voyager Portfolio A 2003 55,906 96,375 (40,469) 2002 77,093 138,464 (61,371) MetLife Loomis Sayles High Yield Bond 2003 - - - 2002 4,862 5,370 (508) MetLife SSR Aurora Portfolio 2003 81,558 77,774 3,784 2002 - - - MetLife SSR Bond Income Portfolio 2003 72,767 72,659 108 2002 - - - MetLife SSR Large Cap Value Portfolio 2003 11,927 12,033 (106) 2002 - - - MetLife Stock Index Portfolio 2003 2,468,592 2,361,662 106,930 2002 - - - MetLife Stock Index Portfolio B 2003 9,748,564 9,554,858 193,706 2002 11,211,932 12,548,635 (1,336,703) MetLife Alger Equity Growth 2003 49,601 49,261 340 2002 - - - MetLife Lehman Brothers Aggregate Bond Index 2003 140,495 142,064 (1,569) 2002 - - - MetLife FI Mid Cap Opportunities 2003 51,607 48,223 3,384 2002 - - - MetLife Harris Oakmark Large Cap Value 2003 5,764 5,448 316 2002 - - - (Continued) 62
485BPOS147th Page of 168TOC1stPreviousNextBottomJust 147th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (7) Realized Gain (Loss) and Change in Unrealized Appreciation (Depreciation), continued: [Enlarge/Download Table] Realized Gain (Loss) ------------------------------------------------------ Aggregate Aggregate Cost Year or Proceeds from Sales of Fund Shares Realized Period of Fund Shares Redeemed Gain (Loss) ------- ------------------- -------------- ----------- MetLife Morgan Stanley EAFE Index 2003 $ 5,261,858 $ 5,187,244 $ 74,614 2002 - - - MetLife Mid Cap Stock Index 2003 90,444 84,986 5,458 2002 - - - Van Kampen Emerging Growth Fund 2003 96,663 158,665 (62,002) 2002 534,912 901,549 (366,637) Van Kampen Enterprise Fund 2003 23,402 31,312 (7,910) 2002 188,175 270,310 (82,135) Van Kampen Growth & Income Fund 2003 11,902 12,468 (566) 2002 247,427 240,568 6,859 Van Kampen Strategic Stock Fund 2003 - - - 2002 306,519 289,211 17,308 Federated American Leaders Fund II 2003 116,855 141,070 (24,215) 2002 857,771 995,497 (137,726) Federated High Income Bond Fund II 2003 33,704 36,939 (3,235) 2002 185,787 210,652 (24,865) Federated Growth Strategic Fund II 2003 19,703 35,708 (16,005) 2002 22,360 41,951 (19,591) Federated Equity Income Fund II 2003 54,074 71,115 (17,041) 2002 277,572 359,951 (82,379) Neuberger Genesis Trust 2003 3,182,881 3,026,016 156,865 2002 3,945,915 3,901,378 44,537 Neuberger Berman Partners 2003 - - - 2002 1,628,818 1,816,376 (187,558) Alger Small Capitalization Fund 2003 5,115,383 10,368,122 (5,252,739) 2002 92,308,865 95,743,000 (3,434,135) T Rowe Growth Fund 2003 21,188,315 31,163,803 (9,975,488) 2002 49,309,288 51,995,771 (2,686,483) T Rowe International Stock Fund 2003 3,663,594 5,833,817 (2,170,223) 2002 7,698,878 8,013,342 (314,464) (Continued) 63
485BPOS148th Page of 168TOC1stPreviousNextBottomJust 148th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (7) Realized Gain (Loss) and Change in Unrealized Appreciation (Depreciation), continued [Enlarge/Download Table] Realized Gain (Loss) ------------------------------------------------------ Aggregate Aggregate Cost Year or Proceeds from Sales of Fund Shares Realized Period of Fund Shares Redeemed Gain (Loss) ------- ------------------- -------------- ----------- T Rowe Prime Reserve Fund 2003 $ 791,463 $ 791,463 $ - 2002 3,106,226 3,106,226 - Janus Aspen Worldwide Growth 2003 5,222,175 8,741,370 (3,519,195) 2002 11,618,006 12,871,450 (1,253,444) American Global Small Capitalization Fund 2003 75,904 69,019 6,885 2002 - - - American Growth Fund 2003 11,710 11,048 662 2002 - - - American Growth & Income Fund 2003 96,825 93,284 3,541 2002 - - - 64
485BPOS149th Page of 168TOC1stPreviousNextBottomJust 149th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (7) Realized Gain (Loss) and Change in Unrealized Appreciation (Depreciation), continued: [Enlarge/Download Table] Unrealized Appreciation (Depreciation) ----------------------------------------------- Appreciation Appreciation Year or (Depreciation) (Depreciation) Period End of Period Beginning of Period Change ------- -------------- ------------------- ------------ Met Investors Lord Abbett Growth & Income Portfolio 2003 $ (9,560,751) $(89,096,088) $ 79,535,337 2002 (89,096,088) (11,523,760) (77,572,328) Met Investors Lord Abbett Growth & Income Portfolio B 2003 76,084,138 (27,212,543) 103,296,681 2002 (27,212,543) 1,177,296 (28,389,839) Met Investors Lord Abbett Bond Debenture Portfolio 2003 38,138 102 38,036 2002 102 - 102 Met Investors Lord Abbett Bond Debenture Portfolio B 2003 39,529,682 1,323,627 38,206,055 2002 1,323,627 66,391 1,257,236 Met Investors JP Morgan Quality Bond Portfolio 2003 743,674 1,146,501 (402,827) 2002 1,146,501 59,526 1,086,975 Met Investors Met/Putnam Research Portfolio 2003 1,276,614 (4,087,958) 5,364,572 2002 (4,087,958) 2,388,915 (6,476,873) Met Investors Met/Putnam Research Portfolio B 2003 7,997,493 (3,226,127) 11,223,620 2002 (3,226,127) 73,143 (3,299,270) Met Investors Oppenheimer Capital Appreciation Portfolio B 2003 49,055,486 (11,624,942) 60,680,428 2002 (11,624,942) (24,399) (11,600,543) Met Investors PIMCO Inflation Protected Bond Portfolio B 2003 2,075,094 - 2,075,094 2002 - - - Met Investors PIMCO Money Market Portfolio B 2003 - - - 2002 - - - Met Investors Janus Aggressive Growth Portfolio B 2003 20,293,587 (6,043,694) 26,337,281 2002 (6,043,694) 63,666 (6,107,360) Met Investors PIMCO Total Return Bond Portfolio 2003 1,790,919 1,879,764 (88,845) 2002 1,879,764 (348,024) 2,227,788 Met Investors PIMCO Total Return Bond Portfolio B 2003 11,925,780 9,787,280 2,138,500 2002 9,787,280 (289,416) 10,076,696 Met Investors PIMCO Innovation Portfolio 2003 55,774 - 55,774 2002 - - - Met Investors PIMCO Innovation Portfolio B 2003 4,712,588 (4,837,981) 9,550,569 2002 (4,837,981) (24,789) (4,813,192) (Continued) 65
485BPOS150th Page of 168TOC1stPreviousNextBottomJust 150th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (7) Realized Gain (Loss) and Change in Unrealized Appreciation (Depreciation), continued: [Enlarge/Download Table] Unrealized Appreciation (Depreciation) ----------------------------------------------- Appreciation Appreciation Year or (Depreciation) (Depreciation) Period End of Period Beginning of Period Change ------- -------------- ------------------- ------------ Met Investors T Rowe Price Mid Cap Growth Portfolio B 2003 $ 23,588,921 $(11,199,294) $ 34,788,215 2002 (11,199,294) 532,265 (11,731,559) Met Investors MFS Research International B 2003 22,674,482 (1,665,261) 24,339,743 2002 (1,665,261) (48,206) (1,617,055) Met Investors AIM Small Cap Growth Portfolio 2003 22,604 - 22,604 2002 - - - Met Investors AIM Small Cap Growth Portfolio B 2003 22,612,855 (3,236,418) 25,849,273 2002 (3,236,418) 44,343 (3,280,761) Met Investors AIM Mid Cap Core Equity Portfolio B 2003 17,247,736 (1,420,926) 18,668,662 2002 (1,420,926) 22,724 (1,443,650) Met Investors Harris Oakmark International Portfolio B 2003 31,414,745 (597,503) 32,012,248 2002 (597,503) 3,825 (601,328) Met Investors Third Avenue Small Cap Value Portfolio 2003 61,093 - 61,093 2002 - - - Met Investors Third Avenue Small Cap Value Portfolio B 2003 38,868,061 66,218 38,801,843 2002 66,218 - 66,218 AIM Premier Equity Fund 2003 (474,806) (880,515) 405,709 2002 (880,515) (651,310) (229,205) AIM Capital Appreciation Fund 2003 (188,091) (446,410) 258,319 2002 (446,410) (482,121) 35,711 AIM International Growth Fund 2003 (179,288) (370,605) 191,317 2002 (370,605) (399,857) 29,252 AIM Balanced Fund 2003 (160,965) (360,735) 199,770 2002 (360,735) (214,518) (146,217) MFS Research Series 2003 (91,755) (199,766) 108,011 2002 (199,766) (200,526) 760 MFS Investors Trust Series 2003 (14,119) (57,009) 42,890 2002 (57,009) (34,738) (22,271) MFS New Discovery Series 2003 (25,403) (156,002) 130,599 2002 (156,002) (69,844) (86,158) (Continued) 66
485BPOS151st Page of 168TOC1stPreviousNextBottomJust 151st
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (7) Realized Gain (Loss) and Change in Unrealized Appreciation (Depreciation), continued: [Enlarge/Download Table] Unrealized Appreciation (Depreciation) ----------------------------------------------- Appreciation Appreciation Year or (Depreciation) (Depreciation) Period End of Period Beginning of Period Change ------- -------------- ------------------- ------------ Oppenheimer Main Street Growth & Income Fund 2003 $ (146,061) $ (552,093) $ 406,032 2002 (552,093) (375,551) (176,542) Oppenheimer Bond Fund 2003 19,683 15,805 3,878 2002 15,805 5,462 10,343 Oppenheimer Money Fund 2003 - - - 2002 - - - Oppenheimer Main Street Small Cap Growth Fund 2003 21,489 (32,864) 54,353 2002 (32,864) (10,662) (22,202) Oppenheimer Strategic Bond Fund 2003 23,852 (735) 24,587 2002 (735) (1,020) 285 Fidelity Asset Manager Portfolio 2003 (17,569,077) (43,474,896) 25,905,819 2002 (43,474,896) (23,531,874) (19,943,022) Fidelity Growth Portfolio 2003 (62,344,841) (146,036,278) 83,691,437 2002 (146,036,278) (54,662,872) (91,373,406) Fidelity Contrafund Portfolio 2003 21,272,380 (34,833,179) 56,105,559 2002 (34,883,179) (13,377,047) (21,506,132) Fidelity Overseas Portfolio 2003 (2,493,615) (7,589,688) 5,096,073 2002 (7,589,688) (5,981,065) (1,608,623) Fidelity Equity-Income Portfolio 2003 128,097 (6,355,406) 6,483,503 2002 (6,355,406) (906,835) (5,448,571) Fidelity Index 500 Portfolio 2003 (1,020,037) (58,062,956) 57,042,919 2002 (58,062,956) 1,429,728 (59,492,684) Fidelity Money Market Portfolio 2003 - - - 2002 - - - Scudder I International Portfolio 2003 (6,796,727) (13,010,946) 6,214,219 2002 (13,010,946) (11,623,392) (1,387,554) MetLife Davis Venture Value Fund 2003 88,012 - 88,012 2002 - - - MetLife Davis Venture Value Fund E 2003 64,517,006 (9,993,308) 74,510,314 2002 (9,993,308) 651,406 (10,644,714) (Continued) 67
485BPOS152nd Page of 168TOC1stPreviousNextBottomJust 152nd
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (7) Realized Gain (Loss) and Change in Unrealized Appreciation (Depreciation), continued: [Enlarge/Download Table] Unrealized Appreciation (Depreciation) ---------------------------------------------- Appreciation Appreciation Year or (Depreciation) (Depreciation) Period End of Period Beginning of Period Change ------- -------------- ------------------- ----------- MetLife Harris Oakmark Focused Value Fund 2003 $ 355,482 $ - $ 355,482 2002 - - - MetLife Harris Oakmark Focused Value Fund B 2003 70,883,090 (3,765,186) 74,648,276 2002 (3,765,186) 1,445,855 (5,211,041) MetLife Jennison Growth Portfolio B 2003 23,105,521 (2,035,146) 25,140,667 2002 (2,035,146) - (2,035,146) MetLife MFS Total Return Series 2003 46,065 - 46,065 2002 - - - MetLife Putnam International Stock Portfolio 2003 (5,061) (111,231) 106,170 2002 (111,231) (65,550) (45,681) MetLife Janus Mid Cap Portfolio 2003 (446,432) (794,013) 347,581 2002 (794,013) (722,067) (71,946) MetLife Russell 2000 Index Portfolio 2003 231,158 (109,899) 341,057 2002 (109,899) (18,838) (91,061) MetLife Met/Putnam Voyager Portfolio A 2003 (158,424) (278,354) 119,930 2002 (278,354) (190,417) (87,937) MetLife Loomis Sayles High Yield Bond 2003 - - - 2002 - (8,635) 8,635 MetLife SSR Aurora Portfolio 2003 348,713 - 348,713 2002 - - - MetLife SSR Bond Income Portfolio 2003 12,545 - 12,545 2002 - - - MetLife SSR Large Cap Value Portfolio 2003 20,377 - 20,377 2002 - - - MetLife Stock Index Portfolio 2003 7,763,978 - 7,763,978 2002 - - - MetLife Stock Index Portfolio B 2003 17,052,043 (4,217,392) 21,269,435 2002 (4,217,392) 13,854 (4,231,246) MetLife Alger Equity Growth 2003 20,041 - 20,041 2002 - - - (Continued) 68
485BPOS153rd Page of 168TOC1stPreviousNextBottomJust 153rd
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (7) Realized Gain (Loss) and Change in Unrealized Appreciation (Depreciation), continued: [Enlarge/Download Table] Unrealized Appreciation (Depreciation) -------------------------------------------- Appreciation Appreciation Year or (Depreciation) (Depreciation) Period End of Period Beginning of Period Change ------- -------------- ------------------- --------- MetLife Lehman Brothers Aggregate Bond Index 2003 $ 8,123 $ - $ 8,123 2002 - - - MetLife FI Mid Cap Opportunities 2003 88,530 - 88,530 2002 - - - MetLife Harris Oakmark Large Cap Value 2003 129,746 - 129,746 2002 - - - MetLife Morgan Stanley EAFE Index 2003 96,659 - 96,659 2002 - - - MetLife Mid Cap Stock Index 2003 144,303 - 144,303 2002 - - - Van Kampen Emerging Growth Fund 2003 (175,497) (354,506) 179,009 2002 (354,506) (473,731) 119,225 Van Kampen Enterprise Fund 2003 (29,725) (73,224) 43,499 2002 (73,224) (82,822) 9,598 Van Kampen Growth & Income Fund 2003 34,636 (33,073) 67,709 2002 (33,073) - (33,073) Van Kampen Strategic Stock Fund 2003 - - - 2002 - 12,418 (12,418) Federated American Leaders Fund II 2003 16,459 (141,566) 158,025 2002 (141,566) (46,418) (95,148) Federated High Income Bond Fund II 2003 3,998 (30,425) 34,423 2002 (30,425) (31,800) 1,375 Federated Growth Strategic Fund II 2003 (112,525) (189,708) 77,183 2002 (189,708) (149,281) (40,427) Federated Equity Income Fund II 2003 (19,625) (103,581) 83,956 2002 (103,581) (79,059) (24,522) Neuberger Genesis Trust 2003 4,451 165,148 (160,697) 2002 165,148 389,444 (224,296) Neuberger Partners 2003 - - - 2002 - (183,291) 183,291 (Continued) 69
485BPOS154th Page of 168TOC1stPreviousNextBottomJust 154th
METLIFE INVESTORS USA SEPARATE ACCOUNT A Notes to Financial Statements December 31, 2003 (7) Realized Gain (Loss) and Change in Unrealized Appreciation (Depreciation), continued: [Enlarge/Download Table] Unrealized Appreciation (Depreciation) ----------------------------------------------- Appreciation Appreciation Year or (Depreciation) (Depreciation) Period End of Period Beginning of Period Change ------- -------------- ------------------- ------------ Alger Small Capitalization Fund 2003 $(44,113,959) $(67,412,861) $ 23,298,902 2002 (67,412,861) (55,736,476) (11,676,385) T Rowe Growth Fund 2003 (1,478,120) (14,537,560) 13,059,440 2002 (14,537,560) (7,799,665) (6,737,895) T Rowe International Stock Fund 2003 (212,016) (2,633,385) 2,421,369 2002 (2,633,385) (1,896,818) (736,567) T Rowe Prime Reserve Fund 2003 - - - 2002 - - - Janus Aspen Worldwide Growth 2003 953 (3,561,087) 3,562,040 2002 (3,561,087) (2,723,972) (837,115) American Global Small Capitalization Fund 2003 134,325 - 134,325 2002 - - - American Growth Fund 2003 611,512 - 611,512 2002 - - - American Growth & Income Fund 2003 404,263 - 404,263 2002 - - - 70
485BPOS155th Page of 168TOC1stPreviousNextBottomJust 155th
METLIFE INVESTORS USA SEPARATE ACCOUNT A FINANCIAL HIGHLIGHTS MetLife Investors USA Separate Account A sells a number of variable annuity products which have unique combinations of features and fees that are charged against the contract owner's account balance. Differences in the fee structures result in a variety of unit values, expense ratios, and total returns. The following table displays the financial information for each sub-account offered by the various products in the Separate Account in ranges of lowest to highest values. [Enlarge/Download Table] As of December 31, 2003 ----------------------------------------- Unit Fair Value* Net Assets Units (lowest to highest) (000) ---------- ------------------- ---------- Accumulation units: Met Investors Lord Abbett Growth & Income Portfolio 12,148,950 $22.54 to $72.18 $298,174 Met Investors Lord Abbett Growth & Income Portfolio B 14,629,558 42.21 to 43.21 626,036 Met Investors Lord Abbett Bond Debenture Portfolio 108,131 5.48 to 16.86 997 Met Investors Lord Abbett Bond Debenture Portfolio B 30,329,280 15.78 to 16.15 485,043 Met Investors JP Morgan Quality Bond Portfolio 2,677,207 11.55 to 26.53 33,184 Met Investors Met/Putnam Research 2,828,413 6.78 to 8.65 22,791 Met Investors Met/Putnam Research B 8,913,001 7.57 to 7.74 68,342 Met Investors Oppenheimer Capital Appreciation Portfolio B 51,511,779 7.80 to 7.99 407,458 (a) Met Investors PIMCO Inflation Protected Bond Portfolio B 25,705,195 10.37 to 10.44 267,767 Met Investors PIMCO Money Market Portfolio B 11,770,319 9.82 to 10.05 117,134 Met Investors Janus Aggressive Growth Portfolio B 26,535,225 6.58 to 6.73 176,919 Met Investors PIMCO Total Return Bond Portfolio 2,852,827 7.90 to 11.94 22,687 Met Investors PIMCO Total Return Bond Portfolio B 41,358,820 11.44 to 11.71 479,813 (a)Met Investors PIMCO Innovation Portfolio 139,123 4.65 to 4.71 646 Met Investors PIMCO Innovation Portfolio B 9,200,629 4.51 to 4.61 42,018 Met Investors T Rowe Price Mid Cap Growth Portfolio B 33,525,139 6.00 to 6.14 203,963 Met Investors MFS Research International Portfolio B 12,883,270 9.30 to 9.52 121,467 (a)Met Investors AIM Small Cap Growth Portfolio 31,568 11.67 to 11.70 369 Met Investors AIM Small Cap Growth Portfolio B 12,475,776 11.38 to 11.63 143,948 Met Investors AIM Mid Cap Core Equity Portfolio B 12,288,221 11.80 to 12.05 146,954 Met Investors Harris Oakmark International Portfolio B 16,889,437 11.53 to 11.78 197,425 (a) Met Investors Third Avenue Small Cap Value Portfolio 50,110 11.52 to 11.54 577 Met Investors Third Avenue Small Cap Value Portfolio B 19,556,732 11.32 to 11.50 223,573 AIM Premier Equity Fund 427,127 3.59 1,531 AIM Capital Appreciation Fund 187,203 4.28 800 AIM International Growth Fund 157,713 4.20 663 AIM Balanced Fund 264,594 4.43 1,173 MFS Research Series 97,097 3.87 376 MFS Investors Trust Series 50,833 3.92 199 MFS New Discovery Series 58,708 5.95 349 [Enlarge/Download Table] For the Year Ended December 31, 2003 -------------------------------------------------- Investment Expense Total Income Ratio*** Return**** Ratio** (lowest to highest) (lowest to highest) ---------- ------------------- ------------------- Accumulation units: Met Investors Lord Abbett Growth & Income Portfolio 1.15% 0.89% to 1.40% 29.24% to 29.90% Met Investors Lord Abbett Growth & Income Portfolio B 0.69% 1.30% to 2.35% 23.90% to 29.04% Met Investors Lord Abbett Bond Debenture Portfolio 3.64% 0.89% to 1.40% 17.86% to 18.46% Met Investors Lord Abbett Bond Debenture Portfolio B 2.75% 1.30% to 2.35% 8.88% to 17.62% Met Investors JP Morgan Quality Bond Portfolio 3.73% 0.89% to 1.40% 2.55% to 3.07% Met Investors Met/Putnam Research 0.03% 1.15% to 1.40% 22.88% to 23.19% Met Investors Met/Putnam Research B 0.00% 1.30% to 2.35% 19.42% to 22.73% Met Investors Oppenheimer Capital Appreciation Portfolio B 0.00% 1.30% to 2.35% 20.90% to 26.87% (a) Met Investors PIMCO Inflation Protected Bond Portfolio B 0.42% 1.30% to 2.35% 3.70% to 4.43% Met Investors PIMCO Money Market Portfolio B 0.41% 1.30% to 2.35% (1.80%) to (0.77%) Met Investors Janus Aggressive Growth Portfolio B 0.00% 1.30% to 2.35% 21.15% to 29.21% Met Investors PIMCO Total Return Bond Portfolio 1.06% 0.89% to 1.40% 3.07% to 3.59% Met Investors PIMCO Total Return Bond Portfolio B 1.38% 1.30% to 2.35% (0.06%) to 2.96% (a)Met Investors PIMCO Innovation Portfolio 0.00% 0.89% to 1.35% 55.73% to 56.45% Met Investors PIMCO Innovation Portfolio B 0.00% 1.30% to 2.35% 38.29% to 55.54% Met Investors T Rowe Price Mid Cap Growth Portfolio B 0.00% 1.30% to 2.35% 27.90% to 34.88% Met Investors MFS Research International Portfolio B 0.89% 1.30% to 2.35% 28.59% to 30.34% (a)Met Investors AIM Small Cap Growth Portfolio 0.00% 1.25% to 1.35% 37.21% to 37.35% Met Investors AIM Small Cap Growth Portfolio B 0.00% 1.30% to 2.35% 32.40% to 37.07% Met Investors AIM Mid Cap Core Equity Portfolio B 1.53% 1.30% to 2.35% 22.83% to 24.55% Met Investors Harris Oakmark International Portfolio B 1.81% 1.30% to 2.35% 31.97% to 34.23% (a) Met Investors Third Avenue Small Cap Value Portfolio 0.62% 1.25% to 1.35% 39.64% to 39.78% Met Investors Third Avenue Small Cap Value Portfolio B 0.48% 1.30% to 2.35% 34.67% to 39.60% AIM Premier Equity Fund 0.31% 1.40% 23.34% AIM Capital Appreciation Fund 0.00% 1.40% 27.72% AIM International Growth Fund 0.55% 1.40% 27.27% AIM Balanced Fund 1.95% 1.40% 14.75% MFS Research Series 0.67% 1.40% 22.97% MFS Investors Trust Series 0.67% 1.40% 20.45% MFS New Discovery Series 0.00% 1.40% 31.86% (a) For the period from May 1, 2003 to December 31, 2003. * Unit fair value amounts are presented as a range of minimum to maximum values, with the lowest value representing the lowest unit fair value of all products offered and the highest unit fair value representing the highest unit fair value of all products offered. ** These amounts represent the dividends, excluding distributions of capital gains, received by the Separate Account sub-accounts from the underlying mutual funds, net of management fees assessed by the fund managers, divided by the average net assets. These ratios exclude those expenses, such as mortality and expense charges, that result in direct reductions in the unit values. The recognition of investment income by the Separate Account sub-accounts is affected by the timing of the declaration of dividends by the underlying funds in which the Separate Account sub-accounts invest. For periods in which a sub-account commenced operations, the investment income ratio is not annualized. *** These ratios represent the annualized contract expenses of the Separate Account sub-accounts, consisting of mortality and expense charges and administrative expenses, for each period indicated. The ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to contract owner accounts through the redemption of units and expenses of the underlying fund have been excluded. **** These amounts represent the total return for the periods indicated, including changes in the value of the underlying funds, and reflect expenses assessed through the reduction of unit values. These ratios do not include any expenses assessed through the redemption of units. Investment options that include a parenthetical notation indicate the effective date of that investment option in the variable account. The total return is calculated for each period indicated or from the effective date through the end of the reporting period. (Continued) 71
485BPOS156th Page of 168TOC1stPreviousNextBottomJust 156th
METLIFE INVESTORS USA SEPARATE ACCOUNT A FINANCIAL HIGHLIGHTS [Enlarge/Download Table] As of December 31, 2003 ----------------------------------------- Unit Fair Value* Net Assets Units (lowest to highest) (000) ---------- ------------------- ---------- Accumulation units, continued: Oppenheimer Main Street Growth & Income Fund 398,851 $4.25 $ 1,696 Oppenheimer Bond Fund 70,248 6.31 443 Oppenheimer Money Fund 100,223 5.40 541 Oppenheimer Main Street Small Cap Growth Fund 25,050 7.28 182 Oppenheimer Strategic Bond Fund 38,061 6.62 252 Fidelity Asset Manager Portfolio 18,335,507 9.39 to 9.51 173,560 Fidelity Growth Portfolio 22,744,437 11.77 to 11.87 269,260 Fidelity Contrafund Portfolio 19,001,001 7.31 to 13.15 249,506 Fidelity Overseas Portfolio 1,619,585 7.08 to 8.18 12,334 Fidelity Equity-Income Portfolio 2,369,870 10.67 25,276 Fidelity Index 500 Portfolio 12,981,916 12.66 to 12.78 164,912 Fidelity Money Market Portfolio 3,919,391 6.76 to 7.08 26,673 Scudder I International Portfolio 3,132,281 6.77 to 6.79 21,280 (a) MetLife Davis Venture Value Fund 27,371 28.56 to 29.79 782 MetLife Davis Venture Value Fund E 39,412,532 10.56 to 10.80 421,803 (a) MetLife Harris Oakmark Focused Value Fund 115,746 31.46 to 33.04 3,642 MetLife Harris Oakmark Focused Value Fund B 29,518,227 13.70 to 14.02 409,860 MetLife Jennison Growth Portfolio B 18,942,898 9.62 to 9.77 184,013 (a) MetLife MFS Total Return Series 19,756 38.75 to 41.84 766 MetLife Putnam International Stock Portfolio 102,075 3.58 365 MetLife Janus Mid Cap Portfolio 472,999 1.92 909 MetLife Russell 2000 Index Portfolio 229,747 5.15 to 13.94 2,228 MetLife Met/Putnam Voyager Portfolio A 199,325 2.10 419 (a) MetLife SSR Aurora Portfolio 170,814 16.11 to 16.37 2,752 (a) MetLife SSR Bond Income Portfolio 14,179 46.37 to 50.92 658 (a) MetLife SSR Large Cap Value Portfolio 19,981 10.62 to 10.64 212 (a) MetLife Stock Index Portfolio 1,956,414 35.45 to 38.01 69,595 MetLife Stock Index Portfolio B 13,065,732 10.26 to 10.48 135,881 (a) MetLife Alger Equity Growth 8,406 24.33 to 24.55 205 (a) MetLife Lehman Brothers Aggregate Bond Index 55,030 12.76 to 12.82 702 (a) MetLife FI Mid Cap Opportunities 71,708 11.41 to 11.50 819 (a) MetLife Harris Oakmark Large Cap Value 144,358 12.12 to 12.18 1,749 [Enlarge/Download Table] For the Year Ended December 31, 2003 -------------------------------------------------- Investment Expense Total Income Ratio*** Return**** Ratio** (lowest to highest) (lowest to highest) ---------- ------------------- ------------------- Accumulation units, continued: Oppenheimer Main Street Growth & Income Fund 0.97% 1.40% 24.96% Oppenheimer Bond Fund 5.47% 1.40% 5.29% Oppenheimer Money Fund 0.95% 1.40% (0.61%) Oppenheimer Main Street Small Cap Growth Fund 0.00% 1.40% 42.36% Oppenheimer Strategic Bond Fund 6.49% 1.40% 16.43% Fidelity Asset Manager Portfolio 3.56% 0.89% to 1.40% 16.34% to 16.93% Fidelity Growth Portfolio 0.27% 0.89% to 1.40% 31.00% to 31.67% Fidelity Contrafund Portfolio 0.46% 0.89% to 1.40% 26.68% to 27.33% Fidelity Overseas Portfolio 0.87% 1.15% to 1.40% 41.38% to 41.73% Fidelity Equity-Income Portfolio 1.89% 1.40% 28.52% Fidelity Index 500 Portfolio 1.67% 0.89% to 1.40% 26.63% to 27.27% Fidelity Money Market Portfolio 1.08% 0.89% to 1.40% (0.40%) to 0.10% Scudder I International Portfolio 0.76% 1.35% to 1.40% 25.98% to 26.04% (a) MetLife Davis Venture Value Fund 0.00% 0.89% to 1.35% 29.12% to 29.71% MetLife Davis Venture Value Fund E 0.27% 1.30% to 2.35% 25.13% to 29.05% (a) MetLife Harris Oakmark Focused Value Fund 0.00% 0.89% to 1.35% 30.88% to 31.48% MetLife Harris Oakmark Focused Value Fund B 0.05% 1.30% to 2.35% 26.99% to 30.62% MetLife Jennison Growth Portfolio B 0.14% 1.30% to 2.35% 20.13% to 28.02% (a) MetLife MFS Total Return Series 0.00% 0.89% to 1.35% 15.43% to 15.97% MetLife Putnam International Stock Portfolio 0.63% 1.40% 26.26% MetLife Janus Mid Cap Portfolio 0.00% 1.40% 32.71% MetLife Russell 2000 Index Portfolio 0.26% 0.89% to 1.40% 44.04% to 44.77% MetLife Met/Putnam Voyager Portfolio A 0.00% 1.40% 24.16% (a) MetLife SSR Aurora Portfolio 0.00% 0.89% to 1.35% 48.13% to 48.81% (a) MetLife SSR Bond Income Portfolio 0.00% 0.89% to 1.35% 4.43% to 4.92% (a) MetLife SSR Large Cap Value Portfolio 1.28% 1.25% to 1.35% 33.86% to 33.99% (a) MetLife Stock Index Portfolio 0.00% 0.89% to 1.40% 26.44% to 27.07% MetLife Stock Index Portfolio B 1.26% 1.30% to 2.35% 20.39% to 26.22% (a) MetLife Alger Equity Growth 0.00% 1.25% to 1.35% 33.34% to 33.47% (a) MetLife Lehman Brothers Aggregate Bond Index 0.00% 1.25% to 1.35% 2.24% to 2.35% (a) MetLife FI Mid Cap Opportunities 0.00% 0.89% to 1.35% 40.62% to 41.26% (a) MetLife Harris Oakmark Large Cap Value 0.00% 1.25% to 1.35% 23.81% to 23.94% (a) For the period from May 1, 2003 to December 31, 2003. * Unit fair value amounts are presented as a range of minimum to maximum values, with the lowest value representing the lowest unit fair value of all products offered and the highest unit fair value representing the highest unit fair value of all products offered. ** These amounts represent the dividends, excluding distributions of capital gains, received by the Separate Account sub-accounts from the underlying mutual funds, net of management fees assessed by the fund managers, divided by the average net assets. These ratios exclude those expenses, such as mortality and expense charges, that result in direct reductions in the unit values. The recognition of investment income by the Separate Account sub-accounts is affected by the timing of the declaration of dividends by the underlying funds in which the Separate Account sub-accounts invest. For periods in which a sub-account commenced operations, the investment income ratio is not annualized. *** These ratios represent the annualized contract expenses of the Separate Account sub-accounts, consisting of mortality and expense charges and administrative expenses, for each period indicated. The ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to contract owner accounts through the redemption of units and expenses of the underlying fund have been excluded. **** These amounts represent the total return for the periods indicated, including changes in the value of the underlying funds, and reflect expenses assessed through the reduction of unit values. These ratios do not include any expenses assessed through the redemption of units. Investment options that include a parenthetical notation indicate the effective date of that investment option in the variable account. The total return is calculated for each period indicated or from the effective date through the end of the reporting period. (Continued) 72
485BPOS157th Page of 168TOC1stPreviousNextBottomJust 157th
METLIFE INVESTORS USA SEPARATE ACCOUNT A FINANCIAL HIGHLIGHTS [Enlarge/Download Table] As of December 31, 2003 ---------------------------------------- Unit Fair Value* Net Assets Units (lowest to highest) (000) --------- ------------------- ---------- Accumulation units, continued: (a) MetLife Morgan Stanley EAFE Index 110,435 $ 9.67 to $ 9.91 $ 1,069 (a) MetLife Mid Cap Stock Index 128,276 11.57 to 11.75 1,484 Van Kampen Emerging Growth Fund 131,352 4.03 529 Van Kampen Enterprise Fund 50,200 3.38 170 Van Kampen Growth & Income Fund 61,622 5.11 315 Federated American Leaders II 140,461 4.61 647 Federated High Income Bond Fund II 48,364 5.43 263 Federated Growth Strategic Fund II 47,399 4.26 202 Federated Equity Income Fund II 81,743 4.11 336 Neuberger Berman Genesis Trust 2,060 8.70 18 Alger American Small Capitalization Fund 9,758,550 6.08 to 6.10 59,470 T Rowe Growth Fund 171,175 62.15 10,638 T Rowe International Stock Fund 117,827 8.98 1,058 T Rowe Prime Reserve Fund 87,209 16.48 1,437 Janus Aspen Worldwide Growth 1,585 6.06 10 (a) American Global Small Capitalization Fund 77,922 16.42 to 16.85 1,280 (a) American Growth Fund 59,754 116.56 to 127.74 6,971 (a) American Growth & Income Fund 53,632 90.71 to 99.40 4,871 Annuitization units: Met Investors Lord Abbett Growth & Income Portfolio B 1,654 39.68 66 Met Investors Lord Abbett Bond Debenture Portfolio B 2,084 14.83 31 Met Investors Met/Putnam Research Portfolio B 19,926 7.10 141 Met Investors Oppenheimer Capital Appreciation Portfolio B 2,224 7.31 16 Met Investors PIMCO Inflation Protected Bond Portfolio B 2,717 10.23 28 Met Investors PIMCO Money Market Portfolio B 16,666 9.20 153 Met Investors PIMCO Total Return Bond Portfolio B 12,808 10.73 137 Met Investors T Rowe Price Mid Cap Growth Portfolio B 1,752 5.62 10 Met Investors MFS Research International Portfolio B 3,885 8.72 34 Met Investors AIM Mid Cap Core Equity Portfolio B 628 11.26 7 Met Investors Third Avenue Small Cap Value Portfolio B 954 10.93 10 MetLife Davis Venture Value Fund E 17,548 9.92 174 MetLife Harris Oakmark Focused Value Fund B 6,375 12.88 82 MetLife Jennison Growth Portfolio B 993 9.29 9 [Enlarge/Download Table] For the Year Ended December 31, 2003 -------------------------------------------------- Investment Expense Total Income Ratio*** Return**** Ratio** (lowest to highest) (lowest to highest) ---------- ------------------- ------------------- Accumulation units, continued: (a) MetLife Morgan Stanley EAFE Index 0.00% 0.89% to 1.35% 35.79% to 36.42% (a) MetLife Mid Cap Stock Index 0.00% 0.89% to 1.35% 33.16% to 33.77% Van Kampen Emerging Growth Fund 0.00% 1.40% 25.58% Van Kampen Enterprise Fund 0.52% 1.40% 24.13% Van Kampen Growth & Income Fund 0.87% 1.40% 26.26% Federated American Leaders II 1.69% 1.40% 25.92% Federated High Income Bond Fund II 7.69% 1.40% 20.52% Federated Growth Strategic Fund II 0.00% 1.40% 38.13% Federated Equity Income Fund II 1.93% 1.40% 25.51% Neuberger Berman Genesis Trust 0.00% 0.89% 30.49% Alger American Small Capitalization Fund 0.00% 1.25% to 1.40% 40.37% to 40.58% T Rowe Growth Fund 0.16% 0.89% 30.06% T Rowe International Stock Fund 0.74% 0.89% 30.12% T Rowe Prime Reserve Fund 0.69% 0.89% (0.30%) Janus Aspen Worldwide Growth 0.01% 0.89% 22.89% (a) American Global Small Capitalization Fund 0.07% 0.89% to 1.35% 51.47% to 52.17% (a) American Growth Fund 0.16% 0.89% to 1.35% 34.97% to 35.60% (a) American Growth & Income Fund 1.38% 0.89% to 1.35% 30.65% to 31.25% Annuitization units: Met Investors Lord Abbett Growth & Income Portfolio B 0.69% 1.40% 25.16% Met Investors Lord Abbett Bond Debenture Portfolio B 2.75% 1.40% 14.08% Met Investors Met/Putnam Research Portfolio B 0.00% 1.40% 19.04% Met Investors Oppenheimer Capital Appreciation Portfolio B 0.00% 1.40% 23.05% Met Investors PIMCO Inflation Protected Bond Portfolio B 0.42% 1.40% 2.32% Met Investors PIMCO Money Market Portfolio B 0.41% 1.55% (3.99%) Met Investors PIMCO Total Return Bond Portfolio B 1.38% 1.40% (0.14%) Met Investors T Rowe Price Mid Cap Growth Portfolio B 0.00% 1.40% 30.82% Met Investors MFS Research International Portfolio B 0.89% 1.40% 26.42% Met Investors AIM Mid Cap Core Equity Portfolio B 1.53% 1.40% 20.80% Met Investors Third Avenue Small Cap Value Portfolio B 0.48% 1.40% 35.39% MetLife Davis Venture Value Fund E 0.27% 1.40% 25.16 % MetLife Harris Oakmark Focused Value Fund B 0.05% 1.40% 26.69% MetLife Jennison Growth Portfolio B 0.14% 1.40% 24.16% (a) For the period from May 1, 2003 to December 31, 2003. * Unit fair value amounts are presented as a range of minimum to maximum values, with the lowest value representing the lowest unit fair value of all products offered and the highest unit fair value representing the highest unit fair value of all products offered. ** These amounts represent the dividends, excluding distributions of capital gains, received by the Separate Account sub-accounts from the underlying mutual funds, net of management fees assessed by the fund managers, divided by the average net assets. These ratios exclude those expenses, such as mortality and expense charges, that result in direct reductions in the unit values. The recognition of investment income by the Separate Account sub-accounts is affected by the timing of the declaration of dividends by the underlying funds in which the Separate Account sub-accounts invest. For periods in which a sub-account commenced operations, the investment income ratio is not annualized. *** These ratios represent the annualized contract expenses of the Separate Account sub-accounts, consisting of mortality and expense charges and administrative expenses, for each period indicated. The ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to contract owner accounts through the redemption of units and expenses of the underlying fund have been excluded. **** These amounts represent the total return for the periods indicated, including changes in the value of the underlying funds, and reflect expenses assessed through the reduction of unit values. These ratios do not include any expenses assessed through the redemption of units. Investment options that include a parenthetical notation indicate the effective date of that investment option in the variable account. The total return is calculated for each period indicated or from the effective date through the end of the reporting period. (Continued) 73
485BPOS158th Page of 168TOC1stPreviousNextBottomJust 158th
METLIFE INVESTORS USA SEPARATE ACCOUNT A FINANCIAL HIGHLIGHTS MetLife Investors USA Separate Account A sells a number of variable annuity products which have unique combinations of features and fees that are charged against the contract owner's account balance. Differences in the fee structures result in a variety of unit values, expense ratios, and total returns. The following table displays the financial information for each sub-account offered by the various products in the Separate Account in ranges of lowest to highest values. [Enlarge/Download Table] As of December 31, 2002 ----------------------------------------- Unit Fair Value* Net Assets Units (lowest to highest) (000) ---------- ------------------- ---------- Accumulation units: Met Investors Lord Abbett Growth & Income Portfolio 12,846,775 $17.44 to $55.57 $256,901 Met Investors Lord Abbett Growth & Income Portfolio B 4,763,078 33.02 to 33.48 158,469 (b) Met Investors Lord Abbett Bond Debenture Portfolio 23,392 4.65 109 Met Investors Lord Abbett Bond Debenture Portfolio B 8,449,518 13.54 to 13.73 115,255 Met Investors JP Morgan Quality Bond Portfolio 3,059,939 11.25 to 25.74 38,254 Met Investors Met/Putnam Research Portfolio 3,520,815 5.52 to 7.02 23,034 Met Investors Met/Putnam Research Portfolio B 4,317,303 6.22 to 6.31 27,062 Met Investors Oppenheimer Capital Appreciation Portfolio B 15,642,954 6.21 to 6.30 97,837 Met Investors PIMCO Money Market Portfolio B 8,981,636 10.00 to 10.14 90,464 Met Investors Janus Aggressive Growth Portfolio B 7,128,991 5.14 to 5.21 36,902 Met Investors PIMCO Total Return Bond Portfolio 3,311,248 7.66 to 7.73 25,487 Met Investors PIMCO Total Return Bond Portfolio B 21,084,805 11.22 to 11.38 238,271 Met Investors PIMCO Innovation Portfolio B 3,459,215 2.92 to 2.97 10,191 Met Investors T Rowe Price Mid Cap Growth Portfolio B 9,490,409 4.49 to 4.55 42,935 Met Investors MFS Research International Portfolio B 6,394,788 7.20 to 7.30 46,398 Met Investors AIM Small Cap Growth Portfolio B 4,064,765 8.38 to 8.48 34,329 Met Investors AIM Mid Cap Core Equity Portfolio B 2,416,396 9.57 to 9.68 23,277 Met Investors Harris Oakmark International Portfolio B 1,441,751 8.74 to 8.84 12,689 (c) Met Investors Third Avenue Small Cap Value Portfolio B 3,106,789 8.19 to 8.24 25,529 AIM Premier Equity Fund 467,409 2.91 1,359 AIM Capital Appreciation Fund 213,116 3.35 713 AIM International Growth Fund 168,594 3.30 557 AIM Balanced Fund 298,328 3.86 1,152 MFS Research Series 114,262 3.15 360 MFS Investors Trust Series 54,292 3.26 177 MFS New Discovery Series 75,459 4.51 340 Oppenheimer Main Street Growth & Income Fund 436,506 3.40 1,485 [Enlarge/Download Table] For the Year ended December 31, 2002 --------------------------------------------------- Investment Expense Total Income Ratio*** Return**** Ratio** (lowest to highest) (lowest to highest) ---------- ------------------- -------------------- Accumulation units: Met Investors Lord Abbett Growth & Income Portfolio 0.91% 0.89% to 1.40% (19.09%) to (18.67%) Met Investors Lord Abbett Growth & Income Portfolio B 1.77% 1.30% to 2.25% (19.94%) to (19.18%) (b) Met Investors Lord Abbett Bond Debenture Portfolio 0.00% 1.40% (1.77%) Met Investors Lord Abbett Bond Debenture Portfolio B 4.91% 1.30% to 2.25% (2.79%) to (1.86%) Met Investors JP Morgan Quality Bond Portfolio 5.20% 0.89% to 1.40% 7.44% to 7.99% Met Investors Met/Putnam Research Portfolio 0.41% 1.15% to 1.40% (21.71%) to (21.52%) Met Investors Met/Putnam Research Portfolio B 0.69% 1.30% to 2.25% (22.58%) to (21.84%) Met Investors Oppenheimer Capital Appreciation Portfolio B 0.01% 1.30% to 2.25% (26.41%) to (25.71%) Met Investors PIMCO Money Market Portfolio B 1.02% 1.30% to 2.25% (1.15%) to (0.21%) Met Investors Janus Aggressive Growth Portfolio B 0.01% 1.30% to 2.25% (29.44%) to (28.77%) Met Investors PIMCO Total Return Bond Portfolio 0.00% 1.15% to 1.40% 8.04% to 8.31% Met Investors PIMCO Total Return Bond Portfolio B 0.00% 1.30% to 2.25% 6.86% to 7.88% Met Investors PIMCO Innovation Portfolio B 0.00% 1.30% to 2.25% (51.83%) to (51.37%) Met Investors T Rowe Price Mid Cap Growth Portfolio B 0.00% 1.30% to 2.25% (45.29%) to (44.76%) Met Investors MFS Research International Portfolio B 0.24% 1.30% to 2.25% (13.77%) to (12.94%) Met Investors AIM Small Cap Growth Portfolio B 0.00% 1.30% to 2.25% (29.12%) to (28.44%) Met Investors AIM Mid Cap Core Equity Portfolio B 0.02% 1.30% to 2.25% (12.80%) to (11.97%) Met Investors Harris Oakmark International Portfolio B 0.24% 1.30% to 2.25% (19.92%) to (19.15%) (c) Met Investors Third Avenue Small Cap Value Portfolio B 0.39% 1.30% to 2.25% (18.14%) to (17.62%) AIM Premier Equity Fund 0.31% 1.40% (31.23%) AIM Capital Appreciation Fund 0.00% 1.40% (25.41%) AIM International Growth Fund 0.55% 1.40% (16.85%) AIM Balanced Fund 2.34% 1.40% (18.25%) MFS Research Series 0.28% 1.40% (25.59%) MFS Investors Trust Series 0.56% 1.40% (22.06%) MFS New Discovery Series 0.00% 1.40% (32.58%) Oppenheimer Main Street Growth & Income Fund 0.81% 1.40% (19.93%) (b) For the period from April 26, 2002 to December 31, 2002. (c) For the period from May 1, 2002 to December 31, 2002. * Unit fair value amounts are presented as a range of minimum to maximum values, with the lowest value representing the lowest unit fair value of all products offered and the highest unit fair value representing the highest unit fair value of all products offered. ** These amounts represent the dividends, excluding distributions of capital gains, received by the Separate Account sub-accounts from the underlying mutual funds, net of management fees assessed by the fund managers, divided by the average net assets. These ratios exclude those expenses, such as mortality and expense charges, that result in direct reductions in the unit values. The recognition of investment income by the Separate Account sub-accounts is affected by the timing of the declaration of dividends by the underlying funds in which the Separate Account sub-accounts invest. For periods in which a sub-account commenced operations, the investment income ratio is not annualized. *** These ratios represent the annualized contract expenses of the Separate Account sub-accounts, consisting of mortality and expense charges and administrative expenses, for each period indicated. The ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to contract owner accounts through the redemption of units and expenses of the underlying fund have been excluded. **** These amounts represent the total return for the periods indicated, including changes in the value of the underlying funds, and reflect expenses assessed through the reduction of unit values. These ratios do not include any expenses assessed through the redemption of units. Investment options that include a parenthetical notation indicate the effective date of that investment option in the variable account. The total return is calculated for each period indicated or from the effective date through the end of the reporting period. ***** This information is not available. (Continued) 74
485BPOS159th Page of 168TOC1stPreviousNextBottomJust 159th
METLIFE INVESTORS USA SEPARATE ACCOUNT A FINANCIAL HIGHLIGHTS [Enlarge/Download Table] As of December 31, 2002 ----------------------------------------- Unit Fair Value* Net Assets Units (lowest to highest) (000) ---------- ------------------- ---------- Accumulation units, continued: Oppenheimer Bond Fund 70,085 $5.99 $ 420 Oppenheimer Money Fund 167,544 5.43 910 Oppenheimer Main Street Small Cap Growth Fund 24,139 5.11 123 Oppenheimer Strategic Bond Fund 43,633 5.69 248 Fidelity Asset Manager Portfolio 20,018,998 8.07 to 8.16 162,779 Fidelity Growth Portfolio 24,650,187 8.94 to 9.05 222,487 Fidelity Contrafund Portfolio 19,592,405 5.74 to 10.37 200,853 Fidelity Overseas Portfolio 1,914,131 5.00 to 5.78 10,274 Fidelity Equity-Income Portfolio 2,727,566 8.30 22,635 Fidelity Index 500 Portfolio 20,168,826 10.00 to 10.06 202,227 Fidelity Money Market Portfolio 4,525,655 6.78 to 7.07 30,913 Scudder I International Portfolio 2,973,433 5.38 to 5.39 16,027 MetLife Davis Venture Value Fund E 15,486,565 8.26 to 8.37 128,845 MetLife Harris Oakmark Focused Value Fund B 10,685,241 10.59 to 10.73 113,939 (c) MetLife Jennison Growth Portfolio B 5,519,181 7.58 to 7.63 42,026 MetLife Putnam International Stock Portfolio 97,675 2.83 277 MetLife Janus Mid Cap Portfolio 486,103 1.45 704 MetLife Russell 2000 Index Portfolio 105,781 3.58 378 MetLife Met/Putnam Voyager Portfolio A 192,732 1.69 326 MetLife Stock Index Portfolio B 5,021,812 8.20 to 8.30 41,490 Van Kampen Emerging Growth Fund 142,960 3.21 459 Van Kampen Enterprise Fund 56,973 2.73 155 (c) Van Kampen Growth & Income Fund 54,474 4.05 221 Federated American Leaders II 162,190 3.66 594 Federated High Income Bond Fund II 54,149 4.51 244 Federated Growth Strategic Fund II 51,227 3.09 158 Federated Equity Income Fund II 91,827 3.28 301 Neuberger Genesis Trust 479,091 6.66 3,193 Alger Small Capitalization Fund 9,818,127 4.33 to 4.34 42,604 T Rowe Price Growth Fund 585,362 47.78 27,969 T Rowe Price International Fund 634,123 6.90 4,375 T Rowe Price Prime Reserve Fund 111,278 16.52 1,839 Janus Aspen Worldwide Growth 1,049,176 4.93 5,172 Annuitization units: Met Investors PIMCO Innovation Portfolio B 1,763 $2.80 $ 5 [Enlarge/Download Table] For the Year ended December 31, 2002 ---------------------------------------------------- Investment Expense Total Income Ratio*** Return**** Ratio** (lowest to highest) (lowest to highest) ---------- ------------------- --------------------- Accumulation units, continued: Oppenheimer Bond Fund 7.68% 1.40% 7.56% Oppenheimer Money Fund 1.47% 1.40% ***** Oppenheimer Main Street Small Cap Growth Fund 0.00% 1.40% (16.92%) Oppenheimer Strategic Bond Fund 8.38% 1.40% 5.95% Fidelity Asset Manager Portfolio 4.00% 0.89% to 1.40% (10.00%) to (9.54%) Fidelity Growth Portfolio 0.25% 0.89% to 1.40% (31.08%) to (30.73%) Fidelity Contrafund Portfolio 0.82% 0.89% to 1.40% (10.61%) to (10.15%) Fidelity Overseas Portfolio 0.84% 1.15% to 1.40% (21.39%) to (21.19%) Fidelity Equity-Income Portfolio 1.84% 1.40% (18.10%) Fidelity Index 500 Portfolio 1.31% 0.89% to 1.40% (23.33%) to (22.94%) Fidelity Money Market Portfolio 1.70% 0.89% to 1.40% 0.28% to 0.79% Scudder I International Portfolio 0.84% 1.35% to 1.40% (19.50%) to (19.46%) MetLife Davis Venture Value Fund E 0.65% 1.30% to 2.25% (18.41%) to (17.63%) MetLife Harris Oakmark Focused Value Fund B 0.12% 1.30% to 2.25% (10.33%) to (11.09%) (c) MetLife Jennison Growth Portfolio B 0.00% 1.30% to 2.25% (24.15%) to (23.67%) MetLife Putnam International Stock Portfolio 0.88% 1.40% (18.64%) MetLife Janus Mid Cap Portfolio 0.00% 1.40% (29.98%) MetLife Russell 2000 Index Portfolio 0.61% 1.40% (21.57%) MetLife Met/Putnam Voyager Portfolio A 0.00% 1.40% (29.90%) MetLife Stock Index Portfolio B 0.56% 1.30% to 2.25% (24.24%) to (23.52%) Van Kampen Emerging Growth Fund 0.37% 1.40% (33.43%) Van Kampen Enterprise Fund 0.50% 1.40% (30.31%) (c) Van Kampen Growth & Income Fund 0.00% 1.40% (15.69%) Federated American Leaders II 1.26% 1.40% (21.33%) Federated High Income Bond Fund II 10.55% 1.40% (0.02%) Federated Growth Strategic Fund II 0.00% 1.40% (27.37%) Federated Equity Income Fund II 2.13% 1.40% (21.84%) Neuberger Genesis Trust 0.00% 0.89% (3.85%) Alger Small Capitalization Fund 0.00% 1.25% to 1.40% (27.25%) to (27.21%) T Rowe Price Growth Fund 0.18% 0.89% (23.68%) T Rowe Price International Fund 1.07% 0.89% (18.91%) T Rowe Price Prime Reserve Fund 1.39% 0.89% ***** Janus Aspen Worldwide Growth 0.86% 0.89% (26.16%) Annuitization units: Met Investors PIMCO Innovation Portfolio B 0.00% 1.55% (51.49%) (c) For the period from May 1, 2002 to December 31, 2002. * Unit fair value amounts are presented as a range of minimum to maximum values, with the lowest value representing the lowest unit fair value of all products offered and the highest unit fair value representing the highest unit fair value of all products offered. ** These amounts represent the dividends, excluding distributions of capital gains, received by the Separate Account sub-accounts from the underlying mutual funds, net of management fees assessed by the fund managers, divided by the average net assets. These ratios exclude those expenses, such as mortality and expense charges, that result in direct reductions in the unit values. The recognition of investment income by the Separate Account sub-accounts is affected by the timing of the declaration of dividends by the underlying funds in which the Separate Account sub-accounts invest. For periods in which a sub-account commenced operations, the investment income ratio is not annualized. *** These ratios represent the annualized contract expenses of the Separate Account sub-accounts, consisting of mortality and expense charges and administrative expenses, for each period indicated. The ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to contract owner accounts through the redemption of units and expenses of the underlying fund have been excluded. **** These amounts represent the total return for the periods indicated, including changes in the value of the underlying funds, and reflect expenses assessed through the reduction of unit values. These ratios do not include any expenses assessed through the redemption of units. Investment options that include a parenthetical notation indicate the effective date of that investment option in the variable account. The total return is calculated for each period indicated or from the effective date through the end of the reporting period. ***** This information is not available. (Continued) 75
485BPOS160th Page of 168TOC1stPreviousNextBottomJust 160th
METLIFE INVESTORS USA SEPARATE ACCOUNT A FINANCIAL HIGHLIGHTS MetLife Investors USA Separate Account A sells a number of variable annuity products which have unique combinations of features and fees that are charged against the contract owner's account balance. Differences in the fee structures result in a variety of unit values, expense ratios, and total returns. The following table displays the financial information for each sub-account offered by the various products in the Separate Account in ranges of lowest to highest values. [Enlarge/Download Table] As of December 31, 2001 ----------------------------------------- Unit Fair Value* Net Assets Units (lowest to highest) (000) ---------- ------------------- ---------- Accumulation units: (g) Met Investors Lord Abbett Growth & Income Portfolio 13,056,744 $21.56 to $68.33 $325,654 (f) Met Investors Lord Abbett Growth & Income Portfolio B 829,894 41.18 to 41.43 34,277 (f) Met Investors Lord Abbett Bond Debenture Portfolio B 949,659 13.91 to 13.99 13,246 Met Investors JP Morgan Quality Bond Portfolio 2,400,419 10.47 to 23.83 27,978 (h) Met Investors Met Putnam Research Portfolio 4,271,829 7.05 to 8.94 35,502 (f) Met Investors Met Putnam Research Portfolio B 1,148,099 8.03 to 8.07 9,240 (f) Met Investors Oppenheimer Capital Appreciation Portfolio B 2,574,330 8.42 to 8.47 21,746 (f) Met Investors PIMCO Money Market Portfolio B 2,040,930 10.10 to 10.16 20,681 (f) Met Investors Janus Aggressive Growth Portfolio B 1,408,153 7.27 to 7.31 10,268 (j) Met Investors PIMCO Total Return Bond Portfolio 3,960,781 7.09 to 7.14 28,189 (f) Met Investors PIMCO Total Return Bond Portfolio B 2,425,689 10.48 to 10.54 25,502 (f) Met Investors PIMCO Innovation Portfolio B 719,543 6.06 to 6.10 4,375 (f) Met Investors T Rowe Price Mid Cap Growth Portfolio B 1,668,902 8.19 to 8.24 13,714 (f) Met Investors MFS Research International Portfolio B 916,898 8.34 to 8.39 7,667 (i) Met Investors AIM Small Cap Growth Portfolio B 119,269 11.83 to 11.86 1,413 (i) Met Investors AIM Mid Cap Core Equity Portfolio B 91,975 10.97 to 10.99 1,010 (i) Met Investors Harris Oakmark International Portfolio B 20,012 10.91 to 10.94 219 AIM Premier Equity Fund 544,055 4.23 2,300 AIM Capital Appreciation Fund 236,958 4.49 1,063 AIM International Growth Fund 189,032 3.97 750 AIM Balanced Fund 334,293 4.73 1,580 MFS Research Series 126,396 4.23 535 MFS Investors Trust Series 60,869 4.18 254 MFS New Discovery Series 90,551 6.69 606 Oppenheimer Main Street Growth & Income Fund 552,681 4.25 2,349 Oppenheimer Bond Fund 66,734 5.57 372 [Enlarge/Download Table] For the Year ended December 31, 2001 --------------------------------------------------- Investment Expense Total Income Ratio*** Return**** Ratio** (lowest to highest) (lowest to highest) ---------- ------------------- -------------------- Accumulation units: (g) Met Investors Lord Abbett Growth & Income Portfolio 0.95% 0.89% to 1.40% (7.24%) to (6.56%) (f) Met Investors Lord Abbett Growth & Income Portfolio B 0.17% 1.30% to 2.25% (8.09%) to (7.21%) (f) Met Investors Lord Abbett Bond Debenture Portfolio B 1.47% 1.30% to 2.25% 1.17% to 2.14% Met Investors JP Morgan Quality Bond Portfolio 4.86% 0.89% to 1.40% 5.33% to 6.10% (h) Met Investors Met Putnam Research Portfolio 0.07% 1.15% to 1.40% 7.00% to 7.00% (f) Met Investors Met Putnam Research Portfolio B 0.44% 1.30% to 2.25% (1.54%) to (0.81%) (f) Met Investors Oppenheimer Capital Appreciation Portfolio B 0.07% 1.30% to 2.25% (1.73%) to (1.00%) (f) Met Investors PIMCO Money Market Portfolio B 1.02% 1.30% to 2.25% 0.66% to 1.29% (f) Met Investors Janus Aggressive Growth Portfolio B 0.00% 1.30% to 2.25% (9.72%) to (9.05%) (j) Met Investors PIMCO Total Return Bond Portfolio 0.88% 1.15% to 1.40% (0.31%) to (0.25%) (f) Met Investors PIMCO Total Return Bond Portfolio B 2.47% 1.30% to 2.25% 3.00% to 3.77% (f) Met Investors PIMCO Innovation Portfolio B 0.00% 1.30% to 2.25% (16.33%) to (15.70%) (f) Met Investors T Rowe Price Mid Cap Growth Portfolio B 0.00% 1.30% to 2.25% 1.03% to 1.78% (f) Met Investors MFS Research International Portfolio B 0.13% 1.30% to 2.25% (5.45%) to (4.75%) (i) Met Investors AIM Small Cap Growth Portfolio B 0.00% 1.30% to 2.25% 18.30% to 18.55% (i) Met Investors AIM Mid Cap Core Equity Portfolio B 0.05% 1.30% to 2.25% 9.70% to 9.94% (i) Met Investors Harris Oakmark International Portfolio B 0.08% 1.30% to 2.25% 9.15% to 9.38% AIM Premier Equity Fund 0.14% 1.40% (11.93%) AIM Capital Appreciation Fund 0.00% 1.40% (21.67%) AIM International Growth Fund 0.34% 1.40% (21.70%) AIM Balanced Fund 1.91% 1.40% (11.33%) MFS Research Series 1.16% 1.40% (8.98%) MFS Investors Trust Series 0.57% 1.40% (15.90%) MFS New Discovery Series 3.11% 1.40% 19.05% Oppenheimer Main Street Growth & Income Fund 0.53% 1.40% (10.63%) Oppenheimer Bond Fund 7.36% 1.40% 7.24% (f) For the period from March 21, 2001 to December 31, 2001. (g) For the period from February 21, 2001 to December 31, 2001. (h) For the period from March 19, 2001 to December 31, 2001. (i) For the period from October 9, 2001 to December 31, 2001. (j) For the period from October 15, 2001 to December 31, 2001. * Unit fair value amounts are presented as a range of minimum to maximum values, with the lowest value representing the lowest unit fair value of all products offered and the highest unit fair value representing the highest unit fair value of all products offered. ** These amounts represent the dividends, excluding distributions of capital gains, received by the Separate Account sub-accounts from the underlying mutual funds, net of management fees assessed by the fund managers, divided by the average net assets. These ratios exclude those expenses, such as mortality and expense charges, that result in direct reductions in the unit values. The recognition of investment income by the Separate Account sub-accounts is affected by the timing of the declaration of dividends by the underlying funds in which the Separate Account sub-accounts invest. For periods in which a sub-account commenced operations, the investment income ratio is not annualized. *** These ratios represent the annualized contract expenses of the Separate Account sub-accounts, consisting of mortality and expense charges and administrative expenses, for each period indicated. The ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to contract owner accounts through the redemption of units and expenses of the underlying fund have been excluded. **** These amounts represent the total return for the periods indicated, including changes in the value of the underlying funds, and reflect expenses assessed through the reduction of unit values. These ratios do not include any expenses assessed through the redemption of units. Investment options that include a parenthetical notation indicate the effective date of that investment option in the variable account. The total return is calculated for each period indicated or from the effective date through the end of the reporting period. (Continued) 76
485BPOS161st Page of 168TOC1stPreviousNextBottomJust 161st
METLIFE INVESTORS USA SEPARATE ACCOUNT A FINANCIAL HIGHLIGHTS [Enlarge/Download Table] As of December 31, 2001 ----------------------------------------- Unit Fair Value* Net Assets Units (lowest to highest) (000) ---------- ------------------- ---------- Accumulation units, continued: Oppenheimer Money Fund 164,326 $5.43 $ 892 Oppenheimer Main Street Small Cap Growth Fund 26,017 6.15 160 Oppenheimer Strategic Bond Fund 60,360 5.37 324 Fidelity Asset Manager Portfolio 21,022,339 8.94 to 9.06 189,787 Fidelity Growth Portfolio 25,015,822 12.91 to 13.12 327,268 Fidelity Contrafund Fund 19,181,427 6.39 to 11.59 219,635 Fidelity Overseas Portfolio 2,228,327 6.34 to 7.35 15,199 Fidelity Equity-Income Portfolio 3,242,873 10.13 32,860 Fidelity Index 500 Portfolio 19,727,766 13.03 to 13.12 257,801 Fidelity Money Market Portfolio 5,072,413 6.76 to 7.02 34,519 Scudder I International Portfolio 2,560,863 6.68 to 6.69 17,139 (f) MetLife Davis Venture Value Fund E 2,649,034 10.11 to 10.16 26,848 (f) MetLife Harris Oakmark Focused Value Fund B 1,863,945 11.89 to 11.96 22,223 MetLife Putnam International Stock Portfolio 94,368 3.48 329 MetLife Janus Mid Cap Portfolio 501,084 2.07 1,036 MetLife Russell 2000 Index Portfolio 89,476 4.56 408 MetLife Met/Putnam Voyager Portfolio A 190,680 2.42 461 MetLife Loomis Sayles High Yield Bond 17,973 4.66 84 (f) MetLife Stock Index B 166,446 10.83 to 10.85 1,805 Van Kampen Emerging Growth Fund 174,665 4.82 842 Van Kampen Enterprise Fund 68,149 3.91 267 Van Kampen Strategic Stock Fund 60,282 4.73 285 Federated American Leaders II 249,732 4.65 1,162 Federated High Income Bond Fund II 60,212 4.51 271 Federated Growth Strategic Fund II 55,308 4.25 235 Federated Equity Income Fund II 116,932 4.19 490 Neuberger Genesis Trust 478,656 6.93 3,318 Neuberger Partners 295,027 5.36 1,583 Alger Small Capitalization Fund 9,374,497 5.95 to 5.96 55,888 T Rowe Price Growth Fund 656,181 62.61 41,080 T Rowe Price International Fund 664,996 8.51 5,658 T Rowe Price Prime Reserve Fund 91,744 16.44 1,508 Janus Aspen Worldwide Growth 1,246,925 6.68 8,326 [Enlarge/Download Table] For the Year ended December 31, 2001 --------------------------------------------------- Investment Expense Total Income Ratio*** Return**** Ratio** (lowest to highest) (lowest to highest) ---------- ------------------- -------------------- Accumulation units, continued: Oppenheimer Money Fund 3.88% 1.40% 2.42% Oppenheimer Main Street Small Cap Growth Fund 0.00% 1.40% 2.07% Oppenheimer Strategic Bond Fund 2.21% 1.40% 3.49% Fidelity Asset Manager Portfolio 4.32% 0.89% to 1.40% (6.25%) to (4.95%) Fidelity Growth Portfolio 0.08% 0.89% to 1.40% (18.67%) to (15.40%) Fidelity Contrafund Fund 0.78% 0.89% to 1.40% (15.42%) to (7.08%) Fidelity Overseas Portfolio 5.65% 1.15% to 1.40% (22.53%) to (21.26%) Fidelity Equity-Income Portfolio 5.65% 1.40% (0.96%) Fidelity Index 500 Portfolio 1.19% 0.89% to 1.40% (13.79%) to (11.98%) Fidelity Money Market Portfolio 4.05% 0.89% to 1.40% 2.59% to 7.92% Scudder I International Portfolio 0.41% 1.35% to 1.40% (8.07%) to (3.38%) (f) MetLife Davis Venture Value Fund E 0.00% 1.30% to 2.25% (13.19%) to (12.36%) (f) MetLife Harris Oakmark Focused Value Fund B 0.00% 1.30% to 2.25% 24.59% to 25.79% MetLife Putnam International Stock Portfolio 0.28% 1.40% (21.72%) MetLife Janus Mid Cap Portfolio 0.00% 1.40% (38.21%) MetLife Russell 2000 Index Portfolio 0.26% 1.40% (0.55%) MetLife Met/Putnam Voyager Portfolio A 0.00% 1.40% (31.81%) MetLife Loomis Sayles High Yield Bond 13.15% 1.40% (2.68%) (f) MetLife Stock Index B 0.00% 1.30% to 2.25% (15.49%) to (14.68%) Van Kampen Emerging Growth Fund 0.00% 1.40% 7.33% Van Kampen Enterprise Fund 0.18% 1.40% (7.70%) Van Kampen Strategic Stock Fund 0.00% 1.40% (10.30%) Federated American Leaders II 1.29% 1.40% (6.74%) Federated High Income Bond Fund II 11.35% 1.40% (0.75%) Federated Growth Strategic Fund II 1.75% 1.40% (20.15%) Federated Equity Income Fund II 1.76% 1.40% (11.74%) Neuberger Genesis Trust 0.00% 0.89% 1.24% Neuberger Partners 0.19% 0.89% (2.45%) Alger Small Capitalization Fund 0.05% 1.35% to 1.40% (23.58%) to (23.56%) T Rowe Price Growth Fund 0.19% 0.89% (2.53%) T Rowe Price International Fund 1.55% 0.89% (22.60%) T Rowe Price Prime Reserve Fund 3.83% 0.89% 3.02% Janus Aspen Worldwide Growth 0.48% 0.89% (23.37%) (f) For the period from March 21, 2001 to December 31, 2001. * Unit fair value amounts are presented as a range of minimum to maximum values, with the lowest value representing the lowest unit fair value of all products offered and the highest unit fair value representing the highest unit fair value of all products offered. ** These amounts represent the dividends, excluding distributions of capital gains, received by the Separate Account sub-accounts from the underlying mutual funds, net of management fees assessed by the fund managers, divided by the average net assets. These ratios exclude those expenses, such as mortality and expense charges, that result in direct reductions in the unit values. The recognition of investment income by the Separate Account sub-accounts is affected by the timing of the declaration of dividends by the underlying funds in which the Separate Account sub-accounts invest. For periods in which a sub-account commenced operations, the investment income ratio is not annualized. *** These ratios represent the annualized contract expenses of the Separate Account sub-accounts, consisting of mortality and expense charges and administrative expenses, for each period indicated. The ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to contract owner accounts through the redemption of units and expenses of the underlying fund have been excluded. **** These amounts represent the total return for the periods indicated, including changes in the value of the underlying funds, and reflect expenses assessed through the reduction of unit values. These ratios do not include any expenses assessed through the redemption of units. Investment options that include a parenthetical notation indicate the effective date of that investment option in the variable account. The total return is calculated for each period indicated or from the effective date through the end of the reporting period. 77
485BPOS162nd Page of 168TOC1stPreviousNextBottomJust 162nd
Part C OTHER INFORMATION ITEM 24. FINANCIAL STATEMENTS AND EXHIBITS a. Financial Statements --------------------------------------------------------------- The following financial statements of the Separate Account are included in Part B hereof: 1. Reports of Independent Auditors. 2. Statement of Assets and Liabilities as of December 31, 2003. 3. Statement of Operations for the year ended December 31, 2003. 4. Statements of Changes in Net Assets for the years ended December 31, 2003 and 2002. 5. Notes to Financial Statements - December 31, 2003 and 2002. The following consolidated financial statements of the Company are included in Part B hereof: 1. Reports of Independent Auditors. 2. Balance Sheets as of December 31, 2003 and 2002. 3. Statements of Income for the years ended December 31, 2003, 2002 and 2001. 4. Statements of Shareholder's Equity for the years ended December 31, 2003, 2002 and 2001. 5. Statements of Cash Flows for the years ended December 31, 2003, 2002 and 2001. 6. Notes to Financial Statements - December 31, 2003, 2002 and 2001. b. Exhibits --------------------------------------------------------------- 1. Resolution of Board of Directors of the Company authorizing the establishment of the Separate Account (1) 2. Not Applicable 3. Form of Principal Underwriter's Agreement (2) 4. (a)(i) Form of 226 RI Contract (1) (ii) Form of 226 RI Certificate and Riders (1) 5. (i) Form of Group Variable Annuity Application (1) (ii) Form of Certificate Variable Annuity Application (1) 6. (i) Copy of Articles of Incorporation of the Company (1) (ii) Copy of the Bylaws of the Company (1) 7. Not applicable 8. (i) Form of Fund Participation Agreement among Metropolitan Series Fund, Inc., Metropolitan Life Insurance Company and Security First Life Insurance Company (now called MetLife Investors USA Insurance Company (3) (ii) Form of Participation Agreement between MetLife Investors USA Insurance Company and Met Investors Series Trust (4) 9. Opinion and Consent of Counsel 10. Consent of Independent Auditors 11. Not Applicable 12. Not Applicable 13. Company Organizational Chart 14. Powers of Attorney for Michael K. Farrell, James P. Bossert, Susan A. Buffum, Michael R. Fanning, Hugh C. McHaffie, Richard C. Pearson, Elizabeth M. Forget, Jeffrey A. Tupper and George Foulke (5) (1) All previously filed Exhibits to MetLife Investors USA Separate Account A registration statement and all post-effective amendments thereto are specifically incorporated herein by reference. (2) incorporated herein by reference to Registrant's Pre-Effective Amendment No. 2 to Form N-4 (File Nos. 333-54464 and 8911-03365) filed electronically on March 21, 2001 (3) incorporated by reference Post-Effective Amendment No. 1 to Form N-4 (File Nos. 333-54464 and 811-03365) filed electronically April 13, 2001. (4) incorporated by reference Post-Effective Amendment No. 4 to Form N-4 (File Nos. 333- 54464 and 811-03365) filed electronically April 30, 2003. (5) incorporated herein by reference to Registrant's Post-Effective Amendment No. 5 to Form N-4 (File Nos.333-54464 and 811-05200) filed electronically on April 27, 2004.
485BPOS163rd Page of 168TOC1stPreviousNextBottomJust 163rd
ITEM 25. DIRECTORS AND OFFICERS OF THE DEPOSITOR The following are the Officers and Directors who are engaged directly or indirectly in activities relating to the Registrant or the variable annuity contracts offered by the Registrant and the executive officers of the Company: Name and Principal Positions and Offices Business Address with Depositor ---------------------- ---------------------- Michael K. Farrell Chairman of the Board, President, 22 Corporate Plaza Drive Chief Executive Officer and Director Newport Beach, CA 92660 Susan A. Buffum Director 334 Madison Avenue Convent Station, NJ 07961 James P. Bossert Executive Vice President, Chief 22 Corporate Plaza Drive Financial Officer and Director Newport Beach, CA 92660 Michael R. Fanning Director 501 Boylston Street Boston, MA 02116 Elizabeth M. Forget Director One Madison Avenue New York, NY 10010 George Foulke Director 501 Route 22 Bridgewater, NJ 08807 Hugh C. McHaffie Executive Vice President Director 501 Boylston Street Boston, MA 02116 Richard C. Pearson Senior Vice President, General 22 Corporate Plaza Drive Counsel, Secretary and Director Newport Beach, CA 92660 Jeffrey A. Tupper Assistant Vice President and 22 Corporate Plaza Drive Director Newport Beach, CA 92660 Helayne F. Klier Executive Vice President One Madison Avenue New York, NY 10010 Kevin J. Paulson Senior Vice President 4700 Westown Parkway West Des Moines, IA 50266 Johanna B. Becker Vice President 501 Boylston Street Boston, MA 02116 Christopher A. Kremer Vice President 501 Boylston Street Boston, MA 02116 Marian J. Zeldin Vice President 501 Route 22 Bridgewater, NJ 08807 Karen A. Johnson Vice President 501 Boylston Street Boston, MA 02116 Debora L. Buffington Vice President 22 Corporate Plaza Drive Newport Beach, CA 92660
485BPOS164th Page of 168TOC1stPreviousNextBottomJust 164th
Betty Davis Vice President 1125 - 17th Street Denver, CO 80202 Louis M. Weisz Vice President, Appointed Actuary 501 Boylston Street Boston, MA 02116 Anthony J. Williamson Treasurer One Madison Avenue New York, NY 10001 ITEM 26. PERSONS CONTROLLED BY OR UNDER COMMON CONTROL WITH DEPOSITOR OF REGISTRANT The Registrant is a Separate Account of MetLife Investors USA Insurance Company ("depositor"). For a complete listing and diagram of all persons directly or indirectly controlled by or under common control with the depositor, see Exhibit 13. ITEM 27. NUMBER OF CONTRACT OWNERS As of February 27, 2004, there were 54,756 qualified contact owners and 58 non-qualified contract owners. ITEM 28. Indemnification None ITEM 29. PRINCIPAL UNDERWRITERS (a) MetLife Investors Distribution Company is the principal underwriter for the following investment companies (other than Registrant): Met Investors Series Trust MetLife Investors Variable Annuity Account One MetLife Investors Variable Annuity Account Five MetLife Investors Variable Life Account One MetLife Investors Variable Life Account Five First MetLife Investors Variable Annuity Account One (b) MetLife Investors Distribution Company is the principal underwriter for the Contracts. The following persons are the officers and directors of MetLife Investors Distribution Company. The principal business address for each officer and director of MetLife Investors Distribution Company is 22 Corporate Plaza Drive, Newport Beach, CA 92660. NAME AND PRINCIPAL POSITIONS AND OFFICES BUSINESS ADDRESS WITH UNDERWRITER ---------------- ---------------- Richard C. Pearson President and Director 22 Corporate Plaza Drive Newport Beach, CA 92660 Elizabeth M. Forget Executive Vice President and Director One Madison Avenue New York, NY 10010 Edward Wilson Executive Vice President and Director 22 Corporate Plaza Drive Newport Beach, CA 92660 James P. Bossert Director 22 Corporate Plaza Drive Newport Beach, CA 92660 Michael K. Farrell Director 22 Corporate Plaza Drive Newport Beach, CA 92660 Lisa S. Kuklinski Director 600 Plaza II Jersey City, NY 07311
485BPOS165th Page of 168TOC1stPreviousNextBottomJust 165th
Helayne F. Klier Executive Vice President One Madison Avenue New York, NY 10010 Paul Hipworth Executive Vice President, Chief 22 Corporate Plaza Drive Financial Officer Newport Beach, CA 92660 Paul A. LaPiana Executive Vice President 22 Corporate Plaza Drive Newport Beach, CA 92660 Leslie Sutherland Executive Vice President 22 Corporate Plaza Drive Newport Beach, CA 92660 Charles M. Deuth Vice President and Director 22 Corporate Plaza Drive Newport Beach, CA 92660 Debora L. Buffington Vice President, Director of Compliance 22 Corporate Plaza Drive Newport Beach, CA 92660 James R. Fitzpatrick Vice President 22 Corporate Plaza Drive Newport Beach, CA 92660 Paul M. Kos Vice President 22 Corporate Plaza Drive Newport Beach, CA 92660 Deron J. Richens Vice President 22 Corporate Plaza Drive Newport Beach, CA 92660 Paul A. Smith Vice President 22 Corporate Plaza Drive Newport Beach, CA 92660 Cathy Sturdivant Vice President 22 Corporate Plaza Drive Newport Beach, CA 92660 Paulina Vakouros Vice President 22 Corporate Plaza Drive Newport Beach, CA 92660 Jonnie L. Crawford Secretary 22 Corporate Plaza Drive Newport Beach, CA 92660 Anthony J. Williamson Treasurer One Madison Avenue New York, NY 10010 (c) Compensation From the Registrant. The following commissions and other compensation were received by the Distributor, directly or indirectly, from the Registrant during the Registrant's last fiscal year: (1) (2) (3) (4) (5) Name of Net Underwriting Principal Discounts and Compensation Brokerage Other Underwriter Commissions on Redemption Commissions Compensation MetLife Investors $169,179,314 None N/A N/A Distribution Company
485BPOS166th Page of 168TOC1stPreviousNextBottomJust 166th
ITEM 30. LOCATION OF ACCOUNTS AND RECORDS MetLife Investors Distribution Company, underwriter for the registrant, is located at 22 Corporate Plaza Drive, Newport Beach, California 92660. It maintains those accounts and records required to be maintained by it pursuant to Section 31(a) of the Investment Company Act of 1940 and the rules promulgated thereunder. MetLife Investors USA Insurance Company, the depositor for the registrant, is located at 22 Corporate Plaza Drive, Newport Beach, California 92660. It maintains those accounts and records required to be maintained by it pursuant to Section 31(a) of the Investment Company Act of 1940 and the rules promulgated thereunder and as custodian for the Registrant. MetLife Investors Group, Inc. is located at 22 Corporate Drive, Newport Beach, California 92660. It performs substantially all of the recordkeeping and administrative services in connection with the Registrant. ITEM 31. MANAGEMENT SERVICES Not applicable. ITEM 32. UNDERTAKINGS Registrant makes the following undertaking: MetLife Investors USA represents that the fees and charges deducted under the Contracts described herein this registration statement are, in the aggregate, reasonable in relation to the services rendered, the expenses expected to be incurred and the risks assumed by MetLife Investors.
485BPOS167th Page of 168TOC1stPreviousNextBottomJust 167th
SIGNATURES As required by the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant certifies that it meets the requirements of Securities Act Rule 485(b) for effectiveness of this Registration Statement and has caused this Registration Statement to be signed on its behalf, in the City of Newport Beach, and State of California on this 29th day of April, 2004. METLIFE INVESTORS USA SEPARATE ACCOUNT A (Registrant) By: METLIFE INVESTORS USA INSURANCE COMPANY By: /s/ MICHAEL K. FARRELL ----------------------------------------- METLIFE INVESTORS USA INSURANCE COMPANY Depositor By: /s/ MICHAEL K. FARRELL ----------------------------------------- As required by the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated. [Download Table] /s/ MICHAEL K. FARRELL Chief Executive Officer, President 4-29-04 ----------------------------- and Director -------- Michael K. Farrell Date /s/ JAMES P. BOSSERT Executive Vice President and Chief Financial 4-29-04 --------------------------- Officer (Principal Accounting Officer) and -------- James P. Bossert Director Date /s/ SUSAN A. BUFFUM* Director 4-29-04 ---------------------------- -------- Susan A. Buffum Date /s/ MICHAEL R. FANNING* Director 4-29-04 ---------------------------- -------- Michael R. Fanning Date /s/ ELIZABETH M. FORGET* Director 4-29-04 ---------------------------- -------- Elizabeth M. Forget /s/ GEORGE FOULKE* Director 4-29-04 ---------------------------- -------- George Foulke Date /s/ HUGH C. MCHAFFIE* Director 4-29-04 ---------------------------- -------- Hugh C. McHaffie Date /s/ RICHARD C. PEARSON Director 4-29-04 ---------------------------- -------- Richard C. Pearson Date /s/ JEFFREY A. TUPPER Director 4-29-04 ---------------------------- -------- Jeffrey A. Tupper Date *By: /s/ RICHARD C. PEARSON --------------------------------------- Richard C. Pearson, Attorney-in-fact
485BPOSLast Page of 168TOC1stPreviousNextBottomJust 168th
INDEX TO EXHIBITS EX-99.B9 Opinion and Consent of Counsel EX-99.B10 Consent of Independent Auditors EX-99.B13 Company Organizational Chart

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘485BPOS’ Filing    Date First  Last      Other Filings
4/30/051216
12/31/047524F-2NT,  N-30D,  NSAR-U
Effective on:5/1/04145485BPOS
Filed on:4/30/04485BPOS
4/27/04162485BPOS
4/15/0485
4/12/0452
3/31/0465
2/27/04164
1/1/0464
12/31/031216224F-2NT,  N-30D,  NSAR-U
12/15/0364
10/1/0364
7/1/0364
6/30/0364
5/1/0393157485BPOS
4/30/03162485BPOS
2/1/036465
1/1/0365
12/31/021816224F-2NT,  NSAR-U
5/1/02118159
4/29/02122
4/26/02116158
1/1/0265142
12/31/015416224F-2NT,  NSAR-U
10/15/01160
10/9/01160
4/13/01162485BPOS
4/1/016677
3/21/01160162N-4/A
3/19/01160
2/21/01160
2/12/011847
1/1/016681
12/31/00505524F-2NT,  NSAR-U
 List all Filings 
Top
Filing Submission 0001019687-04-000941   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., Apr. 24, 3:48:32.4am ET